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 Non-coding RNAs (ncRNAs) are important regulators of gene 
expression in many cellular processes. Long non-coding RNAs (lncRNAs) are 
arbitrarily defined as transcripts larger than 200 bases with no obvious 
protein-coding potential. Genome-wide transcriptome studies identified 
thousands of lncRNAs in multiple organisms including C. elegans, Drosophila, 
mice and humans, but the biological functions of less than 200 are well-
characterised. Therefore, there is a need to determine the function of the 
remaining lncRNAs and address whether these are biologically relevant or 
these are merely transcriptional noise. 
 Using C. elegans, we investigated the function of a predicted ncRNA 
gene cluster associated with a protein-coding gene, bed-3, which encodes a 
transcription factor that regulates larval moults and vulval cell division. The 
ncRNA cluster contains 18 predicted ncRNA genes, of which most are 
intergenic between bed-3 and best-13 (the next upstream protein-coding 
gene). Each predicted ncRNA gene is 100 to 400 bases long.  
 We found that the sequence intergenic between bed-3 and best-13 is 
conserved in Caenorhabditis species, suggesting that predicted ncRNA 
genes are functional. Our initial analysis focused on F25H8.16, F25H8.21 and 
F25H8.13. We confirmed the presence of RNA transcripts for these three 
genes. Using promoter::GFP reporters, we found that these ncRNA genes 
have tissue-specific expression. For example, F25H8.16p::gfp is expressed in 
vulval muscles, which is required for egg-laying.  
 To determine the function of ncRNA genes, we disrupted the ncRNA 
genes and assayed for phenotypes. Deletions that removed eight to 14 
predicted ncRNA genes caused the egg-laying defective (Egl) and male 
	 ix 
abnormality (Mab) phenotypes. The Egl phenotype resulted from defects in 
vulval muscles and the generation of sex myoblast (SM) cells (precursors of 
vulval muscles). Interestingly, these defects are also found in bed-3 mutants. 
Genetic complementation tests and rescue experiments suggested that the 
deletion reduced bed-3 expression in cis. Fluorescence in situ hybridisation 
confirmed that bed-3 expression was reduced specifically in SM cells of 
deletion mutants. Overexpression of bed-3 in SM cells partially rescued the 
Egl phenotype. Therefore, the deleted region positively regulates bed-3 
expression.  
 Because the deletions removed large sections of the genome (7.5 Kb 
to 11.5 Kb), unidentified enhancers of bed-3 could have been removed in 
addition to predicted ncRNA genes. Thus, the element regulating bed-3 
expression could be functional ncRNAs or enhancers. The ncRNAs may also 
function as enhancer-associated RNAs (eRNAs) that are transcribed from 
enhancers and regulate the expression of nearby genes. We found that RNAi-
mediated disruption of F25H8.16, F25H8.21 and F25H8.13 resulted in a low 
frequency of the Egl phenotype, suggesting that these ncRNA products do 
regulate bed-3. Enhancer assays on sub-fragments of the deleted region 
indicated that the ncRNA gene cluster contains enhancer activity in multiple 
tissues including SM cells.   
Together, these results suggest that ncRNAs associated with bed-3 
are required for the development of the egg-laying system in C. elegans. In 
particular, ncRNAs appear to function as a part of enhancer-like elements that 
drive tissue-specific expression of bed-3 in a RNA-dependent manner. 
  
	 x 
List of Tables 
Table 1. Strains used in this study. ................................................................ 19 
Table 2. Oligonucleotides used in this study. ................................................ 26 
Table 3. Plasmids generated in this study. .................................................... 28 
Table 4. Details of microinjections done in this study. ................................... 30 
Table 5. Use of PCR to confirm the presence of deletion. ............................. 34 
Table 6. List of TMR-conjugated smFISH probes targeted against bed-3. .... 42 
Table 7. Sequence similarity of predicted ncRNA genes based on ClustalW 
alignment of C. elegans, C. briggsae, C. remanei and C. brenneri. .............. 47 
Table 8. Probability scores of predicted ncRNA genes near bed-3. .............. 49 
Table 9. Promoter::GFP reporters of ncRNA genes are expressed in distinct 
cell types. ....................................................................................................... 51 
Table 10. Normalisation of the egg-laying response to wild type. ................. 66 
Table 11. Summary of egg-laying related defects in deletion mutants. ......... 89 
Table 12. Summary of the Mab phenotype in deletion mutants. ................... 91 
Table 13. DNA fragments used for RNAi against small clusters of ncRNAs…
 ....................................................................................................................... 94 




List of Figures  
Figure 1. Genomic locations of lncRNA genes relative to protein-coding 
genes. .............................................................................................................. 4 
Figure 2. Long ncRNAs can regulate expression of target genes in cis or 
trans. ................................................................................................................ 6 
Figure 3. Proposed mechanisms of transcriptional regulation by lncRNAs. . 11 
Figure 4. Expression pattern of bed-3::gfp in wild type L4 animals. .............. 14 
Figure 5. Schematic diagram of the egg-laying system (lateral view). .......... 15 
Figure 6. Genomic location of a predicted ncRNA gene cluster near bed-3. 17 
Figure 7. Overview of Mos1-mediated deletion. ............................................ 35 
Figure 8. Location of conserved regions in the predicted ncRNA gene cluster 
upstream of bed-3. ......................................................................................... 47 
Figure 9. ncRNA transcripts were detected for candidate ncRNA genes, 
F25H8.16, F25H8.13 and F25H8.21. ............................................................. 50 
Figure 10. Promoter::GFP fusions of F25H8.16, F25H8.21 and F25H8.13 
exhibit tissue-specific expression. .................................................................. 53 
Figure 11. Genomic regions removed in deletion mutants. ........................... 56 
Figure 12. Deletion mutants have no obvious defects in chemosensation. .. 58 
Figure 13. Deletion mutants and bed-3 mutants exhibit the egg-laying 
defective (Egl) phenotype. ............................................................................. 59 
Figure 14. Deletion mutants and bed-3 mutants exhibit the male abnormality 
(Mab) phenotype. ........................................................................................... 61 
Figure 15. Deletion mutants may have a weak defect in vulval cell division…
 ....................................................................................................................... 62 
Figure 16. Egg-laying response of deletion mutants and bed-3 mutants to 
serotonin and imipramine. .............................................................................. 65 
Figure 17. Deletion mutants and bed-3 mutants have defects in vulval 
muscles. ......................................................................................................... 68 
Figure 18. Mesodermal (M) lineage. ............................................................. 70 
Figure 19. Deletion mutants and bed-3 mutants have reduced number of sex 
myoblast (SM) cells. ....................................................................................... 71 
	 xii 
Figure 20. Deletion mutants and bed-3 mutants may have defects in the 
generation of sex myoblast (SM) cells. .......................................................... 73 
Figure 21. The transgene containing 14 ncRNA genes did not rescue the Egl 
phenotype of D4 mutants. .............................................................................. 76 
Figure 22. The deletion failed to complement bed-3. .................................... 78 
Figure 23. The deletion did not significantly affect the total bed-3 mRNA level.
 ....................................................................................................................... 80 
Figure 24. The deletion did not affect bed-3 expression in the vulva. ........... 82 
Figure 25. bed-3 is expressed in the M lineage. ........................................... 84 
Figure 26. Deletion mutants have reduced bed-3 expression in SM cells. ... 85 
Figure 27. Overexpression of bed-3 in the M lineage reduced the frequency 
of the Egl phenotype in D4 mutant. ................................................................ 86 
Figure 28. Overexpression of ncRNA gene(s) may lead to the rod-like larval 
lethality phenotype. ........................................................................................ 98 
Figure 29. The excretory system. .................................................................. 99 
Figure 30. Location of F25H8.21 promoter and F25H8.19 promoter.. ........ 100 
Figure 31. The ncRNA gene cluster near bed-3 contains enhancer activity.
 ..................................................................................................................... 106 
Figure 32. Proposed models on how the upstream region regulates bed-3..
 ..................................................................................................................... 111 
Figure 33. Putative BLMP-1 binding sites in the predicted ncRNA gene 
cluster associated with bed-3. ...................................................................... 114 
 
	 1 
Chapter 1: Introduction 	
1.1 Non-coding RNAs (ncRNAs) 
 The eukaryotic genome is made up of protein-coding genes and non-
coding genetic elements. The size of the human genome is approximately 30-
fold larger than the 100 Mb C. elegans genome (C. elegans Sequencing 
Consortium, 1998; International Human Genome Sequencing Consortium, 
2004), yet the number of protein-coding genes (~20,000) is similar between 
the two organisms. Thus as the size of the genome increases from worms to 
humans, the proportion of non-coding genetic elements also increases, 
perhaps accounting for the increasing developmental complexity of 
multicellular organisms (Huttenhofer et al., 2005; Mattick, 2009; Taft and 
Mattick, 2003; Taft et al., 2007; Wilusz et al., 2009).  
The non-coding genetic elements refer to genomic regions that are 
transcribed but not translated. These include 5’ and 3’ untranslated regions 
(UTRs) of protein-coding genes, introns, intergenic regions, non-coding RNA 
(ncRNA) genes, pseudogenes and repetitive DNA sequences. Over the past 
decade, genome-wide transcriptome analyses using RNA-seq and tiling 
arrays revealed that the eukaryotic genome is extensively transcribed (Birney 
et al., 2007; Dinger et al., 2009; He et al., 2007; Kapranov et al., 2007; 
Okazaki et al., 2002). In particular, protein-coding genes are not the only 
class of genes transcribed; non-coding genetic elements are also actively 
transcribed. In fact, a large fraction of the transcribed genome produces 
ncRNAs (Bertone et al., 2004; Birney et al., 2007; Brown et al., 2014; Dinger 
et al., 2009; Gerstein et al., 2010; Okazaki et al., 2002). In addition, some 
studies estimated that the number of ncRNA genes might be comparable to 
protein-coding genes (ENCODE Consortium, 2012; Spieth et al., 2014). The 
	 2 
prevalence of ncRNAs challenges the conventional view that revolves around 
protein-coding genes as central players of cellular biology. Instead, ncRNAs 
may play an equally important role in governing cellular and biological 
processes. 
ncRNAs represent a class of RNA transcripts which are not translated 
into proteins. Despite lacking protein-coding potential, there is clear evidence 
that ncRNAs are functional; they often modulate the expression of protein-
coding genes, adding a layer of complexity into gene regulation. They can be 
subdivided into various classes including transfer RNAs (tRNAs), ribosomal 
RNAs (rRNAs), small ncRNAs and long ncRNAs (lncRNAs). Small ncRNAs 
(typically defined as smaller than 200 bases) include microRNAs (miRNAs), 
small interfering RNAs (siRNAs), piwi-interacting RNAs (piRNAs) and small 
nuclear RNAs (snRNAs). These small ncRNAs usually regulate the 
expression of protein-coding genes at the post-transcriptional level (Mattick 
and Makunin, 2006). For example, miRNAs silence gene expression through 
translational repression or mRNA degradation and snRNAs control splicing of 
pre-mRNAs. In C. elegans, mutations in miRNAs lin-4 and let-7 affect 
developmental timing (Ambros and Horvitz, 1984; Lee et al., 1993; Reinhart 
et al., 2000), indicating that small ncRNAs are critical for the development of 
an organism. Furthermore, dysregulation of ncRNAs is associated with the 
development of cancers and diseases (Taft et al., 2010; Wapinski and Chang, 
2011), highlighting the functional significance of small ncRNAs.  
To date, tRNAs, rRNAs and small ncRNAs have received much 
attention and are well-studied. In contrast, lncRNAs (typically defined as 
larger than 200 bases) are relatively overlooked and the biological functions 
are not well-understood. 
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1.2 Long ncRNAs (lncRNAs) 
In the early 2000s, the genomes of various organisms were 
completely sequenced. Since then, numerous collaborative efforts were made 
to identify and annotate functional elements of the genome. In particular, 
FANTOM, ENCODE and modENCODE consortiums investigated the 
genomes of human, mouse, Drosophila and C. elegans. In these organisms, 
they identified novel ncRNA transcripts, transcription start sites, transcription 
factor binding sites, chromatin structure, histone modification patterns and 
regulatory regions, providing a comprehensive annotation of the genome 
(Birney et al., 2007; Cabili et al., 2011; Carninci et al., 2005; Derrien et al., 
2012; Gerstein et al., 2010; Guttman et al., 2009; Lu et al., 2011; Maeda et 
al., 2006; Okazaki et al., 2002; Roy et al., 2010; Young et al., 2012).  
The discovery of novel ncRNA transcripts was based on expression 
profiles obtained from large-scale RNA-seq, tiling arrays or chromatin 
signatures coupled with computational predictions (Rinn and Chang, 2012). 
Of the novel ncRNA transcripts identified, thousands of them were long 
ncRNAs (lncRNAs). Since this discovery, lncRNAs started to gain more 
attention because of the need to address whether these lncRNAs are 
biologically functional or these are merely transcriptional noise.   
lncRNAs is a heterogeneous group including any RNA transcripts 
larger than 200 bases that have no obvious protein-coding potential. The size 
of lncRNA ranges from 200 bases to 23 Kb (Derrien et al., 2012). They carry 
single or multiple exons, which may be spliced or polyadenylated (Mattick, 
2009; Taft et al., 2010; Wapinski and Chang, 2011; Yang et al., 2011). 
Compared to protein-coding genes, lncRNA genes are less evolutionarily 
conserved (Guttman et al., 2009; Ponjavic et al., 2007). Within the classes of 
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ncRNAs, tRNAs and rRNAs are most well-conserved, followed by miRNAs 
and snRNAs. lncRNAs appear to be the least conserved (Qu and Adelson, 
2012). Furthermore, lncRNA genes are often expressed in a spatially and 
temporally restricted manner (Cabili et al., 2011; Derrien et al., 2012). They 
are typically localised to the nucleus or cytoplasm (Derrien et al., 2012; 
Djebali et al., 2012; Ulitsky and Bartel, 2013) and the expression level is 
generally lower than mRNAs (Derrien et al., 2012; Djebali et al., 2012).  
Because the current state of knowledge on functions of lncRNAs is 
limited, functional classification is not possible. Instead, lncRNA genes are 
often categorised based on their genomic location relative to protein-coding 
genes (Figure 1). These include intergenic, intronic or antisense lncRNAs 
(overlaps protein-coding genes and transcribed in the opposite direction). 
lncRNAs can also be grouped according to association with cis-regulatory 
elements such as enhancer-associated RNAs (eRNAs) and promoter-
associated RNAs (paRNAs) (Figure 1).  
 
 
Figure 1. Genomic locations of lncRNA genes relative to protein-coding genes. 
lncRNA genes can contain single or multiple exons. They can be found in the 
intergenic region between two protein-coding genes (lincRNA; long intergenic ncRNA) 
or within an intron of a protein-coding gene. Antisense lncRNA genes overlap protein-
coding genes and are transcribed in the opposite direction. lncRNAs can also be 
transcribed from promoters and enhancers. 
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1.3 Long ncRNAs regulate gene expression 
 Gene expression is highly regulated to govern the production of 
functional RNAs and proteins that are crucial for cellular function. 
Transcription is a key control point in the regulation of gene expression. In 
eukaryotes, transcription is initiated by the binding of transcription factors to 
the promoter, which is located upstream and near the transcriptional start site 
of a target gene. This facilitates the recruitment of RNA polymerase to the 
promoter, leading to synthesis of RNA from the target gene. Additional 
regulatory elements such as enhancers and silencers can influence the 
transcriptional activity of target gene promoters. Enhancers are typically found 
on the same chromosome as the target promoter, upstream or downstream of 
the transcriptional start site of the target gene. Transcriptional activators and 
other protein complexes bind to enhancers and mediate the recruitment of 
transcription factors and RNA polymerase to the promoter, leading to 
activation of target gene transcription. Also, transcription is regulated by 
chromatin modifying complexes that facilitate or inhibit the recruitment of RNA 
polymerase.   
An increasing number of studies demonstrate that some lncRNAs 
regulate gene expression (Mercer et al., 2009; Ponting et al., 2009; Qu and 
Adelson, 2012). In mammals, lncRNAs function in diverse cellular processes 
including dosage compensation, imprinting, chromatin remodelling, 
subcellular compartmentalisation and trafficking (reviewed in (Moran et al., 
2012)).  
lncRNAs can regulate the expression of protein-coding genes in cis or 
trans (Figure 2). In cis-regulation, the effect of lncRNA is restricted to the 
region near the lncRNA gene locus. In other words, the lncRNA can only 
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regulate genes on the same chromosomal molecule. For instance, human 
and mouse Xist is a cis-acting lncRNA expressed exclusively from the 
inactive X chromosome and silences the expression of all genes on the same 
chromosome (but not the homologous X chromosome), leading to X 
chromosome inactivation (Lee, 2012; Nagano and Fraser, 2011; Qu and 
Adelson, 2012; Rinn and Chang, 2012). In contrast to cis-regulation, trans-
regulation allows the lncRNA to regulate genes on other chromosomes. An 
example is HOTAIR. Even though human HOTAIR is expressed from the 
HoxC locus of chromosome 12, it can repress gene transcription on the HoxD 
locus of chromosome 2 (Lee, 2012; Nagano and Fraser, 2011; Qu and 
Adelson, 2012; Rinn and Chang, 2012; Rinn et al., 2007). Besides repressing 
gene expression, some lncRNAs can also activate gene expression in cis or 
trans (see Section 1.4). In addition to protein-coding genes, there is evidence 
that lncRNAs can regulate the transcription of other ncRNAs. For example, 




Figure 2. Long ncRNAs can regulate expression of target genes in cis or trans. 
In cis-regulation, the lncRNA can only regulate genes near the lncRNA locus. In 
trans-regulation, the lncRNA can regulate genes on other chromosomes.  
 
Aside from transcriptional regulation, lncRNAs also regulate mRNA 
processing, which affects the expression of protein-coding genes. For 
example, MALAT1 regulates alternative splicing of pre-mRNAs by modulating 
the activity of splicing proteins (Tripathi et al., 2010). NEAT1 lncRNA 
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regulates nuclear export of mRNAs by promoting retention of mRNAs in 
nuclear paraspeckles, leading to translational repression (Chen and 
Carmichael, 2009).  
 
1.4 Enhancer-like lncRNAs and enhancer RNAs 
In mammals, some lncRNA genes are reported to act like enhancers, 
positively regulating the expression of neighbouring protein-coding genes 
(Orom and Shiekhattar, 2013; Wang et al., 2011). These lncRNAs appear to 
be spliced, polyadenylated, and unidirectionally transcribed from intergenic 
regions carrying high level of H3K4 trimethylation (H3K4me3) relative to 
H3K4 monomethylation (H3K4me1) and high level of H3K36 trimethylation 
(H3K36me3) (Lam et al., 2014). An example is HOTTIP, which is found on 
the 5’ end of the HoxA gene cluster. Looping of the chromosome brings the 
HOTTIP locus in close proximity with HoxA genes, where HOTTIP RNA 
interacts with WDR5-MLL chromatin modifying complex to activate 
transcription of HoxA genes (Wang et al., 2011). Another example is ncRNA-
a7 (Orom et al., 2010), which interacts with the Mediator (an activator protein 
complex) to establish or maintain chromosomal looping between the ncRNA-
a7 locus and promoters of protein-coding genes to facilitate transcriptional 
activation (Lai et al., 2013). 
Aside from lncRNAs with enhancer-like functions, Kim et al. (2010) 
reported that some genomic enhancer regions are actively transcribed to 
produce enhancer-associated ncRNAs (eRNAs) in response to enhancer 
activating stimulus. eRNAs are typically less than 2 Kb, derived from genomic 
enhancer regions bound by RNA polymerase II, CBP/P300 and marked with 
H3K27 acetylation and high level of H3K4me1 relative to H3K4me3 (Kim et 
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al., 2010; Lam et al., 2014; Melo et al., 2013; Rinn and Chang, 2012). eRNAs 
are divided into two classes; bidirectional non-polyadenylated eRNAs and 
unidirectional polyadenylated eRNAs (Darrow and Chadwick, 2013; De Santa 
et al., 2010; Kim et al., 2010; Lam et al., 2014). The polyadenylated eRNAs 
are derived from genomic enhancer sites marked with H3K36me3 (Koch et 
al., 2011). In contrast to enhancer-like lncRNAs, most reported eRNAs are 
unspliced and non-polyadenylated products of bidirectional transcription. 
Additionally, eRNAs are generally more unstable and expressed at a lower 
level than lncRNAs (Kim et al., 2015; Kim and Shiekhattar, 2015; Li et al., 
2016). 
The production of eRNAs is positively correlated to the expression of 
neighbouring protein-coding genes (Kim et al., 2010; Lai et al., 2015). 
Importantly, Li et al. (2013) showed that siRNA-mediated depletion of eRNA 
levels leads to decreased expression of adjacent genes, indicating that the 
eRNA contributes to the enhancer activity. The depletion of eRNA levels also 
reduces the interaction between enhancer and its target promoter, suggesting 
that eRNAs mediate long range interaction. The authors further established 
that eRNAs activate the expression of neighbouring genes by interacting with 
Cohesin (a ring-like protein complex that holds two genomic regions together) 
to stabilize the enhancer-promoter chromatin structure (Li et al., 2013b).   
Recently, it was shown that the Integrator complex, made up of at 
least 12 proteins, is required to generate eRNAs (Lai et al., 2015). The 
Integrator complex was first shown to interact directly with RNA polymerase II 
and mediate the 3’ end processing of snRNAs (Baillat et al., 2005). Similarly, 
the Integrator complex interacts with RNA polymerase II at enhancer sites 
and cleaves the 3’ end of primary eRNA transcript, leading to eRNA 
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transcription termination (Lai et al., 2015). 
Currently, the distinction between enhancer-like lncRNAs and eRNAs 
is largely based on properties of the transcript (i.e. status of splicing, 
polyadenylation, direction of transcription) and the genomic region where it is 
transcribed (i.e. presence of H3K36me3, H3K4me1/H3K4me3 ratio) (Lam et 
al., 2014; Li et al., 2016). Despite the differences, some enhancer-like 
lncRNAs may overlap with a subset of eRNAs, especially the unidirectional 
polyadenylated eRNAs (Lam et al., 2014; Li et al., 2016). Nonetheless, they 
both appear to activate the expression of neighbouring genes through a 
mechanism that involves chromatin looping.  
 
1.5 lncRNA modes of actions 
Most studies show that lncRNA genes affect the transcription of 
protein-coding genes. Specifically, this transcription regulation can be 
achieved through several proposed models (Figure 3) (Ponting et al., 2009; 
Rinn and Chang, 2012; Ulitsky and Bartel, 2013). As mentioned in the 
previous section (1.4), one possible model is that the lncRNA gene may act 
like enhancer to activate the expression of neighbouring protein-coding genes 
(Figure 3A). The nascent RNA transcript may remain at the locus and interact 
with protein complexes such as Mediator or Cohesin to promote interaction 
between the enhancer/lncRNA locus and the target promoter through 
chromatin looping (e.g. ncRNA-a7, eRNAs). Another possibility is that the 
lncRNA can act as a structural guide or scaffold to direct recruitment and 
assembly of proteins to the target site (Figure 3B). For instance, HOTAIR is 
recruited to the HoxD locus by binding to LSD1 (a repressive chromatin 
factor). HOTAIR also binds to PRC2 (another repressive chromatin factor), 
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thereby targeting PRC2 to the HoxD locus. Thus, HOTAIR acts as the 
scaffold for assembly of chromatin factors PRC2 and LSD1 on the HoxD 
locus to alter chromatin state and repress gene expression (Gupta et al., 
2010; Rinn et al., 2007; Tsai et al., 2010). Additionally, the lncRNA can act as 
a molecular decoy that interacts with specific RNAs or proteins to titrate them 
away from their target sites, indirectly regulating gene transcription (Figure 
3C). For instance, NRON lncRNA interacts with the transcription factor NFAT 
and regulates the translocation of NFAT between nucleus and cytoplasm, 
resulting in transcriptional repression of NFAT gene targets (Willingham et al., 
2005). Also, some lncRNAs such as H19 can bind to miRNAs and sequester 
them away from target mRNAs (Kallen et al., 2013). Importantly, these three 
models show that the lncRNA transcript itself interacts with DNA, RNA or 
proteins to affect gene expression. 
In contrast to these three models, another possibility is the lncRNA 
gene may be co-regulated with neighbouring protein-coding genes (Figure 
3D). The transcription of lncRNA may generate an open chromatin structure 
that facilitates the recruitment of general transcription factors and RNA 
polymerase to neighbouring genes. Alternatively, transcription elongation 
through the lncRNA gene may inhibit the expression of neighbouring protein-
coding gene especially when the promoter of protein-coding gene overlaps 
with the lncRNA locus (Osato et al., 2007; Ponting et al., 2009). In particular, 
these mechanisms demonstrate that in some cases, it is the act of 
transcription, not the lncRNA transcript that regulates gene expression. 
However, based on well-characterised examples, many lncRNAs exert their 





Figure 3. Proposed mechanisms of transcriptional regulation by lncRNAs. 
(A-C) The regulation of protein-coding gene expression is dependent on the RNA 
transcript. (A) The lncRNA acts like an enhancer. The RNA interacts with protein 
complexes such as Mediator to promote chromosomal looping and upregulate the 
expression of neighbouring genes. (B) The RNA acts as a guide or scaffold to direct 
the recruitment and assembly of transcription factors or chromatin modifying 
complexes to the target gene loci, thereby modulating the transcription of protein-
coding genes. (C) Top: the RNA interacts with transcription activator and sequesters 
it away from target genes, repressing gene transcription. Bottom: the RNA interacts 
with miRNAs and sequesters them away from their target mRNAs, indirectly affecting 
target expression. (D) The process of transcription at the lncRNA gene locus 
facilitates the transcription of downstream protein-coding gene. The regulation of 





The ability of lncRNA transcript to recruit proteins to a specific locus 
may represent a widely used mechanism. However, mechanisms underlying 
the recruitment of proteins to specific locus are not well established (Moran et 
al., 2012). One possibility is the lncRNA adopts a secondary structure that 
can interact with specific proteins. Alternatively, parts of the lncRNA 
sequence may be recognised by transcription factors. These proteins may be 
recruited to the nascent RNA transcript that may be attached to the 
chromatin, allowing the proteins to modulate the expression of genes that are 
spatially close to the lncRNA locus.  
 
1.6 Significance of lncRNAs 
Clearly, an increasing number of studies highlight the importance of 
lncRNAs in regulating gene expression and cellular processes (Moran et al., 
2012; Rinn and Chang, 2012). Furthermore, lncRNAs may play a crucial role 
in development, where the spatial and temporal expression of protein-coding 
genes is critical. The deregulation of some lncRNAs such as HOTAIR and 
ANRIL has been implicated in the development of cancers and diseases 
(Burd et al., 2010; Gupta et al., 2010; Rinn and Chang, 2012), indicating that 
lncRNAs can be potential biomarkers and therapeutic targets (Huarte, 2015).  
 Although thousands of lncRNA genes have been identified, less than 
200 have been well-characterised to date (http://www.lncrnadb.org/). The 
majority remains uncharacterised and their biological relevance is unclear. 
Therefore, there is a need to study lncRNA genes and determine their 
biological functions. Model organisms provide a useful platform for intensive 
investigation of specific lncRNAs, which will bridge the gap and advance our 
understanding on the functional significance of lncRNAs.   
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1.7 ncRNAs in C. elegans 
 To study lncRNA genes, we are using the nematode worm, C. 
elegans, because of its ease of genetic manipulation, a short life cycle and 
invariant cell lineage (Sulston and Horvitz, 1977). C. elegans has two 
genders, hermaphrodites and males. The life cycle occurs in three days and 
is divided into several stages: egg, larval stage one (L1), larval stage two 
(L2), larval stage three (L3), larval stage four (L4) and adult. Worms also offer 
a convenient in vivo system for perturbation of gene function in an intact 
animal, which is more challenging to achieve in the vertebrate system.  
Since the launch of the modENCODE project, few groups have 
identified large numbers of novel lncRNA genes in the C. elegans genome 
(Gerstein et al., 2010; Lu et al., 2011; Nam and Bartel, 2012). In particular, Lu 
et al. (2011) predicted >7,000 novel ncRNA genes, of which >1,000 are 
lncRNA genes (>200 nt). This prediction is based on an algorithm that 
integrates multiple features of ncRNAs including sequence conservation, 
secondary structure and expression data (RNA-seq and tiling array profiles 
from modENCODE). A probability score is assigned to each predicted ncRNA 
gene, with 1 corresponding to known ncRNA and 0 corresponding to other 
genomic elements such as protein-coding sequence, UTR or intergenic 
region. An independent cross-validation using a set of known ncRNA genes 
indicates that the algorithm is highly accurate in differentiating ncRNAs from 
other genomic elements. In addition, experimental validation of a random 
sample of predicted ncRNA candidates indicates that >90% are true positives.  
Notably, some predicted ncRNA genes are organised into large 
clusters. While individual ncRNA may have a mild modulatory effect on gene 
regulation, we speculate that a cluster of ncRNAs may function as a more 
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powerful gene regulatory unit and have a more pronounced effect on gene 
expression. Additionally, a cluster of ncRNAs may form a complex gene 
regulatory network that co-regulates a biological process. However, the 
current knowledge on the function of ncRNA gene clusters is limiting. 
 
1.8 bed-3 and the egg-laying system 	 Our lab has been working on bed-3, which encodes a BED-type zinc 
finger transcription factor. bed-3 activity is required for larval moulting, vulval 
development and egg-laying (Frand et al., 2005; Inoue and Sternberg, 2010). 
Consistent with its function, a bed-3::gfp reporter is expressed in hypodermal 
cells (equivalent of mammalian epidermal cells) and vulval cells (Figure 4) 
(Frand et al., 2005; Inoue and Sternberg, 2010). In hypodermal cells, bed-3 
activity is likely required to alter the expression of other genes important for 
moulting (Frand et al., 2005). In vulval cells, bed-3 activity is required for the 
terminal division of P5.p, P6.p and P7.p cells, likely through alteration of 
vulval cell type-specific gene expression pattern (Inoue and Sternberg, 2010).  
 
 
Figure 4. Expression pattern of bed-3::gfp in wild type L4 animals. 
Anterior is to the left and dorsal is to the top in all panels. The reporter contains the 
third intron of bed-3 fused to a 1.4 Kb upstream sequence of bed-3 in a GFP vector 
(Inoue and Sternberg, 2010).   
 
Although mutations in bed-3 cause defects in egg-laying (Inoue and 
Sternberg, 2010), the function of bed-3 in the egg-laying system is not well-
understood. The egg-laying system is composed of multiple tissues including 
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the vulva, vulval muscles, uterine muscles, hermaphrodite-specific motor 
neurons (HSNs) and ventral cord (VC) motor neurons (Figure 5) (Sulston and 
Horvitz, 1977; White et al., 1976). There are eight vulval muscles (four type 1 
and four type 2), eight uterine muscles (four type 1 and four type 2), two HSN 
neurons (HSNL and HSNR) and six VC neurons (VC1-VC6). Vulval muscles 
and uterine muscles are collectively termed as sex muscles. In the egg-laying 
process, HSNs and VC neurons release neurotransmitters such as serotonin 
and acetylcholine to activate the contraction of sex muscles to release the 
egg though the vulval opening (Schafer, 2005). In bed-3 mutants, Inoue and 
Sternberg (2010) reported that the vulval cell division defect may contribute in 
part to the egg-laying defect, but does not fully account for the high-
penetrance egg-laying defect observed in some mutants. 
 
 
Figure 5. Schematic diagram of the egg-laying system (lateral view).  
Adapted from Wormatlas (http://www.wormatlas.org/). Anterior is to the left and dorsal 
is to the top. The egg-laying system is made up of multiple tissues including 
hermaphrodite-specific neurons (HSN), VC neurons, vulval muscles (VM), uterine 
muscles (UM) and the vulva. Note: Only left (L) side of the animal is shown here; 
another identical set of vulval muscles, uterine muscles and HSN are present on the 
right side of the animal as well. VC1 and VC2 neurons are present to the anterior of 




1.9 ncRNA gene cluster associated with bed-3   
Recently, it was shown that bed-3 expression is regulated by blmp-
1/PRDM1 transcription factor through an enhancer element found in the third 
intron of bed-3 (Yang et al., 2015). Additionally, bed-3 is located near a 
predicted cluster of ncRNA genes that can potentially regulate bed-3 
expression (Figure 6). The cluster contains a total of 18 predicted ncRNA 
genes within a stretch of 13 Kb sequence. The presence of such a high 
concentration of ncRNA genes within a short stretch of sequence is 
uncommon and beyond random distribution (T. Inoue, pers. comm.), perhaps 
indicating that clustering is important. 16 ncRNA genes are located upstream 
of bed-3, within the intergenic region between bed-3 and best-13 (the next 
upstream protein-coding gene), while two are situated in introns of bed-3. 
Each ncRNA gene is 100 to 400 bases long. None of the 18 ncRNA genes 
belongs to well-known classes of ncRNAs such as tRNAs.  
In addition to genome-wide identification of ncRNAs, Chen et al. 
(2013) predicted thousands of transcribed enhancers in C. elegans. This 
prediction is based on chromatin signatures and an overlap between RNA 
polymerase II transcription initiation sites and transcription factor binding 
sites. In the ncRNA gene cluster associated with bed-3, there are two 
predicted transcribed enhancers (Figure 6). The predicted enhancers are 
approximately 300 bases long and overlap with few ncRNA genes, giving rise 




Figure 6. Genomic location of a predicted ncRNA gene cluster near bed-3.  
There are 18 ncRNA genes, of which 16 are intergenic between best-13 and bed-3 
protein-coding genes and two are found in bed-3 introns. There are two predicted 
enhancers in this ncRNA gene cluster, represented by green boxes.  
 
1.10 Overview of the study 
In this study, we investigate the biological function of predicted ncRNA 
genes near bed-3 and the reason for clustering. Based on the well-studied 
examples in the mammalian system, we formulated few hypotheses: 
• ncRNA genes collectively regulate the expression of a common target  
o ncRNA genes regulate the expression of bed-3 or best-13 in 
cis because of the close proximity. They may or may not 
function through a mechanism related to eRNAs. 
o ncRNA genes regulate the expression of other unknown 
gene(s) in cis or trans. 
 
To test the hypotheses and determine the biological function of 
ncRNA genes, we analysed the conservation of genomic sequence across 
species, expression pattern of ncRNA genes, deletion mutants, knockdown of 
ncRNA genes, overexpression of ncRNA genes and enhancer activity of 
ncRNA-containing genomic fragments. Using these approaches, we sought to 




Chapter 2: Materials and Methods 	
2.1 Worm strains and manipulation  
Worms were cultured on NGM plates seeded with E. coli (OP50) and 
maintained at 20°C as described (Brenner, 1974). Most strains were obtained 
from Caenorhabditis Genetics Center (CGC) or generated by crosses and 
microinjection. The Mos1-containing strain was obtained from the 
NemaGENETAG consortium (Bazopoulou and Tavernarakis, 2009). bed-
3(sy705) and bed-3(sy702) are nonsense mutations and reduction of function 
alleles (Inoue and Sternberg, 2010). Male animals used for crosses were 
generated by heat shock at 30°C for six hours and maintained as described 
(Sulston and Hodgkin, 1988). The genotypes of newly constructed strains 
were confirmed by the presence of specific phenotypes or verified by 
molecular techniques. Details of strains used in this study are provided in 
Table 1.  
 
2.2 Worm synchronisation 
 Adult animals were transferred to seeded NGM plates and allowed to 
lay eggs for six hours before they were removed. Alternatively, for mutants 
that do not lay eggs (e.g. bed-3 mutants), worms were synchronised by 
bleach treatment (Sulston and Hodgkin, 1988). Adult animals containing eggs 
were treated with 20% alkaline hypochlorite solution for five minutes to 
dissolve bodies. The eggs are resistant to the solution. Thereafter, the eggs 
were washed and resuspended in M9 buffer, allowing them to hatch overnight 
into synchronous starved L1s. L1 animals were then distributed to seeded 
NGM plates to resume growth to desired stages.  
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Table 1. Strains used in this study. 
Strain Genotype Description 
N2 wild type   
IE34213 ttTi34213 Mos1 inserted near bed-3 
PS4757 bed-3(sy702)   
PS4758 bed-3(sy705)   
ZF1260 unc-119(ed4)   
CB4088 him-5(e1490)   
ZF1373 mom-2 dpy-11/nT1[gfp]   
BC15833 dpy-5(e907); sEx15833[rCes F32B6.9::GFP + pCeh361] best-13::gfp 
PS5507 unc-119(ed4); syEx962[bed-3::gfp + unc-119(+) + pBSKSII]  bed-3::gfp  
PD4666 ayIs6[hlh-8::gfp] M lineage marker 
NH2447 ayIs2[egl-15::gfp] vulval muscle marker 
PD4595 ccIs4595[ceh-24::gfp] vulval muscle marker 
PD4443 ccIs4443[arg-1::gfp] vulval muscle marker 
GR1366 mgIs42[tph-1::gfp] HSN marker 
TL8 bam-2(cy6); cyIs4[cat-1p::cat-1::gfp] HSN marker 
PS3808 unc-119(ed4) syIs80[lin-11::gfp + unc-119(+)] VC neuron marker 
Strains generated by crosses  
ZF1244 ttTi34213 4x outcrossed Mos1 inserted near bed-3 (outcrossed) 
ZF1525 unc-119(ed4); bed-3(sy705)/nT1[gfp] 
 ZF1257 unc-119(ed4); ttTi34213  
ZF1379 best-13(qw27[Cbr-unc-119(+)]) 3x outcrossed D1 mutant 
ZF1494 qwDf39[D2] 2x outcrossed D2 mutant 
ZF1656 qwDf42[D3] 2x outcrossed D3 mutant 
ZF1436 qwDf31[D4] 2x outcrossed D4 mutant  
ZF1537 best-13(qw27[Cbr-unc-119(+)]); him-5(e1490) D1; him-5 
ZF1597 qwDf39[D2]; him-5(e1490)   
ZF1587 qwDf42[D3]; him-5(e1490)   
ZF1538 qwDf31[D4]; him-5(e1490)   
ZF1604 bed-3(sy702); him-5(e1490)   
ZF1588 bed-3(sy705); him-5(e1490)   
ZF1663 best-13(qw27[Cbr-unc-119(+)]); ayIs6[hlh-8::gfp] D1; ayIs6 
ZF1690 qwDf39[D2]; ayIs6[hlh-8::gfp]   
ZF1691 qwDf42[D3]; ayIs6[hlh-8::gfp]   
ZF1664 qwDf31[D4]; ayIs6[hlh-8::gfp]   
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ZF1674 bed-3(sy705); ayIs6[hlh-8::gfp]   
Strains generated by microinjection  
ZF1359 unc-119(ed4); best-13(qw27[Cbr-unc-119(+)]) initial D1 mutant from MosDEL 
ZF1463 unc-119(ed4); qwDf39[D2] initial D2 mutant from MosDEL 
ZF1456 unc-119(ed4); qwDf42[D3] initial D3 mutant from MosDEL  
ZF1407 unc-119(ed4); qwDf31[D4] initial D4 mutant from MosDEL  
ZF1340 unc-119(ed4); qwEx67[F25H8.13p::gfp + unc-119(+)]   
ZF1347 unc-119(ed4); qwEx75[F25H8.21p::gfp + unc-119(+)]   
ZF1354 unc-119(ed4); qwEx81[F25H8.16p::gfp + unc-119(+)]   
ZF1386 unc-119(ed4); qwEx98[Δpes-10::gfp + unc-119(+)]   
ZF1614 qwDf31[D4]; qwEx186[14 ncRNA genes + myo-2p::yfp] 50ng/μl  
ZF1616 qwEx188[14 ncRNA genes + myo-2p::yfp] 50ng/μl  
ZF1622 qwEx194[14 ncRNA genes + myo-2p::yfp] 10ng/μl 
ZF1633 qwEx201[300 bp fragment of F25H8.21p + myo-2p::yfp]   
ZF1635 qwEx203[500 bp fragment of F25H8.21p + myo-2p::yfp]   
ZF1648 unc-119; qwEx209[F25H8.19p::gfp + unc-119(+)]   
ZF1682 unc-119; qwEx224[left-to-right R2::Δpes-10::gfp + unc-119(+)]   
ZF1686 unc-119; qwEx228[right-to-left R2::Δpes-10::gfp + unc-119(+)]   
ZF1688 unc-119; qwEx230[right-to-left R3::Δpes-10::gfp + unc-119(+)]   
ZF1698 unc-119; qwEx237[left-to-right R3::Δpes-10::gfp + unc-119(+)]   
ZF1700 unc-119; qwEx239[right-to-left R1::Δpes-10::gfp + unc-119(+)]   
ZF1702 unc-119; qwEx241[left-to-right R1::Δpes-10::gfp + unc-119(+)]   
ZF1729 unc-119; qwEx261[left-to-right 1.3 Kb of R1::Δpes-10::gfp + unc-119(+)]  
ZF1728 unc-119; qwEx260[right-to-left 1.3 Kb of R1::Δpes-10::gfp + unc-119(+)]  
ZF1735 unc-119; qwEx267left-to-right 700 bp of R1::Δpes-10::gfp + unc-119(+)]  
ZF1738 unc-119; qwEx270[right-to-left 700 bp of R1::Δpes-10::gfp + unc-119(+)]  
ZF1721 qwDf31[D4]; qwEx255[hlh-8p::bed-3::gfp + lin-18p::DsRed + pBSKSII]   
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2.3 Sequence alignment  
 ClustalW 2.1 (http://www.genome.jp/tools/clustalw/) was used to align 
an 18 Kb syntenic region, spanning from the start codon of best-13 to the 
stop codon of bed-3, of Caenorhabditis elegans, Caenorhabditis briggsae, 
Caenorhabditis remanei and Caenorhabditis brenneri. The default parameters 
were used to generate the multiple sequence alignment. 
 
2.4 cDNA synthesis and quantitative PCR 
Total RNA of wild type animals and deletion mutants was isolated 
using Trizol (Invitrogen). For detection of ncRNA transcripts, extracted RNA 
was first treated with DNase I (Thermo Scientific) before reverse transcription 
was performed using RevertAid first strand cDNA synthesis kit (Thermo 
Scientific). The cDNA was subsequently PCR amplified with primers TI0220 
to TI0225, TI0361 and TI362 (Table 2). For synthesis of bed-3 cDNA, the 
oligo-dT-derived cDNA was amplified with primers TI0434 and TI0435 (Table 
2).  
Quantitative reverse transcription-PCR (qPCR) was done using iScript 
SybrGreen reaction mix (Bio-Rad) and the fluorescence signal was measured 
with iQ5 qPCR detection system (Bio-Rad). act-1/actin was used for 
normalisation. qPCR was carried out in triplicates in a single experiment.  
 
2.5 Molecular cloning  
For all plasmids generated in this study, details of the construction 
including the specific restriction enzymes used are provided in Table 3. The 
primer sequences used for amplification of specific DNA fragments are listed 
in Table 2.  
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For the MosDEL experiment, the targeting plasmids were constructed 
by fusing three DNA fragments together in a pBluescript II KS (pBSKSII) 
vector. The first fragment (L or left) was a 2 Kb sequence upstream of the 
ttTi34213 Mos1 insertion site, amplified by PCR primers TI0160 and TI0161. 
The second (middle) fragment was a 2.2 Kb sequence including the promoter, 
exons and introns of C. briggsae unc-119 (Cbr-unc-119), amplified by PCR 
primers TI0158 and TI0159 from the C. briggsae AF16 strain. The third 
fragment (R or right) was a 2 Kb sequence that defined the endpoint of each 
deletion. To generate four deletions, four different targeting constructs with 
different R fragments (R1 to R4) were constructed. The PCR primers used for 
amplification of each R fragment are listed in Table 2. Each PCR product was 
first purified (Promega Wizard SV Clean-up kit) and cloned into pCR-Blunt II-
TOPO vector (Invitrogen), followed by excision and insertion to pBSKSII.  
To fuse three fragments together, Cbr-unc-119 was first excised from 
TOPO vector and cloned into pBSKSII using PstI sites. Subsequently, the L 
fragment was cloned into Cbr-unc-119::pBSKSII using XbaI/BamHI sites. 
Finally, each R fragment (R1, R2, R3 or R4) was cloned into L::Cbr-unc-
119::pBSKSII using restriction enzymes listed in Table 3. In total, four 
targeting plasmids were constructed and sequence-verified (1st Base).  
The promoter::GFP fusion plasmids were generated by cloning the 
sequence 1 Kb upstream of each predicted ncRNA gene into the promoter-
less GFP vector pPD95.69 (A. Fire, pers. comm.; http://www.addgene.org/). 
The 1 Kb promoter was PCR amplified using primers listed in Table 2. The 
PCR product was purified and cloned into TOPO vector. Subsequently, the 1 
Kb fragment was excised from TOPO vector and inserted into pPD95.69 
vector using restriction enzymes listed in Table 3. The plasmid sequence was 
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verified by DNA sequencing. 
For tissue-specific promoter::bed-3::GFP fusion plasmids, the 
promoter sequence of hlh-8 was fused to bed-3 cDNA in a GFP vector  
ppD95.77. A 1.8 Kb upstream sequence of hlh-8 was PCR amplified from 
genomic DNA with primers TI0432 and TI0433. bed-3 cDNA (1.8 Kb) was 
generated by reverse transcription-PCR using primers TI0434 and TI0435. 
The individual PCR fragments were purified and cloned into TOPO vector. To 
generate the hlh-8p::bed-3::GFP plasmid, bed-3 cDNA was first excised from 
TOPO and cloned into pPD95.77 using BamHI/KpnI sites. Subsequently, the 
hlh-8 promoter fragment was excised from TOPO and cloned into bed-3::GFP 
vector using SphI/SalI sites. The plasmid sequence was verified. 
The RNAi plasmids were built by cloning DNA fragment containing 
individual ncRNA gene or genomic DNA containing small clusters of ncRNA 
genes into L4440 vector (A. Fire, pers. comm.; Addgene). For F25H8.21, a 
300 bp DNA fragment was amplified with primers TI0236 and TI0237. The 
PCR product was cloned into TOPO vector and subsequently excised with 
HindIII/NheI for cloning into L4440. The DNA fragments containing F25H8.16, 
F25H8.13 and small clusters of ncRNA genes were cut out from TOPO 
plasmids containing R fragments and inserted into L4440.  
For the overexpression experiment, a 8.5 Kb DNA fragment containing 
14 ncRNA genes was excised from cosmid F25H8 using PmlI/PspOMI sites 
and cloned into pBSKSII using EcoRV/PspOMI sites. The plasmid sequence 
was verified. Sub-fragments of the 1 Kb sequence upstream of F25H8.21 was 
excised from pKY12.6 and cloned into pBSKSII using restriction sites shown 
in Table 3.  
For enhancer assays, genomic DNA fragments containing small 
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clusters of ncRNA genes were cloned into the Δpes-10::GFP vector 
pPD97.78 (Addgene). The DNA fragments were cut out from TOPO plasmids 
containing R fragments and inserted into pPD97.78 using restriction sites 
shown in Table 3. The same DNA fragment was inserted into ppD97.78 in 
both left-to-right and right-to-left orientations. Left-to-right orientation indicates 
the DNA fragment was inserted into the vector in the same orientation as bed-
3 gene while right-to-left orientation indicates the fragment was cloned into 
the vector in the opposite orientation from bed-3.  
 
2.6 Microinjection and transgenics 
To introduce transgenes into worms, animals were microinjected with 
a DNA mix using the standard protocol (Evans, 2006; Mello and Fire, 1995; 
Mello et al., 1991). The DNA mix was directly injected into the gonad of young 
adult animals to allow transmission of the transgenes to the progeny. In the 
gonad, the injected DNA concatenates to form an extrachromosomal array 
carrying the transgenes. The DNA mix typically contained the plasmid(s) of 
interest and a co-injection marker plasmid (e.g. fluorescence marker myo-
2p::yfp or phenotypic marker unc-119(+)), which facilitates the identification of 
progeny carrying the extrachromosomal array. In few cases, complex DNA 
was incorporated into the DNA mix to prevent silencing of transgenes in the 
germ line. pBSKSII was included in the DNA mix to bring the total DNA 
concentration to a minimum of 100ng/μl. 
To generate transgenic animals carrying promoter::GFP or ncRNA 
gene(s)::Δpes-10::GFP reporters, unc-119(ed4) mutants were injected. The 
unc-119(+) plasmid was used as a co-injection marker because it carried the 
wild type unc-119 gene that can rescue the movement defect of unc-119 
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mutants. Thus, animals carrying the extrachromosomal array move normally. 
To generate transgenic animals that overexpress ncRNA genes or bed-3, wild 
type animals or deletion mutants were injected. A plasmid expressing 
fluorescent protein, myo-2p::yfp (L4640; Addgene) or lin-18p::DsRed, was 
used as the co-injection marker. Animals carrying the extrachromosomal 
array are fluorescent. The genotype of worms used for each injection, 
contents of each DNA mix including the concentration of plasmids used are 
listed in Table 4.  
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Table 2. Oligonucleotides used in this study. 
Purpose DNA fragment Primer Orientation Sequence (5' --> 3') 
Verify Mos1 insertion Mos1 TI0138 Forward CTAGAGAGTGACTCATTCTTTT TI0139 Reverse GTTTTATTATGACATTTTAACT 
MosDEL targeting 
plasmid constructs  
Cbr-unc-119 TI0158 Forward CGCGCTGCAGCCTATGCTTGCACTTTGAGCCAA TI0159 Reverse CGCGCTGCAGTCTTTGCGCAAGTTTGATGGG 
L region to the left of 
ttTi34213 Mos1 site 
TI0160 Forward CGCGTCTAGAGGTAAATTATTCGAGCATTTTTC 
TI0161 Reverse CGCGGGATCCTAAAAGAATGAGTCACTCTCT 
R1  TI0183 Forward CGCGCTCGAGTGGTTTCGTATGTTGCAAAATGTT  TI0184 Reverse CACAGGGCCCACCACCTGCACGGTGTATATTTTG   
R2  TI0185 Forward CGCGGTCGACTTCTCAATTCCCAGTTCATCGAGG  TI0186 Reverse CACAGGGCCCACATAATCGCAGAAATAAGAAAAA 
R3  TI0187 Forward CGCGCTCGAGGAACATACCATTTTGGAAAAGTAGG  TI0188 Reverse CACACGGCCGAGTTAAGCGCTCTGACTGAGCGAA 
R4  TI0189 Forward CGCGCTCGAGCTTATTTCTCCTTCTTCTGTATAC TI0190 Reverse CACACGGCCGGAAAAAAATTATGAATCCCAACGAA 
Verify deletion  
Cbr-unc-119 TI0242 Forward AACATCTATAACATCGAGTTC 
downstream of R1 TI0243 Reverse CTTATGAGAAGCATGATTTCT 
best-13  TI0244 Forward TTCCACTAACTTTTCTACTCGGA 
best-13 TI0245 Reverse CAAAATGAGTAACTACAGTAAC 
bed-3  TI0145 Reverse GCGCGTCTAGAGAAAAAACAAAAGCCTCAGG 
RT-PCR 
F25H8.16  TI0220 Forward GACAAAATATAGTAAAAGTGCACA TI0221 Reverse TGGTCTCAAGAGATCATCTCAGAC 
F25H8.13  TI0222 Forward CCGCGCGGCGCGACACGAAAAA TI0223 Reverse AGATTCTTCTTCAAGTTCTGTCCA 
F25H8.21  TI0224 Forward CTCTTGCGTCAGAGGCATTGTC TI0225 Reverse CACAAAAAATGCTAGTAATACC 
F25H8.19 TI0361 Forward GATTTTTCAAAACTTTTAGGCATA TI0362 Reverse GACCAGTCCTATGGTCATCAACAA 
ncRNA8 ncRNA8 Forward TAGTTTGGCAAAGCTGGACACA ncRNA8 Reverse TGGATGGTGGAGGAGGGCTA 			  
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Purpose DNA fragment Primer Orientation Sequence (5' --> 3') 
Promoter::GFP 
constructs 
F25H8.16 promoter TI0226 Forward CCAACTGCAGTTTCGTATGTTGCAAAATGTTG TI0227 Reverse CAACTCTAGATCCATTTCCTCGGTGACCATTGT 
F25H8.13 promoter TI0228 Forward CCAACTGCAGAATGACACTCAAGAGGAAGGTG TI0229 Reverse CAACTCTAGAAAAGAAGACGCTGAAGGAGGAGG 
F25H8.21 promoter TI0230 Forward CCAACTGCAGCCCAACATCATCTATCCATCA TI0231 Reverse CAACTCTAGAGCGCGGCATTTCTTTTTATCA 
F25H8.19 promoter TI0363 Forward GGTTAACTCCCAACTGCTTATTTT  TI0364 Reverse CGAGCGTGACCTACTTTGACTCAA  
RNAi assay F25H8.21  





bed-3 TI0307 Forward CTGCCGAGTGTCGAATTTGC TI0308 Reverse GCACGGGCTTTTTCTTCCAT 




hlh-8 promoter TI0432 Forward GGAAGCATGCTTGATTAGTTTTAAGGCCTACTTG TI0433 Reverse GGAAGTCGACCTGTGAAAATCATATTTGAAATC 
bed-3 cDNA TI0434 Forward GGAAGGATCCATGCAGACCCAAAGTCCATTTGGT TI0435 Reverse GGAAGGTACCACAAGTTGATCAATGTGATCTACA 
NA: not applicable.   
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Table 3. Plasmids generated in this study. 
Purpose Plasmid  DNA insert Vector 
Restriction enzymes for cloning 
(TOPO/cosmid --> other vectors) 
MosDEL targeting 
plasmids 
pKY11.4 Cbr-unc-119  TOPO NA 
pKY11.5 Cbr-unc-119  pBSKSII PstI 
pKY11.6 L region upstream of ttTi34213 Mos1 site TOPO NA 
pKY11.7 L + Cbr-unc-119 pBSKSII XbaI/BamHI 
pKY11.12 R1 TOPO NA 
pKY11.9 R2 TOPO NA 
pKY11.10 R3 TOPO NA 
pKY11.11 R4 TOPO NA 
pKY11.14 L + Cbr-unc-119 + R1 pBSKSII XhoI/PspOMI --> SalI/PspOMI 
pKY12.1 L + Cbr-unc-119 + R2 pBSKSII SalI/PspOMI --> SalI/PspOMI 
pKY12.2 L + Cbr-unc-119 + R3 pBSKSII XhoI/EagI --> SalI/PspOMI 
pKY11.13 L + Cbr-unc-119 + R4 pBSKSII XhoI/EagI --> SalI/PspOMI 
Promoter::GFP 
constructs 
pKY12.4 F25H8.13 promoter TOPO NA 
pKY12.5 F25H8.16 promoter TOPO NA 
pKY12.6 F25H8.21 promoter TOPO NA 
pKY12.7 F25H8.13 promoter pPD95.69 SpeI/PstI --> XbaI/PstI 
pKY12.9 F25H8.16 promoter pPD95.69 PstI/XbaI 
pKY12.8 F25H8.21 promoter pPD95.69 PstI 
pKY15.1 F25H8.19 promoter TOPO NA 




pKY15.23 hlh-8 promoter  TOPO NA 
pKY15.25 bed-3 cDNA (without stop codon) TOPO NA 
pKY15.26 bed-3 cDNA  pPD95.77 BamHI/KpnI 
pKY15.28 hlh-8 promoter + bed-3 cDNA pPD95.77 SphI/SalI 	 	
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Purpose Plasmid  DNA insert Vector 
Restriction enzymes for cloning 
(TOPO/cosmid --> other vectors) 
RNAi assay 
pKY12.10 F25H8.21  TOPO NA 
pKY12.16 F25H8.13  L4440 SpeI/AgeI 
pKY12.17 F25H8.16 L4440 HindIII/SpeI 
pKY12.20 F25H8.21   L4440 HindIII/NheI 
pKY13.5 R1 L4440 XhoI/KpnI 
pKY13.7 R2 L4440 BamHI/PspOMI 
pKY13.6 R3 L4440 HindIII/XhoI 
Overexpression 
F25H8  
40 Kb DNA fragment  
(covers ncRNA genes cluster and bed-3) Lorist2 NA 
pKY14.1 8.5 Kb fragment containing 14 ncRNA genes pBSKSII PmlI/PspOMI --> EcoRV/PspOMI 
pKY14.2 300 bp fragment of F25H8.21 promoter  pBSKSII XbaI/MfeI --> XbaI/EcoRI 
pKY14.3 
500 bp fragment of F25H8.21 promoter  
(contains F25H8.19) pBSKSII SpeI/XbaI --> SpeI/SpeI 
Enhancer assay 
pKY15.15 R2 in left-to-right orientation pPD97.78 SalI/NsiI 
pKY15.17 R2 in right-to-left orientation pPD97.78 SalI/SphI 
pKY15.18 R3 in right-to-left orientation pPD97.78 XhoI --> SalI  
pKY15.19 R3 in left-to-right orientation  pPD97.78 XhoI --> SalI 
pKY15.20 R1 in right-to-left orientation pPD97.78 NsiI 
pKY15.21 R1 in left-to-right orientation pPD97.78 NsiI 
pKY15.31 1.3 Kb fragment of R1 in left-to-right orientation pPD97.78 SpeI --> XbaI 
pKY15.32 1.3 Kb fragment of R1 in right-to-left orientation pPD97.78 SpeI --> XbaI 
pKY15.35 700 bp fragment of R1 in left-to-right orientation pPD97.78 SpeI/NsiI --> XbaI/NsiI 
pKY15.36 700 bp fragment of R1 in right-to-left orientation pPD97.78 SpeI/XhoI --> SalI/XbaI 
NA: not applicable.  
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qw27 unc-119(ed4); ttTi34213  
L::Cbr-unc-119::R1::pBSKSII (pKY11.14) 50 
glh-2p::mosase (pJL43.1)  50 
myo-2p::yfp (L4640) 7 
lin-18p::DsRed (C6) 20 
complex DNA 70 
qwDf39 unc-119(ed4); ttTi34213  
L::Cbr-unc-119::R2::pBSKSII (pKY12.1) 50 
eft-3p::mosase (pCFJ601) 50 
myo-2p::yfp (L4640) 7 
lin-18p::DsRed (C6) 20 
hsp-16.41p::peel-1 (pMA122) 10 
qwDf42 unc-119(ed4); ttTi34213  
L::Cbr-unc-119::R3::pBSKSII (pKY12.2) 50 
eft-3p::mosase (pCFJ601) 50 
myo-2p::yfp (L4640) 7 
lin-18p::DsRed (C6) 20 
hsp-16.41p::peel-1 (pMA122) 10 
qwDf31 unc-119(ed4); ttTi34213  
L::Cbr-unc-119::R4::pBSKSII (pKY11.13) 50 
eft-3p::mosase (pCFJ601) 50 
myo-2p::yfp (L4640) 7 
lin-18p::DsRed (C6) 20 
hsp-16.41p::peel-1 (pMA122) 10 
Promoter::GFP 
qwEx67 unc-119(ed4) F25H8.13p::gfp (pKY12.7) 50 unc-119(+) 50 
qwEx74 unc-119(ed4) F25H8.21p::gfp (pKY12.8) 50 unc-119(+) 50 
qwEx81 unc-119(ed4) F25H8.16p::gfp (pKY12.9) 50 unc-119(+) 50 









8.5 Kb ncRNA cluster::pBSKSII (pKY14.1) 50 
myo-2p::yfp (L4640) 7 
pBSKSII 50 
qwEx188 wild type 
8.5 Kb ncRNA cluster::pBSKSII (pKY14.1) 50 
myo-2p::yfp (L4640) 7 
pBSKSII 50 
qwEx194 wild type 
8.5 Kb ncRNA cluster::pBSKSII (pKY14.1) 10 
myo-2p::yfp (L4640) 7 
pBSKSII 90 
qwEx201 wild type 
300 bp of F25H8.21p::pBSKSII (pKY14.2) 50 
myo-2p::yfp (L4640) 7 
pBSKSII 50 
qwEx203 wild type 
500 bp of F25H8.21p::pBSKSII (pKY14.3)  50 






hlh-8p::bed-3::gfp (pKY15.28) 50 
lin-18p::DsRed (C6) 20 









qwEx98 unc-119(ed4) Δpes-10::gfp (ppD97.78 empty vector) 50 unc-119(+) 50 
qwEx224 unc-119(ed4) Left-to-right R2::Δpes-10::gfp (pKY15.15) 50 unc-119(+) 50 
qwEx228 unc-119(ed4) Right-to-left R2::Δpes-10::gfp (pKY15.17) 50 unc-119(+) 50 
qwEx230 unc-119(ed4) Right-to-left R3::Δpes-10::gfp (pKY15.18) 50 unc-119(+) 50 
qwEx237 unc-119(ed4) Left-to-right R3::Δpes-10::gfp (pKY15.19) 50 unc-119(+) 50 
qwEx239 unc-119(ed4) Right-to-left R1::Δpes-10::gfp (pKY15.20) 50 unc-119(+) 50 
qwEx241 unc-119(ed4) Left-to-right R1::Δpes-10::gfp (pKY15.21) 50 unc-119(+) 50 
qwEx261 unc-119(ed4) Left-to-right 1.3 Kb of R1::Δpes-10::gfp (pKY15.31) 50 unc-119(+) 50 
qwEx260 unc-119(ed4) Right-to-left 1.3 Kb of R1::Δpes-10::gfp (pKY15.32) 50 unc-119(+) 50 
qwEx267 unc-119(ed4) Left-to-right 700 bp of R1::Δpes-10::gfp (pKY15.35) 50 unc-119(+) 50 
qwEx270 unc-119(ed4) Right-to-left 700 bp of R1::Δpes-10::gfp (pKY15.36) 50 unc-119(+) 50 
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2.7 Mos-1 mediated deletion (MosDEL) 
Deletion mutants were generated using the MosDEL protocol as 
described (Frokjaer-Jensen et al., 2012; Frokjaer-Jensen et al., 2010). 
MosDEL relies on the presence of a Mos1 transposon near the gene(s) to be 
deleted. In our case, we used the ttTi34213 Mos1 insertion near the ncRNA 
gene cluster (Figure 7). We did not use the reported ttTi26743 Mos1 insertion 
that was closer to the ncRNA gene cluster because it was unavailable. The 
presence of Mos1 insertion (1.3 Kb) was verified by PCR using primers 
TI0138 and TI0139.  
A schematic diagram of the MosDEL technique is shown in Figure 7. 
A mixture of DNA containing the transposase plasmid, targeting plasmid and 
negative selection plasmids (e.g. fluorescence marker and phenotypic marker 
peel-1) were microinjected into unc-119; ttTi34213 mutants to form an 
extrachromosomal array. Details of the DNA mix used to generate the 
deletion mutants are provided in Table 4.  
The targeting plasmid contained three fragments fused together in a 
pBSKSII backbone. The L fragment contained the sequence immediately 
upstream of the ttTi34213 Mos1 insertion site. The middle fragment contained 
the wild type sequence of C. briggsae-unc-119 (Cbr-unc-119), which was 
used for positive selection. The R fragment contained an arbitrary sequence 
that specified the end-point of deletion. The targeting plasmid served as a 
repair template as well as a positive selection marker.  
In the germ line of injected worms, transposase is activated to excise 
Mos1, generating a double strand break (DSB). The DSB is repaired by 
homologous recombination using the targeting plasmid as a template. 
Following homologous recombination, the deletion is generated, stretching 
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from the point of Mos1 excision to an arbitrary point in the genome defined by 
the 5’ end of R fragment. Along with the repair, wild type Cbr-unc-119 is 
integrated into the genome, thereby rescuing the movement defect of the unc-
119 mutant.  
To isolate the deletion mutants, we screened F2 progeny for unc-119 
rescued worms that were fluorescence-negative (i.e. lost the 
extrachromosomal array). The fluorescence markers (myo-2p::yfp and lin-
18p::DsRed) were used to counter-select against unc-119 rescued progeny 
that carried the extrachromosomal array (i.e. fluorescence-positive). In some 
cases, hsp-16.41p::peel-1 plasmid (pMA122) was used as an additional 
negative selection marker to speed up the isolation of deletion mutants 
(Frokjaer-Jensen et al., 2012).  
The presence of the deletion was confirmed by PCR. The primers 
used for verification of deletions are listed in Table 5. To verify each deletion, 
two sets of PCR were performed. The first set amplified the region stretching 
from Cbr-unc-119 (TI0242) to an arbitrary point downstream of the deletion. 
The second set amplified a region within the deletion. The wild type strain 
was included as a negative control.  
 
Table 5. Use of PCR to confirm the presence of deletion. 
Deletion  Primers Size of amplicon (Kb) 
Deletion 
mutant Wild type  
D1 TI0242/TI0243 3.0 + - TI0244/TI0245 0.5 - + 
D2 TI0242/TI0188 5.5 + - TI0230/TI0231 1.0 - + 
D3 TI0242/TI0190 4.5 + - TI0185/TI0186 2.0 - + 
D4 TI0242/TI0145 3.5 + - TI0185/TI0186 2.0 - + 
“+” indicates presence of the amplified fragment while “-” indicates absence of the 




Figure 7. Overview of Mos1-mediated deletion.  
To delete ncRNA genes, we used the ttTi34213 Mos1 insertion site present to the left 
of the ncRNA gene cluster. We did not use the ttTi26743 Mos1 insertion because it 
was unavailable. To generate four deletions, targeting plasmids containing four 
different R fragments (R1-R4) were constructed. The genomic location of each R 
fragment is shown above. The 5’ end of each R fragment specified the endpoint of 
each deletion. To generate the deletion mutant, a mixture of DNA including the 
mosase plasmid, targeting plasmid and fluorescence plasmids were microinjected 
into unc-119; ttTi34213 mutants to form an extrachromosomal array. In the germ line, 
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activation of transposase leads to excision of Mos1, which creates a double strand 
break (DSB). Using homologous recombination, the DSB is repaired from the 
targeting plasmid on the extrachromosomal array. The repair generates a deletion, 
which stretches from the point of Mos1 excision to an arbitrary point in the genome 
defined by the 5’ end of R fragment. Concurrently, the repair also results in the 
integration of wild type Cbr-unc-119 into the genome, which rescues movement 
defects of unc-119 mutants. To isolate the deletion, we screened F2 progeny for unc-
119 rescued animals that were fluorescence-negative (population B). The 
fluorescence marker was used for negative selection to avoid selecting unc-119 
rescued animals that contain intact ncRNA genes and extrachromosomal array 
(population A).  
 
2.8 Genetic complementation test 
 To generate the deletion/bed-3(sy705) transheterozygotes, wild type 
males were first crossed to mom-2 dpy-11/nT1[gfp] hermaphrodites. The 
fluorescent cross progeny (nT1[gfp]/+) males were then crossed to the 
homozygous deletion mutant. Finally, the fluorescent cross progeny 
deletion/nT1[gfp] males were crossed to unc-119(ed4); bed-3(sy705)/nT1[gfp] 
mutant to generate deletion/bed-3; unc-119/+ transheterozygotes. The 
transheterozygotes were selected based on the absence of GFP signal and 
presence of wild type movement. The unc-119 mutation was used to facilitate 
distinction between self progeny (movement defective; the Unc phenotype) 
and cross progeny (wild type movement; non-Unc). The transheterozygotes 
were assayed for the egg-laying defective phenotype in the adult stage under 
well-fed condition.  
 
2.9 RNAi 
RNAi was performed using two methods, feeding and injection. For 
the feeding method, worms were fed with HT115 (DE3) bacteria transformed 
with RNAi plasmid on NGM plates containing 1mM IPTG and 100μg/ml 
carbenicillin as described (Kamath et al., 2001). The RNAi plasmid contained 
the ncRNA gene(s) flanked by T7 promoters on both ends in a L4440 vector 
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(Addgene). To induce dsRNA expression, the RNAi plasmid was transformed 
into RNase III-defective HT115 with IPTG-inducible T7 polymerase activity. L4 
animals were placed on plates containing dsRNA-expressing bacteria and the 
progeny were examined for RNAi phenotypes. In each RNAi feeding assay, a 
negative control (L4440) and a positive control (par-5) were included. RNAi 
against par-5/14-3-3 causes the embryonic lethal phenotype (Morton et al., 
1992; Morton et al., 2002) and this was included to ensure the RNAi reagents 
and conditions were effective.  
For the injection method, the RNAi plasmid was first linearised with 
BssHII and purified. The linearised plasmid served as a template for 
synthesis of dsRNA using HiScribe T7 high yield RNA synthesis kit (NEB).  
The RNAi injection was performed using the standard protocol as described 
(Ahringer, 2006). The dsRNA, at a concentration of 0.5μg/μl or 1μg/μl, was 
directly injected into the gonad of young adult animals, where the germ line 
nuclei are in a syncytium. The injected worms were picked to individual plates 
and moved to a new NGM plate every 24 hours for three days. At various 
post-injection time points, the progeny of injected worms were analysed for 
phenotypes caused by RNAi.  
For all RNAi experiments, the progeny were examined for phenotypes 
because C. elegans RNAi is heritable and thus gene silencing is maintained 
in the progeny (Fire et al., 1998; Grishok et al., 2000). A caveat of RNAi 
experiments is that we did not validate the reduction in gene expression level. 
In C. elegans, dsRNA covering the entire length of the target gene is typically 
used for RNAi, thus it is difficult to design qPCR primers that only amplify the 
endogenous target but not the dsRNA. Unlike siRNA and shRNA experiments 
done in other systems, it is difficult to validate the knockdown efficiency 
	 38 
induced by dsRNA in C. elegans. Thus, although the RNAi treatment is likely 
to be effective when a phenotype is observed, negative result is inconclusive.  
 
2.10 Chemotaxis assay 
The chemotaxis assay was performed as described (Bargmann et al., 
1993). On a 10 cm NGM plate, a chemoattractant containing 10x dilution of 
isoamyl alcohol in ethanol was spotted on one end of the plate. Ethanol was 
used as a control and spotted on the opposite end of the same plate. 1μl of 
1M sodium azide was added to both ends of the plate so that animals 
became paralysed upon reaching the region. Chemotaxis index (CI) was 
calculated using the formula below.  
!" =  !". !" !"#$% !" !""#!$"!%" !"#$%& − !". !" !"#$% !" !"#$%"& !"#!"# !"!#$ !". !" !"#$%  
 
2.11 Dye-filling assay 
The dye-filling assay was performed as described (Hedgecock et al., 
1985) using 20μM DiI (Invitrogen), a lipophilic red fluorescent dye. L1 and L2 
animals were assayed. The uptake of DiI by amphid and phasmid neurons 
was visualized with fluorescence microscopy. 
 
2.12 Mating assay 
 To test the efficiency of male animals in mating, him-5(e1490) 
mutation was used to generate large numbers of male animals. The mating 
assay was performed as described except using the unc-119 mutant 
(Hodgkin, 1983). Six L4 male animals were crossed to six L4 unc-119(ed4) 
mutants. All male animals were removed after 24 hours. All cross progeny 
were heterozygous for unc-119, thus conferring the non-Unc phenotype (not 
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defective in movement). The number of cross progeny (non-Unc) was 
counted three days later.  
  
2.13 Drug treatment assay 
 To induce egg-laying response, adult animals containing eggs were 
treated with serotonin or imipramine as described (Trent et al., 1983). The 
drug treatment was carried out in a 96-well microtiter plate using 5mg/ml 
serotonin (Sigma) and 0.75mg/ml imipramine (Sigma) diluted in M9 buffer. A 
single animal was loaded into each well and incubated with 50μl of solution 
for an hour. Thereafter, the number of eggs laid in each well was counted. In 
each assay, ≥10 animals of each genotype were treated with each solution. 
The drug treatment assay was repeated at least once for each genotype. 
 
2.14 Phalloidin staining 
 To visualize vulval muscles, animals were stained with FITC-phalloidin 
(Sigma) as described (Shaham, 2006; Strome, 1986). Synchronised young 
adult animals were used for staining. After freeze/thaw and acetone 
treatment, the dried animals were resuspended in S mix (0.2M sodium 
phosphate, 1mM MgCl2 and 0.004% SDS) and stained with 2μl of 50μg/ml 
FITC-phalloidin diluted in PBS. The staining was performed in the dark at 
room temperature for an hour. Subsequently, worms were washed and 
mounted onto glass slide with VectaShield mounting medium containing DAPI 
(Vector Labs) for observation.  
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2.15 Single molecule fluorescence in situ hybridisation (smFISH) 
 smFISH was carried out using the standard protocol as described (Ji 
and van Oudenaarden, 2012; Raj et al., 2008). 48 DNA probes targeting 
against bed-3 mRNA and UTR were synthesized with a 3’ mdc(TEG-Amino) 
modification (Biosearch Technologies). The probe sequences are provided in 
Table 6.  
All 48 probes were conjugated to a succinimidyl ester derivative of 
tetramethylrhodamine (TMR) (Invitrogen) in a coupling reaction. To obtain the 
TMR-conjugated probes, the reaction mixture was first purified by ethanol 
precipitation to remove unbound TMR molecules. To separate the TMR-
conjugated probes from the unbound probes, reversed phase HPLC was 
performed using a C18 column (Alltech Vydac 218TP54). The aqueous 
solution was 0.1 M triethylammonium acetate (Sigma) and the organic solvent 
was acetonitrile (Fisher). The TMR-conjugated probes were eluted with a 
gradient of 7% to 30% acetonitrile over a course of 30 minutes, at a flow rate 
of 1ml/min.  The TMR-probes were lyophilised and resuspended in TE buffer, 
forming the concentrated probe stock solution. To determine the optimal 
working concentration of TMR probes, a range of dilutions were tested. A 7.5x 
dilution of the TMR probes stock was eventually used as the working 
concentration.   
Synchronised worms were fixed in 4% paraformaldehyde (Sigma) 
diluted in PBS for 15 minutes at room temperature. After two washes, the 
fixed worms were frozen and thawed two times and then treated with 70% 
ethanol overnight at 4°C. Subsequently, worms were washed with 10% 
formamide buffer (Ambion) and incubated with hybridisation buffer containing 
2μl of 7.5x diluted TMR-probes. The hybridisation reaction was carried out in 
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the dark at 30°C overnight. Thereafter, worms were washed with 10% 
formamide buffer for two times, first being a quick rinse and the second wash 
was done at 30°C for 30 minutes. After the washes, worms were 
resuspended in 2x SSC (Ambion) and mounted onto glass slide with 
VectaShield mounting medium containing DAPI for observation.  
The absolute number of fluorescent spots was quantitated with an 
ImageJ macro, written by Takao Inoue. When different strains were assayed 
in parallel to compare the bed-3 mRNA count, all images were taken with the 




Table 6. List of TMR-conjugated smFISH probes targeted against bed-3. 
S/N Probe name Sequence (5' --> 3') 3' modification 
1 bed-3_p1 AAATGGACTTTGGGTCTGCA  3’ mdc(TEG-Amino) 
2 bed-3_p2 GCAAGGATGATGAAATCCCG  3’ mdc(TEG-Amino) 
3 bed-3_p3 TGCTGCTACTGTAACTGGAG  3’ mdc(TEG-Amino) 
4 bed-3_p5 GCCGACGGAAATGTTGTCAA  3’ mdc(TEG-Amino) 
5 bed-3_p7 GATTGCAGCTGATTATTTCT  3’ mdc(TEG-Amino) 
6 bed-3_p9 ATCCCATACCACCATTCAAT  3’ mdc(TEG-Amino) 
7 bed-3_p10 AATGGAGTTCCTGGACCATT  3’ mdc(TEG-Amino) 
8 bed-3_p11 ATGAGCATAATTATTCCGTG  3’ mdc(TEG-Amino) 
9 bed-3_p13 CGAATCTTTCCAACATGCTG  3’ mdc(TEG-Amino) 
10 bed-3_p15 TTGATCCACCAACACGTTTT  3’ mdc(TEG-Amino) 
11 bed-3_p17 GTTGGAAGCTCATCGAAATA  3’ mdc(TEG-Amino) 
12 bed-3_p18 ACACTCGGCAGCTTGTTCAA  3’ mdc(TEG-Amino) 
13 bed-3_p19 CCAGTAGTGCTTGAATTAGT  3’ mdc(TEG-Amino) 
14 bed-3_p21 GCTGATACTCTTGAACATGA  3’ mdc(TEG-Amino) 
15 bed-3_p23 TTCCATTTTGACGATCATAC  3’ mdc(TEG-Amino) 
16 bed-3_p25 ACTTTTTCGTTCATTTCTCG  3’ mdc(TEG-Amino) 
17 bed-3_p26 GTGTTTTCAATTCCATTCGT  3’ mdc(TEG-Amino) 
18 bed-3_p27 GGGACTCTTTCTTCACAATC  3’ mdc(TEG-Amino) 
19 bed-3_p29 CAGAAGCTGATGAGGATGCA  3’ mdc(TEG-Amino) 
20 bed-3_p31 GCTGGAAGACCTATCAAAGG  3’ mdc(TEG-Amino) 
21 bed-3_p33 AGTTTGAAGGAGTTGGTGGA  3’ mdc(TEG-Amino) 
22 bed-3_p34 GACTTTGGCTTAGATTGAGA  3’ mdc(TEG-Amino) 
23 bed-3_p35 GGATTCTGATTTTGGCACTG  3’ mdc(TEG-Amino) 
24 bed-3_p37 CTCTTGAACGCTTTTGTTCA  3’ mdc(TEG-Amino) 
25 bed-3_p39 AAAAAACATTTTCGTGCCCA  3’ mdc(TEG-Amino) 
26 bed-3_p41 ATGATCTTCTAATGGGGTGA  3’ mdc(TEG-Amino) 
27 bed-3_p42 CATCTTCAATTTTCTTCTGG  3’ mdc(TEG-Amino) 
28 bed-3_p43 AAGCATCAGAGCAATCTGCA  3’ mdc(TEG-Amino) 
29 bed-3_p45 AAACAGCGATCGAATGCCTG  3’ mdc(TEG-Amino) 
30 bed-3_p47 AAGACATCACCACTGGGCAT  3’ mdc(TEG-Amino) 
31 bed-3_p49 GTTGTTTCATTTGATTCAGT  3’ mdc(TEG-Amino) 
32 bed-3_p50 TTATGAACAAGGGCTTCGAT  3’ mdc(TEG-Amino) 
33 bed-3_p51 AATGCTGCTTAATGAGCTGC  3’ mdc(TEG-Amino) 
34 bed-3_p53 CTTCATATGATGACGTGGCA  3’ mdc(TEG-Amino) 
35 bed-3_p55 CTCATCACCCACATTTGGTC  3’ mdc(TEG-Amino) 
36 bed-3_p57 TCAACATTCTCATCTTCCTC  3’ mdc(TEG-Amino) 
37 bed-3_p58 CTGACGATGTATCGTCTTCG  3’ mdc(TEG-Amino) 
38 bed-3_p59 TCCGTGTCAATTGACGATGA  3’ mdc(TEG-Amino) 
39 bed-3_p61 GGGAAATGCGTCATTTCCAA  3’ mdc(TEG-Amino) 
40 bed-3_p63 GGACGAGTTGAGAAGTAGGT  3’ mdc(TEG-Amino) 
41 bed-3_p65 GGACTTGTTGAACTAATGGC  3’ mdc(TEG-Amino) 
42 bed-3_p66 TTGACAGGTTTGAGGTAACA  3’ mdc(TEG-Amino) 
43 bed-3_p67 GTCTGTCGGATATAGTCAGA  3’ mdc(TEG-Amino) 
44 bed-3_p69 CATTGCCTCCTGATTTACTG  3’ mdc(TEG-Amino) 
45 bed-3_p71 ACAGCTACAGAGTATCTTGA  3’ mdc(TEG-Amino) 
46 bed-3_p73 AGGGGTTCAGGATACCAAAG  3’ mdc(TEG-Amino) 
47 bed-3_p75 AAGGGATAAGTGGGAGGCAT  3’ mdc(TEG-Amino) 




2.16 Microscopy and phenotype observation 
The egg-laying defective and rod-like larval lethal phenotypes were 
examined under a dissecting microscope (Olympus SZ61). To observe the 
egg-laying defective phenotype, well-fed adult animals were scored for the 
presence of two rows of eggs. To observe the rod-like larval lethal phenotype, 
L1 and L2 animals were scored for fluid accumulation and rod-like 
morphology.  
To score phenotypes that require higher magnification, animals were 
mounted on glass slides containing 5% agar pad and paralysed with 10mM 
levamisole for observation under the Nomarski/fluorescence microscope 
(Olympus BX51). For bed-3::gfp, promoter::GFP and ncRNA gene(s)::Δpes-
10::GFP constructs, animals of mixed stages were examined and sites of 
expression were determined based on the location of the fluorescence signal. 
The cell identity was determined by the size, shape and position of the cell in 
the animal.  
To observe the vulval cell division defect, animals in the mid-L4 stage 
were mounted and the number of vulval nuclei was counted for each animal 
(Inoue and Sternberg, 2010). The defects in vulval muscles and male tail 
structure were observed in young adult animals. To observe defects in the 
early M lineage, the expression of ayIs6[hlh-8::gfp] was examined near the 
posterior end of L2 animals. The defects in SM lineage division were 
observed by monitoring the expression of ayIs6[hlh-8::gfp] at the gonad 
centre between early L3 to mid L4 animals. The SM stages were determined 
in parallel to vulval development (Schindler and Sherwood, 2013; Sharma-
Kishore et al., 1999). The 2 SM stage occurs in early L3 animals, where P5.p, 
P6.p and P7.p vulval precursor cell (VPCs) have not divided. The 4 SM stage 
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occurs in mid L3 animals, where P5.p, P6.p and P7.p VPCs each divided 
once or twice. The 8 SM stage matches the migrating phase of VPCs during 
L3/L4 moult, before the invasion of anchor cell. The 16 SM stage occurs in L4 
animals, where the anchor cell has invaded the basal lamina and the vulva 
appears as an invagination.  
 
2.17 Statistical analysis 
 For categorical data, p value was determined using Fisher’s exact 
test. For smFISH data, p value was determined using unpaired t test. All tests 




Chapter 3: Expression of ncRNA genes 	
3.1 Introduction  
 The functional potential of a gene can be assessed from its sequence 
conservation and expression pattern. It is widely accepted that strongly 
conserved gene sequence indicates that the gene is functional. Compared to 
protein-coding genes, lncRNA genes are less evolutionarily conserved 
(Guttman et al., 2009; Ponjavic et al., 2007). The lack of sequence 
conservation, however, does not imply lack of function (Pang et al., 2006). 
For example, although the sequence of HOTAIR lncRNA gene is poorly 
conserved between mice and humans (Diederichs, 2014; Schorderet and 
Duboule, 2011), HOTAIR still functions to repress the expression of HoxD 
genes in both organisms (Diederichs, 2014; Li et al., 2013a). Although the 
full-length lncRNA gene sequence appears to be poorly conserved, short 
stretches of sequences within the lncRNA gene tend to be conserved to 
preserve the secondary structure or sequence-specific interactions with some 
proteins (Nam and Bartel, 2012; Qu and Adelson, 2012).  
 The expression pattern of lncRNA genes can provide insights into 
their functions. lncRNA genes are typically expressed in a spatially and 
temporally restricted manner (Cabili et al., 2011; Derrien et al., 2012). They 
are usually expressed at a lower level compared to protein-coding genes 
(Derrien et al., 2012; Djebali et al., 2012).   
 In this study, we investigated the sequence conservation of a 
predicted ncRNA gene cluster associated with bed-3 (Figure 8). We also 
determined whether selected ncRNA genes are transcribed and examined 
their expression pattern.   
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3.2 Results 
3.2.1 The sequence upstream of bed-3 is moderately conserved in 
Caenorhabditis species 
To evaluate whether predicted ncRNA genes contain any functional 
potential, we searched for sequence conservation in a 18 Kb syntenic region 
spanning from best-13 to bed-3 of C. elegans, C. briggsae, C. remanei and C. 
brenneri (see Methods, Chapter 2.3). We found that the sequence upstream 
of bed-3 was generally conserved across these four species (Appendix I, 
Figure 8, Table 7). Of the 16 predicted ncRNA genes that are located 
upstream of bed-3, 12 of them shared >50% sequence identity in other 
Caenorhabditis species (Table 7, Figure 8). The sequence conservation level 
is dependent on the gene or genomic region. On average, protein-coding 
genes share approximately 80% amino acid sequence identity between 
orthologs in C. elegans and C. briggsae (Stein et al., 2003). Similar to the 
conservation at the protein level, a blastn analysis of the bed-3 coding 
sequence between C. elegans and C. briggsae revealed 78% sequence 
identity. An alignment between individual bed-3 introns of C. elegans and C. 
briggsae demonstrated approximately 30-40% sequence identity. Consistent 
with previous studies in mammalian systems (Derrien 2012; Ponjavic 2007; 
Guttman 2009), ncRNA genes associated with bed-3 are less conserved than 
protein-coding genes.  
In addition, few unannotated genomic regions in the sequence 
upstream of bed-3 appeared to be conserved (Appendix I, Figure 8), 
suggesting the presence of possible cis-regulatory elements. These elements 
may regulate the expression of ncRNA genes. Alternatively, they could be 
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unrelated to ncRNA genes; they may regulate the expression of nearby 
protein-coding genes.  
 
Table 7. Sequence similarity of predicted ncRNA genes based on ClustalW 





% Identity Sequence 
conservation 
F25H8.16 Forward 129 25 Poor 
F25H8.14 Reverse 152 13 Poor  
F25H8.9 Reverse 115 59 Moderate 
F25H8.24 Forward 137 69 Moderate 
F25H8.21 Reverse 220 14 Poor 
F25H8.19 Reverse 113 63 Moderate 
F25H8.20 Reverse 259 74 Good 
F25H8.10 Forward 122 80 Good 
F25H8.23 Reverse 140 66 Moderate 
F25H8.25 Reverse 145 76 Good 
F25H8.18 Forward 286 69 Moderate 
F25H8.22 Forward 205 65 Moderate 
F25H8.11 Reverse 132 23 Poor 
F25H8.13 Reverse 347 78 Good 
F25H8.15 Reverse 196 55 Moderate 
F25H8.17 Reverse 140 78 Good 
Orientation is indicated with respect to bed-3 gene; forward indicates the predicted 
ncRNA gene is transcribed in the same direction as the bed-3 gene. Arbitrary 
thresholds used for sequence conservation: poor <30% identity; moderate 30%-70% 





Figure 8. Location of conserved regions in the predicted ncRNA gene cluster 
upstream of bed-3.  
The orange boxes indicate approximate position of DNA sequences that shared 
>50% identity in C. elegans, C. briggsae, C. remanei and C. brenneri (Table 7). 
Conserved regions in protein-coding genes, best-13 and bed-3, are not shown.  
 
On the other hand, predicted ncRNA genes near bed-3 did not share 
significant sequence similarity with species outside of nematodes, suggesting 
that ncRNA gene sequences are rapidly evolving (Pang et al., 2006; Ulitsky et 
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al., 2011). This contrasts with protein-coding genes that typically share 
sequence homology even in species that are not closely related.  
 
3.2.2 Candidate ncRNA genes  
Instead of studying all 18 predicted ncRNA genes near bed-3, we 
focused our initial analysis on three candidates F25H8.16, F25H8.21 and 
F25H8.13. These three genes were selected because they have the highest 
ncRNA probability scores within the cluster as assigned by Lu et al. (2011) 
(Table 8, Figure 9). The probability score indicates the likelihood of a 
predicted gene to be a ncRNA gene and it is determined by an algorithm that 
integrates multiple features (sequence conservation, secondary structure, 
expression) based on characteristics of known ncRNAs (Lu et al., 2011). 
According to Lu et al. (2011), an integration of multiple features is required to 
predict ncRNA because no single feature could accurately distinguish ncRNA 
from protein-coding sequence, UTR and intergenic region. Thus, the ncRNA 
probability score is a useful indicator to identify novel ncRNAs because most 
known ncRNAs have a score larger than 0.69 while most known protein-
coding sequence, UTR, intergenic regions have a score lower than 0.18 (Lu 













F25H8.16 129 0.50 Medium 
F25H8.14 152 0.20 Medium 
F25H8.9 115 0.23 Medium 
F25H8.24 137 0.36 Medium 
F25H8.21 220 0.78 High 
F25H8.19 113 0.27 Medium 
F25H8.20 259 0.23 Medium 
F25H8.10 122 0.25 Medium 
F25H8.23 140 0.27 Medium 
F25H8.25 145 0.36 Medium 
F25H8.18 286 0.31 Medium 
F25H8.22 205 0.36 Medium 
F25H8.11 132 0.23 Medium 
F25H8.13 347 0.43 Medium 
F25H8.15 196 0.24 Medium 
F25H8.17 140 0.26 Medium 
F25H8.12 93 0.20 Medium 
F25H8.8 123 0.25 Medium 
According to Lu et al. (2011), P>0.69 is classified as high-confidence prediction, 
P<0.18 is low-confidence prediction and any score between these two thresholds is 
classified as medium-confidence prediction. 
 
3.2.3 ncRNA genes are transcribed 
Because the ncRNAs near bed-3 are predicted genes, we first 
validated whether these are true ncRNA genes using reverse transcription-
PCR (RT-PCR). Prior to reverse transcription, we treated the RNA template 
with DNase I to eliminate genomic DNA contamination. In the reverse 
transcription step, we used either random hexamers or gene-specific primers 
to synthesize the cDNA. We did not use oligo-dT primer because not all 
ncRNAs are polyadenylated (Yang et al., 2011). In the reaction, we included 
both positive (ncRNA8; a previously validated C. elegans ncRNA from Lu et 
al. 2011) and negative (without reverse transcriptase) controls. When we 
performed reverse transcription with random hexamers followed by PCR, we 
detected the expected DNA bands for three candidate ncRNA genes 
(F25H8.16, F25H8.13, F25H8.21), confirming that these predicted ncRNA 





Figure 9. ncRNA transcripts were detected for candidate ncRNA genes, 
F25H8.16, F25H8.13 and F25H8.21.  
(A) The positive control is ncRNA8, a predicted ncRNA gene that was validated in a 
previous study (Lu et al., 2011). Arrows indicate the expected product of the 
corresponding ncRNA genes. The positive control and F25H8.16 should yield a 
product of 120 bases, F25H8.13 should give a product of 350 bases and F25H8.21 
should give a product of 220 bases. A 100 bp DNA marker was used, where the 
lowest molecular weight band corresponds to 100 bases with increment of 100 bases 
for every higher molecular weight band. Abbreviations are 6mer, random hexamers; 
FP, forward primer; RP, reverse primer; -RT, without reverse transcriptase. (B) 
Location of candidate ncRNA genes and the direction of transcription. Based on the 
RT-PCR result in panel A, there are transcripts in the predicted direction of 
transcription (blue arrows) and transcripts in the opposite direction (maroon arrows). 
Note that arrows only indicate directions and the length of the arrow does not 
correspond to the size of transcript.  
 
To test if ncRNA genes are transcribed in the predicted direction, we 
performed reverse transcription with gene-specific primers. To distinguish the 
direction of transcription, we used two types of gene-specific primers, forward 
and reverse primers. As expected, reverse transcription with the reverse 
primer followed by PCR produced the expected DNA bands for F25H8.16, 
F25H8.13 and F25H8.21, indicating that the direction of transcription is 
consistent with the prediction (Figure 9, red arrows). Interestingly, reverse 
transcription with the forward primer followed by PCR also amplified the 
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expected product for F25H8.16 and F25H8.13, suggesting that transcription 
for these two ncRNA genes occur in both directions (Figure 9, green arrows). 
 
3.2.4 ncRNA genes have tissue-specific expression 
To gain insight into the function of ncRNA genes, we examined their 
expression pattern using promoter::GFP reporters, where the upstream 
regulatory sequence of a ncRNA gene was fused to GFP (see Methods, 
Chapter 2.5). We observed expression of F25H8.16p::gfp, F25H8.21p::gfp 
and F25H8.13p::gfp in distinct cell types (Table 9), indicating that DNA 
sequences immediately upstream of these ncRNA genes contain promoter 
activity. Moreover, the presence of GFP expression provides further evidence 
that corresponding ncRNA genes are transcribed and functional.  
 
Table 9. Promoter::GFP reporters of ncRNA genes are expressed in distinct 
cell types. 
F25H8.16p::gfp F25H8.21p::gfp F25H8.13p::gfp 
Pharyngeal cells 
• I1, I4, I5 interneurons 
• 3 unidentified 
neurons 
Pharyngeal cells 
• M1 motor neuron 
• I6 interneuron 
• pm5 pharyngeal 
muscle 
• 2 unidentified 
neurons 
Pharyngeal cells 
• 4 unidentified 
neurons 
Head and tail cells* 
• unidentified neurons 
Head and tail cells* 
• unidentified neurons 
Head and tail cells* 
• unidentified neurons 
Sex muscles 
• vulval muscles 
• spicule muscles 
• diagonal muscles 
Neuronal support cells 
• amphid sheath 
• phasmid socket 
 
 Excretory duct cell  
*Among these reporters, the specific sites of expression in the head and the tail 
appeared to be different based on cell position.  
 
Additionally, promoter::GFP reporters demonstrated that ncRNA 
genes are expressed in specific tissues (Table 9, Figure 10). For instance, 
F25H8.16p::gfp is strongly expressed in sex muscles (Figure 10A). In 
hermaphrodites, F25H8.16p::gfp is expressed in vulval muscles, which form a 
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part of the egg-laying apparatus (Trent et al., 1983). In male animals, 
F25H8.16p::gfp is expressed in spicule protractor muscles, spicule retractor 
muscles and diagonal muscles. These male-specific muscles are required for 
proper mating with hermaphrodites (Garcia et al., 2001).  
F25H8.21p::gfp is expressed in neuronal support cells and the 
excretory duct cell (Figure 10B). The neuronal support cells include amphid 
sheath cells (found in the head) and phasmid socket cells (found in the tail). 
Similar to glial cells, they provide structural support to amphid and phasmid 
chemosensory neurons and also regulate neurite extension of some sensory 
neurons (Bacaj et al., 2008; Oikonomou and Shaham, 2011). The excretory 
duct cell forms a part of the excretory system, which is required for osmotic 




Figure 10A. See legend on the next page.  
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Figure 10. Promoter::GFP fusions of F25H8.16, F25H8.21 and F25H8.13 exhibit 
tissue-specific expression.  
Anterior is to the left and dorsal is to the top in all images except vulval muscles. (A) 
F25H8.16p::GFP. Vulval muscles are characterised by the X-shaped structure 
observed from the dorsal/ventral view. White arrowheads indicate the position of 
spicule muscles. (B) F25H8.21p::GFP. (C) F25H8.13p::GFP. Red arrowheads 
indicate head neurons, yellow arrowheads indicate pharyngeal neurons and cyan 
arrowheads indicate tail neurons.  
 
3.3 Discussion 
3.3.1 ncRNAs are likely not transcriptional noise 
 The protein-coding genes, best-13 and bed-3, flanking the predicted 
ncRNA genes are transcribed in the left to right (here referred to as "forward") 
orientation. The presence of RNA transcripts for F25H8.21 and F25H8.13, 
which are transcribed in the opposite direction to best-13 and bed-3, suggests 
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that ncRNA transcripts are not transcriptional noise resulting from failure to 
terminate transcription (Figure 9). The tissue-specific expression observed for 
F25H8.16 and F25H8.21 provides further evidence that ncRNA genes are 
likely functional (Figure 10).  
 
3.3.2 ncRNA genes may have tissue-specific functions 
Although F25H8.16 and F25H8.21 are poorly conserved among 
Caenorhabditis species (Table 7), these two predicted ncRNA genes have the 
highest ncRNA scores assigned by Lu et al. (2011) (Table 8) and both also 
appeared to be expressed in specific tissues (Figure 10). Consistent with 
some known lncRNAs, the lack of sequence conservation does not 
necessarily indicate the lack of function because the secondary structure and 
expression profile of lncRNAs may play a more important functional role 
rather than the primary sequence of lncRNAs (Moran et al., 2012; Qu and 
Adelson, 2012). The expression pattern of ncRNA genes may confer tissue-
specific functions in certain biological processes. F25H8.16 may regulate 
egg-laying and male mating. F25H8.21 may regulate chemosensation and 
osmotic balance. 
Overall, the expression pattern of ncRNA genes F25H8.16, F25H8.21 
and F25H8.13 differs from the reported expression of bed-3::gfp in the 
hypodermis and vulval cells (Inoue and Sternberg, 2010). It is useful to note 
that the promoter fragment tested in the analysis of bed-3 expression did not 
contain any ncRNA genes transcribed in the same direction (see Chapter 
1.8). Because a short fragment was assayed, bed-3::gfp reporter might not 
accurately reflect the expression pattern of endogenous bed-3. Indeed, 
fluorescence in situ hybridisation revealed that endogenous bed-3 is 
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expressed in mesoblast daughter cells and sex myoblast cells (see Figure 25, 
Chapter 4.2.4.3), but this was not observed in the bed-3::gfp reporter. 
Similarly, assaying the individual promoters of ncRNA genes may not 
accurately reflect the expression pattern of all the ncRNA transcripts from the 
ncRNA cluster. Additionally, if the entire cluster is co-regulated by a common 
mechanism, the effect of this regulation may not be obvious from studies of 
individual ncRNA gene promoters.  
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Chapter 4: Analysis of the ncRNA gene cluster 	
4.1 Introduction 
To study the function of ncRNA genes near bed-3, we deleted ncRNA 
genes using MosDEL (see Methods, Chapter 2.7) and examined deletion 
mutants for phenotypes. We generated four deletion mutants, D1 to D4, each 
removing a different number of ncRNA genes (Figure 11). The D1 mutant 
serves as a negative control because it only deletes the upstream protein-
coding gene best-13 and does not delete any ncRNA genes. D2, D3 and D4 
mutants delete 8, 11 and 14 predicted ncRNA genes respectively. best-13 
encodes a bestrophin chloride channel. best-13p::gfp is expressed in the 
excretory canal cell, vulval cells, rectal epithelial cells, head neurons and tail 
neurons. The D1 mutant, which completely removed best-13 gene, exhibited 
no obvious phenotypes.  
 
 
Figure 11. Genomic regions removed in deletion mutants.  
Four deletion mutants, D1-D4, were generated using MosDEL. Black bars indicate 
deleted regions. Each deletion mutant removed a different number of ncRNA genes. 
The D1 mutant serves as a control for possible effects of best-13 deletion. 
 
Given that F25H8.16 and F25H8.21 are likely expressed in sex 
muscles and neuronal support cells respectively (Chapter 3.2.4), we tested 
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the requirement of these ncRNA genes in these cells by assaying deletion 
mutants for functional defects in these cells. Additionally, because most 
ncRNA genes are located closer to bed-3 than best-13, one of our main 
hypotheses was the cluster of ncRNA genes regulates bed-3 expression in 
cis. To test this, we investigated the deletion mutants for phenotypes that are 
similar to bed-3 mutants and changes in bed-3 expression. We do not rule out 
the alternate possibility that ncRNA genes may regulate best-13 expression.  
 
4.2 Results   
4.2.1 Deletion mutants have no obvious defects in chemosensation 
Since F25H8.21 is likely expressed in neuronal support cells (Chapter 
3.2.4), we tested the D4 mutant for a role in chemosensation. The neuronal 
support cells generate an opening (lumen) to expose the cilia of amphid and 
phasmid chemosensory neurons to the surrounding environment, allowing the 
neurons to respond to food and chemical cues (Bargmann, 2006; Ward et al., 
1975; Ware et al., 1975). The proper formation of the lumen is required for 
chemosensation (Bargmann, 2006; Perens and Shaham, 2005), which can be 
tested by chemotaxis assay (Bargmann et al., 1993). In a chemotaxis assay, 
wild type animals move preferentially toward the chemoattractant. This results 
in an increase in the number of animals at the attractant area as compared to 
the control area, giving a positive chemotaxis index (see Methods, Chapter 
2.10). The integrity of the lumen can also be assessed by the ability of 
chemosensory neurons to uptake external dye through its cilia (Perkins et al., 
1986; Starich et al., 1995). In wild type animals, six pairs of chemosensory 
amphid neurons and two pairs of phasmid neurons can take up fluorescent 
dyes (e.g. FITC, DiI) from the external environment. We found that the D4 
	 58 
mutant, where F25H8.21 was completely deleted, did not exhibit obvious 
defects in chemotaxis and dye-filling when compared to the D1 control 




Figure 12. Deletion mutants have no obvious defects in chemosensation.  
(A-B) The D4 mutant, which removed 14 ncRNA genes, did not exhibit any obvious 
defects in chemotaxis and dye-filling when compared to the D1 control. For the 
chemotaxis assay, isoamyl alcohol was used as the chemoattractant. For dye-filling 
assay, DiI was used. See Methods (Chapter 2) for assay details.  
   
4.2.2 Deletion mutants exhibit phenotypes similar to bed-3 mutants 	
4.2.2.1 Deletion mutants and bed-3 mutants exhibit the egg-laying 
defective (Egl) phenotype 
D2, D3 and D4 mutants all exhibited the egg-laying defective (Egl) 
phenotype, characterised by the presence of two rows of eggs in adult 
animals under the well-fed condition (Figure 13A). In contrast, D1 mutants 
and wild type animals only have one row of eggs under the well-fed condition. 
In wild type animals, eggs are laid as they are being produced and thus the 
uterus contains a limited number of unlaid eggs. In Egl mutants, the rate of 
egg-laying is slower, resulting in an accumulation of unlaid eggs in the uterus 




Figure 13. Deletion mutants and bed-3 mutants exhibit the egg-laying defective 
(Egl) phenotype.  
(A) Nomarski images of adult hermaphrodites. Under the well-fed condition, a wild 
type animal has one row of eggs but the D4 mutant has two rows of eggs, caused by 
a defect in egg-laying. (B) Frequency of animals exhibiting the Egl phenotype. As the 
number of deleted ncRNA genes increases, the percentage of Egl animals also 
increases.  
 
To rule out the possibility that the Egl phenotype arises due to 
background mutations (including unc-119), we outcrossed deletion mutants to 
remove background mutations. After outcrossing, deletion mutants still 
exhibited the Egl phenotype. The presence of the Egl phenotype in all three 
independently-generated deletion mutants provides further evidence that the 
deletion of ncRNA gene(s) causes the Egl phenotype. Thus, ncRNA genes 
near bed-3 may be required for the egg-laying process.  
Intriguingly, D2, D3 and D4 mutants exhibited the Egl phenotype with 
varying degrees of penetrance (Figure 13B). The penetrance of the Egl 
phenotype increased as more ncRNA genes were deleted. This suggests that 
multiple ncRNA genes in the cluster (or at least one in each sequential 
deletion) contribute to proper functioning of the egg-laying process. This is 
consistent with the hypothesis that ncRNA genes collectively regulate a 
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common target and this target gene may be progressively inactivated as more 
ncRNA genes are deleted. We also observed the Egl phenotype in almost 
100% of bed-3 mutants (Figure 13B) (Inoue and Sternberg, 2010).  
 
4.2.2.2 Deletion mutants and bed-3 mutants exhibit the male 
abnormality (Mab) phenotype 
In addition to the Egl phenotype, D2, D3 and D4 mutants also 
exhibited the male abnormality (Mab) phenotype, which represents an 
abnormal morphology of the male tail. In C. elegans, the male tail is 
morphologically distinct from the hermaphrodite tail and contains many male-
specific sensory neurons and sex muscles that are required for mating with 
hermaphrodites. The him-5 mutation was used to increase the frequency of 
males without affecting the morphology of male tails (Hodgkin et al., 1979). 
We found that D1 mutants had no obvious defects in male tail morphology. In 
contrast, male tails of D2, D3 and D4 mutants had defective spicules and this 
phenotype was highly penetrant (Figure 14A-B). Consistent with the 
requirement of spicules for sperm transfer during mating with hermaphrodites 
(Hodgkin, 1983; Liu and Sternberg, 1995), D2, D3 and D4 mutant males were 





Figure 14. Deletion mutants and bed-3 mutants exhibit the male abnormality 
(Mab) phenotype.  
(A) Nomarski images of the male tail (ventral view). him-5 mutants have wild type 
male tail morphology including normal (elongated) spicules, sensory rays (finger-like 
projections containing neurons) and fan. deletion; him-5 mutants had deformed 
spicules. bed-3; him-5 mutants had deformed spicules and were missing sensory 
rays and fan. (B) Frequency of animals having deformed spicules. (C) Absolute 
number of cross-progeny produced from male mating assays.  
 
Interestingly, bed-3 mutants also exhibited the Mab phenotype. This is 
a novel phenotype that was not reported previously for this mutant. Similar to 
deletion mutants, bed-3 mutant males also had defective spicules and mating 
deficiency (Figure 14). In addition, bed-3 mutants had defects in other 
structures of the male tail. They appeared to lack sensory rays and fan 
structures (Figure 14A). In deletion mutants, other structures of the male tail 
appeared to be intact. Thus, the Mab phenotype is more severe in bed-3 




4.2.2.3 Deletion mutants may have a weak defect in vulval cell division   
To further test the possibility that ncRNA genes regulate bed-3 
expression, we examined the deletion mutants for other phenotypes of the 
bed-3 mutant, which include vulval cell division and moulting defects (Frand 
et al., 2005; Inoue and Sternberg, 2010).  
In wild type animals, the vulva contains 22 nuclei. In bed-3 mutants, 
the vulval cell division defect occurs specifically in the terminal division of the 
vulval lineage, resulting in less than 22 vulval nuclei (Inoue and Sternberg, 
2010). As a result, the nuclei of undivided vulval cells are slightly larger and 
the morphology of the vulval structure appears abnormal. We found that a 
small percentage of D2, D3 and D4 mutants had less than 22 vulval nuclei 
and the vulval structure also appeared similar to bed-3 mutants (Figure 15).  
 
 
Figure 15. Deletion mutants may have a weak defect in vulval cell division.  
(A) Nomarski images of the vulva (lateral view). Anterior is to the left and dorsal is to 
the top in all panels. In the mid-L4 stage, the vulva is shown as an invagination of the 
ventral hypodermal tissue (white arrow). The wild type vulva has 22 nuclei and 
appears like a Christmas tree with finger-like projections (red arrowheads). bed-3 and 
deletion mutants had reduced number of vulval nuclei and an abnormal vulval 
structure with loss of finger-like projections (red arrowheads). bed-3 mutants also had 
slightly larger vulval nuclei (black arrowheads). (B) Frequency of animals exhibiting 
the vulval cell division defect.  
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In bed-3 mutants, the moulting defect is characterised by the presence 
of an unshed cuticle (Frand et al., 2005; Inoue and Sternberg, 2010). We 
found that D2, D3 and D4 mutants had no obvious defects in moulting. A 
possible explanation for the absence of moulting defect is the effect of the 
deletion could be restricted to particular tissue(s) since the expression of 
ncRNA genes appears tissue-specific.  
 
4.2.3 Further analysis of the egg-laying defective phenotype 
Since deletion mutants and bed-3 mutants both exhibited the egg-
laying defective (Egl) phenotype, we focused on this phenotype to identify the 
defective tissue(s) that caused the Egl phenotype. As mentioned in Chapter 
1.8, egg-laying requires the coordinated function of HSNs, VC neurons, vulval 
muscles, uterine muscles and the vulva. A defect in any egg-laying tissue can 
result in the Egl phenotype.  
 Given that deletion mutants had a weak defect in vulval cell division 
that results in an abnormal vulval structure (section 4.2.2.2), this vulval defect 
may contribute to the Egl phenotype. However, the Egl phenotype is unlikely 
to be caused solely by a defect in the vulval tissue because of differences in 
the penetrance of the phenotypes. For example, 65% of D4 mutants exhibited 
the Egl phenotype but only 1% of D4 mutants had abnormal vulval 
morphology. Therefore, the Egl phenotype of deletion mutants is likely to 





4.2.3.1 Deletion mutants may have defects in sex muscles and/or vulva 
In hermaphrodites, HSNs play a major role in regulating the egg-laying 
behaviour. HSNs are positioned on the posterior side of the vulva and they 
form neuromuscular junctions with vulval muscles (Figure 5, Figure 16A) 
(Schafer, 2005; White et al., 1986). In wild type animals, HSNs secrete 
neurotransmitters such as serotonin to stimulate vulval muscles contraction 
(Desai et al., 1988; Trent et al., 1983), leading to expulsion of the egg into the 
environment through the vulva (Schafer, 2005; Shyn et al., 2003).  
To test if the egg-laying defect is caused by a defect in HSNs or 
downstream components (vulval muscles or vulva), we treated the deletion 
mutants and bed-3 mutants with serotonin and imipramine (see Methods, 
Chapter 2.13). In wild type animals, treatment with serotonin or imipramine 
induces the egg-laying response (Trent et al., 1983). Imipramine is a tricyclic 
antidepressant that inhibits the re-uptake of serotonin from the synaptic cleft 
into the presynaptic HSN, thereby potentiating the activity of serotonin (Sze et 
al., 2002; Trent et al., 1983). Because of this mechanism, imipramine does 
not induce the egg-laying response in animals lacking serotonin or HSNs. In 
contrast, serotonin acts directly on muscles and thus can induce egg-laying 
even if HSNs or serotonin production is defective. Therefore, if the mutant 
lays eggs in response to serotonin but not imipramine, the mutant is defective 
in HSN. However, if the mutant does not lay eggs in respond to both drugs, 





Figure 16. Egg-laying response of deletion mutants and bed-3 mutants to 
serotonin and imipramine.  
(A) Schematic diagram of a neuromuscular junction between HSN and vulval 
muscles. In wild type animals, HSN releases serotonin into the synaptic cleft, which 
binds to receptors on vulval muscles, stimulating contraction of vulval muscles, 
leading to expulsion of the egg through the vulva. Imipramine inhibits the re-uptake of 
serotonin from the synaptic cleft, thus potentiating serotonin activity. (B) The egg-
laying response to each treatment. Error bars indicate SEM of at least two 
independent assays. For each assay, at least 10 animals were tested with each drug. 
See Methods (Chapter 2.13) for drug concentrations and assay details.  
 
In response to serotonin and imipramine, wild type animals produced 
an average of 15 eggs (Figure 16B). In contrast, bed-3 mutants failed to lay 
eggs in response to both drugs, indicating the vulva and/or vulval muscles are 
defective (Figure 16B, Table 10).  
Compared to wild type animals, serotonin treatment caused D1 and 
D4 mutants to lay approximately 50% and 70% fewer eggs respectively 
(Figure 16B, Table 10). On the other hand, imipramine treatment caused D1 
mutants to lay similar number of eggs as the wild type while D4 mutants laid 
approximately 70% fewer eggs than D1 and wild type controls (Figure 16B, 
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Table 10). In summary, D1 mutants responded partially to serotonin and 
normally to imipramine when compared to the wild type. The normal egg-
laying response of D1 mutants to imipramine suggests that HSNs are 
functional and the activity of endogenous serotonin is normal. In addition, 
vulval muscles and the vulva are likely to be intact. A possible explanation for 
the partial egg-laying response of D1 mutants to serotonin is that exogenous 
serotonin may promote active re-uptake of serotonin, leading to silencing of 
HSN activity and thus inhibiting egg-laying (Shyn et al., 2003). Similar to bed-
3 mutants, D4 mutants exhibited a markedly reduced egg-laying response to 
both drugs, indicating that the vulva and/or vulval muscles are defective. 
 
Table 10. Normalisation of the egg-laying response to wild type. 
Genotype Serotonin Imipramine 
Wild type 1.00 1.00 
D1 0.53 1.00 
D4 0.33 0.27 
bed-3(sy705) 0.00 0.00 
0 = no egg-laying response; 1 = wild type egg-laying response 
 
4.2.3.2 Deletion mutants and bed-3 mutants have defects in vulval 
muscles  
To examine the integrity of vulval muscles in deletion mutants and 
bed-3 mutants, we stained them with FITC-phalloidin (see Methods, Chapter 
2.14). Wild type animals have four pairs of vulval muscles including four VM1 
and four VM2 cells. These four pairs of vulval muscles are distributed equally 
on both sides of the animal, two pairs on the left and two pairs on the right. 
Each pair is made up of one VM1 and one VM2 cell. In the dorsal or ventral 
view, they are arranged in a X-shaped structure. In the lateral view, vulval 
muscles appear as a V-shaped structure (Figure 17A).  
We found that approximately 20% of D3 and D4 mutants exhibited 
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partial loss of vulval muscles, where one or two pairs of vulval muscles were 
absent (Figure 17). Of these 20%, most animals lost two pairs of vulval 
muscles from the same side of the animal (i.e. either left or right side). In 
addition, about 10% of D3 and D4 mutants completely lacked vulval muscles. 
Together, approximately 30% of D3 and D4 mutants exhibited defects in 
vulval muscles. Consistent with the expression of F25H8.16p::gfp in vulval 
muscles (Chapter 3.2.4), removal of ncRNA genes may lead to defects in 
vulval muscles. Almost 100% of bed-3 mutants exhibited complete loss of 
vulval muscles (Figure 17), a novel phenotype that was not reported 







Figure 17. Deletion mutants and bed-3 mutants have defects in vulval muscles.  
(A) GFP and Nomarski images of vulval muscles (VM). Wild type animals have four 
pairs of vulval muscles, which appear as a V-shaped structure in lateral view or a X-
shaped structure in ventral view. Partial loss of vulval muscles includes animals that 
lacked one or two pairs of vulval muscles. (B) Frequency of animals with partial or 
complete loss of vulval muscles.  
 
	 69 
4.2.3.3 Deletion mutants and bed-3 mutants have reduced number of 
sex myoblast (SM) cells  
 Vulval muscles are derived from sex myoblast (SM) cells in the 
mesodermal (M) lineage (Sulston and Horvitz, 1977). In wild type animals, 
two SM cells (SML and SMR) are born near the posterior end of the animal in 
the L2 stage, after multiple divisions of the M mesoblast cell (Figure 18). 
These two SM cells migrate anteriorly to the centre of the worm. In the L3 
stage, each SM cell undergoes three rounds of division to produce eight 
descendants, four vulval muscles and four uterine muscles. In the late L4 
stage, these cells differentiate into mature muscle cells. Taking into account 
the number of SM cells on both left and right sides of the animal, the division 
of SM cell can be divided into four stages: 2 SM stage (1 SM/side), 4 SM 
stage (2 SM/side), 8 SM stage (4 SM/side), 16 SM stage (8 SM/side).  
To determine the reason behind the loss of vulval muscles in deletion 
mutants and bed-3 mutants, we first analysed the division pattern of SM 
lineage using the ayIs6[hlh-8p::gfp] transgene, which is expressed in all cells 
of the M lineage throughout development until right before differentiation 
(Harfe et al., 1998). The hlh-8 gene encodes a basic helix loop helix 
transcription factor required for proper muscle development (Harfe et al., 
1998). We counted the number of ayIs6-expressing cells at each division of 







Figure 18. Mesodermal (M) lineage.  
(A) Schematic representation of the M lineage, adapted from (Jiang et al., 2005). The 
M cell undergoes four to five rounds of division to produce body wall muscles (BWM), 
coelomocytes (CC) and sex myoblast (SM) cells on the posterior end of the animal in 
the L2 stage. Then, SM cells migrate to the centre, where they undergo three rounds 
of division to produce eight vulval muscles (VM) and eight uterine muscles (UM). (B) 
Images showing the number of SM nuclei after each division (lateral view). Note: 
another identical set of cells is present on the other side of the animal (on another 
focal plane). L: left; R; right.  
 
In the 16 SM stage, most D1 mutants had 16 SM cells (the wild type 
pattern) (Figure 19A). In contrast, the percentage of D2, D3 and D4 mutants 
that had 16 SM cells was reduced. Approximately 15% of D2, 30% of D3 and 
20% of D4 mutants had partial loss of SM cells (i.e. 8 SM cells), which 
appeared to occur on the left or right side of the animal at random. In addition, 
15% of D3 and D4 mutants completely lacked SM cells. Together, these data 
are consistent with the loss of vulval muscles in the FITC-phalloidin-stained 
animals (Section 4.2.3.2). The deletion is unlikely to affect the third round of 
SM division from 8 SM to 16 SM because there was no significant increase in 





Figure 19. Deletion mutants and bed-3 mutants have reduced number of sex 
myoblast (SM) cells.  
(A-D) Frequency of animals with x number of SM cells. The number of SM cells 
includes ayIs6-expressing cells found on both left and right sides of the animal. At 
each SM stage, blue bars represent wild type number of SM cells, red bars represent 
partial number of SM cells and green bars represent absence of SM cells. Abnormal 
includes animals with abnormal positioning of SM cells such as all cells being found 




In 8 SM and 4 SM stages, the overall distribution across all genotypes 
was similar to the 16 SM stage (Figure 19B-C). Thus, the deletion also likely 
does not affect the first and second rounds of SM division. Notably, deletion 
mutants also exhibited partial and complete loss of SM cells in the 2 SM 
stage (Figure 19D), suggesting that SM cells are probably lost before SM cell 
division starts.  
In 100% of bed-3 mutants, SM cells and SM descendants were absent 
in all four SM stages (Figure 19), suggesting that defects in SM cells and 
vulval muscles likely occur much earlier in development. Specifically, defects 
may occur in the migration of SM cells from the posterior end to the centre or 
the generation of SM cells near the posterior end of the animal.  
To test if deletion mutants and bed-3 mutants had defects in the 
generation of SM cells near the posterior end of the animal, we counted the 
number of ayIs6-expressing cells at the L2 stage, before SM cells migrate to 
the centre. In wild type animals, the M cell undergoes four to five rounds of 
division to produce a total of 18 cells, including 10 cells on the ventral side 
and eight cells on the dorsal side (Figure 20A). On the ventral side, two 
become SM cells and the remaining eight become body wall muscles. On the 











Figure 20. Deletion mutants and bed-3 mutants may have defects in the 
generation of sex myoblast (SM) cells.  
(A) Schematic representation of the M lineage, adapted from (Jiang et al., 2005). The 
M cell undergoes four to five rounds of division to produce 18 cells including 14 body 
wall muscles (BWM), two coelomocytes (CC) and two SM cells near the posterior end 
of the animal in the L2 stage. 10 cells are found on the ventral side and eight cells are 
on the dorsal side of the animal. ayIs6[hlh-8::gfp] is expressed in all M-derived cell 
types. (B-D) Each L2 animal was assayed for the number of ayIs6-expressing cells 
on dorsal and ventral sides. The total cell count in (B) was the sum of dorsal and 
ventral cell counts.  
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When we counted the total number of cells (including cells on the 
dorsal and ventral sides), most D1 mutants had 18 cells (Figure 20B). The 
percentage of D2, D3 and D4 mutants having 18 cells was reduced and there 
was a simultaneous increase in the percentage of animals having 16-17 cells. 
The majority of bed-3 mutants had 15-17 cells. Therefore, the total cell count 
was reduced in deletion mutants and bed-3 mutants, suggesting that the cell 
division of M descendants was affected.  
To determine if the reduced total cell count is related to defects in the 
generation of SM cells, we also looked at the number of cells on the ventral 
side (Figure 20C). Similar to the distribution in the total cell count, deletion 
mutants and bed-3 mutants had reduced number of ventral cells as compared 
to ayIs6 and D1 controls. Since SM cells are born on the ventral side, these 
results suggest defects in the generation of SM cells. Therefore, the loss of 
vulval muscles in deletion mutants and bed-3 mutants is likely caused by 
defects in the generation of SM cells. 
To confirm the reduction in total cell count is not related to a lack of 
cell divisions on the dorsal side, we also noted the number of dorsal cells 
(Figure 20D). More than 50% of D2, D3 and D4 and bed-3 mutants had eight 
cells. Interestingly, we observed an increase in the percentage of animals 
having extra cells (i.e. >8 cells). The presence of extra cells on the dorsal side 
and the parallel reduction in cell number on the ventral side suggests some 
cells on the ventral side may undergo cell fate change to become cells on the 
dorsal side (e.g. SM à CC). Alternatively, extra cell divisions may have 
occurred on the dorsal side.  
Therefore, deletion mutants and bed-3 mutants have an overall 
decrease in the total number of ayIs6-expressing cells, which is largely due to 
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the reduced cell count on the ventral side. It is important to note that the ayIs6 
transgene is expressed in all 18 M-derived cells, including SM cells, body wall 
muscles and coelomocytes. Thus, we cannot be certain that the reduced cell 
count on the ventral side corresponds to the loss of SM cells because body 
wall muscles and coelomocytes also express ayIs6.    
 
4.2.4 Effect of the deletion on bed-3 expression  
Deletion mutants exhibited many phenotypes that are also found in 
bed-3 mutants including the Mab phenotype, the Egl phenotype, vulval cell 
division defect, vulval muscle defect and reduced number of SM cells. Given 
the phenotypic similarity, we hypothesized that ncRNA genes regulate bed-3 
expression in cis. The deletion of ncRNA genes may reduce bed-3 
expression, thus resulting in the phenotypes observed. Alternatively, the 
deletion of ncRNA genes may affect the expression of other unknown 
target(s). However, it is also important to note that the phenotypes observed 
may be unrelated to the deletion of ncRNA genes. Rather, the phenotype may 
be caused by loss of specific bed-3 regulatory element (e.g. enhancer).  
To test whether the deletion affects bed-3 expression, we carried out 
rescue experiments, genetic complementation test, qPCR and single 
molecule fluorescence in situ hybridisation.  
 
4.2.4.1 The deletion likely affects bed-3 expression in cis  
 To determine whether the deletion regulates the target gene 
expression in cis or in trans, we carried out a rescue experiment. We 
reintroduced a 8.5 Kb DNA fragment containing 14 wild type ncRNA genes 
(Figure 21A) into the D4 mutant and observed whether the Egl phenotype is 
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rescued. A rescue of the Egl phenotype in the progeny carrying the transgene 
indicates that ncRNAs act in trans to regulate the target expression because 
ncRNAs are expressed from the extrachromosomal transgene. On the other 
hand, a lack of rescue suggests that the deletion acts in cis to regulate its 
target expression.  
We found that D4; qwEx186[14 ncRNA genes] animals carrying the 
ncRNA transgene still exhibited the Egl phenotype at a frequency that was 
comparable to the D4 mutant (Figure 21B), indicating an absence of rescue. 
This suggests that the deletion is likely to regulate its target expression in cis.  
 
 
Figure 21. The transgene containing 14 ncRNA genes did not rescue the Egl 
phenotype of D4 mutants.  
(A) Location of the 8.5 Kb fragment containing 14 ncRNA genes (green box). (B) 
Frequency of animals exhibiting the Egl phenotype.  
 
If the deleted region affects a neighbouring gene, the most likely cis-
regulated target is bed-3 because bed-3 gene is closest to the ncRNA gene 
cluster and mutations in bed-3 cause the Egl phenotype. Mutations in the 
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other adjacent protein-coding genes, such as best-13 and dur-1 (downstream 
of bed-3) do not cause the Egl phenotype. 
 To test whether the deletion regulates bed-3 in cis, we performed a 
genetic complementation test. The complementation test is used to determine 
whether two mutations affect the same gene when (i) both mutations cause 
the same phenotype, (ii) both mutations are present on the same 
chromosome and (iii) both mutations are recessive. 
 Since both the deletion and the bed-3 mutation are found on the same 
chromosome and both cause the Egl phenotype, we used the 
complementation test to determine whether the deletion causes the Egl 
phenotype by affecting bed-3 expression. We crossed deletion mutants to 
bed-3 mutants to generate deletion/bed-3(sy705) trans-heterozygotes, in 
which one chromosome carries deleted ncRNA genes and wild type bed-3 
while the homologous chromosome carries wild type ncRNA genes and 
mutated bed-3 (Figure 22A). Subsequently, we examined the frequency of the 
Egl phenotype in deletion/bed-3 trans-heterozygotes. If the deletion and the 
bed-3 mutation affect different genes (i.e. the deletion does not affect bed-3), 
we expect deletion/bed-3 trans-heterozygotes to have no Egl phenotype (i.e. 
phenotypically wild type) because the wild type copy of each gene is sufficient 
to compensate for the function. The absence of the Egl phenotype indicates 
that the deletion and bed-3 mutation complement each other. On the other 
hand, if the deletion affects bed-3 expression, we expect deletion/bed-3 trans-
heterozygotes to exhibit the Egl phenotype. The presence of the Egl 
phenotype indicates that the deletion and bed-3 mutation do not complement 
each other.  
In wild type and D1/bed-3 trans-heterozygotes, the frequency of 
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animals exhibiting the Egl phenotype was close to 0% (Figure 22B). In 
contrast, deletion/bed-3 trans-heterozygotes for D2, D3 and D4 exhibited the 
Egl phenotype, indicating that the deletion did not complement bed-3.  
 
 
Figure 22. The deletion failed to complement bed-3.  
(A) Schematic representations of homozygotes, heterozygotes and trans-
heterozygotes. (B) Frequency of animals with the Egl phenotype. “+” indicates a wild 




Additionally, deletion/bed-3 trans-heterozygotes consistently exhibited 
the Egl phenotype at a frequency intermediate between homozygous deletion 
mutants and bed-3 mutants (Figure 22B). For example, the Egl phenotype 
was observed in 86% of D4/bed-3 trans-heterozygotes, a frequency higher 
than D4 homozygotes (65%) but lower than bed-3 homozygotes (97%). This 
intermediate frequency of the Egl phenotype found in deletion/bed-3 trans-
heterozygotes suggests that the deletion reduces the expression of the wild 
type copy of bed-3 in cis. In other words, if the linked deletion reduces 
expression of the wild type copy of bed-3, the overall bed-3 function is 
expected to be further reduced (compared to bed-3/+ heterozygotes), 
resulting in the Egl phenotype. The deletion reduced bed-3 function less than 
the bed-3(sy705) mutation because deletion/bed-3 trans-heterozygotes 
exhibited a frequency of Egl phenotype that was lower than homozygous bed-
3 mutants. Consistently, the frequency of the Egl phenotype in deletion/bed-3 
trans-heterozygotes was higher than in homozygous deletion mutants.  
To rule out the possibility that the Egl phenotype observed in 
deletion/bed-3 trans-heterozygotes was due to a dominant effect of the 
deletion or bed-3 mutation, we constructed the corresponding heterozygotes 
(deletion/+ or bed-3/+) and examined them for the Egl phenotype (Figure 22). 
We found that both the deletion and the bed-3 mutation were recessive. 
Together with the lack of rescue, these results suggest that the deletion 
affects bed-3 expression in cis.  
 
4.2.4.2 The deletion does not affect the total bed-3 mRNA level 
To further test whether the deletion affects bed-3 expression, we 
evaluated bed-3 mRNA level in deletion mutants using qRT-PCR. Relative to 
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the wild type, we found that the bed-3 mRNA level of D1 and D4 mutants was 
slightly increased by about 1.5 fold (Figure 23). Although slightly up-
regulated, there was no significant difference in the relative bed-3 mRNA 
expression between the D1 control and the D4 mutant, indicating that the 
deletion had no obvious effect on the total amount of bed-3 mRNA. 
Nonetheless, there is still a possibility that bed-3 mRNA level is depleted in 
deletion mutants in a tissue-specific manner and this could be undetected 
when we used total RNA isolated from whole worms.  
 
 
Figure 23. The deletion did not significantly affect the total bed-3 mRNA level.  
act-1/actin was used for normalisation. The graph represents the average fold change 
calculated from three assays carried out in parallel (see Methods, Chapter 2.4).  
 
4.2.4.3 The deletion reduces bed-3 expression in SM cells 
To test whether the deletion affects endogenous bed-3 expression in 
specific tissues, we carried out single molecule fluorescence in situ 
hybridisation (smFISH). In contrast to conventional RNA in situ hybridisation, 
smFISH is a quantitative and highly sensitive method for detection of RNA 
transcripts at the single molecule level (Femino et al., 1998; Raj et al., 2008). 
The detection is based on the binding of multiple fluorophore-conjugated 
short DNA probes to the entire length of a RNA transcript, yielding a 
fluorescence spot. Each fluorescent spot corresponds to a single RNA 
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transcript. To carry out smFISH, we generated 48 tetramethylrhodamine 
(TMR)-conjugated probes targeting bed-3 mRNA (see Methods, Chapter 
2.15).  
Since deletion mutants and bed-3 mutants exhibited many egg-laying 
related defects, the deletion may affect the expression of bed-3 in specific 
tissues of the egg-laying system. Using smFISH, we first determined whether 
bed-3 is expressed in tissues of the egg-laying system, including vulval cells, 
vulval muscles, HSNs and VC neurons. Consistent with previously reported 
bed-3::gfp expression (Figure 4, Chapter 1.8) (Inoue and Sternberg, 2010), 
endogenous bed-3 mRNA is predominantly expressed in hypodermal cells 
and vulval cells.  
Since deletion mutants exhibited a weak defect in vulval cell division, 
we quantitated the expression of bed-3 in vulval cells (Figure 24). The bed-3 
mRNA level in vulval cells of the D4 mutant was not significantly different from 
D1 and wild type controls. In contrast, the bed-3 mRNA level in vulval cells of 
the bed-3(sy705) mutant was significantly reduced compared to the wild type. 
bed-3(sy705) is a nonsense mutation that results in premature termination 
(Inoue and Sternberg, 2010). The reduction in bed-3 mRNA may occur due to 







Figure 24. The deletion did not affect bed-3 expression in the vulva.  
(A) Images showing the level of bed-3 TMR signal in the vulva of mid-L4 animals. The 
location of the vulva is indicated by the white dotted triangle. Each TMR spot 
represents a single bed-3 mRNA molecule. (B) Quantitation of bed-3 mRNA level. 
Each black circle represents the number of bed-3 mRNA molecules in one animal, as 
detected by smFISH. Synchronised mid-L4 animals were assayed. Unpaired t test 
was used. Error bars represent SEM. 
 
In addition to reported sites of bed-3::gfp expression, we also 
determined previously unknown sites of endogenous bed-3 expression by 
hybridising TMR-conjugated bed-3 probes to tissue-specific GFP strains and 
looked for colocalisation. Specifically, we used ayIs2[egl-15::gfp], 
ccIs4595[ceh-24::gfp] and ccIs4443[arg-1::gfp] strains to facilitate the 
identification of fully differentiated vulval muscles (i.e. X-shaped structure). To 
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identify VC neurons, we used the syIs80[lin-11::gfp] strain. However, we did 
not observe bed-3 TMR signal in fully differentiated vulval muscles and VC 
neurons during late L4 and adult stages. For HSNs, we used mgIs42[tph-
1::gfp] and cyIs4[cat-1::gfp] strains but did not observe colocalisation possibly 
because these two strains only express a visible GFP signal in HSNs during 
the adult stage but bed-3 expression is low in adults.  
We next examined whether bed-3 is expressed in the M lineage using 
the ayIs6[hlh-8::gfp] strain. We found that bed-3 is expressed in M daughters 
and descendants as well as SM cells (Figure 25), an expression pattern that 
was not documented previously. In L1 and L2 stages, the bed-3 TMR signal 
appeared stronger in 2 M and 4 M stages as compared to 8 M, 16 M and 18 
M stages. In the L3 stage, bed-3 is expressed in SM cells in the centre of the 
animal.  
Since deletion mutants exhibited defects in vulval muscles, we next 
investigated whether bed-3 expression is affected in SM cells, the precursor 
cells of vulval muscles. Compared to wild type and D1 controls, the bed-3 
mRNA level in SM cells of D2, D3 and D4 mutants was significantly reduced 
(Figure 26). Therefore, the reduced bed-3 expression in SM cells may 









Figure 25. bed-3 is expressed in the M lineage.  
Anterior is to the left and posterior is to the right in all panels. All images show the 
lateral view. The ayIs6[hlh-8::gfp] transgene was used to facilitate identification of 
cells in the M lineage. bed-3 TMR signal was first observed in the 2 M stage and was 
also present in the 4 M stage (not shown). In the 8 M stage, the level of bed-3 TMR 
signal appeared reduced as compared to the earlier M stages. Moreover, a strong 
bed-3 TMR signal was observed in SM cells (white arrowhead) at the centre of the 





Figure 26. Deletion mutants have reduced bed-3 expression in SM cells.  
(A) Images showing the level of bed-3 TMR signal in SM cells of L3 animals (lateral 
view). White arrowheads indicate the location of SM cells. Each TMR spot represents 
a single bed-3 mRNA molecule. The ayIs6[hlh-8::gfp] transgene was used to facilitate 
identification of SM cells. (B) Quantitation of bed-3 mRNA level. Each black 
circle/square represents the number of bed-3 mRNA molecules detected by smFISH 
in one animal. Synchronised L3 animals were assayed. Unpaired t test was used. 
Error bars represent SEM. 
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4.2.4.4 Overexpression of bed-3 in the M lineage partially rescues the 
Egl phenotype of D4 mutant  
 To confirm that the reduced bed-3 expression in SM cells causes the 
Egl phenotype observed in deletion mutants, we overexpressed bed-3 cDNA 
in the M lineage under the control of the hlh-8 promoter (the same promoter 
used in the ayIs6 transgene). We found that overexpression of bed-3 in the M 
lineage reduced the frequency of the Egl phenotype in D4 mutant from 65% to 
approximately 50% (p=0.0028) (Figure 27). The incomplete rescue of the Egl 
phenotype suggests that other defects may be present in the egg-laying 
system, in addition to the loss of SM cells and vulval muscles. Another 
possibility is the deletion may affect the expression of other unknown cis-
regulated target (apart from bed-3) that is also required in the egg-laying 
process. Alternatively, the C-terminal GFP tag may interfere with bed-3 
function. Nonetheless, the reduced bed-3 expression in SM cells likely 
partially accounts for the Egl phenotype observed in deletion mutants. 
 
 
Figure 27. Overexpression of bed-3 in the M lineage reduced the frequency of 
the Egl phenotype in D4 mutant.  





4.3.1 The deleted region positively regulates bed-3 expression in a 
tissue-specific manner 
We have shown that deletion mutants exhibited two distinct 
phenotypes, the Egl phenotype and the Mab phenotype. Further analysis of 
the Egl phenotype indicated that defects in vulval cell division, vulval muscles 
and generation of SM cells might contribute to the Egl phenotype of deletion 
mutants. All the phenotypes exhibited by deletion mutants are also found in 
bed-3 mutants. Using genetic complementation test and rescue experiment, 
we found that the Egl phenotype of deletion mutants is likely caused by a 
decrease in bed-3 expression. smFISH experiments further demonstrated 
that the deletion reduced bed-3 expression specifically in SM cells. The 
overexpression of bed-3 in the M lineage reduced the percentage of D4 
mutants exhibiting the Egl phenotype. Therefore, the deleted region positively 
regulates bed-3 expression in a cis-acting and cell type-specific manner. The 
tissue-specific regulation is generally consistent with the previous observation 
that ncRNA genes have tissue-specific expression (Chapter 3.2.4). Although 
we did not observe F25H8.16p::gfp expression in SM cells, ncRNA genes 
may still affect bed-3 expression in SM cells. One possibility is that the 
promoter included in the F25H8.16p::gfp reporter may not carry the regulatory 
element that is required for expression in SM cells. Alternatively, other ncRNA 
genes whose expression pattern have not been characterised may be 
expressed in SM cells. 
How does the deletion affect bed-3 expression in a cis-acting and 
tissue-specific manner? The deleted regions in D2, D3 and D4 mutants 
removed a large number of ncRNA genes. Additionally, because the deleted 
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regions are relatively large (7.5 Kb to 11.5 Kb), the deletion may also remove 
unidentified enhancer elements present in the region. The size of enhancers 
can range from 100 bases to several Kb, but are typically around 500 bases 
(Loots, 2008). Therefore, the element(s) that affect bed-3 expression in cis 
could be (i) ncRNAs with tissue-specific expression or (ii) tissue-specific 
genomic enhancers. ncRNAs with tissue-specific expression could also 
include eRNAs. 
 
4.3.2 The Egl phenotype of deletion mutants may result from a 
combination of defects in egg-laying tissues  
 As mentioned previously, the egg-laying system comprises multiple 
tissues including the vulva, vulval muscles, uterine muscles, HSNs and VC 
neurons (Sulston and Horvitz, 1977; White et al., 1976). A defect in any of 
these tissues can result in the Egl phenotype. Our results indicate that defects 
in vulval cell division, vulval muscles and generation of SM cells may 
contribute to the Egl phenotype of deletion mutants. Because the deletion did 
not affect bed-3 expression in the vulva, the vulval cell division defect likely 
contributes a minor part to the Egl phenotype of deletion mutants. The defects 
in vulval muscles and generation of SM cells likely play a larger role in 
causing the Egl phenotype of deletion mutants. In support of this, the 
penetrance of the vulval muscles and SM cells defects is higher than the 
penetrance of the vulval cell division defect (Table 11). It is also important to 
note that defects in the generation of SM cells can also lead to defects in 
uterine muscles, since both uterine muscles and vulval muscles are derived 
from SM cells. However, in this study, we did not examine deletion mutants 
for defects in uterine muscles.  
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The frequency of the Egl phenotype observed in deletion mutants did 
not correspond to the frequency of defects in any particular egg-laying tissue 
(Table 11). Therefore, additional defects may be present. Since bed-3 is not 
expressed in VC neurons, VC neurons are less likely to contribute to the Egl 
phenotype of deletion mutants. Perhaps, there could be defects in the 
connection between egg-laying tissues (e.g. the attachment of vulval muscles 
to the vulva).  
Our results also showed that D2, D3 and D4 mutants had similar 
reduction in bed-3 mRNA level in SM cells, yet, D3 and D4 exhibited more 
severe SM defects and a more penetrant Egl phenotype than D2 mutants. 
This suggests that the element regulating bed-3 expression in SM cells may 
be located in the D2 deleted region. The stronger SM defect and the Egl 
phenotype in D3 and D4 mutants suggest that ncRNA or enhancer present in 
the D3/D4 deleted region may affect the expression of other unknown gene(s) 
that is required for egg-laying. 
 
Table 11. Summary of egg-laying related defects in deletion mutants. 
Genotype % Egl % vulval cell division defect 
% loss of vulval 
muscles 
% loss of SM 
cells 
Wild type 0 0 0 0 
D1 1 0 0 2 
D2 25 6 0 6 
D3 52 3 27 37 
D4 65 1 26 43 
bed-3(sy705) 97 100 100 100 
Loss of vulval muscles includes animals that exhibited partial and complete loss of 
vulval muscles. Loss of SM cells includes animals that exhibited partial and complete 




4.3.3 The Mab phenotype of deletion mutants may result from defects 
in rectal B cell lineage or M lineage  
 In deletion mutants, the Mab phenotype is characterised by the 
presence of deformed spicules in the male tail. Spicules are derived from the 
rectal epithelial B cell in the tail. The B cell in males undergoes multiple 
rounds of division to produce 47 descendants including spicule cells, 
proctodeal (male rectum) cells and hypodermal cells (Sulston and Horvitz, 
1977). The proctodeal cells are important for shaping the morphology of 
spicules. The extended structure of spicules results from the anterodorsal 
migration of two proctodeal cells, resulting in the elongation of spicules 
(Sulston et al., 1980). The migration of proctodeal cells requires TGF-β-like 
signalling (Baird and Ellazar, 1999). Thus, deformed spicules can result from 
defects in migration or generation of proctodeal cells in the B lineage. Since 
deletion mutants may have division defects in the M lineage, we speculate 
that the deletion may also affect the generation of proctodeal cells in the B 
lineage, possibly through affecting bed-3 expression.  However, we did not 
test whether bed-3 is expressed in the B lineage in this study.  
Alternatively, deformed spicules can also result from defects in the M 
lineage. Previously, it was reported that male animals with ablated M cell or 
spicule retractor muscles (descendants of M cell) also have deformed 
spicules (Sulston et al., 1980). This is likely because spicule muscles provide 
the source of TGF-β-like signal, which is required for proper migration of 
proctodeal cells (Baird and Ellazar, 1999). Since we observed expression of 
F25H8.16p::gfp in spicule muscles (Figure 10, Chapter 3.2.4), we speculate 
the deletion may lead to defects in spicule muscles and thus affect the 
migration of proctodeal cells. Our data appear to support this possibility. In D2 
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mutants, 69% of the animals exhibited deformed spicules yet 100% of them 
are deficient in mating (Table 12). This discrepancy may be explained by a 
defect in spicule muscles, such that the muscles fail to insert spicules into the 
vulva of hermaphrodites during mating (Garcia et al., 2001).  
 
Table 12. Summary of the Mab phenotype in deletion mutants.  
Genotype % deformed spicules % mating deficient 
Wild type 0 0 
D1 0 0 
D2 69 100 
D3 100 100 
D4 100 100 
bed-3(sy705) 100 100 
 
 
4.3.4 bed-3 may regulate other lineage division in addition to vulval 
lineage  
 We observed that bed-3 mutants exhibited the Mab phenotype as well 
as the complete loss of vulval muscles and SM cells. These phenotypes have 
not been reported previously. Since bed-3 mutants may have defects in the 
generation of SM cells, bed-3 may affect the division of M lineage, similar to 
how bed-3 affects the division of the vulval lineage (Inoue and Sternberg, 
2010). Consistent with the function of bed-3 in the M lineage, we showed that 
bed-3 is expressed in M descendants and SM cells, a previously unknown 
site of expression. This observation also suggests that the regulatory element 
required for M lineage expression is not found within the 1.4 Kb promoter and 
intron 3 enhancer used in the bed-3::gfp reporter because the reporter is only 
expressed in hypodermal cells and vulval cells (see Figure 4) (Inoue and 
Sternberg, 2010). Thus, the M lineage-specific element may be found further 
upstream or downstream of bed-3 gene.  
 Additionally, the Mab phenotype of bed-3 mutants includes defects in 
spicules, sensory rays and fan. As mentioned earlier, deformed spicules may 
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result from defects in B lineage or M lineage (Baird and Ellazar, 1999; Sulston 
et al., 1980). The sensory rays are derived from posterior seam cells V5, V6 
and T (Sulston and Horvitz, 1977). In males, these cells undergo additional 
cell divisions (as compared to hermaphrodites) to generate sensory rays. The 
absence of sensory rays in bed-3 mutants suggests loss of divisions in these 
cells. However, Inoue and Sternberg (2010) reported that bed-3 mutation did 
not affect the division of seam cells in hermaphrodites. One possibility is that 
bed-3 may affect the male-specific divisions of V5, V6 and T cells.  
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 As mentioned in Chapter 4, the element whose deletion caused the 
reduced bed-3 expression and the resulting Egl phenotype could be (i) 
functional ncRNAs or (ii) enhancers. To determine whether the RNA product 
is required for regulating bed-3 expression, we attempted knockdown 
experiments to deplete the level of RNA transcript and test for presence of the 
Egl phenotype. In mammalian systems, siRNAs are effective in reducing the 
expression of some lncRNAs (Lai et al., 2013; Orom et al., 2010). In this 
study, we used two RNAi methods, feeding and injection that relied on dsRNA 
to knockdown the level of ncRNA expression (Fire et al., 1998; Kamath et al., 
2001). We also tested the effect of locked nuclei acid (LNA) gapmers, a type 
of antisense oligos effective against mammalian lncRNAs, in reducing gene 
expression in C. elegans (Appendix II).  
 To further test the function of ncRNA genes near bed-3, we also 
overexpressed ncRNA genes and examined the phenotypic consequences.  
 
5.2 Results 
5.2.1 RNAi by feeding against ncRNA genes cause no obvious 
phenotypes 
Since deletion mutants exhibited the Egl phenotype, we hypothesized 
that we may observe the Egl phenotype when we deplete the expression of 
ncRNAs. We fed worms with bacteria expressing dsRNA corresponding to 
individual or small clusters of ncRNAs. The RNAi vector (L4440) was used as 
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a negative control (see Methods, Chapter 2.9). We did not observe the Egl 
phenotype when we fed dsRNA corresponding to F25H8.16, F25H8.21 and 
F25H8.13 individually. Similarly, feeding of dsRNA corresponding to small 
clusters of ncRNAs (R1, R2, R3; Table 13) also did not give the Egl 
phenotype. Furthermore, we did not observe other obvious phenotypes in all 
RNAi-treated animals.  
 
Table 13. DNA fragments used for RNAi against small clusters of ncRNAs. 
DNA fragment 
inserted into L4440 ncRNA genes present in the DNA fragment 
R1 F25H8.16, F25H8.14, F25H8.9, F25H8.24 
R2 F25H8.23, F25H8.25 
R3 F25H8.22, F25H8.11, F25H8.13 
L4440 is the RNAi empty vector (see Methods, Chapter 2.9). For exact location of the 
DNA fragment, see Figure 7. 
 
5.2.2 RNAi by injection against ncRNA genes may cause a low 
frequency of the Egl phenotype  
 We next tested the effect of RNAi on ncRNA genes using the injection 
method. The injection of dsRNA into the syncytial germ line cells tends to give 
a more reliable knockdown of gene expression (in the progeny) as compared 
to the feeding method (Ahringer, 2006; Kamath et al., 2001). To ensure that 
RNAi injection works in our hands, we included a positive control, par-5, 
which encodes a 14-3-3 protein. Depletion of par-5 expression results in the 
embryonic lethal phenotype (Morton et al., 1992; Morton et al., 2002). 
Consistent with the expectation, we observed the embryonic lethal phenotype 
when par-5 expression is depleted by the injected dsRNA (Table 14).  
 When we injected dsRNA at a high concentration (1ng/μl), bed-
3(RNAi) animals exhibited the Egl phenotype at a moderately high 
penetrance (>50%) (Table 14). Interestingly, RNAi against individual ncRNA 
genes F25H8.16, F25H8.21 and F25H8.13 also resulted in the Egl phenotype 
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at a low frequency (Table 14). RNAi against individual ncRNA genes also 
resulted in the sterile phenotype. To ensure that the Egl phenotype did not 
result from a high dose of dsRNA injection, we also injected 1ng/μl of dsRNA 
targeting against miro-1 (a mitochondrial Rho GTPase). miro-1 was used 
because a mutation in miro-1 does not cause the Egl phenotype (Y. Shen and 
T. Inoue, pers. comm.). As expected, RNAi against miro-1 did not result in the 
Egl phenotype (Table 14), indicating that the Egl progeny observed in bed-
3(RNAi) and ncRNA(RNAi) are not due to the high concentration of dsRNA 
injection. Similar to ncRNA(RNAi) animals, miro-1(RNAi) animals also 
exhibited the sterile phenotype, suggesting that this phenotype is likely 
caused by high concentration of dsRNA injection.  
 When we reduced the concentration of injected dsRNA to 0.5ng/μl, 
bed-3(RNAi) animals consistently exhibited the Egl phenotype (Table 14). 
However, the Egl phenotype observed in F25H8.16(RNAi), F25H8.21(RNAi) 
and F25H8.13(RNAi) animals was no longer present (Table 14). This 
suggests that RNAi against individual ncRNA genes may have a weaker 
effect on bed-3 expression.  
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No. of WT 
injected (P0) 
% P0 that survived 
on day 2 
Phenotypes of progeny from day 2  
(24-48hr post-injection) 
par-5 1.0 2 100 •100% of injected P0 produced 100% embryonic lethal and sterile progeny 
miro-1 1.0 14 79 
•82% of injected P0 produced progeny with no obvious phenotype 
•18% of injected P0 produced some sterile progeny 
bed-3 1.0 14 79 
•82% of injected P0 produced >50% Egl progeny 
•18% of injected P0 produced progeny with no obvious phenotype 
F25H8.16 1.0 14 79 
•55% of injected P0 produced progeny with no obvious phenotype 
•27% of injected P0 produced ~10% Egl progeny 
•27% of injected P0 produced some sterile progeny 
F25H8.21 1.0 14 50 
•71% of injected P0 produced ~5% Egl progeny 
•29% of injected P0 produced some sterile progeny 
F25H8.13 1.0 14 64 
•11% of injected P0 produced ~30% Egl progeny 
•33% of injected P0 produced progeny with no obvious phenotype 
•56% of injected P0 produced some sterile progeny 
bed-3 0.5 7 57 •100% of injected P0 produced >50% Egl progeny 
F25H8.16 0.5 14 79 •100% of injected P0 produced progeny with no obvious phenotype 
F25H8.21 0.5 14 86 •100% of injected P0 produced progeny with no obvious phenotype 
F25H8.13 0.5 14 64 •100% of injected P0 produced progeny with no obvious phenotype 
Wild type (WT) animals were injected with dsRNA at different concentrations (see Methods, Chapter 2.9). Day 2 indicates 24-48hr post-
injection. The phenotypes were examined in the immediate F1 progeny of injected P0. Egl: egg-laying defective. The percentage of P0 in the 
right-most column was calculated based on the number of P0 that survived on day 2.  
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5.2.3 Overexpression of ncRNA gene(s) may lead to the rod-like larval 
lethality phenotype  
In addition to the analysis of deletion mutants (Chapter 4), we also 
attempted to overexpress ncRNA genes. Wild type animals that contained a 
high copy number of 14 ncRNA genes (8.5 Kb DNA fragment; qwEx188) 
exhibited the rod-like larval lethality phenotype, a well-established phenotype 
that is observed in animals with excretory defects (Nelson and Riddle, 1984). 
The rod-like larval lethal phenotype is characterised by an accumulation of 
fluid in the body cavity and distinctive rod-like appearance of arrested animals 
(Figure 28). This phenotype was observed in approximately 20% of animals 
carrying the ncRNA transgene. When we reduced the injected concentration 
of ncRNAs-containing DNA fragment to 10ng/μl (qwEx194), the frequency of 
rod-like larval lethality phenotype was significantly reduced (Figure 28). This 
suggests that the rod-like larval lethality phenotype is dependent on the level 
of ncRNA gene expression.  
 To narrow down the region (within the 8.5 Kb fragment) that gave rise 
to the rod-like larval lethality phenotype, we tested two smaller 1 Kb regions 
within the 8.5 Kb DNA fragment (Figure 28). Of these, wild type animals that 
carried a high copy number of predicted ncRNA genes F25H8.19, F25H8.20 
and F25H8.10 displayed the rod-like larval lethality phenotype at a frequency 
similar to the larger fragment containing 14 ncRNA genes. We further tested 
two sub-fragments (500 bp and 300 bp fragments) of this 1 Kb region (Figure 
28). Wild type animals that carried a high copy number of predicted ncRNA 
gene F25H8.19 (500 bp DNA fragment) exhibited the same phenotype, with a 





Figure 28. Overexpression of ncRNA gene(s) may lead to the rod-like larval 
lethality phenotype.  
(A) Schematic representation of the regions that were overexpressed. (B) Nomarski 
images of wild type larva and rod-like lethal larva. (C) Frequency of animals that 
exhibited the rod-like larval lethality phenotype. The bars are colour-coded with the 
corresponding regions in (A). Fisher’s exact test was used.  
 
The rod-like larval lethality phenotype is caused by a defect in the 
development or function of the excretory system (Nelson and Riddle, 1984), 
thus resulting in fluid accumulation. C. elegans excretory system is the 
functional equivalent of human kidneys (Figure 29). The proper functioning of 
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the excretory system is dependent on the integrity of three excretory cells, the 
canal cell, the duct cell and the pore cell because ablation of anyone of these 
cells resulted in the rod-like larval lethality phenotype (Nelson and Riddle, 
1984). Previously, it was shown that EGF/Ras signalling is required to specify 
the excretory duct cell fate and mutations in EGF/Ras pathway components 
cause the rod-like larval lethality phenotype (Sundaram, 2013; Yochem et al., 
1997). These data suggest that overexpression of F25H8.19 may lead to loss 
of EGF/Ras signalling in the excretory system, thereby leading to the rod-like 
larval lethality phenotype. Alternatively, overexpression of F25H8.19 may also 
lead to defects in the development of canal cell, pore cell or the connection 
between these cells.  
 
 
Figure 29. The excretory system.  
(A) The excretory system is made up of four main cells, canal cell (red), duct cell 
(beige), pore cell (yellow) and gland cells (blue) connected to one another. These 
cells are found in the head near the posterior bulb of the pharynx and on the ventral 
surface of the animal. Image taken from Wormatlas (http://www.wormatlas.org). (B) 
Nomarski image depicting the excretory system. The pore cell and gland cells are 




To test if F25H8.19 is likely to function in the excretory system, we 
examined the expression pattern and also determined whether the ncRNA 
transcript is present. Using promoter::GFP reporter, we found that 
F25H8.19p::GFP was not expressed in the excretory system. However, we 
observed F25H8.21p::GFP  expression in the excretory duct cell (Chapter 
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3.2.4) and there is a partial overlap in the promoter sequence of F25H8.19 
and F25H8.21 (Figure 30). The specific element required for expression in the 
excretory duct cell is likely found within the first 500 bases of F25H8.21 
upstream sequence, which overlaps with F25H8.19. Coincidentally, this 500 
bp region coincides with the presence of a predicted transcribed enhancer 
(Chapter 1.9) and overexpression of this region resulted in the rod-like larval 
lethality phenotype.  
 
 
Figure 30. Location of F25H8.21 promoter and F25H8.19 promoter.  
The red box indicates the region that likely contains the element required for 
expression in the excretory duct cell. The red region also contains F25H8.19 ncRNA 
gene and a predicted transcribed enhancer (green box). Overexpression of the red 
region resulted in the rod-like larval lethality phenotype (see Figure 28).  
 
However, RT-PCR failed to detect the F25H8.19 RNA transcript. This 
could be due to the RNA product being shorter than the predicted length or it 
could be rapidly degraded. Alternatively, the phenotype observed may be 






5.3.1 ncRNAs near bed-3 may be functional  
 Using RNAi injection, we have shown that the dsRNA targeting 
individual ncRNA genes F25H8.16, F25H8.21 and F25H8.13 resulted in 
progeny that exhibited the Egl phenotype. If depletion of ncRNA expression 
results in a phenotype, the RNA product is functional. The presence of the Egl 
phenotype in the RNAi of three independent ncRNA genes is also consistent 
with the hypothesis that ncRNA genes in the cluster co-regulate bed-3.  
 
5.3.2 ncRNA genes may affect the expression of unknown trans-
regulated targets in the excretory system   
 We demonstrated that introduction of high copy number of ncRNA 
genes, in particular F25H8.19, leads to the rod-like larval lethality phenotype. 
In overexpression experiments, the ncRNA gene is expressed on an 
extrachromosomal transgene, in addition to the endogenous gene. Since the 
ncRNA is expressed from an extrachromosomal transgene, it can only affect 
the expression of its target genes in trans (i.e. on other chromosomes). The 
rod-like larval lethality phenotype suggests that ncRNA gene may affect the 
expression of unknown target gene(s) that function in the excretory system. 
Possible targets include regulatory and core components of EGF/Ras 









 As mentioned in Chapter 1.4, some mammalian lncRNAs (e.g. 
ncRNAa-7 and HOTTIP) and enhancer RNAs (eRNAs; defined as ncRNAs 
transcribed from genomic enhancers) positively regulate the expression of 
neighbouring protein-coding genes in an RNA-dependent manner (Lai et al., 
2013; Li et al., 2013b; Orom et al., 2010; Wang et al., 2011). The mechanism 
of gene activation involves an interaction of the RNA transcript with protein 
complexes (e.g. Mediator, Cohesin) to promote interaction between the 
lncRNA/enhancer locus and the target promoter through chromatin looping 
(see Figure 3, Chapter 1.4) (Lai et al., 2013; Li et al., 2013b). While it is 
unclear whether enhancer-like lncRNAs are truly distinct from eRNAs (Lam et 
al., 2014; Li et al., 2016), they appear to share a common mode of regulation. 
The activation of adjacent gene expression is dependent on the interaction of 
the RNA product with protein complexes to promote chromosomal looping 
(Orom and Shiekhattar, 2013).  
In the ncRNA gene cluster associated with bed-3, the deletion of 
ncRNA genes (or enhancers) resulted in reduced bed-3 expression, which is 
indicative of positive regulation (Chapter 4). RNAi against ncRNA genes 
suggests that the RNA product is required for regulating bed-3 expression 
(Chapter 5). Furthermore, Chen et al. (2013) predicted two transcribed 
enhancer regions in the ncRNA gene cluster (Chapter 1.9). Thus, ncRNA 
genes in the cluster may function like enhancers or they may act as eRNAs to 
positively regulate bed-3 expression.  
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To test whether ncRNA genes in the cluster contain enhancer activity, 
we used the Δpes-10::gfp reporter assay, an established and widely adopted 
method for studying enhancers (Cui and Han, 2003; Hwang and Sternberg, 
2004; Kirouac and Sternberg, 2003). We placed genomic DNA fragments 
containing ncRNA gene(s) upstream of Δpes-10 promoter in a GFP vector 
(see Methods, Chapter 2.5). Δpes-10 is a minimal promoter, which does not 
drive GFP expression on its own. It only drives GFP expression when an 
enhancer is placed upstream. Because enhancers function in an orientation-
independent manner with respect to their target genes (Khoury and Gruss, 
1983), the DNA sequence containing ncRNA gene(s) was inserted into Δpes-
10::gfp vector in both left-to-right and right-to-left orientations.  
 
6.2 Results 
6.2.1 ncRNA gene cluster contains enhancer activity 
 We assayed three fragments (R1, R2, R3) for enhancer activity in both 
orientations (Figure 31). Each fragment is 2 Kb long and carries several 
predicted ncRNA genes. We found that all three fragments drove strong GFP 
expression in both orientations, suggesting that all three fragments contain 
enhancer activity (Figure 31). For each fragment, GFP expression was 
observed in similar tissues when the fragment was tested in the left-to-right 
and right-to-left orientations.  
R1::Δpes-10::GFP is expressed in SM cells, vulval muscles, vulval 
cells, HSNs and unidentified head cells. R2::Δpes-10::GFP is expressed in 
vulval cells, rectal epithelial cells, amphid socket and phasmid socket. 
R3::Δpes-10::GFP is expressed in phasmid sheath, hypodermal cells and 
rectal epithelial cells. 
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Intriguingly, many of the observed sites of R1::Δpes-10::GFP 
expression correspond to tissues of the egg-laying system. The R1 fragment 
carries four ncRNA genes F25H8.16, F25H8.14, F25H8.9 and F25H8.24 
(Figure 31). This fragment was removed in D2, D3 and D4 mutants but not in 
the D1 mutant. Perhaps, the reduced bed-3 expression in SM cells of deletion 
mutants (Chapter 4.2.4.3) results from the removal of the R1 fragment 
carrying the enhancer element required for bed-3 expression in SM cells. To 
further localise the SM-specific enhancer element, we split the 2 Kb R1 
fragment into two smaller sub-fragments, a 1.3 Kb fragment containing 
F25H8.16 and a 700 bp fragment containing F25H8.14, F25H8.9 and 
F25H8.24. The sub-fragments were tested for enhancer activity in both 
orientations (Figure 31). The 1.3 Kb fragment of R1 drove Δpes-10::GFP 
expression in SM cells, vulval muscles, HSNs and unidentified head cells. 
The 700 bp fragment of R1 drove Δpes-10::GFP expression in vulval cells 
and unidentified head cells. Thus, the SM-specific enhancer element is found 
in the 1.3 Kb fragment containing F25H8.16. Notably, the expression pattern 
of 1.3 Kb fragment of R1::Δpes-10::GFP (Figure 31) did not overlap with 
F25H8.16p::gfp (Figure 10).  
In addition, both R1::Δpes-10::GFP and R2::Δpes-10::GFP are 
expressed in vulval cells, suggesting that vulval-specific enhancer elements 
are dispersed in the sequence upstream of bed-3. Furthermore, both 
R2::Δpes-10::GFP and R3::Δpes-10::GFP  are expressed in rectal epithelial 
cells. In male animals, the rectal B cell adopts a proliferative fate and divides 
to form spicules (Sulston and Horvitz, 1977). We speculate that the spicule 
defects observed in deletion mutants (Figure 14, Chapter 4.2.2.2) might arise 
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from the removal of R2 and R3 regions containing the enhancer element 










Figure 31. The ncRNA gene cluster near bed-3 contains enhancer activity.  
(A) Genomic location of the regions tested for enhancer activity. Each region was 
tested in both orientations. The R1 fragment (purple) carries four ncRNA genes 
F25H8.16, F25H8.14, F25H8.9 and F25H8.24. The R2 fragment (blue) carries two 
ncRNA genes, F25H8.23 and F25H8.25. The R3 fragment (orange) carries three 
ncRNA genes, F25H8.22, F25H8.11, F25H8.13. The R1 fragment was further divided 
into two sub-fragments (pink), 1.3 Kb fragment and 0.7 Kb fragment. (B-D) 
Expression pattern of R1::Δpes-10::GFP, R2::Δpes-10::GFP, R3::Δpes-10::GFP. 
Anterior is to the left and dorsal is to the top in all panels. 
 
6.3 Discussion 
6.3.1 ncRNA genes may function like enhancers 
 We have shown that the predicted ncRNA gene cluster, upstream of 
bed-3 gene, contains enhancer activity in multiple tissues. This suggests that 
additional cis-regulatory elements are present further upstream of bed-3, up 
to 9 Kb to the left of bed-3 gene. Importantly, the M lineage-specific enhancer 
is present in the R1 fragment containing F25H8.16. Thus, F25H8.16 ncRNA 
may function like an enhancer or act as an eRNA to activate the expression of 
bed-3 in the M lineage. Similarly, other fragments (R2 and R3) containing 
ncRNA genes are also tested positive for enhancer activity, suggesting that 
ncRNA genes may function like enhancers to regulate the expression of bed-
3 in specific tissues. Enhancers can range from 100 bases to several Kb but 
are typically around 500 bases (Loots, 2008). Because we tested relatively 
large regions (2 Kb) for enhancer activity, we have not identified the minimal 
fragment that contains enhancer activity.  
	 107 
Chapter 7: Conclusion and Future Directions 
 
7.1 Conclusion 
In this study, we investigated the function of a predicted ncRNA gene 
cluster associated with bed-3. bed-3 encodes a transcription factor that 
regulates larval moults and vulval cell division (Frand et al., 2005; Inoue and 
Sternberg, 2010). Consistent with its function, bed-3::gfp was reported to be 
expressed in hypodermal cells and vulval cells (Inoue and Sternberg, 2010). 
Mutations in bed-3 cause defects in moulting, vulval cell division and egg-
laying (Frand et al., 2005; Inoue and Sternberg, 2010). 
The ncRNA gene cluster associated with bed-3 contains 18 predicted 
ncRNA genes. Each ncRNA gene ranges from about 100 to 400 bases. Most 
of them are intergenic between bed-3 and another upstream protein-coding 
gene, best-13. We found that the sequence intergenic between bed-3 and 
best-13 is generally conserved in Caenorhabditis species, suggesting that 
predicted ncRNA genes are functional. To determine the function of ncRNA 
genes, our initial analysis focused on three predicted ncRNA genes 
F25H8.16, F25H8.21 and F25H8.13. Using RTPCR, we confirmed that 
F25H8.16, F25H8.21 and F25H8.13 are transcribed, suggesting that the 
predictions are true. Analysis of the expression pattern revealed that ncRNA 
genes have tissue-specific expression. F25H8.16p::gfp is expressed in vulval 
muscles, which is required for egg-laying. F25H8.21p::gfp is expressed in 
neuronal support cells and the excretory duct cell. 
To determine the biological processes regulated by ncRNA genes, we 
disrupted the expression of ncRNA genes. Deletions that removed eight to 14 
ncRNA genes caused two distinct phenotypes, the egg-laying defective (Egl) 
phenotype and the male abnormality (Mab) phenotype. Notably, the 
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penetrance of the Egl phenotype increased as the number of deleted ncRNA 
genes increased, suggesting that multiple ncRNA genes contribute to the 
proper functioning of the egg-laying system.  
The egg-laying system is made up of multiple tissues including vulval 
cells, vulval muscles, uterine muscles, HSNs and VC neurons. Further 
analysis revealed that the Egl phenotype of deletion mutants is likely caused 
by defects in vulval cell division, vulval muscles and the generation of sex 
myoblast (SM) cells.  
All phenotypes exhibited by deletion mutants are also found in bed-3 
mutants, suggesting that the deletion affects bed-3 expression. Genetic 
complementation test showed that the deletion did not complement the bed-3 
mutation, indicating that the deletion reduces bed-3 expression in cis. 
However, the deletion did not significantly affect total bed-3 mRNA level. 
Nonetheless, the deletion may affect bed-3 expression in a tissue-specific 
manner. Indeed, single molecule fluorescence in situ hybridisation 
demonstrated that bed-3 mRNA level was significantly reduced in SM cells of 
deletion mutants. Overexpression of bed-3 in SM cells partially rescued the 
Egl phenotype of deletion mutant. Together, these results indicate that the 
deletion caused the Egl phenotype, in part, through reduction of bed-3 
expression.   
  In deletion mutants, the Egl phenotype may result from the deletion of 
ncRNA genes or unidentified cis-regulatory elements (e.g. enhancers of bed-
3). We found that depletion of F25H8.16, F25H8.21 and F25H8.13 expression 
by RNAi resulted in a low-penetrance egg-laying defect, suggesting that these 
ncRNA products regulate bed-3. We also assayed sub-fragments of the 
deleted region for enhancer activity. We found that the ncRNA gene cluster 
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contains enhancer activity in multiple tissues, including SM cells and tissues 
of the egg-laying system. Therefore, ncRNA genes may function like 
enhancers to regulate the expression of bed-3. 
 To further test the function of ncRNA genes, we overexpressed a 8.5 
Kb fragment containing 14 ncRNA genes and observed the rod-like larval 
lethality phenotype. Further analysis revealed that the rod-like larval lethality 
phenotype resulted from the overexpression of a 500 bp fragment containing 
predicted ncRNA gene F25H8.19. The rod-like lethal phenotype is indicative 
of defects in the excretory system. Thus, F25H8.19 may affect the expression 
of unknown trans-regulated targets that function in the excretory system.   
 In conclusion, the phenotypes observed from the disruption of ncRNA 
gene(s) expression indicate that ncRNAs are biologically relevant and unlikely 
to be by-products of background transcription. In the egg-laying system, 
ncRNA genes may positively regulate the expression of bed-3 in cis. In the 
excretory system, ncRNA genes may regulate the expression of unknown 
target(s) in trans.  
 Collectively, these findings advance our understanding on the gene 
regulatory function of ncRNA genes in the nematode worm and are applicable 
to the wider community working on ncRNAs. Because the effect of ncRNA 
genes appears to be tissue-specific, targeting ncRNA gene could provide an 
alternative mean to the disruption of protein-coding gene expression in a 
tissue-specific context. We also discovered new phenotypes of bed-3 mutants 
and identified novel sites of bed-3 expression, providing new insights into 
developmental pathways regulated by bed-3.  
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7.2 Future Directions 
 Based on the experimental data that we gathered so far, the 
mechanism underlying bed-3 regulation is still unclear. Additionally, we have 
not shown that ncRNA(s) and bed-3 are expressed and functioning in the 
same cell type.  
We propose several models of how the upstream region containing 
ncRNA genes and enhancers can regulate bed-3 expression (Figure 32). In 
one model, the ncRNA activates transcription of bed-3 in a RNA-dependent 
manner, possibly by interacting with protein complexes such as chromatin 
modifying factors or transcription factors (Figure 32A). Another related 
possibility is that the ncRNA transcribed from genomic enhancers (i.e. eRNA) 
activates bed-3 transcription (Figure 32B). In these two models, the activation 
of bed-3 expression requires a functional ncRNA transcript. In another model, 
conventional genomic enhancers activate the expression of bed-3 
independent of ncRNAs (Figure 32C). Another possibility is that ncRNA 
genes may be co-regulated with bed-3 and the transcription of ncRNA genes 
promotes the transcription of the adjacent bed-3 gene (Figure 32D). In the 
latter two models, the activation of bed-3 expression occurs in a RNA-






Figure 32. Proposed models on how the upstream region regulates bed-3.  
(A-B) A functional RNA product interacts with protein complexes to activate bed-3 
transcription. Models A and B differ in the genomic region that gives rise to the RNA 
product. The transcription at ncRNA gene locus typically occurs in one direction but 
the transcription at enhancer can occur bidirectionally from the site of CBP binding. 
(C) Conventional enhancers regulate transcription of bed-3 gene, independent of a 
functional RNA product. The same enhancer may regulate the transcription of ncRNA 
to carry out its function unrelated to bed-3. (D) The transcription of ncRNA gene is co-
regulated with bed-3 transcription. The presence of RNA polymerase and associated 
factors at the ncRNA promoter may promote the transcription of the adjacent bed-3 
gene. 
  
Our RNAi results showed that ncRNA products of F25H8.16, 
F25H8.21 and F25H8.13 might be required for regulating the egg-laying 
process. However, we did not provide direct evidence to show that the ncRNA 
transcript is required for regulating the expression of bed-3. We used the Egl 
phenotype as a phenotypic readout of reduced bed-3 expression. Therefore, 
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it is necessary to use smFISH to show that bed-3 expression is reduced when 
ncRNA expression is depleted. To provide further evidence that ncRNA genes 
act through a RNA-dependent mechanism to regulate bed-3 expression 
(Figure 32A-B) and to rule out RNA-independent mechanisms (Figure 32C-
D), we could use other forms of antisense technologies, such as siRNAs and 
2-O-methyl oligonucleotides (Hutvagner et al., 2004), to deplete the 
expression of ncRNAs and examine the effect on bed-3 expression. For 
knockdown experiments, it will be important to quantitate the expression level 
of ncRNAs to justify for changes in bed-3 expression. Another method is to 
use CRISPR/Cas9 to integrate a reporter gene downstream of bed-3 and 
check for changes in reporter expression when ncRNA(s) is depleted. We 
could also use CRISPR/Cas9 to delete or replace individual ncRNA gene 
sequence with an arbitrary sequence and examine the effect on bed-3 
expression. Since we found that the 1.3 Kb fragment of R1 containing 
F25H8.16 and its upstream sequence carry SM-specific enhancer activity 
(Chapter 6), we could delete the endogenous F25H8.16 gene or the upstream 
sequence and examine the effect on bed-3 expression. In addition, it will be 
useful to further profile the expression pattern of endogenous ncRNA(s) and 
bed-3.  
 To distinguish between ncRNAs (Figure 32A) and eRNAs (Figure 
32B), we could use CHIP-seq to test individual ncRNA sequence for 
properties of enhancers, which include binding to CBP/P300, H3K4me1 and 
H3K27Ac modification (Kim et al., 2010; Melo et al., 2013; Rinn and Chang, 
2012). We could also test individual ncRNA gene for enhancer activity using 
the Δpes-10::gfp reporter. Alternatively, we could use CRISPR/Cas9 to invert 
the ncRNA gene and examine the effect on bed-3 expression. In addition, 
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GRO-seq (global run on sequencing) could be used to detect the orientation 
of nascent RNA transcripts at the ncRNA gene locus (Core et al., 2008). 
Based on the well-studied examples, ncRNAs with gene activating function 
are typically unidirectional transcripts while eRNAs include bidirectional 
transcripts.  
 Furthermore, it will be interesting to determine how the RNA transcript 
activates the expression of bed-3. One possibility is that the RNA interacts 
with protein complexes that activate gene transcription. The candidate 
proteins include BLMP-1 (a transcription factor) and histone 
acetyltransferases (HATs). Previously, a genome-wide CHIP-seq study under 
the modENCODE project determined the binding sites of 22 transcription 
factors (Niu et al., 2011). BLMP-1 was one of the 22 transcription factors 
tested and the data showed that it has seven putative binding sites within the 
ncRNA gene cluster associated with bed-3 (Figure 33). The binding of BLMP-
1 protein to the third intron of bed-3 was confirmed by EMSA in a recent study 
(Yang et al., 2015), suggesting that these putative binding sites are real. 
Moreover, recent reports indicated that BLMP-1 acts as a transcriptional 
activator as well as a repressor (Powell et al., 2013; Yang et al., 2015). 
Therefore, we could test the interaction between BLMP-1 and ncRNAs as well 





Figure 33. Putative BLMP-1 binding sites in the predicted ncRNA gene cluster 
associated with bed-3.  
There are six binding sites in the region intergenic between best-13 and bed-3 and 
one binding site in the third intron of bed-3.  
 
Additionally, previous work on enhancer-like lncRNAs and eRNAs in 
the mammalian system demonstrated that chromosomal looping is required 
for the activation of neighbouring gene expression (Lai et al., 2013; Li et al., 
2013b; Wang et al., 2011) (see Chapter 1.4). Thus, we could also assess the 
chromatin interaction between the RNA and bed-3 gene loci using chromatin 
conformation capture.  
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Appendix I: Multiple sequence alignment 
 
ClustalW 2.1 alignment of an 18 Kb syntenic region spanning from best-13 to bed-3 
of C. elegans, C. briggsae, C. remanei and C. brenneri. The gene sequences are 
highlighted in red. The position of each predicted ncRNA gene in the alignment is 
indicated. The genes highlighted in magenta are transcribed in the forward orientation 
while the genes highlighted in cyan are transcribed in the reverse orientation. The 
arrows in front of the genes indicate the direction of transcription. 
 
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         ATGACGATTTCCTACAGTGGAAATGTTATTCGAATACTTCTTCGGTGGAAGGGATCTATT 
brenneri        ------------------------------------------------------------ 
                                 >>best-13                                            
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         TGGAGGTAAGCAAGAATAGTAAGAAATTATAATTGAATGAAACATAGTAGCTAGACTTTA 
brenneri        ------------------------------------------------------------ 
                                                                             
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         AAAATATACATTTTAGTAAAAAGATTGTAGTATGTAATTACCTCGATGAAGTGTATAGTT 
brenneri        ------------------------------------------------------------ 
                                                                             
 
briggsae        ------------------------------------------------ATGACGATTTCC 
remanei         ------------------------------------------AGTACAATGACGATTTCC 
elegans         AAAATGTCATAATAAAACACTCACATTTATATAAGATTGTTGAAAAAAAATTCAAACACA 
brenneri        ATGACGATTTCTTACAGTGGTAATGTAGTTCGGTTGTTGCTGCGTTGGAAAGGATCCATT 
                                                                *            
 
briggsae        TACAG-TGGAAATGTGATCCGTTTGCTGTTACGGTG--GAAAGGATCTATTTGGAGGTTA 
remanei         TACAG-CGGAAACGTCGTTCGCTTGCTATTACGGTG--GAAAGGATCTATTTGGAGGCTA 
elegans         TACAAATTTGAACACAAACCATCAAGTAA-ACTATA--AAACCCGTAGACAAAACAACTA 
brenneri        TGGAGGTTCGCTTTTATTTCTCTTCGAAACATTGTATTGGTTTAACCTATA-GGCAATTT 
                *  *               *          *   *             *         *  
 
briggsae        ----GGTTCGAATTGAAGGG--TGCTCA-GTAAGGTTTTCATTTTC------AGAACAGT 
remanei         ----GTTTCAGAATGTAAGCGCTGATTC-TGAAAGTTATTATTTTT------AGAACCGT 
elegans         TCTTGATTAACTTCCAAAATTATGGTTG-GTGAAACAACGATTTTTC-----AGAACAGC 
brenneri        TTTCATTTAATCTTGGAAATTTTGATTATATAAGGCCGTCATTTTTCAATTCAGAACAGC 
                      **        *     ** *      *       *****       ***** *  
 
briggsae        CTGGAGAGAGCTTCTCATTTATCTATTCTTCTTCTATTCAATTCGCCTGTTCTACCTGAA 
remanei         CTGGAGAGAGCTACTCATATACCTGTTGTTCTTCTATTCTATCCGCGTATTCTACTTGAA 
elegans         ATGGAAGGAGCTTCTAATATATTTAATTCTTTACTATTCCGTACGTGTATTCTACCTCAA 
brenneri        TTGGAAAGAACTTCTGATTTATCTCATCTTCTTCTATTCAATCCGTCTGTTCTATCTCAA 
                 ****  ** ** ** ** **  *  *  * * ******  * **  * *****  * ** 
 
briggsae        GGGAATAGATTTCATTGATGACGATGACGACGACAGAAACAAAATTCGGCGTAAGATTCT 
remanei         AGGGATTGATTTGATTGATGACGACGATGATGATAGATTGAAAATTAGAAGTAAG-TTCA 
elegans         GGGGATTGATTTGATTGATGATGACGAAGATGATAGACTAAAAATGCGTCGTAAGCAGCT 
brenneri        GGGAATCGATTTCATAGATGACGACGATGATGATAGGGATAAGATTCGAAGTTTGTTTTT 
                 ** ** ***** ** ***** ** ** ** ** **    ** **  *  **  *      
 
briggsae        TGGTGTTCTTTGTTTAAATCGACCTATT--CAATTGAAGGAATGTTTGAATCATTCTGTC 
remanei         AAACACTTCTACTTTTCATTAGATAACT--TTTTT--AGGAATGTTCGAAACATTCTGTC 
elegans         TCAGATT--TATTCAGGAATATATTTCT--GAATTTCAGGAATGTTTGAAACATTTTGCC 
brenneri        ---CGTTCATAAACAATATTCGGACGTCAGTATTTTCAGAAATGTTCGAATCCTTCTGTC 
                      *  *       *               **  ** ****** *** * ** ** * 
 
briggsae        GACAGTGTGATTCATATACTCGTTTGATTCCTCTCACATTCCTTCTTGGATTCTATGTAT 
remanei         GGCAATGCGATTCATATACTCGTCTCATTCCACTGACTTTCCTTCTCGGATTCTACGTCT 
elegans         GCCAATGTGATTCCTACACTCGTCTCATTCCACTAACTTTTCTACTCGGATTCTACGTTT 
brenneri        GTCAATGTGATTCCTACACTCGTCTCATTCCACTCACCTTTCTACTTGGATTCTATGTGT 
                * ** ** ***** ** ****** * ***** ** ** ** ** ** ******** ** * 
 
briggsae        CCAACGTTGTTGCTCGTTGGTGGCGTCAATTTGAAACCCTTTACTGGCCAGAAGACATTT 
remanei         CAAATGTTGTCGCTCGTTGGTGGCGTCAATTCGAAACTTTGTATTGGCCTGAAGATATTC 
elegans         CCAATGTGGTTGCTCGTTGGTGGCGTCAATTTGAGACACTTTATTGGCCAGAAGATATTC 
brenneri        CAAACGTGGTTGCCCGTTGGTGGCGTCAATTTGAAACACTCTATTGGCCAGAAGATATTC 
	 125 
                * ** ** ** ** ***************** ** **  * ** ***** ***** ***  
 
briggsae        TGTCCGTTCTCTGTACCGTACTCCATCAGCATGATGATAAAAGTAAACGGAGACGACATA 
remanei         TCTCTGTTCTTTGTACTGTTCTCCATCAACATGACGATAAGAGCAGGAGAAGAAGACATA 
elegans         TATCAGTTCTCTGTACAGTACTTCACCAGCACGACGAGAAGAGCAAACGGAGACGGCATA 
brenneri        TTTCTGTTCTCTGCACAGTTCTGCACCAACATGATGAGAAAAGTAAACGAAGAAGGCACA 
                * ** ***** ** ** ** ** ** ** ** ** ** ** ** *   * *** * ** * 
 
briggsae        CAATTGCCAGATATCTTAATCTTTCGAATGCATTGGCTTGGTAAGACA--------AAAA 
remanei         CAATCGCCAGATATTTGAACCTTTCTAATGCACTCGCTTGGTAA------------AAAA 
elegans         CGATTGCTAGATATTTGAATCTAGCTAATGCCCTGGCATGGTAT------------ACAC 
brenneri        CTATTGCTCGATATTTGAACTTGGCTAATGCATTGGCATGGTCAGTTAACCATAGGAAAT 
                * ** **  ***** * **  *  * *****  * ** ****              * *  
 
briggsae        TTTCCTTAAAAGTTTTTTCCTGAATCC-TGTTT----------TTTAGGCGCGACATTTC 
remanei         TATCATATTGACTGACCCTATAAATAA-TTCCTA---------TTCAGGCGAGATATCTC 
elegans         TTTCAAAAGTTCTGAATCAGAGATTAAGTTTTTG---------TTCAGGCGAGATATCTC 
brenneri        ATTGAAATAGGGCGAAAGAAAAGACAACTGATACCAGCTCAATTTTAGGCGCGACATCTC 
                  *                         *              ** ***** ** ** ** 
 
briggsae        ATCAAAAATCCGTCTTCGTTTCCCAACCGTTCACAGTTTGATAGAGGGAGGACTTTTGAC 
remanei         TTCTAAAATTCGTCTTCGTTTCCCTTCTGTACACAGTTTGATAGAAGGTGGACTTCTTAC 
elegans         TTCAAAAATCCGTCTTCGTTTTCCATCTGTTCATAGTCTTATAGAAAGTGGACTATTGAC 
brenneri        ATCGAAAATTCGCCTTCGTTTCCCAACAGTCCATAGTCTCATAGAAGGTGGTCTTCTTAC 
                 ** ***** ** ******** **  * ** ** *** * *****  * ** **  * ** 
 
briggsae        TGAGAAGGAATATCAAATTCTGGAAACGATGCATGTATGAT---TCAAAACTAAGAAACC 
remanei         TGAGAAAGAATACCAAATTCTTGAAGCTATGCATGTTAGTC---TGAAAATAATTTAACT 
elegans         TGAAAAAGAATATCAAATTCTTGAGGCAATGCATGTAAGTT---ATTATATTGAACATTT 
brenneri        CGAAAAAGAATACCAGATATTAGAGATAATGCATGTAAGTTCATTCACAATAGTCAAAAA 
                 ** ** ***** ** **  * **    ********  *          *      *    
 
briggsae        ATTA-TCCAA--TTTGT----ATTTTCAGACAGAGAACGAATCCAGTCGCTGGATGACAC 
remanei         TTTC-TTATAGCTTCTT----TTTTTCAGAATGAAAACGAAGCGAGTCGTTGGATGACTC 
elegans         AACAATTTAAATATTTT----ATATTCAGGCTGAAAACGAATCAAGTCGTTGGATCACAC 
brenneri        AAAAATGATATTGTGATCACAATTCACAGAGTGAAAATGAATCCAGTCGCTGGATGACAC 
                     *   *   *  *     *   ***   ** ** *** * ***** ***** ** * 
 
briggsae        CTCTTCATTGGATCCAACAGATTATGAGACAAGTAGAAGACG------------------ 
remanei         CAATTCATTGGGTTCAGCAGATCATGAGACAAGTGGAGGAAGTGAGTTGCTG-------- 
elegans         CACTTCATTGGATTCAACTAATTATGCGACAAGTTGAAGAGGTACGTTATCATAGGCAAT 
brenneri        CTCTCCATTGGGTTCAACAAATAATACGACAAGTCGAAGAGGTACTCCAAGATTG----- 
                *  * ****** * ** *  ** **  ******* ** ** *                   
 
briggsae        -------------------------------------AAACCAAGCCAACAGCTTCGCTC 
remanei         ATACCGTATTTATGCCATCTGAAATTTGTTTTCCAGGAAACAAAACCAACTGCTTCTCTA 
elegans         GGGTTACTGTAGTTACTCATTTTGCTTTCATTTCAGGAACACAAACCAACGGCTTCCCTT 
brenneri        ----CGAGATGAGACTCTTCAACAATTTTTATTCAGGAAACAAAGCCGACTGCTTCTCTA 
                                                     **   ** ** ** ***** **  
 
briggsae        CTTAACCAGTTTGTTGCTGAACTCCGGATCTTCCGGCAATCGCTTCGCAAATTGTACTCA 
remanei         CTCAATCAATTTGTAGCAGAACTTCGAATTTTCCGTCAATCTCTCCGTAAATTGTACTCA 
elegans         TTCAACCAGTTTGTTGGTGAACTTCGAATTTTCCGTCAATCTCTTCGTAAGCTGTATTCA 
brenneri        CTCAATCAGTTCATAGGTGAACTCAGAATCTTCCGTCAATCTCTTCGTAAACTGTATTCA 
                 * ** ** **  * *  *****  * ** ***** ***** ** ** **  **** *** 
 
briggsae        TACGATTGGGTTTGTGTTCCACTTGTGTACACTCAAGTGGCAGCTCTTGCCACGTATTCA 
remanei         TACGATTGGGTGTGTGTTCCACTTGTATACACTCAAGTAGCTGCTCTTGCCACATATTCA 
elegans         TATGATTGGGTGTGTGTTCCTCTTGTTTATACACAAGTCGCTGCTTTGGCAACCTACTCT 
brenneri        TATGATTGGGTTTGTGTTCCACTTGTATACACTCAAGTAGCTGCTCTTGCCACGTATGCA 
                ** ******** ******** ***** ** ** ***** ** *** * ** ** **  *  
 
briggsae        TTCTTCTTCTTCTCACTCTTTGGACGTCAACCGCTGCTCCCCGAAATTGAATCAGGAAAA 
remanei         TTCTTCTTTTTCTCACTTTTTGGTCGTCAGCCACTACTTCCAGAAATTGAATCAGGAAAA 
elegans         TTCTTCTTTTTCACACTTTTCGGCCGTCAACCACTTTTCCCAGATATTGAAACTGGAAAA 
brenneri        TTCTTTTTCTTCACACTTTTTGGTCGTCAACCACTCATTCCTGATATAGAATCTGGAAAA 
                ***** ** *** **** ** ** ***** ** **  * ** ** ** *** * ****** 
 
briggsae        GAAATCGATCTGAAGGTTCCGATTTTCACTATAGTCCAGTTTCTATTCTTTGTCGGATGG 
remanei         GAAATTGACTTGAAAGTTCCCATTTTCACGATAGTCCAGTTTCTGTTCTTCGTCGGCTGG 
elegans         GAGCTTGATCTAGTTGTACCAGTGTTTACAATAGTTCAATTCTTATTCTTCGTTGGATGG 
brenneri        GAAATTGATCTGAGAGTTCCAATATTCACAATCGTACAGTTTTTGTTCTTTGTGGGATGG 
                **  * **  *    ** **  * ** ** ** ** ** **  * ***** ** ** *** 
 
briggsae        TTCAAGGTGACCCAATTTAAAAAATTTCATATGCAAGCAAAATTAT-TTTTAAAGGTTGG 
remanei         TTTAAGGTTAGCAA--TCGTTAAATCAAATTTTCATTGCAATACAT-ATTTTCAGGTTGG 
elegans         TTTAAGGTAGGTG---TTATAATACGTTTTCTGTAGAACAAATGTTGAAAAATAGGTCGG 
brenneri        TTCAAGGTTTGTAA--CTACCGCATGCATTGATTTTTCAACTTCTAGTTTTTAAGGTTGG 
                ** *****               *     *         *             **** ** 
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briggsae        TCAAGATTTGATGCGGCCGTTCGGTTTGGATGATGATGATATCGAGTTGAACTACATTTT 
remanei         CCAAGATCTGATGAGACCTTTCGGATTGGACGACGATGATATCGAGCTGAATTATATATT 
elegans         ACAAGATTTGATGCGACCCTTTGGATTAGATGATGATGACATCGAACTGAACTACATTTT 
brenneri        TCAAGATTTAATGAGACCATTCGGATTGGATGATGACGACATTGAGCTGAATTATATTCT 
                 ****** * *** * ** ** ** ** ** ** ** ** ** **  **** ** **  * 
 
briggsae        GGATAGAAACGTTCGCATTTCATTTGCCATTGTCAATCATCTTCAGGAAGCTCCAATTCG 
remanei         GGATCGCAATGTTCGCATTTCATTTGCCATTGTTAACCAGTTGCAGGAATCACCAATGCG 
elegans         GGATAGGAATGTTCGAATTTCTTTTGCTATTGTAAATCAACTCCAGGAATCACCAATTCG 
brenneri        TGATAGAAACGTTCGTATATCGTTTGCAATTGTTAACCATCTACAAGAATCAAATATTCG 
                 *** * ** ***** ** ** ***** ***** ** **  * ** *** *    ** ** 
 
briggsae        TTAGTTTCTCGTGACTCTGATTTCCCAAA--AATAATGTTTTTTTCCAGCTGATTTTGAA 
remanei         TACGTTAC--AAAATTGAGAGTAGACACTCTACCAATTCCATTTTTCAGCAGACTTCGAG 
elegans         TAAGTTTTAAGTAATC---ATTTGCTAAAATCAAAATAATTATTTATAGCGGATTTCGAA 
brenneri        TAAGTTAA--AATGTATAAAATTGTTTTA---ATAAT--CTCTTTTCAGCTGACTTTGAA 
                *  ***             * *            ***     ***  *** ** ** **  
 
briggsae        AACGACGACGACAAGATGTGGGAAGAAATGCACCCGCCTGTCAAGGATGGAGAAACTTCA 
remanei         AACGACGACGACAAAATGTGGGAAGAAATGCACCCACCAACAAAAGACGGAGAAACTTCA 
elegans         AGTAACGACGATAAACTTTGGCACGAAATGCATCCACCAACCAAAGATGGAGAAACGTCT 
brenneri        AATGACGATGATAAGTTGTGGCAGGAGATGCACCCACCAACTACGGACGGTGAAACTGCT 
                *   **** ** **  * *** * ** ***** ** **    *  ** ** *****  *  
 
briggsae        CCTTCATTACGCATACCACAACTTCCGCACTCGAAATACTCAAGCCAACTTTCCGAGCAT 
remanei         CCTGGTGTGAGAATGCCACAACTGCCACATTCGAAGTACTCAAGCCAATTATCTGAACAT 
elegans         CCAATACCAAGAATCCCACAACTTCCACATTCAAAGTATTCGAAACAACTTTCTGAACAT 
brenneri        CCAGCTCTTAAGATTCCAACACTCCCACATTCCAAGTACTCTAGACAACTTTCCGAACAT 
                **          ** ***  *** ** ** ** ** ** ** *  *** * ** ** *** 
 
briggsae        CCACCACGTCTTCATGCCTACGTTCCTATAGACGATGACAGAACAAGTATCAAGGATATG 
remanei         CCTCCACGTCTTCATGCCTACGTTCCTATAGACGATGATAGAA---GTATCAAAGATATG 
elegans         CCACCACGTCTTCATGCTTATGTTCCCATAGATGATGGCAAGGGAAGTATCAAGGATTTG 
brenneri        CCACCACGTCTTCACGCCTACGTTCCTATAGACGACACCCTCA---GCATCAAGGATATG 
                ** *********** ** ** ***** ***** **           * ***** *** ** 
 
briggsae        GAGAGCCATCACGGATGTATTTCAGTCAAAAAGGACAAGAAGCATCTGAATTGGTAGATG 
remanei         GAAAGTCATCATGGATGTATTGCTCTCAAAAAAGACAAGAAACACTTGAGTTGGTAGTTG 
elegans         GAGAGTCATCACGGATGCGTTTCCCTGAAAAAAGACAAGAAACATATCAGCTGGTAGCTG 
brenneri        GAGAGTCATCATGGATGCATGGCTCTCAAAAAAGACAAGAAGCATCTCAATTGGTAGAAA 
                ** ** ***** *****  *  *  * ***** ******** **  * *  ******    
 
briggsae        G---TCAAGATCAGCTATTGTACAATTGTTCCCATAATTGCATAATTTTCATTTTGCTGT 
remanei         GAAACCCGATTTTACAGCTCTACAATACCTGCCGCCTTCATAATATTTTT-CACTGTTAT 
elegans         AA----TTATTCATAATCTGTAAAATTATTGTTGTTCTCATTTGTTCTCTGTTCTACTTA 
brenneri        A-----TTCCTATATCTCCTTGTAATTCCTCACACCTT------GTTTTTGTTATGTT-- 
                          *         *  ***   *       *       * *      *  *   
 
briggsae        TTTTATTCTACTTACCCACTTCCTATT-TTGTCCCATTCGTCGGATCGAGATCACGAGAT 
remanei         TTGCACTCTACTTACCCATTTTCAAAAATTGCCCTATTCATTGAAACGAAA---CGAGTT 
elegans         CCATATTTGATTTTTTTTTAATTGAAACTTGTATTTTTTGATGAATCAAAC-------AT 
brenneri        TTATTATCTACTTACCCAC---TGAAA--TGCTTTGTCCATCAATCCGAAAC-----GAG 
                      *  * **           *    **     *         * *            
 
briggsae        CAATTTTTCCTTAAAAAGTATTTCTCCATTTCTATGAATATCTCGCCACTAAT-AATTTT 
remanei         CAGTA---CCTCGGAAAA---------------ATCAAAAC---------AAT-AATTCC 
elegans         TATTA---TATCCGAAAAC--------------ATCAAACATACATATCTAAC-CAATTT 
brenneri        TATCATATCATTCAAAAGA--------------ATCAAGTCTGATGTATTAGTTCGCTTT 
                 *        *   ***                ** **            *      *   
 
briggsae        GCTTTGTTGTGTTTAGACTAATAATATTCGTTTCAGAACTTCCGATAAACTGTACCATTC 
remanei         AAATTGCT----TTATGCCAGTATTTTTCC------AATTTCA---------------TC 
elegans         ATTATTTTTATTCTATTATAAATGTGTTAAATAAAAACCATATGTTGTTGAAAACAATAC 
brenneri        AATTCTCTACCCTCTCTGAAAATATCATCAATGCATATCTTAA----------------- 
                       *           *    *  *        *   *                    
 
briggsae        GAAAATCCCTATCATCTGCTTTTCTCCGAACCATCCTTCCTGCGCACCCCAATATTTTGT 
remanei         GAAAGTACATATC--------------------TCGTCCATA---ATTTCATTTTATTGT 
elegans         GAAAGTCCATGATTCT--------------CCTTAGATCAGATGCATCA-GTTATATTAT 
brenneri        -AAATATTATTTTGTAAA--------------TCTGAACCAATGAATGAAGAGTTATCAT 
                 ***     *                            *      *        * *  * 
 
briggsae        TCCGTTTTGATATCGGATTTCAAGCGACACCAAATCGTAAAAGCCCTTTCTGATGTCACC 
remanei         TGTAAACTAATA----ATTTC--------TTAAGCTTCAGATGCTC-------------- 
elegans         TTTACTCCAGAA----AGTTTTTGAGAAATCGCTCGGAAGGGATATCGAAT--------- 
brenneri        TTTCCACAAGAAAAATTTTTGTTTTGGGGTGAAAGTGGAAAAAAACTGGCAAA------- 
                *          *      **                  *                      
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briggsae        CTTCAACTCATCTTTCCCACTCTACGAAACTCGGAAAACCTGTAAATCACGAGAAGGCAT 
remanei         -----ACTCAACTTTTT-------TGGAAT-----AAAGTGATTGTTTTTCCAAAAAAAT 
elegans         -----ACTTGGATTTAAGCGACT-CAAAATGGGACAAATCTACCAATTTCGTAATGAGAC 
brenneri        --ACGGCTTGCCCTTAA-------TAGAAGT-GCATGTTTTGCTGTTCACCCTAAGGAAA 
                      **     **            **                 *      *    *  
 
briggsae        CCCTGTCGCCAACATGAAAAGCTTCAGGGAAAGGTTATTAGTCTTATACTGTCCTTCTCC 
remanei         CCCTTCTTTCTCTATCAACACCTTT--------------------------TCATTCTTG 
elegans         GGTATAAAAATTTATCAAAAAAAGCTATGGCAGTT----------------CAAAGTTTG 
brenneri        GTTCTCAAATCATTTCTGTA--TTCAACGAAAATCCCCAACTGCGGAGATTCATGATTTC 
                              *    *                                     *   
 
briggsae        TCCGAAATTCCTTCTGTTCCCTTCTTTTTTCTTCTTTATGATGAATTAGGGAAGAGACGA 
remanei         TTCTCGATTCTGACTGCTCTCCAACATATTGTTCCGCTTAA------------------- 
elegans         GGAGAAATATATACTTTTAGCCGAAATCTCAATTCTGCCAA------------------- 
brenneri        CCATCGATCGGATACTTGATTCACAATATTGTTCCATCGGA------------------- 
                      **                  * *   *       *                    
 
briggsae        GTGTGCGTGTGTGTGTGAGCAACACATAAGAGAGCCAACACACATGTTTTACGAGCTCTC 
remanei         ATAT-CGTATTT---CAACCAACACCTAATCGTAAAAGATCCTATGTTACCCTTCAGATC 
elegans         -TTTGCCAGTTT-CGCAACGAACGG--AGCTTTTTAAAAACTAATGATCGCTTTTAAAT- 
brenneri        -TCT-CATATTT---CATCTCATATAAAATTCTATGTCTTCACGTATTCCCCATCCGAA- 
                 * * *   * *         *     *            *   *  *             
 
briggsae        CAAATAGTTTATGAACTTGCCGACGGAGTGAAACCAAGAAAAGGAGAGTATCATAATGTG 
remanei         CAGAAGGTATTCCGACTTTCCGA--------AACTTGTAAA---------TCACACGGAG 
elegans         --AATTTTTTATAAGCTT-------------AATCAAGGAA-----------ATAGGGCC 
brenneri        --AACTTTCCAATGCCTGT-----------AAATCACAGGA-----------AGAGACCG 
                   *   *       **              **       *           * *      
 
briggsae        ATTTCCCATTTTCGGAAATGGGGTTTCAACACTCAAAAGGCGGTCGAAATCTTTTTGATT 
remanei         ACATCGC---TTCG-----------CCAACATAAAAAGCTTCTCCGAAAGAATATTAGTT 
elegans         ATTTTGGGC----------------CTAACACAGAAAAGTTTT---AAATTTCGGTACTC 
brenneri        ATGTCGCG-------------------AACATGAAAAGCTTCTCAGAAAGGTTATTAGTT 
                *  *                       ****   ***         ***      *  *  
 
briggsae        -TATAGTTCACTTCAGTTGACTTTCCTTTTCCGGTGAGTACACACTGTGAGGAGTAACAT 
remanei         ATACTGTCTTTTTC------CTCTTCTTTCCC--------CCTATTGC------CCCCGT 
elegans         -CATCTTTACCGTCCCCTGATTGTTCGGCTCCGAGAAG--TTTATTGC----ATCTCTAA 
brenneri        ATACTGTCCTCATCCGTTTTCCCCTTCTCTCCCTGGTCCCTTTCTTTT-----ATGATGA 
                  *   *     **                **             *               
 
briggsae        GTCAAGTCATCAGTGAAATACAACTG-AAAATGTTACCGAACA---TGGTGAAGGTGGTG 
remanei         GCT---TCTTCACTTTATGATAAATG-GAAAT-------AAGA---AGGGGATGGTG-TG 
elegans         ACCATATTGTTTCTGATGGTAAGGTATAGAATTTCAACCAACACCTAATCGTAAACCACA 
brenneri        ATGGAATGAACCACTGCGTGTGAGCATAAGAAAGAAAGAGGAAAAGAGCAACACATGTTT 
                      *                       *           *                  
 
briggsae        AAGAAGTACACCATGTATACAGAGAAGATGTTCAC-ATTTAAT--GCTAGAACTGTGAAA 
remanei         CGTGTGTG-AGCACAAAAGAAAGGAGAGAGCCAAC-ACATGTT--TTACGAGCTCTCCAA 
elegans         CACCGACATCCCTTACTTTTACACAGATTTCTGAC-ATTCCATAGTCTTAAATCACACGT 
brenneri        TACGAGCTCTCCAAATAGTTTATGAACTTGCCGACGAAATGGAAACCATAGTCAAGAGAC 
                           *            *        ** *                        
 
briggsae        AAAATCAATTGATATTA-TTCTGATTAAAAAAATAATCGGAGATGTGGAAGAGAAACTCC 
remanei         ATAGTT------TATGA-ACTTGCCGACGAAATGAAACCAACTCGCGAAAA--------- 
elegans         GGAACCCTCGGCTTACA-TGTCAAAAACACAAAAGACTCATCCGACAGGTTATTAGTTAT 
brenneri        AAAAGGAATTGACACTAGACCCCATCATAATGTGATTTCACATTTTCGGAAA-------T 
                  *             *         *                                  
 
briggsae        GGTGACCTTGGCCGAATGTCCCATAGCTACAAATACCGTAACCTAAAAATGTTTTTTTCC 
remanei         ---GACAATAGTAGAATGTGACATTG--------AGCCTAATCTAA-------------- 
elegans         ACGGTCTCCTTCCGGCTGTTCCGTCCCTTC---TTCTTTATGATGAATATA--------- 
brenneri        GTGGTTCCTTTTAGGCGGTTGAAATCCTTTGA-TTTTATAGTTCAGTAGAAATGTTTCAT 
                   *         *   **                   **                     
 
briggsae        GCATTTATTTTTTCGTACTGTTTTTTCGTACTGTTTTTTCGTACTGTCTGAAATTTTCCG 
remanei         ------------------------------------------------TGGGGTTTCCC- 
elegans         ------------------------------------------------TGGGAGTAATGC 
brenneri        TTAGAAA-----------------------------------------TGTACACAATAA 
                                                                **           
 
briggsae        GGATTTGCGGAATTTTAGGTTACTGTAGAAAACTTTGTTTTCTGTAGTTATTTTTCAGAA 
remanei         --ATTTTCGGAAATG-GGGTTCCTTTAGGCGG-TTCGTCTTTGAT--TTATTCTTCCGAA 
elegans         GTGTGTGTGTGGATACCAGAATGAGGAGAGCAACACATGTTTTAC---GAGCTCTCCAAA 
brenneri        GAAAGTAAACTATCTGCAAAATGTGAAGAGCC-AAAGTGCTTGAAGATTACTGTAAGTAT 
                     *                    **         *  *        *        *  
 
briggsae        AAAAACACACAGTTTTTATCTGCAGTTTGAAGTTATTGTGTTTGCAAAAAACCACAAAAG 
	 128 
remanei         AGTAA-----ACTTGATAAC--------GAAATAA----GTTTAATTAGTAGTAGAAAAG 
elegans         TAGTTTATGAACTTGCCGACAACGAAACGAAATGA----AACAGAGAATGAAGTCAAGAG 
brenneri        AGTATGGCAATCATTTCATTCGCTTACCGAATTTACA--GTTTATGAATCATCAAGAAGT 
                             *              *** * *            *  *     *    
 
briggsae        GAAATTAGTTTTCTACAGTAATCTACAGTAACCTACAATAATCAAACACCGTTCCATCAA 
remanei         G---TTAAAATTCCA------TTTGTACT----------------------TTTCATCAA 
elegans         ACAAAGAAAGTGACA------CTAACAGAGG---------AAAGAGCATGATAATGTGAA 
brenneri        G---TTGAACCTAAAT-----CCAACAGAAA---ATGCTCATTCAGAACGATTTTATAAA 
                              *           *                        *    * ** 
 
briggsae        ATTTCAGACAAAAAACTGGAAAAATCGAGAAAGAATCCTTGAAAAAGGCTGAAAAACTTA 
remanei         GTTT----------ATTG---ATTTAGAGCATCAGTTTGTG--------TGATTACTGTA 
elegans         TTCTCATTTTCGGAAATGGG-GTTCCAAAAGGCGGCTCGATTCTTTGATTTATTGATATA 
brenneri        CTCT------GTATGCTAGTAGTTCAAAGAAATTCCTTGT---------CTAATAATGAA 
                 * *            *          *                       *       * 
 
briggsae        AAAAGGTCTAAAAAACTTGCCAGAAATCGAATAAAAATTAAGTTTTTCTCTCGAAAAATA 
remanei         AAAGTG-------AATTTG-------TTGAATA----------TTTTTCTGAAAGAAATA 
elegans         GTGAGTCGAACAAAAATACAC--AAACTGAATAGGTAAATCAGTATTATCCAACTGTTGA 
brenneri        TTATTCGTCCTATGATATGATCTGCACAGAAAAAAGAAAGTTTTATCAATTTTGAATTTT 
                              *             *** *          * *               
 
briggsae        GCGAAAAATCGCTAAATTTTTAGGATACGGTAGTTGTCGCTGTGGGGCCTCGGGCCAAGG 
remanei         CTGAAAAAATG--------TTAGGACAT--TCATATTCACA-------TACAGACAAA-- 
elegans         ATAAATACGCTC-AAGCTATTGATATGTGTACATAGTTACAGTA---CCCTGGATTTTAG 
brenneri        TTCGGAACTTGG-----GGTTACTGTA-GTTCCTATCCAATATAGAGAACCAAAGAGTAA 
                      *            **            *                           
 
briggsae        CATCCCGGGTTTCTCTTCCACAATTCCGATTTTTCGTAATAGAATAATGATAAAAAAAAT 
remanei         ---------------TTCCAAAACTACG-TTCAGCTTGA----------ATAAAACAAAT 
elegans         TTTTACAG-----TTTTTTGTAGGTTTTATCTAATTTGA-------GTAGTGAGACCCTT 
brenneri        CTTTATAACCTTACCGTTTTAAGCACGTTTTTGACTAAA---------AAGAAAAACAAG 
                                *    *       *        *             * *      
 
briggsae        AATGGATCAGTAGATGTATCTACAAGACAAAATGCAGAATCAAAACTTCAAAAGTTACAG 
remanei         CAT------------------------------------TCAAGAGTTCCAGAGTT---- 
elegans         AATCAAC--------------------------------TCCAGTATGCAAATACTCGGT 
brenneri        AAACAGCGATTTTAGCTTGATAGAAT----------GTGACAACTTTATCAGAACCTGTG 
                 *                                      * *   *   *          
 
briggsae        CTTTAGGATTAAACCAAAATCTATCGAAATTCGTTTGATTCTCAATAAACCTTCTCATGG 
remanei         -------------CTACAATATTCCAAA--------------TAATGAGCG-----ATGG 
elegans         CTC---GACACGACTGAAATATACTAAAA------------TTATTAAACGTCTTAGTGC 
brenneri        TATGTCGCTACAGTAGGATTACGGTAGACACTTTATTCTTCGCGTTTCGAATATAATCAT 
                                 * *       *                 *               
 
briggsae        TCCCTTGTCTCCATGATACATTTCCCGCACACTATAAAATGAA-TATATGCCCTTGCCAA 
remanei         TCCCTACTCCCAA------ATCTCCTTCA--------AATAAA-TGTATCTCCT------ 
elegans         TGGCGAGACCGAGTGCTG-ATTTCTGGTTTCGTATGTTGCAAAATGTTGCATCTTGATAA 
brenneri        TTCCTAAAATGTT--ATCTGTCCCCAATGAAATTTCTCAGAAGGTCCCTTTACTTCTAAA 
                *  *                *  *                 *  *       **       
 
briggsae        TTGACTATTTTCTCTAAAAAGGTTGTTCTAATGGATGCCTTCACCGAGTTAATAGTCAAT 
remanei         ---------------GAAAAGGTTGTCTTAATGGATTGG------AAGTTAATAGTCAAT 
elegans         TAAG------TCTACATTATTATTACTACAGTAACCTAGCTCTATTATTT--TAACTATG 
brenneri        CTTATATATTTATGAGAGAAGGTTGTCTTAATGGATCCTTTTTAATAGTCAATCGACCTC 
                                  *   **     * *              * *   *        
 
briggsae        CGACTTTTCTCATTCAAAACGGCAA-CAATATCGGT-TCCGATCCTCCCTTTCTTTCTTT 
remanei         CGACCTCTCTCTCTCTCATTCACAAACCGCAACAAT-AATACTCCGTGTCTTTTCTCTTT 
elegans         TGAAGTATTTTAATCAAAACAGGAAACTCTTGAAATGAAGAATTCGAGTTTAACGTAGCA 
brenneri        TATTTCCTTCTTTTTCCCATTCAAAACCGCAACAAT-ATCGCCCATCATTCTCCCTTTTC 
                       *     *         ** *        *                   *     
 
briggsae        TCGCAACACAACCTTATTGTTGCATCTTATTAATAATTAACTC-GTTTGTAGTAGTGGGA 
remanei         TCGCAACACAACCTTATTGTTGCATCTTATTAATAATTAACCGAGTGTGAACCTAATGGA 
elegans         TATTAATACAACTCTATTTAGCTGGTCCCATAGCCATCAACTTCCCTTTTCCTCCATATG 
brenneri        GCAACACACAACCTTATTGTTGCATCTTATTAATAATTAACTC----ATTGCCCAGTGAA 
                     * *****  ****            **   ** ***                    
 
briggsae        ATCTAATGGGTTTTGGAG-TGAACTACAGTAATCTGAACCCCTCAATTGAAAACTCTTCT 
remanei         TTTTGAGAAAAAGAGAACCTAAACTACCGTATTCT---CATGTGAATTCATCCCCCTTTG 
elegans         AGCCATTGTTTTTAGAAG-----TAACAATTTCCT-------AGAAAAGGTTGTTCTTAA 
brenneri        ACCTAATGGATTTAGTGA--AAAGTAACATAAACTACCGTATTCTTTTCCCCTCGCTTTG 
                              *          *   *   **                    ***   
 
briggsae        TTTTTTTCA-----AATCTGAGAATCTTGAATTCATTTGAAAACTTAAGATTGACCTTGT 
remanei         TCTTTTGAATTCTTGATTTCAAAATCTAGAATCAATTCGAAAACTTTGAATCGACCTTCA 
	 129 
elegans         TGGATACCT------AGTTAATAGTCAATCGTCTTTCTTTTGCCTTT---TTCCCATTCA 
brenneri        TCTTTATTCCA-TTGAGTTTGAAATCTTGAATT--TTCGAAAAA--AGGGTTTTCAGGTA 
                *   *          *  *   * **     *   *              *   *      
 
briggsae        AGACTTCGGTGGCTCATAAAATTACACCT----ATGGGAAGGAAAGAAAGAATGTTTGCA 
remanei         AAAT---GGTAGTTCATAAAATGTCACCTTCGAGCGGGAAACGAAGAGAGAAGTGTTGAA 
elegans         AAACCGCAACAAT--ATCGCTCATCGTCTCTTTTCGCAACACAACCACCTTATTGTTGAA 
brenneri        ACCTTGAGATAGCTCATAAAATGACACCTCCGAGCGGGAAACTGAGAAA-------TTCG 
                *              **       *  **      *  *       *         *    
 
briggsae        TTTTACGATGGTTTTGAAACGAAG--AAACCGTTTTGATGGTTTTTGATGATTTCTCGAC 
remanei         TTTTACGATGATTTTGAAAC----------CGTTTTGATGGGTTTTGG------------ 
elegans         TCTTATTAATAATT-AACTCATCG--ATGGAAACCTAATGGACTTGGACAAAACATGACG 
brenneri        TTTTATGATTATTTCGAAACGAAACTAAACTGTTTTGATGGGTTTTAG------------ 
                * ***  *    **  *  *               * ****  **                
 
briggsae        ATGAT-AACAGATTTTCAAAAAAGTTTTATAGTACCGTAAAACCTGTAATAGAAGGGCCC 
remanei         GTGTC-AATGATTTCTCGAAATGAT-------------AAGATGTATAGAAAA------- 
elegans         ACTAC-CGTAATCTTTCAATCCCCATTTG---------AGAGTTTGAATTTGAAA----- 
brenneri        ATGTTGAATGATTTCTCGAAACGATA----------AGAAAGTTTGAAATTCA------- 
                             * ** *                   *     *  *    *        
 
briggsae        TGACTTTTAACTTTAAGCCAATTTATCTCGGTAACTGTAAAAGATATAAAAAAGTAGTCA 
remanei         ------------------CGCTTTGT-------------AAAAAGACAGTACAGTACTCT 
elegans         ------------------TATTGAGTTTCAACA------TAAAAGTTTGAGAATTTGAAA 
brenneri        ---------------------TTTGA-------------AGAATTGTTTTAATTTAAACG 
                                     *                   *            *      
 
briggsae        ACGGATATATTGTTTATCATACTATCGAAAGTGTTTTGTTAGTTCACACAATTTTGAGAT 
remanei         ACAGTAAT--------CCACGTTATGAAAAGA--------AGTGAAAACAG--------- 
elegans         ATTGAAAAATG----ACCTTCACACCGGTAGCTCATAAAAGGTTGACTGAG--------- 
brenneri        ACAAAAACATA----AACAT-TTATATGAGGT--------GGTGATGATAG--------- 
                *     *          *     *      *          **      *           
 
briggsae        CTGTCGTAGGAATTGAGATAATTGAGCTCAAACTTGGCAGTGGGGGCCCTTCTATTACAG 
remanei         -------AAAATTTGAGA-ATTTCAGGTTA----CGGTAGAGGAAGCTCCCC------AG 
elegans         ----CGGGAAAGAAAAGCGATACAAGGTTGCATTTTATTATGAGACCAAATTGAAATAAA 
brenneri        ---------GATAAGTTTCATTCAGAACT--------TTTTTAACACTTCTC------AG 
                          *        *                          *           *  
 
briggsae        GTTTTACGGTTGTACAGTACTTCATGAAGAGCTATCTTCTAACTTTAGTAAATTTCTCCC 
remanei         CCCCTAT-------------------------CATCTTC--AATTCGTTCGGTTTTCTTC 
elegans         ACTGATCGGTT----------TGATGTGTAAATGATTTCTCGATAAGATAAGAAAGTTTG 
brenneri        ATAATG-----------------------ACATGTTTTTATGAGAAAACAGGAAAATCGA 
                                                    **                       
 
briggsae        TC--CCCCTCTGTTCTTCAAATTCCCTTCTTGTTGGATTCTAAATCAAGATTCTTCTGTT 
remanei         TT--CCCAGCTCCTGCTC---TTTCTCTCCCGT-GAATTGTCTATCAAGATATTCCGATC 
elegans         AA--AATA-CAGAAAAGCAGAGTTTCCCTAGATCCCATTCTCTA-CAAGCTTTATCTGCC 
brenneri        ATGTTCCAGCAGATCTTTTGTGGTCCCTCCACTTTCAATACTTCTCAATAT-----GATC 
                         *                      *   * *      ***  *          
 
briggsae        CTTTTTGCTCCCGTGATCCATTCCGTCAGATGCTCACCAAGTGCGCAATCTTCTCTCCGG 
remanei         GAC---GATCCCGTGATTCATTCCGTCAGATGCTCACCAAGTGCGCAATCATCATTTCGT 
elegans         CAT--CGCTCCCGTGATTCACT--GTCATATGCTCACCAAGTGCGCAATCGTCTCTGCGT 
brenneri        CAC--TGCTCCCGTAATTCCCTTCGTCAGATGCTCACAAAGTGCGCAATACACTCCGGAT 
                      * ****** ** *  *  **** ******** ***********   *        
 
briggsae        CTCCTGGACCCGTACACTATTTTTC-ACCTATTTTCGATATATATTCGTTTTCTTTACTG 
remanei         CTCCTGAATCTTCACACTCTTTCTCCACCTATTTTCGATATATACTCGTTTTCTTTACTG 
elegans         TTCCAACGACTTCACCCTTTTTCTC-ATTCAATTTCGATATATACTCGTTTTCTTTACTG 
brenneri        CTCTTCGATCGTCCTGCTATTT-TCATCTTATTTTCGATATATACTCGCTTTCTTTACTG 
                 **      *      ** *** **     * ************ *** *********** 
 
briggsae        CTTTGCCGGGCTTCGTA---AGAACTCCTGACTCGAG----GAACACTTTTTTG-TGCTT 
remanei         CTTTGTCGGGTATCCGA---AACGAACAAAAACTCCT----GAACACTTTTTTG-TGCTT 
elegans         CTTTGTCGGGTTCT------AACAAAAAAAACTCCTG----AGCCGAACACTTT-TGCTT 
brenneri        CTTTGTCGGGCTTCCAAACAAAAAAAAAAGACTCCTGACCCGATCACTTTTTTCCTGCTT 
                ***** ****          *         *             *      **  ***** 
 
briggsae        GCTCTTTTTTTTGCTCGGCTCGTTGGGAATCCGGGTGCGCA-------GATCGGTGTAAT 
remanei         GCTCTTTTTTCCTGTTG-CTCGATGGGAATC-GGGTGCGCAAGACGTCGATCAGTGTAAT 
elegans         GCTCGCTTTGT--------TCGATGGGAATC-GGGTGCGCAAGACG--AGTCGGTGTAAT 
brenneri        GCTCTTTTTTCGATT--ACTCGATGGGAATC-GGGTGCGCAAGACGTTGATCTGTGTAAT 
                ****  ***          *** ******** *********         ** ******* 
 
briggsae        ATAATGAGCATATGTGAAATGAAAAATAGCATTGGAAAAGAAGAAACACAGAGATAAATT 
remanei         ATAATGAGCATATGTGAA-CATGGAATACTGTGGGAAATTGAGAGACGTAGAGAAAAAAT 
elegans         ATAATGAGCATATGTGAA--TGAAAATATTGTAGAGGATCGTGAGATTCCGAGAAAAATC 
	 130 
brenneri        ATAATGAGCATATGTGAG-TGAGAAATAATATCGGAATACAGGAGATTCTGAGAAAAATC 
                *****************       ****   * *        ** *    **** ***   
 
briggsae        -ATGGTGAAAAGTGTAGAAGAGTGGAATAAAGAAGTAAAATAGTGCACAAGAAAAAAAAT 
remanei         GACGATGGAAAGTAGAAGAGA-TGGAATAAAGGAATAAAGTA-------------AAAGT 
elegans         -ACAATGGTCACCG-AGGAAA-TGGAATGACAAAATATAGTA-------------AAAGT 
brenneri        -------ACGAGTGGAAGCAA-TGGAATAAAGGAGTAAAGTA-------------AAAGT 
                          *    *    * ****** *   * ** * **             *** * 
        >>F25H8.16 
briggsae        GCATCTCGGTGATCGGCAAAAAGGATAAATGAGTCACATGAAGACTTTGTTACATTGTTA 
remanei         GCAC------------------AAATAAACAAG--------------------------- 
elegans         GCACACGAGAGA-CACATACAAAAAAAAACAAGAAGA----------------------- 
brenneri        GCAC------------------AAGAACACAAGA-------------------------- 
                ***                       * *  **                            
 
briggsae        TATTGTATTATTCTAGTACAAAAAATCGGTGCCGGAGGTCCCTAAACGACAACTACCGTA 
remanei         -------------------AAAAAA-----GTCGGAATTGTCCAGAAAAAAACCA----- 
elegans         -----------CCTGGAAAAAATAAAATGGCTCAGAGAGTAGATCAGGAAAGTTATGTCG 
brenneri        -----------------ATAAGAAGT--------GAGGCTTCTTGAGAAAGTATATCAAG 
                                   **  *          **         *  *     *      
 
briggsae        ACCTAAAAATGTTTTTATTTTCTGAGTTTATTTTCTCGATTCTAGTACTTTTCCAGGCAG 
remanei         ----AGAAG-------ATCACATGA---------CACGACTGAATGACT-------ACGA 
elegans         TCTGAGATG-------ATCTCTTGAGACCATAC-AACAACTTAGAGATTTCCGAGCAAAA 
brenneri        GTTAATAAT-------AGTTTTTATTGAAGTACGGTGGATTCAGAGA----------AGA 
                    * *         *     *               * *     *              
 
briggsae        ATTTCTCACTATCAAAAATAGTAATTTTCAGACTTTTTTTGGGAAAATAACAGAAAACTT 
remanei         GTTGTATACTGT-----------ATCCTCG--------------------------ACTT 
elegans         GTTTGAAATTTTGACGTTTCAGGAATCTTGTTT---------------------GAACCT 
brenneri        GTCTACCGTTAGCAGGAACAA-AGTTTTTAT-----------------------AGATTT 
                 *       *                 *                            *  * 
 
briggsae        CACGAAAAACAGTAAAAGTCGAGATAACAAATTCTTAAAATAAAATTTTTTTAGGTTACG 
remanei         C--------CAG-----------------AATTCT----------TTTTTTCAGGTCA-- 
elegans         GCTGAAAAATTATCAAACTATCAAAAAATTACTTTC----CACGATTTTCAAAGGGCAAA 
brenneri        CTCTTGGAGAGACGGCTACAGTACAAAAAAACGTTCG----GATCCCTATTCCAACAAAC 
                                              *   *            *         *   
 
briggsae        GTAGTTGTCGTTGTGGGAACTTCGGTCACGGTCACCGGCATTTCTTTTCCACAGCTCCAA 
remanei         GCCGATCCCTTCGAAAGTATCTCAG----------------------------GTCCCAG 
elegans         CCGGGATTCAGAGCTGAAATTAAACACTAGTTC-------TTAAAGTTAAACTACTTAAA 
brenneri        TCGGAGATTCGTATGTTCATTACAC-----------------------------TTTGAT 
                   *              *                                       *  
 
briggsae        TTTTATGGTACCAGCGAACGCTATGTATTACGTAATATCAATTCCCCTGCTTCCATGGAG 
remanei         TTCCATG----------------------------------------TGAATCCATGTGA 
elegans         TTGTGTGATAATAC---------TCTGTAAAGTCCTATTTATTTTTTTCCAAACTTGATT 
brenneri        TCCCAGAACGAAG-------------------------------CCCTCATTGGATCTCA 
                *                                              *       *     
 
briggsae        GTCGAGAATTTCTGAAAAAGTGTCGGAAGATCTTTTCCAATCAGAGGATCTCTAAGAAAT 
remanei         ATCCACAAGT------AAATTG-------ATTGCTCTAAATC------------------ 
elegans         TCCTATACATTTCC--AAAATG-----GATTTGTTTTCAGACC----------------- 
brenneri        TCCCATTCATTT-----GGCTC-------CTCAATCTTCATCTT---------------- 
                  * *    *          *         *   *      *                   
        <<F25H8.14 
briggsae        AAAACCCTACAATCCAGTCTAATTTCGAAACTCATGAGTTCCACTTGACCCAGGATCACC 
remanei         ------------TTCATCTGAATCCTGAGA---ATAAATGTTCCTTTGTCC--------- 
elegans         -AAATTTCCAAAATTTGTTCAACTTCAAAACGATTGGCTCCCCGCCAATCT--------- 
brenneri        ------------TTTAACTCAAAGACAAGA---ATAAATGTTCCTTTGTTT--------- 
                                    **     * *    *   *                      
 
briggsae        GTTCCCAGTTGATGGCTCTAAATCTTCATCCGGATT-------CCAAGAATGAATGTTCC 
remanei         --------TTGTTGACTTC---TCCCCA-----------------------GGGTGCTTC 
elegans         -----CAGTAGCTAACTCTAAATCTTCATATGTCTTGATCCAGTGAACAATAAATGTTCC 
brenneri        --------CAACAACCCCCCCCTCCCCA-----------------------GGAAGCTTC 
                               *      **  **                           * * * 
 
briggsae        TTTGTCTTTGTATGCTTCTCCCCAGTGGGGTGCTTTCTTTCCATCTCATCACATCCAAAA 
remanei         TTCTCCTTCGTTTTTTTCTCCG-------------TTCACCCATCTTATCCCATCCAAAA 
elegans         TTTGTCCTTTCCAATTTCACCCCAGGGTGCT--TCTTCTTCCTACTCATCACAGCTACAA 
brenneri        TC--CTCTACTCAATGTCAT---------------TTCACCCGTCTCAT--CAACCACAA 
                *      *        **                 *    **  ** **  ** * * ** 
 
briggsae        AAAACACCTGGGGAACACGAAAAA-GTATGTCAACCGGCTGGGAAAGGTGTGAAATGTGC 
remanei         AAA-CACCTGGGGAACATGAAAAT-GTATGTCAACCGGCTGGGAAAGGTGTGAAATGTAC 
elegans         AAAACACCTGGAGAACACAAAAAA-GTATGTCAAGCGGCTGGGAAAGGTGTGAAATGTGC 
brenneri        AAAACACCTGGGGAACACGAAAAAAGTATGTCAACCGGCTGGGAAAGGTGTGAAATGTGC 
	 131 
                *** ******* *****  ****  ********* *********************** * 
 
briggsae        GAGGAGTGACCTAGTAGCTAA----C-----ACAAAGCTCATTTAGCATT---GGTGCCC 
remanei         GAG---TGACCTAGTAGCCAA----C-----ACAAAGCTCATTTAGCATC---ACCCCCA 
elegans         CTGG--TGACCTAGTGCCGAA----CCCACAACAAAGCTCATTTAGCATC---ATCCC-- 
brenneri        GAG---TGACCTAGTAGCTAAACGCCACCACACAAAGCTCATTTAGCATTTCGGTGCCCA 
                  *   *********  * **    *     ******************        *   
    <<F25H8.9 
briggsae        AGTGTCGAGTCAGGAGGACATATACAACCGGTATTCCTCTTCTTCTTGCCCTTTGTCTTT 
remanei         CGCAGAGAGTCACTCCGA-----ACAACCGGT------CTTCTTCTTGCCCTTTGTCTTT 
elegans         --AGAAGAGTCACTGAAG-ACACCCAACCGGT-----CTTCTCTCTTGCCCTTTGTCTTT 
brenneri        GCAGAGGAGTCACTCCGG-----ACAACCGGT---------CTTCTTGCCCTTTGTCTTC 
                      ******            ********           ****************  
 
briggsae        CTCT--ACTCGTTCAGCGTACCGCCAGGAGGAGAAGAATCCATGACAATCCATCCGGTCA 
remanei         CT----ACTCGTTCAACGTACCGCTATGG--------ATCCATGACAATCCATCCGGTCA 
elegans         T--------------------CCCCGCGG--------ATCCATGACTTTCCATCCGGTCA 
brenneri        TTTTTTACTCGTTCAACATACCGCCCGTGTGAG---GATCCATGACAATCCATCCGGTCA 
                                     * *             *********  ************ 
 
briggsae        TATAACTGTGTTGGTGTAACCCAGTTCTCTC-ATTTTGACTAAAGGGAAAAGTCATGCTT 
remanei         TATAACTGTGTTGGTGTAACCCAGTTCTCTC-ATTTTGACTAAAG--ACAAGTCATGCTT 
elegans         TATAACTGTGTTGGTGTAACCTAGTTCTCTCTATTTTGCCCTAAAG-AGAAGTCATGCTT 
brenneri        TATAACTGTGTTGGTGTAACCTAGTTCTCTC-ATTTTGACTGAAG--AGAAGTCATGGTT 
                ********************* ********* ****** *  **   * ******** ** 
 
briggsae        CGATGAGTTTCGTCACCCCTAGG-TAGTGGACTCGA--ATGAAAACAAAGGACAGGTGTT 
remanei         CAATGAGTTTTGTCACCCATCTACTAGCATCTCCGACAGTCAAAACAAAGGACAGGTGTT 
elegans         CGATGAGTTTTGTCACTAGCCATCCACCGATAGTGA-AATGAAAACAAAGGGCAGGTGTT 
brenneri        CGATGAGTTTCGTCACCCATCTACTAGCCAT-CCGACAGTCAAAACAAAGGACAGGTGTT 
                * ******** *****         *        **   * ********** ********
        >>F25H8.24 
briggsae        CGTGTG----------ATGCAGCGGTGTTTCTTAAG-ATATCACAAGTA-----AAAGTG 
remanei         CGAAAAGA--GAGGATATGCAGCGGTGTTTCTTAAG-ATATCAGAAGAACGAAAAAAGTG 
elegans         CGGACGG-----------GTAGCGGTATTTCTTAAGGATATCAAGAGAA-----AAAGTG 
brenneri        CAGAAAAACGGGGAGGATGTAGCGGTATTTCCTTAAGATATCACAAGTA-----AAAGTG 
                *                 * ****** **** * *  ******  ** *     ****** 
 
briggsae        AACATGATTGTTTAATGAGTTGTTCATTTTGAGAAGAATACACAGGAATCTGGGTCAATC 
remanei         AAAATGATTGCTTAATGAGTTGTTCATTTTGTGAAAA------------CTGGGTCAACC 
elegans         AACATGATTGCTTAATGAGTTGTTCATTTTGAAACGAAAA----------TGGGTCAATC 
brenneri        AACATGATTGCTTAATGAGTTGTTCATTTTTACATGGAAT----------TGGGTCAATC 
                ** ******* *******************   *                ******** * 
 
briggsae        AGTT-GAGCGGGACGA---ATTTCGAATATCTCATTAT-GGCAGGTGTTTCTACTGGAAT 
remanei         AAT--GAGCGAGATGA---G----GAATTTCGAATTGTTGGCAGGTGTTCTT-CTGG--T 
elegans         AGT--GAGCGGGATGATTTATTTCAAAATATACACCGT--GCAGGTGGTTGTGAAGATTG 
brenneri        AGTACGAGCGAGATGGGG-CTTTTGAATGAAGAATTGT-GGCAGGTGTTCTTACTGTAGA 
                * *  ***** ** *          **      *   *  ******* *  *   *     
 
briggsae        GGGCTACGAG-ATAAGGAGGAGTATGATTTAGTGGGAAA-----GAAATAGATTATTTTG 
remanei         GGAAAACGGA-ATT-GTTGAAATCTGGAATGGAGCCATC-----GAGAAATGTTCTATAC 
elegans         AAACCATTACTGCTAAAAAAAATTTGGTTTGAGCCCAACTTCCTAAGAAAAATATTTCAG 
brenneri        AGGAAAGAAA-TTGAAATGAAAAATGAGATATT--------------AAATGTTTCTCAC 
                     *              *   **   *                 * *  *        
 
briggsae        AAATTTGGAAAAGGATTTGAGAC-AGGGTCTTCATGATTGGACATCAAGACATACCGTAT 
remanei         GTCCTTTGCTGGAAATTGCAGA------TCTTCTTAA--AGTCAACTGAACATATCTAAA 
elegans         AAATGCTTGAAGATCTTAGAAATCATGCTTCTCATAAGGAAGGACTTGTGAAAGGCGCCC 
brenneri        A---GTTGGAAAATGTGGGAAAT--ACTTTTTTGTAGACAGAAATCAACACAGAGTGGAA 
                               *   * *      *  *  *        *       *         
 
briggsae        TTTCTCTAATTGAAGCCCACCCAAACCGTCAACGTTGAGCTCAGTTCTCGAT---TATGT 
remanei         GTA---TAAACAAGGGCTTTAAAAGCATTTACAGACTCCCTGATTACATTAT---TGTCT 
elegans         GCCACCCATCGATCTGTTAGAATGCCTACTATAAAGTTCTTGA--ACTCAAT---TATCT 
brenneri        CTCAGATATTAGTTGCC---AGACTTCAAGAATGAGTTTCTAAATTCGCAATATCTTTGC 
                       *                      *         * *   *   **   * *   
 
briggsae        GCAAGATGTCAAACATTGTCCACAATCCTGGAGTTCGCTTCTCCCTCTACCGTAACCTTG 
remanei         ATGAAATTTCAAGAAA-----ACGAGCC---GACCCCCTCTCATCTCCACC--------- 
elegans         TTGAAAT---AAAATTACATCAGAATTTC--AATTCACAAAAAATGCTAGTAATACC--- 
brenneri        TTGAAATAATTAAACGATCCCTTGCTCTA--ATTCTCGAAGTATTCCCAATGA------- 
                   * **    *                                  * *            
        <<F25H8.21 
briggsae        GCGCCAGTCCCTCAACTCTCTTGCCGCACGCCATTTCTCTCTTCGAAACAATGACTCAAC 
remanei         ---------CCTCA-CTCTGGTGTCATACAAG-----------TGAGAAAGTAAGCGACA 
elegans         --------CCTACAGTACTCCAACTGTACATTTGTTTTTCATCCCAAGCTATCATCATTC 
brenneri        ----------GTCAATTCACTAGACCTCCATG----CCCAATAGGTAAAAAGCTTTGAAA 
                            **   *          *                                
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briggsae        TCATTCGACCCCCATGTTGACTCGTAGAAAGCTTTTAAAGTAAGCGACACCCTCTCTCTT 
remanei         CCACTCCATCTC---------------AAGGC-----------------------CCCCC 
elegans         ATCCTATATACCTCCTTCCATCTC---AAAGT--------------------------CA 
brenneri        TCAGCCGACACCTCCTC------------GAT---------------------------- 
                       *   *                                                 
 
briggsae        TTCCAC-CAATGAGGTTGACGCAAC--GGCGGCTCCTCC---TTTATGATCCCTTTTCAG 
remanei         GGCGAC-CAATGACGCCAACGCAACA-GGCGGCTTCTCT---CTTGTGATGAACTTTT-- 
elegans         TTCCGC-CAATGA-GTCAACTCACTG-GACCCCCGTGTTGGATGAAGAATAGCTTTGGAA 
brenneri        TGCGACACAATTGTGCTGACGCAACAAGGCGGCTCCTTTTCCTTCCTAATTCCCAATCGC 
                  *  * ****   *   ** **    * *  *               **           
 
briggsae        ATGGATAGGTCATTTTTGATTACGCCATCATCTGGATTTTTTTCTGAACCAGATTCTTTT 
remanei         -TTCATTGGTGAC---AGGTTATGACATAATATAG----TCTCGGGAATCATAAAAGACT 
elegans         GTAAGCGAGTCACATCAGGCGCC--CCTTACCGACAATGCCTCTGACGCAAGAGGCGCGG 
brenneri        TTTTTTGTATCATTAATATTCGAAACTCCACT-------CTCTTTGAGTTAATTTTTTTT 
                 *       * *             *   *                    *          
 
briggsae        TGAAGGTCCGAATGTGCAAAGCTTCTACGCGGGGT-CCCATGGGAAAACGAATAACCTCG 
remanei         TCATACTC---AT---TGAAGTGATCATGGGAGTCACTTATTAGTTGATGACTAATCTAG 
elegans         CATTTCTTTTTATCAGAAGGAATCTTGCACAACTGCAACTTTGTGACGTATTTAGGTTGG 
brenneri        TGCAAATT-GCAT----GATGTTTTGATGAGAACAAATTCTCGTGAGATGAAAATTTATG 
                      *    **                           *            *     * 
 
briggsae        --ATGTGCTTGATATT--TCAATTATTT-TTTTTCTTGTTTTCTTCCTGAGGTTGAAAAC 
remanei         --AAATGTCTCATA------GAGAATCT-TGCTTCTAGATTT-TCCTTTTTCTCGTGGA- 
elegans         --AAACTAGCGAGACTAGTAGAGTATATATATATTTACAGTTACTGTAAATTAGCAAGGC 
brenneri        TGATATGAACATAATGAGTAACCTACATGAGCTTTCGAACTATCATGTTTTTCTAAATGT 
                  *          *          *  *     *      *                    
 
briggsae        AAACTCATATTC-AGTTTTTGCCAGAGATTTTCCTGAGAACAACTCAACCAAACAATAA- 
remanei         -------TATTC-AGAAATCAACCGAGATT---------ACTACTAGA--AAACAATAA- 
elegans         TTGTAAATTTTCGAGATTTTCCTTTAAAAGTGCTTGGCAACGAATAAAT-AAACACTGAA 
brenneri        TTTCCTTTTTTCCATTTACTTTTTATCAAAATAAAAACAATTTTTCTGGAAAGTAAATAT 
                       * *** *             *           *    *     **  *   *  
 
briggsae        ---CCGGAA--TGGAATCCTTAACTAGAT--ATAAACG-GACCAGTCCCGCATCC-CCTC 
remanei         ---CCGGAA--TCGAGCCCTTAACTAGAT--ATAACCT-ATTCACCAACTGACCAGTCGA 
elegans         AGTTTAGGG--TATGAGAAACAATCGGAACAAAAAACC-GGCTACCTATCTTTAACTAGA 
brenneri        TTTTTGAGTGCTTCCAACAATAACCGGAATAGAATCCTTAACCAGTAACCTAACTGACCA 
                           *         **   **     *  *      *                 
 
briggsae        TCTTTCCCGATGGTCATCATCATCATCAGCAAAATCAACAATTTTTCAT-CATAATCGGA 
remanei         TCCTATCCCTTTCTCTCGTTGGTCATCA-CCAATCAAACATTTTCCTATTCATAATCGGA 
elegans         CCCAAACTGACCAGTCCTATGGTCATCAACAACCTAGTCTATCTCTT---CATAATCGTA 
brenneri        GTCCATTCCCTCTCTCTCTCGGTCATCACCAA--TCAAAATTTCTCTATTCATAATCGGA 
                                      ****** * *         *        ******** * 
       <<F25H8.19 
briggsae        TTTCAAATCGGTCTCTCTCCGGAAGCTCGTTGTCTCGACTGTTTTATGCCTAAAAGTTTT 
remanei         TTC--AATCGGTC----TCCGGAAGCTC---GTCTCGACTGTTTTATGCCTAAAAGTTTT 
elegans         TTA--AATCCTCTTC--TCCGGAAGCTC---GTCTCGACCGTTTTATGCCTAAAAGTTTT 
brenneri        TTC--AATCCGCTC---TCCGGAAGCTC---GTCTCGACCGTTTTATGCCTAAAAGTTTT 
                **   ****        ***********   ******** ******************** 
 
briggsae        GAAAA-TCACGAGCGTGACCTAGTTTGACTCAAAGCGCACGGAAATCCGCTCTCGATTTT 
remanei         GAAAAATCACGAGCGTGACCTACTTTGAGTCAAAGCGCGCGGAAATCCGCTCTCGATTTC 
elegans         GAAAAATCACGAGCGTGACCTACTTTGACTCAAAGCGCGCGGAAATCCGCTCTCGATTTC 
brenneri        GAAAAATCACGAGCGTGACCTACTTTGATTCAAAGCGCGCGGAAATCCGCTCTCGATTTC 
                ***** **************** ***** ********* ********************  
 
briggsae        GGATGTG--TGTAAATGGACGCACGGGGTGAAAATCGAAAAATGAACTCT-TTTG----G 
remanei         GATATTT--TGGATGTGTGTGGACACGGGGCTAAATGATGAACTCCTCTG-TTTGT---G 
elegans         GATTTTG--TATGAATGTATG--TGTGGACACGGGGGATGAACTCTTTCTATTTGTAATG 
brenneri        GATTTTGGATTTATTTGGACACCACCGGGGGGAGAGGAGAAAATGAACTCCTTTTCTCTG 
                *    *   *     **         **        **  **         ***     * 
 
briggsae        TGTTCCATTCTCGCTTTTTTTAGGACTTAGGTGGCTATCTGATTCACATGAGATTCAGTT 
remanei         TGTTCCATTCTCACTTTTATT----------------------TCAAAT----------- 
elegans         TGTTCCATTCACTTATTTGTTATTATTT----------TTCTTTCAATTT---------- 
brenneri        TAT---GTTCACTTTCAAGCAAGCATACTGTATCTTATTTCTTTCAAAGTCAA------- 
                * *    *** *                               ***               
 
briggsae        TTTTTCATTTGTTGTAGGTATATATACCGTATACGGTAGATACTGTATCTTGAAGTTTCT 
remanei         ---------------------------------CGGTA-----TGGATTTTCATGTTAGC 
elegans         ---------------------------------TTGAA-----TCAACTTCCAAGTTA-- 
brenneri        ---------------------------------CCTTGTTCCATTTCCTCTGAAGTCTAG 
                                                           *        * **     
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briggsae        TTCAACCTTCCACTTAGCTGAATCCAGTCTTGTATTACCGTATTTCCTCTAATAGAATCC 
remanei         TTCAA---------------------------------------TTCGTTAATG------ 
elegans         TTGAATTGTTCACTTTAGGGAA-------------------AACTTACTGTATACCATCA 
brenneri        TTCTA--GGAAAGATAAGTGAA----------------------TTGATCAATCAATCAC 
                **  *                                       *      **        
 
briggsae        CACCTAAATTTGAGCACATATATCTCGCTTCCTGTAGAAGAAATCAAAAAGAGATCAACT 
remanei         --TCCAAATT-----------------------GTAGGA----------------CGACC 
elegans         TTTCAAACCTC----------------------GGAGAATAATACTTTTAG-----AAAT 
brenneri        ACATTAATTTTAATCTGGT------TATGATTTGTAAATACTGAGATGTAG-----TAAT 
                     **  *                       * *                     *   
 
briggsae        GACAAATTATTTATCGTAATATCACTAATATTTTATCAGTTGACAAACTTTTTCTATATT 
remanei         GA---------------------------------TCAG--------------------- 
elegans         AA----------------------------------CAGTGG------TTTTGTAATATC 
brenneri        AA-------------------------------TTCTAGATG--------CTCATTTGTA 
                 *                                   **                      
 
briggsae        TAACAAGAATCGAGATAACTGAGCTTAAAGTTAACGGCTTGAGTGGGATTCTATACCATC 
remanei         -AGTAAGAA--------------------------GTTTTGA------------------ 
elegans         TAGATAAAATT-----------------------CCTTTTGA------------------ 
brenneri        TAGGATAAACTTT---------------------CGTGTTGAGGCA-------------- 
                 *     **                             ****                   
 
briggsae        GGCAGCTTTAGTTTCGTCCAAGTGGCTCAGCCGGTAGCGGCACAACGTTTTCAATACTTG 
remanei         ---AGCTTCTGCTTTG----AGTTGTCCAG----------------------AACTTTTG 
elegans         --TTTAATTAGATTTGA--AGGTGTTTCAGTTCATA----------------GGCACATG 
brenneri        --TTCTTTCCGCTTTTTTTTTGGTTTTCAG--AAAAGTTGGCTCTCAAATCTTGATTCAG 
                       *  * **       *     ***                             * 
 
briggsae        TCCCACAAGTTCAACTCTTCGAGAGGGTTATGTGAACAAACTTTCAAGACAGTTATTATT 
remanei         ------GAGCTCATTTTTT----------ATG-------ATCCCTAAGA-GATCGTCATT 
elegans         ATCCGTAGGTGGGTCTTGCC---------ACG-------ATCTCAGACATAGTGTGGGCT 
brenneri        AACATCAAATTCATCTTTGAGTTTTGTCGACAC---TAGATCTTCATGTTTCTGTTCGAA 
                               *             *         *            *        
 
briggsae        TCCATGTTCGGCAACTTTAAGCATATGCTCAGTAAAAATTTCCCATCCCAATTCTTTGGA 
remanei         TCCTT----------------------------------TTTCCATCCGATTCTTGTACA 
elegans         TACCCTC--------------------------------CTTTAAGCTTACTGTCATATA 
brenneri        TCATTACAAACTTTTCTTC--------TCAACGAGGGAATATTTTCTTGAAAATTGAGAA 
                *                                                *         * 
 
briggsae        AACTCTTAAGACCTTTTTCACTTGTTCATAACCTCTAACTCTCGATGTTTCCATGAAAAC 
remanei         AG---------------------------------------TCGAGAGTTTCATGAAACC 
elegans         TA----------------------------ATGTATAGTTCTCGAGTAATCTGCAAACCC 
brenneri        AAGTGTTC-----------------------CATAATAGTCTCGAGAGTATCATGAAAAC 
                                                         ****          **  * 
 
briggsae        CATTTCCAAAATT--GAATCTCAAAACGCTTGATTGACCACA--CAAAGA---------- 
remanei         CATTTCGGAAATT--GA-TCTCAAAACGCTTGATTGACCACAA-CAATAC---------- 
elegans         GAAACATTGCCTTCAAAATGTCAAAACGATTGATTGACCAATA-CAATACCCAACACTTT 
brenneri        CTTGTCCGAAAT----AGGACTAAAACGCTTGATTGACCACAACCAATACTCGATACAT- 
                           *    *     ****** ***********    ***              
 
briggsae        ---AATTGAGACA-CAACAATCGTTCCATTAAC-----CATCTCTGCAACATTTCC-ATC 
remanei         ---AAGAGTAGAC-CTAAAATCGTTCCATTAAC-----CATCTCTGCAACATTTCC-ATC 
elegans         TCGGGTTGTGGAAACAACAATTGTTCCATTAACTAACCCATCTCTGCAACATTTC--GTC 
brenneri        ---GTCAGAAGAGACAACAATTGTTCCATTAACTAACCCATCTCTGCAACATTTCGTGTC 
                       *      * * *** ***********     *****************   ** 
       <<F25H8.20 
briggsae        CCGACCTGAACATACCAATTAGGTGTCCGGTAG--G-----GGTGACGAGAAAAGTGACC 
remanei         CCGACCTGAACATACCAATTAGGTGTCCGGCAGTTG-----GGTGACGAGAAAAGTGACC 
elegans         CCGACCTGAACATACCAATTAGGTGTCCGGTAGTTGTGGT-GGTGACGAGAAAAGTGACC 
brenneri        CCGACCTGAACATACCAATTAGGTGTCCGGTAGTTGTATTGGGTGACGAGAAAAGTGACC 
                ****************************** **  *     ******************* 
     >>F25H8.10 (bold) 
briggsae        GGTACTAT--------TCGCTTTCTACTTGT-TT-CTGATGGATAGATGATGTTAGTAGG 
remanei         GGTACTCTCATTCTCTTCGCTTTTTACTTGTCTT-CTGATGGATAGATGATGTTGG-ATG 
elegans         GGTACT-----------CGCTTTCTACTACT-TG-CTGATGGATAGATGATGTTGG---- 
brenneri        GGTACTCG--------TTGCTTTCTACTTCTTTGGCTGATGGATAGATGATGGAAACACG 
                ******            ***** ****  * *  *****************         
 
briggsae        GTGGTGTTGGCGGAGAGTGAAAGAGAGAGACTTGGTAAATGCACCACCGCTTCCAATTAT 
remanei         GTGGCGGTG--TGAGAGAGGGAGAGAGAGACTTCGTAAATGCACCACCGCTCCCAATTAT 
elegans         ----------------GTGGCGGTAGAAG-----GTAAATGCACCACCGCTCCCAATTAT 
brenneri        G---------------GGGGCCAATGGAGACTTTGTAAATGCACCACCGCTCCCAATTAT 
                                * *        **     ***************** ******** 
 
briggsae        CGTGTTCATGTTATGTTTGTGGAAGAAAT---------------ATAGAAGGGACGGTCC 
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remanei         CGTGTTCATGTTATGTTTGTG---------------------------AAGGGACTGTCC 
elegans         CGTGTTCATGT-GTGTTTGTGGAAGAGAATTGAGAAGAGGGGGAATGGAGAAGACTGTCC 
brenneri        CGTGTTCATGT---GTTTGTGTGAGAAAGAGGAGAAAACGG---GCAAAAGGGACTGTCC 
                ***********   *******                           *   *** **** 
 
briggsae        GAGAATCATCATTATCGTTTTGGAAGAAAAAGAAGAAGGCGACGGGTTG-CAAATGGTAT 
remanei         GAGAATCATCATTATCGTTG-AGGTGACGGTTGCAAATGTTATTGTTAC-CACCCCGTTT 
elegans         GAGAATCATCATTATCGGT---GGTGACGGTTGCAAATGTTATTGTTAC-CTCCCACCTT 
brenneri        GAGAATCATCATTATCGTTGGTGGAAGGTAGGCAAAATGTTATTGTTACACCCCTTATGT 
                ***************** *   *            ** *  *  * *   *        * 
 
briggsae        TGTTATACT-CTTCCCCGTTTCCATTTAC--GGTTTGATGGGTTCTTGGGAACAGTTTCT 
remanei         TCCTA-----CCACCCATCTTCCATTAAG--GGTTTCACGGGTTCCTAATTTCTTGGACG 
elegans         CATTTTCCTACCACCCATCTTCCATTAACAAGAGTTTAAAACTTCCTTGGAGCAATTTAA 
brenneri        CTTCTTCCTACCACCCAGCTTCCATTAAC--GTCTCGAGAGGTT---------------- 
                          *  ***   ******* *   *  *  *    **                 
 
briggsae        GTTTTGTTATT--CTCGAATTATCGATATATTTTCTTGGCTAGTGAATATTGTTCGGCTT 
remanei         TCTTCAAGATTGATTCAAACCGATTTTCTATTTTTTGAGACAGTTT-TCGAGTCGAGATT 
elegans         TTT----AATT---TTCACTGTTTTTTATCTTTTTCGGTAAAAGCCAAGTAGTTTTACAT 
brenneri        --------------TTGAGTCATTTTTA-ATTTGCTGA---AACTTGTGAAACCTCA-TT 
                              *  *        *   ***        *                 * 
 
briggsae        AATTAAGCTTAGCTCTTTTATTACCTTCTGATATTTTTCTGTAGATTTAACATTATTTTT 
remanei         CTTGAATGTTTCGACTTCAATAACAGTCTGGAA-----CCAGGGTTCTGACG--ATTTCC 
elegans         TGTCAGAA--AAAGTTTTAGTTATGATTACTCAAT---TTATGAGCTTCAGAGCTTTTTC 
brenneri        ATTTGATGTTTTACTCATGGAAACTACTTGTCG-------ATAGCTTTTA---------- 
                  *                   *                        * *           
 
briggsae        GAAAGGGAATTAGTTTCCTGATATGGAATATCCACTTTTAAATGTCTGAAGTTTATCACT 
remanei         GATTCTGGA--AATTCCC-------GAGCATTT--CTCGAAGTGATTGGGATCT-TCACG 
elegans         ----CTGGT--ACTTCAT------AAAATAAGCAGTTGGGAGTTAACCAGAAGAATCGCT 
brenneri        -----------AACTACC-------AAATAAAAATTTTGAGGTAGCTT------------ 
                           *  *           *  *      *     *                  
 
briggsae        TTTATTATTCTGGCACTAAAACATCGGAGCTGTGGCCAAAGGTCTCACACCGACAACTAC 
remanei         AGAATT-TTCTATCTAT------TCATAGGTTTTTTTTAGATTCTT---CTGA-AGCTTC 
elegans         AAAACA-TTTTTACACTGAGTAGCCTCTTCACCCGGTTAAGACGTGACGGGGGCGCCTCC 
brenneri        ----------TAACG------------AGACTGAGCTAAGAGTTTT-----TAGAGGTCA 
                          *  *                        *     *            *   
 
briggsae        CGTAACCTAAAAATTTTGCGATTTTTGCAATTTTTCGAGAGAAAAACAATTA-TTCGAGG 
remanei         TACTCTCATAGAAATTCCAAATCTT----ATCCTTCGATACTACGGTATTCCCTTCTAAA 
elegans         TCCCGCCTCTCAACTC----GCCCT-----CCTCACGCCCAGCCGGCATCCCTGCGTTGA 
brenneri        TGAAGTTCATGAGTTCTAGAAGCCT--------------GAGAAGAAATT-------AGA 
                           *  *         *                      *             
 
briggsae        ATTTTTTGTCGATAATTTTATGGAACAGTGTTTTATTACT-GTAGGTTACTGTAGATTAC 
remanei         TCTTTTTCCCCCTCATCCCACCGAA-ACTCCGAAATCCCGAGTGATCCACCATTCATTTC 
elegans         GATGATTTTCAAATATTGTAGATGCCTTTCTCCTTTTTATAATTCTCTTTCTCAATTCCC 
brenneri        CCCATTAGTCAATGAGCTTTGGGAAAAGCTCACCGTTTACCATCCCTTAAC-TGAATCTC 
                     *   *    *                    *      *             *  * 
 
briggsae        TGTTGAAAACTAACTTCCTCTTGTGGTTTTTTGTTGCAAACACTATCACGTCAAACTGCA 
remanei         TTTTCGAA--TAGTTACATTTCGAGA---------AGAGATTATACTACTGTATACCCCT 
elegans         AGTTCA----TCGAGGCGTTCTTAGGGCGAGAGGCGGGGAGGTGAAGGTTTCA-GCTGCA 
brenneri        TGCCTTCT--CCTTTATATCCCGAAAGT-------CAAAACTGTATTTTTTCA-ATATCC 
                                  *                    *    *       *     *  
 
briggsae        GATGAAAACTGTGTTTTTTCCTGAAAAAAAAAACAAAATACAAAGTTTTCTACAGTAATC 
remanei         CTCTACCACTTTATTTTCCGTTT----------TTCCGTTTCTTGCATCCGATCATAATT 
elegans         CTTTCGAATTCTGCCTCGAACT-----------CCTAATATTAGGCAAAC-ACTTCAA-- 
brenneri        ATTCAGTATATTATTTTT---T------------CAAGTGTTTCCTAATC---------- 
                       *   *   *     *                *          *           
 
briggsae        TAAAGTTATCTTCCGTATCAAGAACACCATCCCGTCAAATTTCAGACAAAAGATACAAAG 
remanei         GTCGGTTTTCA-CCATTTCTCAAATACACACAAACGGAGCGTCCGAGCGATAGTAAGGGG 
elegans         -AAAATTTCCATCGAAATCTCTTTGACTTCCGTGAAGACTTTTAAAATCCCGAGTCATCA 
brenneri        -CTGATTATGCACCGTTTAAAATCTATTTTCTATGAGATTCTTGAAAAACTAATTCTAGG 
                     **     *    *       *    *      *   *   *               
 
briggsae        AAATAGAACAAGAATCTTCAAAAATAGCTGAAAAACCGAAAAAGGTCTAAAAATTTTGAA 
remanei         ATTGAGGACATGGGGAAATGAGAA-AGAAAAAGAACAGGAAGTGGGAAGAAGAAGAAGAG 
elegans         TCCCCGATCCCGTCTCAACGGTTACAATACGAGAGGAGATTATACTACTGTATCCTCTCA 
brenneri        AATCACTTGATTATTTTCCTTCTCCACTTTCG----ATTTTTTAACTCTCAATCTATTCG 
                                         *                                   
 
briggsae        TAATAACGCTCTTTGAAAACCTTTTCAAACCACTATTGTTCCAGTTTCTGAACTTCTCT- 
remanei         AAAGAA-GCTTACTGGGA-------TAGAACATT-------CAGAAACTGAAAGTC---- 
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elegans         TTTCCCTTCTTATTTTCCGTTTCTTTCGATCATAATTGCCGGTTTTTCTCAAAAACCCTT 
brenneri        AATGTTGTTTCGCTGAAT---------GTTCACT-------------CCGGAAGTC---- 
                         *   *                **               *   *   *     
 
briggsae        ---AAAATTACCAA---ATATCTGAAATTTCGAACTGTCGAATTCTTTTTTTTCCCATTC 
remanei         ---GAGATCAAACA---GTGTTCAA------GGACTGTGAATTGAGATTTAGTTGGATTA 
elegans         CTCAAATACACACACAAGCATCTGAA--TGGATAGTGAGGGATTGGGGACATTTGGAAAA 
brenneri        ----AATGTGAAAT------CCCGAA-----GGACTGATCTATTACATCC--TTGAAATA 
                    *                   *        * **     *         *   *    
 
briggsae        CCCTCCGGAAGTTCATCCTGTGATCCCGAAAAATCTCCGATTTCTTTTTCTCATTTTCCA 
remanei         ---TTCGGCTGTTGAAATTGAGCTCTC---AAATATCCG--CTGTGTTACTCAGCT---- 
elegans         TACAAGAGAAAAGGAACAGGAAGTGGTATGAAGAAAAAGGGATAAGCTTTGGAAGTAAAT 
brenneri        ----GTTACAATTCGAGAAGAGATTAT-----ACTACCGTATTTTCTTTCTC-------- 
                                   *   *              *   *    *             
 
briggsae        TTGAATTGTTACACTTCGAGAAGAGATTATACTACAGTATTCGTGCCTCTTTATTTTCCG 
remanei         --------------TTCGAAGCTAGGACCTGCTAAAA---------------ATTATTCG 
elegans         GTGAAATAGGTTGGTTTAAGGT--GGCTCTGGAAGAG-----------CTCTGCGAACTG 
brenneri        -------------------------------------------------TTTATTTTCCG 
                                                                           * 
 
briggsae        TTTTTCCGTTTCTTCCCGATCATAATTGTCGGTTTTC---GATCATTCTCAAATACACAC 
remanei         TTTTTCCAGTTCCCAACAGAGCCAATTGT--ATTTT--------GTAGTTGACAACTTTT 
elegans         GAATGAAGTTGGCTGGCACATGTCATTGGT-ATTGTA---TCTCATTTCTCAATTTTGAC 
brenneri        TTTCTTC-TTCTTTTCCGATCATAATTGTCGGTTTTCGCCTCTTTTTCTCAAATACACAC 
                         *      *       ****    ** *         *     *         
 
briggsae        AAACGGAGTGAAGGGATTGAGGACAAGAAGAAGAAGAACAGGAAGTGGTTGAGAAGAGAA 
remanei         AGACTGGCT--TGTTCTTCCTCATGAAAACAGGGAGGACCATTCCTATTAGCTACTATTA 
elegans         AGCTGATATCTCGGTTTTTTTGATAAATTTTTGATAAA--AACTTTATCAAAAATTATAT 
brenneri        AAACGGAGTGTAAGGATTGAGGACATGAAGAAGAGGGATGATGAACAGGAAGTGGTAAAA 
                *       *       **    *         *    *                  *    
 
briggsae        TGGAGAAGGATAAGCTTACTCGGAAAGAGAAGAAACTGAAAGTCGAGATCACAATGACCG 
remanei         CTG---TGGGTCAACTT--TTAGACAAGAACTCGTCCAAAAAAAGGCACCACAAAAACAA 
elegans         TTT-GTTTGCTAGTTTTGTAATTAAAAAAATCTCTCTGCAGAAATCTGCAGAACTCACCG 
brenneri        GAG----GATAAAGCTT-------ACCAGAACTGTTCGAAGAC--------CGAAAGTCG 
                               **            *         *                     
 
briggsae        GAGGAGATTCCGGTGAATCTAGATTTTGTTGCGAAGAAGATGTTGCCAGTTTTAGACTCT 
remanei         AG--------------ATCTAGGTTT----GCTATGAAAACCATCTGAGCATTAAATTCA 
elegans         TG--------------ATATATGCAGT----CAAAGGGAAGTAAAAAAATGTCAGCTCAA 
brenneri        AG--------------ATCTA----------CCAAGAAAACCTC-----TAATAGACGGA 
                                ** **          * * *   *             *       
 
briggsae        TTCAGAAAGTATGGACCTAGGCTTATACTCGAGAATCCATATTCTTTCCACCTAGGTTTT 
remanei         T-CAGATAGTAGGT-----------CACTTTTTAATTCATTTTC---------AAATTTT 
elegans         TACATA-AGTATTGCC--------ATAGTTTATGATCAATAGTTC--------ATGTAGT 
brenneri        --CATGTGACACTTTC---------CAGCTGGTATGCCACGTTCA--------AAATTTC 
                  **      *               *           *   *          *  *    
 
briggsae        TCGAAAATATATTCTTGATCAAACCAAAATAGGTATGTTCCAATAATTTCACATTCCATT 
remanei         C-------ACATTATCGA--AGAGCAAAAACGATA--ACCTATTTGGTCGGTACTCCATC 
elegans         C--------CTCACTTAAAATGCCAGAAAAAGGAAAAATCCA--CATTAAAAACTTTTTT 
brenneri        C----------GTTTCGA---------------AATCTTCCA----------CTTCTGCT 
                              *  *                *    * *            *      
 
briggsae        TAGAGAACCAAAATACCGTACTTCCTTTCAGTTAGTAACCGTATACCGTTTTCGAACTCT 
remanei         -AAAGTTCAATGAGAATTTACTTT-TTGCACTTTTTGGTAAAGAGCAACAGTGAATTTGA 
elegans         ------ACCATCATATAAGTTTTCCATCCAAATCTCGGCACCCTGGAA----GAACATGG 
brenneri        C---GCGGAGCAGGAACTGGTTCTGTTCCAGTTTTAGATTTCGGAGCT-----AATTCCT 
                              *      *    * **  *                     *      
 
briggsae        GACTATCTCTTACTGGAGTTAGTGCTGGGTCATGGCGATATTTCCGAACCCTGCCTGAGT 
remanei         AACTAGCTCAT-CTCAAGATTATGAAAAGTTAT---------TTTGACCATAAACTCAGT 
elegans         ATCTAGTCCAT---------------GAGAAAC----------CTAGATACGA--TAAAT 
brenneri        GATTGGCTTC-----------------ATCAAC---------TTTGAATCTTGCTTCCGC 
                   *                           *                       *     
 
briggsae        CCTCTTGTCCTCTTTGTGATTTTGAACCTTTGAAAATCTCATTTTCAATCCGCTTACCGA 
remanei         ATTCGGAC----------AACCGAGATCTTTTGAAATTTCAATT---ATTTAATTGACAA 
elegans         ACGGAAGT-----------TACAAAGACTGTTTAAATTAAAATTTGAATGT-CCTAATGG 
brenneri        CCAGGACA----------ATTAAAAAAGTATTTCCACTCAAAATTAGATTGATAGAAAGG 
                                            * *    *    *  *   **            
 
briggsae        ATGACCGTAAGATACCGCAACATGAC--CACTTTGT-ACTGAACTAGTAACT-TCTTCCT 
remanei         GTGACCGTAAGTTACGGTACCGCAACATCACTTTGT-ACTAAACTAGTAACT-TCTTTTT 
elegans         T--ACAGATAGGTACCGCAACATTACTGGACTCTAAGAGTGAACTTCTAACAGTCTCTTT 
	 136 
brenneri        T--ACAACTTGGTACAGCAACATAATT---CAGTAT-ACTGAACTAGTAACAGTCTTTTC 
                   **     * *** * * *   *     *  *   * * ****  ****  ***     
 
briggsae        CTTTTTCATCAAAATGTTATTCTTGTCGG-TCTGTGCAACGATCCGTTTCCTGTCCCGTT 
remanei         CATT----TGGAAATGTTATTCTTGTCGG-AATGTGCAACGATCCGTTTCCTGTCCCGTT 
elegans         CATT----TTGCAATGTTATTCTTGTTGGGTATGTGCAATGATCCGTTTCCTGTCCCGTT 
brenneri        TATC--CATCAAAATGTTATTCTTGTCGG-TATGTGCAATGATCCATTTCCTGTCCCGTT 
                  *     *   ************** **   ******* ***** ************** 
 
briggsae        TCCTCTCT--CTTTCTT----------------------CGAGGCTAATTACCTACATGT 
remanei         TCCTCTTTTTCTTCCTT----------------------CGAGGCTAATTACCTACATGT 
elegans         TCCTGCATGTCTTCTCTTTTTCATCTA------------CGAGGCTAATTACCTACATGT 
brenneri        TCCTTTCCTTTTTCTCTTCTTCTTCTTCTTCTTTTTCTTCGAGGCTAATTACCTACATGT 
                ****       **   *                      ********************* 
       <<F25H8.23 
briggsae        GCTGTGTACCGTATCAAAATACCCTT--CTTTCCTCCCGTTTCCGT-GGCGTTCTTCAAG 
remanei         GCCGTCTACCGTATCAAAATACCCCCGATTTTCTTCCCGTCTCTTTTGGTGTTCTTCAAG 
elegans         GCTGTGTACCGTATCAAAATACCCTCT-TCTTCCTCCCGTTTCCGT-GGCGTTCTTCAAG 
brenneri        GCTGTGTACCGTATCAAAATACCCTT---------CCCGTTTCCGT-GGTGTTCTTCAAG 
                ** ** ******************           ***** **  * ** ********** 
 
briggsae        AAAA-TGACACTTTTTGAATATCCATCCCGATCCTTGTTGGGCTGA-ATACATGTTG-CA 
remanei         AAAACTGACACTTTTTGAATATGTATCC-GATACTGTTT--GCATG-TTGCAAGGT--TT 
elegans         AAAT-TGACACTTTTTGAATATCCGATCCGTCTATCCTT--ACATG-TTGCATCTTGAAG 
brenneri        AAAA-TGACACTTTTTGAATATCCATTCGGACTATTGTTGCATTTGACTTCATTTCTTTT 
                ***  *****************     * *    *  **         * **         
 
briggsae        TTTCCTGAATCGAAAAATGGTACGTTGGACCACACGCAGCACAGCTGTCTCTCGAGGAGC 
remanei         CTTCTTG--TCCTAGAATAAAACATGGACCC-----CAACACAGCTGTCTCTCGAGCGCC 
elegans         ACAGACGTGCCCTAGAAT---ACGCGGACCCCAAACCATCACAGCTGTCTCTCGAGCGCG 
brenneri        TTTGTCTCTTTTCTGGACATGTCCTAGAATGGACTCCATCACAGCTGTCTCTCGAGCGCC 
                                *     *   *         ** *****************     
 
briggsae        GCGGCGCCTGTCTTGT---------TGTGGTTAGTGCCCCCAAATGTCACCTGTTTGTAC 
remanei         G--GCGCCTATTTTGTGGAGCGTCTTGTTGTGGGTGCCCCCAAATGTCACCTGTTTGTAC 
elegans         G---CGCCTGTTTTGTG------CGTCTTGTT-GTACTCCAAAATGTCACCTGTTTGTAC 
brenneri        G--GCGCCTGTTTTGTG------TGTCTTGTT-GTGCCCCCAAATGTCACCTGTTTGTAC 
                *   ***** * ****         * * **  ** * ** ******************* 
      <<F25H8.25 
briggsae        CATTCATCACTTTGACACCCCCTTCCCATCTCTAGAAGAACAG---------AATACTTC 
remanei         CATTCATCACTTTGACACCCACC------CTCTGAATGAACAG---------AATACTTC 
elegans         CATTCATCACTTTGACACCCTCC------CTCTGAGGGAAGGCCTTACTACTACTACTTC 
brenneri        CATTCATCACTTTGACACCCCACCACCACCACTGAGAGAAGAT-----------TACTTC 
                ********************         * **    ***              ****** 
 
briggsae        TCTTGTCTCGGTGTCTACTAGTACCTACTAATTTACGACTCGATTCGGATTCGCACTCTT 
remanei         TCTTGTCTCGGTGCCTACTAGTACCTACTAATTTACGACTCGATTTCGATTCGCACTCTT 
elegans         TCTTGTCTCGGTGCCTACTAGTACCTACTAATTTACGACTCGATTC-GATTCGCACTCTT 
brenneri        TCTTGTCTCGGTGCCTACTAGTACCTACTAATTTACGACTCGATTTCGATTCGCACTCTT 
                ************* *******************************  ************* 
 
briggsae        T-GATGGTC------ACCATGTTTTTGATGATGTGACATCGGATT---CAAGGTCTT--G 
remanei         T-GATGGTCTTGGTCACCATGTTTTTGATGATGTGACATAGAATC---CAAGGTCTTCCA 
elegans         T-GATGGTCGTGGTCACCATGTTTTTGATGATGTGACATGAGACT---CAAGGCCTTCTA 
brenneri        TTGATGGTCGTGGTCACCATGTTTTTGATGATGTGACATGGCATTATTCAAGGTCTTGTT 
                * *******      ************************   *     ***** ***    
 
briggsae        GGTTTCCAGATTTTT--------------------------CATTTCTTG--------TT 
remanei         TGTTTCCAGATTTAG--------------------------CATTTCTTG--------TT 
elegans         GGTTTCCAGATTTAGG-------------------------CATTTCACGAG-----GTG 
brenneri        CCATTCCAGATTTAGTTTCTCCTGCACGAGGTGTTCAATAATGTCTCATGAGTTTTAGTT 
                   **********                              * **  *        *  
 
briggsae        TCATTATT------ATAGAGTTACTTACTCTGATTCCCACTTAAAATGTTTTTGTGCATG 
remanei         CT----TT------TTAGAGT--------------------------------GTGAACG 
elegans         GCCTGATT------TTAGAACACCTC------TTGTCCTCTAGAAGAGCAATCATCAGTA 
brenneri        TTTTAATTAGATCTTTAAAGTGTTTCTGACTATATTACATGAATCATTTTGATTTTTCTA 
                      **       ** *                                   *      
 
briggsae        ATTAGGAAGTTTAG--------GAATCGAATCTACCGTATTT---CCTCTAATGAAACCT 
remanei         CCT----------G--------GAATAGAA------------------------------ 
elegans         CCTCCAACAGTCTC--------CACAAGGTTTTGGCAG-----------CACTCAACATC 
brenneri        ACTCAAAAAACTAGTCAGCTCTCAATCAGTTATCCTATATTGAGGCAGTGAGTTGAAGAC 
                  *                    *                                     
 
briggsae        AACCCGTTAACTTTGAGCTTAATTATCTTGATTCCTGTGATATCAAAAATTTGTCAACTG 
remanei         ----------CTCTGTG------TATCTGTATCCAGGTGA-------GATGTGTCTTTTA 
elegans         AGAGGTGTTCGGCTGGGCATA-CTGTCAATCCTCAAAGTAAGT-AGAGCTCCGCAATTTT 
brenneri        TTTTCTAAAGCTCAACGAGTCAGTTTTCCTTTTCTTAAAATCGACGCTTCTTATGAATCG 
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                                *      * *       *     *                     
 
briggsae        ACAAATTATCGATCATAATAACACCAATATTTTACCAGTTGACCAATTTTTGATATCTTT 
remanei         A---------------------------ATCTTACTG----------------TATCTT- 
elegans         GGAAAGTTCAAAAGTTTTAAATCCCCTCACTTTTTTGTGTTATC--TTCCGTAAGTTTTT 
brenneri        GCAAAAATTCTAAAGTCATTAAGCTCTATTCCTACCGTACTTCTCTACCCCGATTCCTTT 
                                                *                        **  
 
briggsae        TCCAGGAATTGAGATGGTACAGCTCAAAGTTGACGGTTTGGGTGGGATTCAGTTAGAGGA 
remanei         -------------------------------------------------------GGGGA 
elegans         GAAATAAATTGAAAT-------TCCTGGGCAATTCAAACAAATGTATTGCATGTACGGAA 
brenneri        G--ATTTGTCGATTTTTTTTAATTATGTGATCCTTGAAATGAATGCTCCGGAATAGAAGG 
                                                                             
 
briggsae        AATACGGTAGGAATCGGATCTATTACAGTAGCCAGTTTTCAGATGGCTACATACTAGTTA 
remanei         ------------------------------------------------------------ 
elegans         ATCTTCATA---ATTTGTTGAGCTTGGCAGCACACATTTTTGGTAAAAGCGAACAACAGG 
brenneri        ATCGGACCATGAAACAACTCTTGTATATCCCTTCATTCACTTTTGCTCTAGCAAGATTGC 
                                                                             
 
briggsae        ACTCTATCAACTCTTCTTCAACTTTTTGCAAACGTAGATTTGTGT---TTTCTATAATTC 
remanei         ----TATCAA-------------------------------------------------- 
elegans         GCAAACTCCAGTGTTCTACAAATTTTTGAACTTTGCCGGATACCC---CTGATGTGCAAC 
brenneri        ACAGATGTAGACTTCTTTCAAGATATTTTGTGCGGTACCTAATCCAAATAGATAGTAAGG 
                                                                             
 
briggsae        CGATCTGATTCCGAGCTCGCAGAACCTC--GCTAGCTAACCTCCGAAAAATAGATCCACA 
remanei         ------------GAGCTT--------------------------------------TACA 
elegans         TAGAATCTTTAAAAAAATTGCCATATGT--ACCATCCGCCAATCTTTTGCGAGCTTTACA 
brenneri        ATGTTTCCATTTGAATCCAATAAAACCCGAATCGAATCTTACAGATAAGGAGACTTTCTA 
                             *                                             * 
 
briggsae        CTGACCATTTGATACG-TTGAAACACTTCTA-GAATCAACTATGTTCTTATCTTCTTTCC 
remanei         CTGTCATTCTGATACA-TTTAAACACCTTCT-GAATCAGCCATGTTCTTATCTATTTTCC 
elegans         CTTATGTTCTGAAACACTTTCAAAACCACGC-TTTCTTATCTTTTCGTTATCCCTATTCC 
brenneri        TAGATCCTCTAACAGTGTTTTAACACTTTTCAGAATCAACTATTTTCTTATCTCCTTTCC 
                       * * * *   **  ** **                * *  *****    **** 
 
briggsae        ACCTTCTCTTCTTTTTTTTCTTC-------GATTATGTCATGTTGTGATGTTCCTTTCAT 
remanei         ACCTTTTCCTTCTTTTTTTCTTCC------GATTATGTCATGTTGTGATGTTCGTTTC-- 
elegans         ACCTTCATCACTTTTTTTTCTTATTTCTGCGATTATGTCATGTTGTGATGTTCGTTTCAT 
brenneri        ACCTTCTCCTTCTTTTTTTTCTTC------GATTATGTCATGTTGGGATGTTCGTTTCAT 
                *****       *******  *        *************** ******* ****   
        >>F25H8.18 
briggsae        CCATCTCATCATCGTCCATCATCACCATTAACAGGAGCGTCCTCCTCTTCCTTT------ 
remanei         --ATCTCATCATCGTCCATCATCAGCA---ACAGGAGCGTCGGCGTGCG----------- 
elegans         CTGTCTCATCATAGTCCATCATCACCA-------GAGCGTCAGGGCGCGCG--------- 
brenneri        CTATCTCATCATCGTCCATCATCACCAGCAACAGGAGAGTAGTGGTGGTAAGATTAAAAA 
                   ********* *********** **       *** **                     
 
briggsae        ---------------------------------------------------------CCA 
remanei         ---------------------------------------------------------CCA 
elegans         ---------------------------------------------------------CCA 
brenneri        AAATGTAACTTGGGCTTTATTAATCTTACCACCACTACTCAGGAGCGTCGGCGTGCGCCA 
                                                                         *** 
 
briggsae        TTCATCCTCATTTTTTTTGCTTAGTGTGTTTGGTATTGCATCGT--TTTTCTTTGATTCT 
remanei         TCCACACTCATTTTTT--GCTTAGTGTGTTTGGTATTGCATCTTCTTTTTCTTTGATTCT 
elegans         TCCACACTCATTTTTT--GCTTAGTGTGTTTGGTATTGCATCTT--TTTTCTCATCCTCT 
brenneri        TCCACACTAATTTTTT--GTTTAGTGTGTTTGGTATTGCATCTT--TTTTCTTTGCTTCT 
                * **  ** *******  * ********************** *  ******     *** 
 
briggsae        CCAACTTCT--TTGGCTTCTTTTCTGATTCCTGCCAAGTCGTCTTCGATCAAC------C 
remanei         CCAACTTCTGCTTCTTCTCTTTTCTGATTC-TGCCAAGTCGTCTTCGATCATCATCGCAT 
elegans         CTAGCTTCTG-CTACTTCTTTAGCTTCTTC-TGCCAAGTCGTCTTCGATCATCATCGTAT 
brenneri        CCAACTTTTG--TATTTTCTTTA--GCTTC-TGCCAAGTCGTCTTCGATCATCATCG--T 
                * * *** *   *      **      *** ******************** *        
 
briggsae        ATCGGCATAGAGTGTCCACT--C--CTCCCACTTC------TTCCAAGAGGGCGATGGT- 
remanei         ATCGGCATAGAGTGTCCACT--CTCCTCCCACTCTC--TTATTCCAAGAGGGCGCTTCTC 
elegans         ATCGGCAAAGAGTGTCCACT--C--CTTCCTTCTT-----ATTCCAAGAGGGCGCTTCT- 
brenneri        ATCGGTATAGAGTGTCCACCTCCTCCTCCCCCTCCAACTACTTCCAAGAGGGCGCTTCTC 
                ***** * ***********   *  ** **           ************* *  *  
 
briggsae        --TCTGTCCTGTTGCGCAATCGAGTCTTGCTTCTTCTCTTTTTTTCTT--GGTTGTTGAA 
remanei         --TCTGTCCTGTTGCGCAATCGAGTCTTGCTTCTTCTTTTTTCTTTTT--TATTTCTTG- 
elegans         ---CTGTCCTGTTGCGCAATCGAGTCTTGCTGCTTCTTTTCTTTTTTTCTTATTTCTTG- 
brenneri        TTTCTGTCCTGTTGCGCAATCGAGTCTTCTTGCTTCTTCTTTTTTCTTCGTATTTCTTG- 
                   *************************  * *****  * * ** **    **  *    
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briggsae        GACGTCGGAGGATCTACGATGTCTCCCCCA------CGTCGTATATCCAGTTTTGTGTCA 
remanei         GTTGTTGAAG-----ACGTCGGATCGCCT---------TCGTATATCCAGTTTTGTGTCA 
elegans         GTTGTTGAAGA--CGTCGTCGGATCGACGATTTCGCCGTCGCATATCCAGTTTTGTGTCA 
brenneri        GTTGTTGAAG-----ACGTTGAATCGAAGATGTCGCCGTCGTATATCCAGTTTTGTGACA 
                *  ** * **      **  *  **             *** *************** ** 
 
briggsae        GGGGATGTGGTGGTTGTCTACGAGAAATCGGAAGAAGAGCGGAGGGTTCAGAGAAGT-GG 
remanei         GAA-ATGTAAAGGGTGTCTGCGAGAAATCGGAAGA-GCGAAGAGGGTGGAGAGAAATCGA 
elegans         GCG-ATGTCGTGG-TGTCTACGAGAAATCGGAAGA-GCGAAGAGGGCTTAGAGAAGT-GG 
brenneri        GAG-ATGTGATGG-TGTCTACGAGAAATCGGAAGA-GCGCAGAGGATTCAGAGAAATGAA 
                *   ****   ** ***** *************** * *  ****    ****** *    
 
briggsae        TGTTAAACGGATCGGAAGAACTTAACTATCAGGTAGAATGG-CATCTGATCGT-GGTTTA 
remanei         AACAAAACGAATCTGAACA-CGTAACTATCAGGTAGAATGG-CATCTGATGGG-GGT--- 
elegans         AGTTA-------TGGAAGAACTAATTTAACAGGTAGAACTG-AAA--AAAAAA-GAT--- 
brenneri        GTTAAGGGCAAGCGGAAGACCCTAACTATCAGGTAAAACGGACATTCGATGGGTGGTCAA 
                    *         *** * *  *  ** ****** **  *  *    *     * *    
 
briggsae        AAG-ATCGGAA---AGATCTGATAATAAGACGCTCAGAGTTTGGAAATCAAATGATAGGA 
remanei         ------CAGGG---AGAC-----AATAA---------AGTCT----ATTAAGGGATAG-- 
elegans         ------CGGAG---AAATCTG--AGTGAG-----------------AACAATCAATAAG- 
brenneri        AAGGATCAGAATTCGAACGGAAAAGAAAGATCTCATGAATTCTTGATACAGTGGAGAGCT 
                      * *       *      *   *                     *    * *    
 
briggsae        TTGTGGTTGCCTAGGAAACGGTTAG----GTGTTTTTAAACAGATGGAGCAGTTTCAAGC 
remanei         -TGAACAGATCTAGGGAACAGTTCA----ATGCCGTCCA------GGATCAGCTAAGAG- 
elegans         --TTATCAATTTAGGCAAGTATTGC----ATGGATCTTATC---TGAAGTGGCCCGCAGT 
brenneri        CCGAAAAGATTAGCGGATTTTCTGGCAGTATGGATTCAGAATTCAACACTGCTTTGGATA 
                              * *     *       **               *         *   
 
briggsae        TTCCAATGTGTC--AAGCTTATTGATCTTTCTTC---------CAATGAGAGTCACCTTT 
remanei         --------------AAA--TATTGGTT------------------ATGGAATACACCACT 
elegans         GTCAAAAGT-TC--AAACATATTTATA------------------AAAGCATATGGCTTT 
brenneri        ATCAGTCGATACGAGAACTTCTGAGTTGAGCTCCAAACTACTGTAAACATATGAATATCT 
                               *   * *   *                   *    *        * 
 
briggsae        AGGTTCTGCTCCAACGAAATTTTCCTACTTTACCGTAAATCCTGTATTAAAATTCTATTG 
remanei         GAAGAGTG----AAGTAAATGGT-------TATCTTAAATTCC-----AAGATTC--CTG 
elegans         ATGAATGA----AAGTTTAGTACAGACTGATAGACCAAATCTTG----AACATACCATTT 
brenneri        TGGAATGCATCAGAAACTACAGTATCCACTGATTTCTAATCCGATACGTAAATAACAACA 
                             *    *            *     ***         * **        
 
briggsae        TTCGAAGGTACTTCCAGACGGCCTTTC-TATTTCAGGAACCTTCGATTTTTCCAA----- 
remanei         CACCAATG-------AAACAGTT-------------GAAAACTCAACTAGCAAAA----- 
elegans         TGGAAAAGT------AGGAAGTGTG---------ATGTAGTTAGTGTTGAGCAGA----- 
brenneri        AAAACACAAACACGTATCAAGTTCTTTATCAATCAAGAGAGTCGTACTCTCGAAAAGGAA 
                     *         *    *               *          *      *      
 
briggsae        -GTCCCTCTTGGAGGGCCGTTCTTTTAAAAGGACCCTTTCAATACACATTTTACGGTACT 
remanei         -GTATCTC------GACTATGTTT---------CCCT---------CATTTT-CGACAC- 
elegans         -TTACCTT--------TTGCTCCA---------CCCTAGAAAT--AAGCTATCAGCTTCT 
brenneri        GGCATTTTTCAACATTTCGTCGAAATCTTTTGAGTCTGCTACAGAAAAAGACTGAATATT 
                      *                            **                        
 
briggsae        C----TATCAACCCTTCTTCAAAGAATTTTTCTGTGATTCTCGTTCTG-----------T 
remanei         C----TA------CTTTTTCCCAAAACTTTTCT----TTCTCGCCA-------------- 
elegans         C----TTAGTTCCCTTAGACATCAAATTTTTTTG---TGAACAGTTT------------- 
brenneri        CAAGATTATTTTCCTTTCATTTGGTGTTCCCCTG-GCTACTCATCTTCCAAAACTTTTCT 
                *    *       ***           *    *    *   *                   
 
briggsae        TTGGCATCCATTTTTTGGTCTGATTCAATTGTCCATTCATTTTTTCGACATAAAAAAGTG 
remanei         -------CCATTTTTTCAT-TGATTCAATTGTCCA-----TTTTTCCATATAAAAA-GTG 
elegans         ------TCCATGATTTTTATGGATTCAATTGCCAACT--TTTTTTTCATATAAAAA-GTG 
brenneri        TCCATCTCCAGTTTTTTCATTGATTCAATTGTCCA----TTTTTTCCATCTAAAAA-GTG 
                       ***   ***     ********** * *     *****  *  ****** *** 
 
briggsae        TCTCATCCCGTCTCGAAATTCGCATAAAAAAGCCTCCGTAGGTGTGTGGGGTGGATCTCG 
remanei         TCTCAATGCGTCTCGAAATGCGCATAAAAA-GCTTCTCCAGGTGTGTGG--TGGATCTCG 
elegans         TATCATCTCATCCCGATGTGCGCATAAAAA-GCTGAGACAGATGTGTGG-----ATCTCG 
brenneri        TCTCATCTTGTCTCGAAATGCGCATAAAAA-GCTGCGTCAGGTGTGTGAA-TGGATCTCG 
                * ***     ** ***  * ********** **      ** ******      ****** 
           
briggsae        TTTTTGTCAATTTTCCTCCAGGCTTCTTCATTC-TTTTCTTTAGCTTCTTCTCGCACTTT 
remanei         TTTTTGTCAATTTTCCTACCG-CTTCTTCATCC-TTTTCTTCAGCTTCCTCTCGCACTTT 
elegans         TTTTTGTCA---TTCCTACCG-CGTCTTCTTCCACCTTCTTCAGCTTCCTCTCGCACTTT 
brenneri        TTTTTGTCATTTTTCCTACCG-CTTCTTCAGCC-TTTTCTTCAGCTTCCTTTCGCACTTT 
                *********   ***** * * * *****   *   ***** ****** * ********* 
>>F25H8.22 
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briggsae        ACCATCATTGCAAAAACGAGATTCCAC--CTGGGT-GATCTTGTCTCGGGGGATGAAAAG 
remanei         ACCATCATTGCAAAAACGAGATTCCAC--CTGGGT-GATCTTGTCTCGG---------AC 
elegans         ACCATCATTGCAAAAACGAGATTCCAC--CTGGGT-GATCTTGTCTCGGTCC------GA 
brenneri        ACCATCATTGCAAAAACGAGATTCCACACCTGGGTTGATCTTGTCTCGGAGGAC----CG 
                ***************************  ****** *************            
 
briggsae        AGGGACCGAGAAGGCGATTAAATACCTCTGTTTTCTCGATC--TTCGGTATTTTTCC--- 
remanei         CGAAGCTGA--AGCCGATTAAATGCCCCCTATGTGTCGATCGGTACGACAACGTTGCCAA 
elegans         GAAAAAAGACGAGGCGATTAAATGCCCTCGCTCCAAATGAAA-AAGGGCAACTT------ 
brenneri        AAGAAGCTTTGAAGCGATTAAATGCCCCCTCTCGATCGGGAC-GTTGCCAAAA------- 
                           *  ********* **     *              *  *           
 
briggsae        -----AAAAGGGCAACACCGTCTTC----TGAAACTGGCGCAACATTTTTACGGATGACG 
remanei         AACGAAAAAGGGCAACGTCTTCTGA----AGAATCTGGCGCAACATT--TACGGATGACG 
elegans         -----GGGCAACCAACGTCTTCTGA----AGAATCTGGCGCAACATTTGCATTGACGCCG 
brenneri        -----AGGGCAACAACGTCTTCTGGTGGGAGATTCTGGCGCAACATT--TTTGGATGACG 
                            ****  * ***       **  *************      ** * ** 
 
briggsae        AACGTGA----------AGGGGATAGATTACTTTACGACACGCTTAGTCGGAGAGTAGAA 
remanei         ACGACGACAGT------GAGGGATCGACGACTTTACGACACGCTTAGTTGAAG--TAGAA 
elegans         TCTGTCTGTGTTGGAAGAAAGGATCGACGACTTTACGACACGCTTAGTTGACG---AAGA 
brenneri        ACGTCGTCGGC---GACGAAGGATCGACGACTTTACGACACGCTTAGCTGAAG------- 
                                    **** **  ******************  *  *        
 
briggsae        GCTGAAGCAGAAGAGACTATGAAGCCGTTGACCACTACCATTCGATTATTCGGGTTTT-- 
remanei         GCTGAAGAAGAAGA--CTATGAAGCCGTTGACCACTACCATTCGAT-ATTCGGGTTTTTT 
elegans         CCTAGACTATGAAG--CTATGATGCCGTTGACCACTACCATTCGAT-ATTCGGGTTTTTT 
brenneri        ----AAGCCGAAGA--CTATGAAGCCGTTGACCACTACCATTCGAT-ATTCGGGTTTTTT 
                     *     *    ****** *********************** ***********   
 
briggsae        ---GTTGGTTCGACCGATTACAACGACGCCATCGTC---GTTGACGGTGTG----TGTGT 
remanei         G--GTTTGTTCGACCGATTACAACG---CCATCCTC---TTCTACGTTGC-----CGTGT 
elegans         TTCGTTCGTTCGTTCGATTACAACACCATCGTCTTCGGCTTCTACGTCGA-----CGTGC 
brenneri        A--GTTGGTTCGACCGATTACAGCGC--CCAACGTCTTCTTCTACGTTGTCCGTGTGTGT 
                   *** *****  ******** *     *  * **    *  ***  *       ***  
 
briggsae        GTCAGAAGAGTTTCGAGAGAGGAGACGCAGAATTACAGGAAAAAGCTAAAATTGCGTAGT 
remanei         GTCAGAAGCGNNNNNNNN----------NNAACAGCAGAAGCATACAAAAATGG------ 
elegans         GCCAGAAACATTTTCAGAA--GAGACGCAGAATCTAAGTAAAAAAT-AAAATTGCGTAGT 
brenneri        GTCAGAAGAGTTTCGAGAGAAGAGACGCAGAAATTCTAGGAAAAGCTAAAATTGCGTAGT 
                * *****                       **          *    ***** *       
        >>F25H8.11 
briggsae        TGCGTAATCGTAATAACGCCGCCGTGATGGCGTCGTCAAGGGTAAGAA-AAAATGAAGAG 
remanei         ------ATTATGATATT-------------------------TTGGAA-AAAATGGAATA 
elegans         TGCGCAATCGTAATAAAGCCGCCGTGATGGCGTCG-------TTGCGG-ATAGCAGAAAG 
brenneri        TGCGCAATCGTAATAACGCCGCCGTGATGGCGTCGTCGCGGATAGCAACAAAAAATGATG 
                      **  * ***                           *      * *         
 
briggsae        GAGGAGGAGAGGATCGGATATTGATAAGATATCAGAAAAATGAAACAG--AGAAGAGAAG 
remanei         AAGAAGAAGG------------AAGAAGTCATGCAGAAATTAACAACG--AGGGACTGAA 
elegans         GAGGATCAGA--------TATTGATAAGATAAACGAAAAATGAAACAGCAAGCGACGCAA 
brenneri        AGGAGGGAAAGGATCGGATATTGATAAG----GAGAAAAATGAAACAGATATAGACAAAA 
                  *    *               * ***        *** * * *  *  *       *  
 
briggsae        CATACTTATGATATTTTTGGAAAAAAA---AGGAAAAGCCAATTCATGCAGAAACGCACA 
remanei         CCTCTGTATAACATTAGTAAGGGACAG---AAGGAGATT---TTCA-GTAGGAGTTCGAT 
elegans         ATGGCATCAGATATTTTGGAGGAATATTTCAAGAATATT-GATAAATATAGGATCTGTTA 
brenneri        ATAAATTATGATACTTTGAATTGAGGG---AGGCTAATAAGAAAGAGGTACTGAAAAGCC 
                      *   * * *        *      * *   *        *   *           
 
briggsae        GGAATGGACT-CACATGGGTAGCTTAGTGAGGGACCATTTGAACTTTTGAAAACTGCTTC 
remanei         GGTCAACACT-C-TACGGGT----------GAGACCATTT-------------------- 
elegans         GAATAATGTTGCAAACCTATAAATTATTGTTAGACGAACT------------------TT 
brenneri        AGTAGAGGCTAGAATTGAGAAAAGGAGATCAGGATTACTGTAGA--------------CA 
                         *                      **  *                        
 
briggsae        AGAGGACAGTTCAGTCAGGAGCTTCTACCTCGATGCTCGTTTTGAGAGATCCCTTTCGGA 
remanei         ----------TCAGCTAAGAAGAGCAA-----GTGCATGTCCT----------------- 
elegans         AAATAGGATTTCTCAAATGATGAACCAAC---ATATTTATCATATCTA--CAGCGTCGGC 
brenneri        AGACTGGAGTGCAACAAATAGGATTGA-----ATTTATAGATTGAATG---------GGC 
                           *    *  *      *      *        *                  
 
briggsae        CTATAGTCAGCACAACAGCACC-ATTCAGTTTCAGTCAGATTGCGTCAAATCAACCCCGA 
remanei         CTATAATAAAAACATGAAC-------------CAGTTGAACTGC--CAAATCGA------ 
elegans         CAAAAGTATATGTATATATTTTTATTAAATAATAATGATAGCAC-TCGAATGGACCTTTA 
brenneri        TCAGACTGTTCATTCGGTTTCATTTTTTTTCATAATTTTTTAATCAGAAACGGT------ 
                  * * *                          * *            **           
 
briggsae        TCTAGGTTAGGCGGACCTCGACTCTTGTGCATTTCCCGGTACAGAGCCGCGGCCAGCCGC 
	 140 
remanei         -------------------GACTTATGAA-GCTCTCTAGTCAAGAGT------------- 
elegans         AATAAAAA-----------TACTTTTAAA-TTTGTCACATGATGAATC------------ 
brenneri        -------------------AACTATGCTAGATTTCTAGCTCGTTACT------------- 
                                    ***         *      *    *                
 
briggsae        TGCCGGGCGCTGCTCGGATCGTTCTGTGGGTAGGTTGCCGTGGACCAAATCGTTCGTTCT 
remanei         -----GGTTCTCCTC-----------------------------------CATTTTCTGC 
elegans         -----CGAACTTGTCGTAAC--------------------TACAAGAAATGGTTCATTGT 
brenneri        -----AGAATTGAT----------------------------------ATCATTTTGGCA 
                      *   *  *                                      **       
 
briggsae        TTTGGAAAGAAGCGCAGCCAACCAGTAACTTCTAGGACCGTTAGGCCGCCGTATCATACA 
remanei         TCTG----------------------AACCTCTAGAAACATT------------------ 
elegans         TTCAAAAATT-----------CTTCAAAATTCGCGAAACTTT------------------ 
brenneri        TCCATATGGA---------------TAGAACTCGGAAAGATTA----------------- 
                *                         *       * *   **                   
 
briggsae        TATCCCAGAAATAACCTAACCAAAATATTGTGGCCGGTCGTGGCATAGCCTTGTCGAGGA 
remanei         -------GAAAT--------------------------------------CTGGAGAAAT 
elegans         ----TCTGGAATAAAATA------------------------TGAGTTTTCTAGATTTAT 
brenneri        ----TCTTATACGTTTGAA-----------------------------TTCTGAAAGTAC 
                          *                                        *         
 
briggsae        GGACATCGACTCATGAAATGTGCATTTTTCCAGTTTGCATTGAAGAAGGGTGAAGGATCA 
remanei         GAGCAGTCACTCATAC------CATCTTTC------------------------------ 
elegans         CAACATAATCTGGCAGGTAACCTACCTGCTGCG-------------------------CC 
brenneri        CGTAATCCTGTCTTCAAAGGAGTTTCTCATTTT--------------------------- 
                    *     *               *                                  
 
briggsae        ATTTCAGTCTCATCTTATTACTCTAGAAATGATCCCAATAATTGCTCCTGATTTCTTAGT 
remanei         -------TCTCCCCTTCCTTCT----------TCCCAA-ACTTTTCCCAGA------AGT 
elegans         AAATCCCTTTAGATTTACTTCT----ACATAGTTACAG-AAGCGTAGAAGGTAGGCAAGT 
brenneri        -GCTAAAGTTCGACTTCCAGCCGTC-GGATATAACCAGAACAATATTCAAAT---CTCAT 
                         *    **    *              **  *                   * 
 
briggsae        TTCTTTTTTCAAACTCTGACCAACATCTATTAACACCCAACATTTCTACATTAACCCATA 
remanei         CACTTCATCTGGCCCCTGCCAAAC---TATCT--------TATGTGTACACT-------- 
elegans         GGGATCATCT--TTACTGGCTGGCA--TACCTA--------GTTTCCACATAT------- 
brenneri        ATCAACAATTCTGCTCTGTCGAACCCTTTTTTTCTG-----ATTTTCAGATCTTTCAA-- 
                               *** *   *   *              * *  * *           
 
briggsae        ACGATTTAACTTCTGGACCAAT-AAACCAGTAGATGTGAAGCTTAGACAAACTTATGTTG 
remanei         ----TTCAGCATGAAAACCTGT-AAACTAGTAGATAT-AAGCTTAGACAAACTTATGTTG 
elegans         ----TGTAGTCTTTAGACCTA--GAACTAGTAGACA--AAACT-----AGACTAATGTTG 
brenneri        ---GCTTCTTCTGTACTTCCATAGAACCAGTAGATAC--AGCCTAGACAAACTAATGTTG 
                           *      *     *** ******     * *      * *** ****** 
 
briggsae        TGGTCATTGTCTATCTCATAATCATATAATGATCACATGGCAATCTTGC----------- 
remanei         TGGTCATT------CTCATAATCATATAATGATCACATGGCCATCTCAA----------- 
elegans         TGGTCATT------CTCATAATCATATAATGATCACATGGTCATCTTCATTCGTTTTCTG 
brenneri        TGGTCATTCT----CATATAATCATATAATGATCACATGGTCTTCT-------------- 
                ********      *  ***********************   ***               
 
briggsae        ATTTTCCT---GCCATTGCTTTTCTCTTTATTCTGGCATA---TAGTCTTCAAGTTCTTT 
remanei         CATATGCT---GCCAATGATTTTC--TTTATTCTGGCATA---T--TCTTCAAGTTCTTC 
elegans         ATTTTCCTTATGCCAATACTTTTC--TTTATTCTGCCATAGATTCTTCTTCAAGTTCTG- 
brenneri        -----------GCCAGAGATTTTCT-TCTATTCTGCCATTC-TGATTCTTCAAGTTCTG- 
                           ****    *****  * ******* ***       ************   
        <<F25H8.13 
briggsae        TCCACTTATTATGCATGCTTCTTCTT---------GCTATTTTACTACAATAACAACATA 
remanei         TCCACTTATTATGCATGCTTCTTCTT---------GCTTTTTTACTACAATAACAACATA 
elegans         TCCACTTATTATGCACGCTTCTTCTTCTTATTCTTGCTTTTTTACTACAATAACAACATA 
brenneri        TCCACTTATTATGCATGCTTCTTCTT---------GCTTTTTTACTACAATAACAACATA 
                *************** **********         *** ********************* 
 
briggsae        AGCAGAAGATGTTCCACTCTCA---TCCTCTACTACGTTCACGTCTTCTTCTTCTTCTTT 
remanei         AGCAGAAGATGTTCCACTCCC----TCTCTTTCTACGTTCACGTCTTTTTCTTCTTCTTT 
elegans         AGCAGAAGATGTTCCACCCTTG---TCCCTC----CGTTCACGTCGTCTTATTTCTCCTT 
brenneri        AGCAGAAGATGTTCCACTCCCCCCTTCTCTTCCTACGTTCACTTCTTATTCTTTATTTCT 
                ***************** *      **        ******* ** * ** **  *   * 
 
briggsae        CGTTTTTTCTTCTTTCTGTATACTTTTACGTTGTTTCTTGTCTGA---GACGAA--GAGG 
remanei         C----TTTTTTCTTTCTGTATACTTTTACGTTGTTTCTTGTCTGA---GACGGG--G--- 
elegans         C------------TTCTGTATACTTTTACGTTGTTTCTTGTCGTATCCAACGAAACGAAG 
brenneri        T----------CTTTCTGTATACTTTTACGTTGTTTCTTGTCTGAGACAGTGGGG----- 
                             *****************************  *      *         
 
briggsae        GGACCCCGAACGGTACGGCAAAAAGCCGGTTTATCCATCTGCCCATTGGCTGCCAAAAGC 
remanei         -----CCGAACGGTACGGCAAAAAGCCGGTTTATCCCTCTTCCCATTGGCTGCCAAAAGC 
	 141 
elegans         GGCCCCCGAACGGTACGGCAAAAAGCCGGTTTATCCCTCTGCCCATTGGCTGCCAAAAGC 
brenneri        -----CCGAACGGTACGGCAAAAAGCCGGTTTATCCCTCTGCCCATTGGCTGCCAAAAGC 
                     ******************************* *** ******************* 
 
briggsae        CGATGGTCAGTTGGAAAATTAAGGAAGAAAGAT---AGGCGGAGTCGAGAGAAATGAGAT 
remanei         CGATGGTCAGTTGGAAAATTGAGGAAGAAAGA-----GGCGGAGTCGAGAGAAATGAGAT 
elegans         CGATGGTCAGTTGGAAAATTGAGGAAGAAGGGCCGGGGGCGGAGTCGAGAGAAATGAGAT 
brenneri        CGATGGTCAGTTGGAAAATTGAGGAAGAAAGG-----GGTGGAGTCGAGAGAAATGAGAT 
                ******************** ******** *      ** ******************** 
 
briggsae        GGCAACGCGAGGGAGAGGACGGGGGGCGACTTCTTTTTCGTGTCGCGCCGCGCGGAAAGA 
remanei         GGCAACGAG-----------GGAGGACGACTTCTTTTTCGTGTCGCGCCGCGCGGAAAGA 
elegans         GGCAACGAG-----------GGAGGACGACTTCTTTTTCGTGTCGCGCCGCGCGGAAAGA 
brenneri        GGCAACGAG-----------GGAGGATGACTTCTTTTTCGTGTTGCGCCGCGCGGAAAGA 
                ******* *           ** **  **************** **************** 
 
briggsae        AGACGTCCGA--------TTGGGG--AGGCACGGATCGCGTCACACCTTGTCTAGAAGCG 
remanei         AGACGTTGGAGGCA----CCATGG--ACG-ACGGATCGCGTCACACCTTGTCTAGAAGCG 
elegans         AGACGCTGAAGGAGGAGGTTGGATTCACGGACGGATCGCGTCACACCTTGTATAGAAGCG 
brenneri        AGACGTCGGAGGAG----GCACGG--ACGGACGGATCGCGTCACACCTTGTCTAGAATCG 
                *****    *                * * ********************* ***** ** 
 
briggsae        CTGACGCAACCGGTGTGT--ATCTAAGGATGCGCA----ATCCTTGTGATGCGTCTTC-T 
remanei         CTGACGCAACCGGTGTGT--ATCTAAGGATGCGCACGCAATCCGAGAGAT-CGTCTTC-T 
elegans         CTGACGCAACCGGTGTGTGTATCTAAGGATGCGCA----ATCCATTTTGACCATCTACAC 
brenneri        CTGACGCAACCGGTGTGT--ATCTAAGGATGCGCA----ATCCTCATGAT-CGTCTTC-T 
                ******************  ***************    ****        * *** *   
 
briggsae        TGATGGCAGATAT--TCAAGATATTTATGAAG-----TTTTTGGAAATGC-CACACAGGC 
remanei         TGATGGCAGATATATTCAAGATATTTGAAAAAGTTTTTTTTTGGAAATGC-AACAGTTTT 
elegans         CAATGGCAGAATT--TCAAGAAAATTAAGAAG----TTTTTTTGAGATGCCAAGAATTGC 
brenneri        TGATGGCAGATAT-TCCAGGATATTTACAAAG-TTTTTTTTTGCAAATGA-AATGTTTTT 
                  ********  *   ** ** * **   **      *****  * ***   *        
 
briggsae        GA---CTGTTTTTCT--TTGCTTTTGCAAGTGTA---ACATGTTGCTCATGATCCTG--A 
remanei         AG---AGGTTTTTC-----ACACATGAAAGT-TA---GTATATCAACATCTCAACTA--G 
elegans         AGCTTATATGATTGT--ATAATTCTAGAAGAATC---TCACAGAGCTTATTGCACGA--A 
brenneri        TGTTTGAACTTCACAGCTCCATCCTAGAGACCTAAGAGCATTTTGATCGTTGCACAATTA 
                                        *  *    *      *              *      
 
briggsae        AACAGTTA--CTA-GTTGAGCTGATAAGCCTACTTGTTTGCTGAGTTCC--TTTACCAGA 
remanei         TAGAGCT----CA-AATATTGTAATTCTGCTCATCGTGATCTGAAACCG--TCT-CTACA 
elegans         GCTCTTTCGCTCA-GTCAGAGCGCTTAACTTTATTTACCGTTTAAAATA--GTTAGTGCT 
brenneri        GGTTTTTACTCTATACCAGTGAAGTTAGCATCGACAGGAGCATAGACTGAGTCTTTCACA 
                      *     *           *     *            *         *       
 
briggsae        GTTTTAAGCCTACTTTTTAATTTGACATGT-------------TTTCTGTTCATTCTAAG 
remanei         GTTCTCCACTTG-TTTGCGTTTTCAAATTC-------------TCCATTTTCGCTC-GTT 
elegans         CACTTCTGTCTTTTTTCCAATTTTGCTCTC-------------TTGATTTCCAATA-CCT 
brenneri        AAGTTCTACTTCTATGATAATCTCTAAGTCCGAAACAGAAGAGTTCGTGCTGATAGTGTG 
                    *     *   *     * *                    *   *             
 
briggsae        ATCTTCCAGGTAGGCTACCTCTAGCTACTACTCTTTTC-ATAGTTCTTTTTTTCATGGTT 
remanei         TTTGTTGTTTTTGATCAGTTTCAGCCTCTATTATAATCTATAATGTTTTCTTCCAATGTA 
elegans         CCAAAAATAGTCGTTTTATTCGTGTCCCTATTTTATGTTGCTGAAACTTATTACGAGATT 
brenneri        TGATTTTTGGATGAAGTGGCTCCATCTCTTTTCATCTTTCTTGT-CTTTTTTACGTTCCG 
                            *              **  *               ** ** *       
 
briggsae        CCTTCAGTATC--CAGTATGAAACTAAAGTTATCA------T-GCTCATTTC----CTTT 
remanei         TTCAAACTGACATCTTTATTTACTATTTCTCATTA------CCGTATACTTCAAAGTCTT 
elegans         CTGCTATTCCCA-TTTTCTGCTCTAAATATTTGCA------TTCCGTATTCC----TTGT 
brenneri        GATGAATTATCTTCTTTTTTGTGCTCATTTTATCAATTCACTTAAACATTCCAATTCTAC 
                     * *  *     * *          *    *            * * *         
 
briggsae        GTC---------------CCAACTCTCGTGTCAACTCTCAACCGTTTCCCATCTTTTCTG 
remanei         GCT---------------CAAACTCTCGTCCCAA-TTTCATCCATT-CCATTCCTTCCTG 
elegans         TTC---------------CAAAAGCTC--CATAATTTACAATATTGTGATTTTCTTGATC 
brenneri        ATCTGAGCATCTTCGGAGCCAACTCTTGTCATTA-TTCTGTCGACTTCCGATCCTTGTTG 
                                  * **  **       * *               *  **  *  
 
briggsae        ACCTCATTAATCGCCACC---CACACATTGACCCATTCCCTTCC--TGAACTCTTTTTCC 
remanei         ACCTCATCAATCGTCGCC---CCCACATTGACCCATTCTCTCTC--CGAACTCTGTATCT 
elegans         TTCCCATCAACTTCTATTG--CCCTCATCAATCCTCTTTGACCCA-TTCTCTCTTCAACT 
brenneri        ACCTCATTAATCGTCGTCGCCCACACATTGACCCATTCTCTTTTTCTGAACTCTGTCTCT 
                  * *** **           * * ***  * **  *             ****    *  
 
briggsae        -TCTCTTGACTCCGCCCCCATCCTCTTGC--TCTCTATTGTCTCACCTCCTTCTCCAACA 
remanei         GTCTCTTGACTCCGCCCCT----TCCTGT--CCCTTCTTG-CTCTTTTGTCTTCCCACCT 
elegans         CCATCTTGACTCCTCCCCT----TCCCGT--ACAA-CTTGCTCTTTTTACTCCTCCAACC 
	 142 
brenneri        ----CTTGACTCCGCCCCC-TTTTCCTATTGCCTCCGTTTGCTCTTTTGTCTTACCTCTT 
                    ********* ****     **       *    **        *      **     
        <<F25H8.15 
briggsae        CCAATCAC-----CCATCGTTCGCCCGTCGCTCCCCTCCCCATCCTCT--ACCGTCACCA 
remanei         CCTCCTTC-----TTCCTCTTCACCAATCGCCCTCCCGCCGCTCCTCTTCACCATCACCA 
elegans         ATCTCTCT-----TCTCCTTTCACCAATCGCCCGCCCGCCGCTCCTTC--ACCAACACCA 
brenneri        GTCTCTTCCACCATCCCTTTTCACCAATCGCCCGCCCGCCGCTCCTCC--ACCATCACCA 
                                   *** **  **** * **  **  ****    ***  ***** 
 
briggsae        ATGTCTTGACTCCGCCTTT-TTTGTTCACCCTCGCCCATCACCA---TAAAGCCTCGAGC 
remanei         -TCTCTTGGCTCCGCCCCT-TTTTTACACCCTTCGCCAATACCA---TAAAGCTTCGA-T 
elegans         -TTTCTTGACTCCGCCCCCATTTATTCACCCATCGCCATCACCA---TAAAGCCTCGA-A 
brenneri        -TTTCTTGACTCCGCCCTCTTTTGTTCACCCATCACCATCACCACCATAAAGCCTCGACT 
                 * ***** *******    *** * *****    ***  ****   ****** ****   
 
briggsae        GGAGGGATGACCACCAGCGGACGTTCCGCTCTATTGATCCGAA---TTTCAATTTCACTT 
remanei         ACCCGAGCG--CGAGGCCGGACGTTCCGCTCTCTTGATCCTCT---TTTCAATTTT-CAC 
elegans         ACCCGA-----CGGGGCCGGACGTTCCGCTCTCTTGATCC------CTTTAACTTGCTAT 
brenneri        GACCGAAGGGGC-CGCCCGGACGTTCCGCTCTCTTGATCCTCTTCTCTTCAAATTT-CAC 
                    *      *     *************** *******       ** ** **      
 
briggsae        TTTTTCTACCGGATTCATTCGAAACACAATAAACTCTTGAGACTGAATCCTAATCCCTTC 
remanei         TTTTTCTTTTAAATCCCTCC-----TCTTCCAACTCTTGAAACTTTA--CTAATCCTTTC 
elegans         CTTTTCAA-----------------------AATTCTTGA----------TTGTCATTTC 
brenneri        TTTTTCCTCCAATTCCACCA----------AAACTCTTGA--CTGTA--CTAATCCTTTC 
                 *****                         ** ******          *  **  *** 
 
briggsae        CGTCTTGAC-TGTTT----CTGAAA--AGATCTTCGCAACTCTATCGCTCTTTTTTGTCT 
remanei         CGATTTGAC-CGTTTATTTCTGGAA--ACATCTTCAAGACTTCATCATTCTTCTTTCTTT 
elegans         CGACCTAAA-TATAAAAACCGGCCCT-AGATCTTCAAGACTTAATCATCATTTTCGAAAA 
brenneri        CGATTCGGGGTTTCTATTTCTAAATGAAGATTTTCAAGACTTGATCTCATTTTTC----- 
                **          *      *       * ** ***   ***  ***    ** *       
 
briggsae        TCGTTT-TCTTCATGGGTCATAAAAAACTGAGAAGGAATCGAGACAC-AAATCTAAAAGT 
remanei         TTCTTGGTCTTCATGGGTCATAAAATAACGAGA--GAATCGAGACA--AAATCTAAAAGT 
elegans         CTCTTCAT-TGCACGGGTCATTAAA-ATTAGGCGAGAATCGAGTCAGAAAATCTAAAAGT 
brenneri        TCCACTGTCTTCATGGGTCATAAAATTACGAGACAGAATCGAGACAAAAAATCTAAAAGT 
                       * * ** ******* ***      *   ******** **  ************ 
           
briggsae        GCACCACCTCCCATACAACCACCTTCGTTTCAAAAAA----GATCCTTATCGATCTCTTT 
remanei         GCATCACC-----CACGACCACCCTCATTTCAAAAAAA---GATCCTTATCGATTTCTTT 
elegans         GCACC--------CACGACCACC--CATTTCAAAAAAATAAGATCTTTATCGACTTCTTT 
brenneri        GCATC--------CACGACCACCCTCATTTCAAAAAA----GATCTTTATCGAGTCCTTT 
                *** *         ** ******  * **********    **** *******   **** 
<<F25H8.17 
briggsae        GTTTGCAAGAATCGGCGCGTGCCGAGACTCATCCACACCTCCTTCT-TGGGTGTCAGTT- 
remanei         GTTTGCAAGAATCGGCGCGTGCCGAGACTCATCCACACCTCCTTTTCTGAGTGTCATTTT 
elegans         GTTTGCAAAAATCGGCGCGTGCCGAGACTCATCTACACCTTCCTCT-TGAGTGTCATTTT 
brenneri        GTTTGCAAGAATCGGCGCGTGCCGAGACTCATCTACACCTTCCTTTCGAAGTGTCATTTT 
                ******** ************************ ****** * * *    ****** **  
 
briggsae        GTCCGGTCTAAACGATTTTTTTCGATAAAAAAAGCGAACATGATTAACCTACCCGATGA- 
remanei         GTCCCGTCTGGGCGATCTTTTTTTTCGAAAA---CGAACATGATTTACCTCCCTGAAGAG 
elegans         GTCTCGCCTAAACGATTTTTT-------------CGAACGTCAGCTAATCTTTGGCGGGA 
brenneri        GTCCCACCTAAACGATTTTTTCTT----------CGAAAAAACGAACATTTTCATTTAAG 
                ***    **   **** ****             ****                       
 
briggsae        --ATTTCAACACTTCCACCGCTTACCTT--------AACTCTCTCACTTG---TCTTTTA 
remanei         AAATCTGAACGCCTCTAACTATAACTTTTCCATTCTGCCTCCTCTATTTGATTTATTTTC 
elegans         GATTCCGAACATATATTCCTTCTTCTAA-------TTCTTTTTTTAGTTGTTCTGCTTT- 
brenneri        AACTATCACCGTTCCTATTCCATTTCTT--------ACTATCCCTTCTCGATTCCTAATT 
                   *   * *                                     * *        *  
 
briggsae        TTCAA-CTATGTG-----TCCTATTCCTATATATTCCAGGTTCCGCAGATCCTGGTATGC 
remanei         TCCAATCTATATTCATATTCCTATTTCTATCAATTCCAGGTCCCCCAGATTCTGGAATGC 
elegans         TGCACACTTTTCTATCCTAACTGTTTCATATCCTTTCAGGTATCCCATTACCTGGAATGC 
brenneri        ATCAAAAT-TCCTACTATTTCCAACTCTGTGAATTCCAGGTACCCCATATCCTGGAATGC 
                  **   * *          *     *      ** *****  * **    **** **** 
        >>bed-3  
briggsae        AGACACAGAGTCCATTTGGTCCGCTGATTGCTCTGCCGCCAGCACTTCTGCAATCTCCAG 
remanei         AGACACAGAGTCCATTTGGTCCGCTGCTTGGTCTTCCCCCATCAATGTTACCATCACCAG 
elegans         AGACCCAAAGTCCATTTGGTCCGTTACTCGGGATTTCATCATCCTTGCTCCCATCTCCAG 
brenneri        AGACACAGAGCCCATTTGGACCGCTGCTCGGTCTGCCTCCAGCTTTGCTCCCTTCTCCAG 
                **** ** ** ******** *** *  * *   *  *  ** *  *  * *  ** **** 
 
briggsae        CTACGGTAGCAGCAGC---TGCAG---CAAATGGACATGCTCCGCCGGTTTCTTTGGCGA 
remanei         TTACAGTACCAGCAAC---AGCAGGAGCAAATGGACATGCTCCA---GTGTCTCTGGCCA 
elegans         TTACAGTAGCAGCAGCCGCTGCAGCCGCCAACGGACATCAAGGACCAGTATCGTTGACAA 
brenneri        TTACAGTAGCAGCAGC------------AAATGGTCATGCACCGCCTGTTTCCTTGGCAA 
	 143 
                 *** *** ***** *             ** ** ***         ** **  ** * * 
 
briggsae        CGTTCCCGTCTGCATTCGCCGCATTCGCCTCACAAATCAGAAGCACTCAACTGCAGTCAC 
remanei         CGTTTCCATCAGCATTTGCTGCATTTGCTTCCCAAATAAGAAGTACTCAACTTCAATCAT 
elegans         CATTTCCGTCGGCGTTTGCCGCTTTCGCTTCCCAAATCAGAAATAATCAGCTGCAATCAT 
brenneri        CCTTTCCCTCAGCGTTCGCTGCATTTGCTTCTCAAATCAGGAGTACACAACTTCAATCAT 
                * ** ** ** ** ** ** ** ** ** ** ***** ** *  *  ** ** ** ***  
 
briggsae        TGCTCCAATCACAGTTACAAGCATTGAATGGGGATATGGGATCTACAGGGAATGGACCTG 
remanei         TGCTTCAATCACAGTTACAAGCATTGAATAGGAATATGGGATCACCAGGAAACGGTCCGG 
elegans         TGCTCCAGTCTCAGATTCAAGCATTGAATGGTGGTATGGGATCACCTGGAAATGGTCCAG 
brenneri        TGCTTCAATCACAGTTACAAGCATTGAATGGAGATTTGGGACCACCAGGGAATGGCCCAG 
                **** ** ** *** * ************ *   * ***** *  * ** ** ** ** * 
 
briggsae        GTACTCCACTGTCCAGGAATAACTACGGGCATCATATGCAGAATCAGCAACATCCACAGC 
remanei         GAACTCCTCTGTCCAGAAACAACTACGGACATCATCTGCAAAATCAACAACATCCACAAC 
elegans         GAACTCCATTATCACGGAATAATTATGCTCATCATCATCAGCAACATCAAAATCAACAGC 
brenneri        GAACACCTCTCTCCAGGAATAACTATGCACATCATCTCCAAAATCATCAGAACCAGCAAC 
                * ** **  * **  * ** ** ** *  ******   **  * ** **  * *  ** * 
 
briggsae        ATGTAGGGAAGATTCGTGGAGTAAGTGGAAATTTTTTGAATGAGGGAGGAGGTTCTAAGA 
remanei         ACGGAGGAAAGATTCGTGGGGTAAGTCGG--------GAACGGAGAACGGGTTTT--GGC 
elegans         ATGTTGGAAAGATTCGTGGAGTGAGTTGAA-------AGGGTCTGAAGGGTGTTTAAATA 
brenneri        ATGGAGGCAAAATTCGAGGGGTTAGTTTGT------TAAGCTTTGATATGGTTT---AGA 
                * *  ** ** ***** ** ** ***                  *       **       
 
briggsae        TCAGAAGTCTATCAGAATATCGAAAATTTTGAGAGCTTGAGCAAGGCTGTCAAACACAGA 
remanei         TCGGTGAGTTGT---------------TTTAAAACCAT-----AGTTTCCTAGATAAGTA 
elegans         GAGGAATGTTGT---------------TATTAAGGCG------AAATTGTTTCCCGCGTC 
brenneri        CTGGTTTTATACATTTTGA--------CATGAATCCTTTATCCAGAAACCTAGGAAAATA 
                   *     *                   * *   *       *                 
 
briggsae        GTTGCTGCTTTTCAGTTAGGGTACTTCTGGGATGGGTAGGATTCGGCGGCCTAGCGACTT 
remanei         GTTTATTCTTCTAGTTAAGAATACTTT-------GGAAGGATACGT--GCTCAAAGAT-- 
elegans         AATGATTTTTTGAGTTCGGAGCTCGTTT-----------TATTCGT-----AAACAAAT- 
brenneri        CTTTTGTGCTATAGATACCAGCTAGTCC---AAACGTAAAATTCATTTGACCCAGGGTTA 
                  *      *     *         *              ** *                 
 
briggsae        CAGAAGTTTCTGGTTGGCCGAGCTTATTTCCGGAAGAACGGACTGTTTGGTACACGGCAA 
remanei         ---ATGTTTTT-----------CTTGATTCT-----------CTTCCTCGTA------AA 
elegans         ---ATGATTTT-----------CGTGAGCCTACCGTAA--GATTTTTTCATGCTC---AA 
brenneri        CGGCAGTTTCT-----------CCGAGTGCC-----------CTCATTCTAA------AT 
                     * ** *           *      *             *   *          *  
 
briggsae        ACTACCCATAGCCATGGACCAGTTTCCGACCGCCGTATGCTTGAGAACCTCATTAATATC 
remanei         ACGTCCCA----------CTACTTTTC-------------TCGA------TATT--TACC 
elegans         ATGTTTTGAAA------GCGAGTCTCTAA-----------AAGA-------AATAATGGC 
brenneri        ACGATTCA------------GCTTTTT--------------------------------C 
                *                     * *                                  * 
 
briggsae        CTGATATGCGCATAATTATAATCCAACTCAACCTTATCTGTTTCAGACAACGGAGTACCC 
remanei         TCGA-----ACGTATTT---------CTCAATCAGAACATTTTCAGACTACCGAGTATCC 
elegans         TCTACGCGCGCACCGCTG-------ATAAGACAAGCTCCGAACTGAAAAGCTGTTTTCCT 
brenneri        CTGAAGTGAAAATG---------------AGTGGAATCTTTTTCAGACGACAGAGTATCC 
                   *                                 *        *   * *  *  *  
 
briggsae        ATTACGGAAAAGAGTCGGAGGGTCAACAGTCAAAACT-GCCAAAGTCTGGAGGTATTTCG 
remanei         GTTGAGAAAGAGAGTCGGCGGGTCCACAGTGAAAACT-GCCAAAGTTTGGAGGTATTTCG 
elegans         GACATGAGATTCCCCTGCTCCATGAACCCTCTGGATTCGTTGGGATTCATAATTTTTTTC 
brenneri        TTTGAGGAAACGAGTAGGTGGTTCGACTGTAAAAACT-GCAAAGGTATGGAGGTATTTCG 
                     *  *       *     *  **  *    * * *      *    *  * ***   
 
briggsae        ATGAGCTTCCAACTAT-TGAGCAAGCCGCAGAATGCCGAATTTGTCGGAAGAAGATCAAG 
remanei         ATGAGTTACCAACGAT-TGAGCAAGCTGCAGAATGCCGGATTTGCCGGAAAAAGATAAAA 
elegans         TTGATTCTCGAATGTTCTTTATTCTTTCCTGATAGTCGTTCATTCTTTTTTCAAACTAGA 
brenneri        ACGAGTTACCGACGGT-TGAGCAAGCTGCAGAATGCAGAATCTGTCGGAAAAAGATCAAG 
                  **    *  *   * *          * **  *  *    *         * *  *   
 
briggsae        GCAACTAATTCGAGGTAAGGATCTAGAAAGCTCATT-----TTCTTAGAGGAAGAGGGAC 
remanei         GCCACGAACTCAAGGTAAGCAT-----AATCTCAGT-----CT----------------- 
elegans         TCTGCGATTTAAAACTAGTCAT------GATTCGTT-----CT--------GAAAATATC 
brenneri        GCAACTAACTCAAGGTAAGGATAGTTGAGACTTATGGAACACTCAAAAGTGGTTGGAATC 
                 *  * *  *  *  **   **         *          *                  
 
briggsae        AGGAGTT----TTTTCAGAGATTTTTGGG--GTTACGGTATGCATTCTGAAGGGACTGTG 
remanei         -GATTTT----TCCCTATTGCCTTTTTGA--TTTTTGATGAATATATTGA---------- 
elegans         TAGTTTT----TGGTTAGAAAAAGCTTTA--CACATTTTCTGTAGCCTGCATGGTTCCAA 
brenneri        AGTTACTATGATACCTAAAGTAGGCTTGAAAGCATCATTATATCATCCGAAGAAGCTCAT 
                      *    *    *        *            *         *            
	 144 
 
briggsae        TACAGTGTTTCGTGTTCACACAGCGCGTGGCTATCGTGCCTCGCACCATCGGGCGGGCGT 
remanei         ------------------------------------------------------------ 
elegans         AACTTTTCTT--------------------------------------------AAATGC 
brenneri        AGTGATGTTGTTTTTAAATACGATTTCGAAAAAGATAATGTGTTTCTAGC-----ATTCC 
                                                                             
 
briggsae        TCTAGCTTCG-CCCGCTTGGCTCAGTCGGTAGTCGTACCTTCAATACTAGTCCTGAAAGT 
remanei         --TAGTTTCA-ACCACTT--------TTGTAGTATTAC--TCTATCTTCTTCC---AAAT 
elegans         TATAATTTCAGACAACCGAATATCCGCTGCGAAAACGTGTTGGTGGATCAACAGTGAAAA 
brenneri        AAGAAGTAAAGAAGAATAATAGAAACTTGAAATAAAAACAGAGAACACTTGCAGTTATTA 
                   *  *                     *                      *    *    
 
briggsae        T--CAAC-TCCTCGAGAGGCGTATATGAACA--AAATTTCGAGACAGTTATTTTTTTTTC 
remanei         C--CAGTATATTCAAGAAACCTACAGTATCT--CTTCTTCAAAACAAGTTTGTTTTTGAC 
elegans         CAGCAAAAGTTTGGAGATATTTCGATGAGCTTCCAACTATTGAACAAGCTGCCGAGTGTC 
brenneri        GTTAAAGTTGCTCTCGATTCCTAC-TAATTTCAGTTTTTTAGTTTCAGATTACTATATTC 
                    *      *   **    *     *         *                     * 
 
briggsae        CTATCTCCCTCACCTTTAAACAATCTGAAAAAAGCTTT-CCATGGGTTGTGCTACGTCTT 
remanei         AAGTCT----------TGAACA--CCGAAAACACTGAT-TTACAATTCGT--TATTTCTT 
elegans         GAATTTGCCG------GAAAAAAATAAAAGCAACTAAT-TCAAGGTATGC---AATTCTT 
brenneri        CCGTATAGTTTTGTTATGAACGTTCCACGACCTTCTTCGTTTCAGTGAATTGTAGTTCTT 
                   * *            **                                 *  **** 
 
briggsae        TTTTAGTTCTAGCGCTAGTCA-----AGCTGGACTCCAGC------TACAGTACCTCTGC 
remanei         TCTTCGGATT--------TTT-----AGCAGA----CACC------TTTTGAAAATCTCA 
elegans         TTCAA-------------CTC-----AGCTACCGTACGCC------CACCGG-----TTC 
brenneri        TTATACGAAAAGTATTCTTTCTAAGAATCCAGCATCCAGCGCTCACTACAGTAATTAAGC 
                *                         * *       *  *          *          
 
briggsae        TCCAAAATAAACATGTTTTCGACTTCAGAAGTCTTGAACACCGC----TTCAAAAACACT 
remanei         TTGAAAATCA-------------TTCGAGCGTCTCAACTACTCG----TATCAATTCTTC 
elegans         TTCAAAATACGTTTGTTTTTGACTTTCGAAGTCTTGAACACCTCACTTTTCAATAACAGT 
brenneri        TCCAGAAAAGAGCTTGTTTT---CCTGAAAGTCTTGAACACCATTCT-CTCAAAAACACT 
                *  * **                       ****  *  **           *   *    
 
briggsae        GATTAACAATTCGTTATTTCCTCTTTTTTTTCGCCGGAATTCGAAAA--GACTCATTGTC 
remanei         TGTTTTTTCTCCGAAGCTTTTGTTTTTTTTT-----GTGTTTGAGA------------CC 
elegans         AATTTAAAATTCTGAGCCATATTTTCTTCGT----GGGATCCCAAAATTAAGACTTCTTT 
brenneri        GATTAACAATTCGTTTTTTCTTTCTTTGGAT-----TACTAACAGACACCTTTTTTTCAC 
                  **     * *            * *   *        *   * *               
 
briggsae        CGAAC-TCCCATTCAAAATCAGTCGAGCGTCTCACCTACTCGTATCAATTTTTGCTGTTT 
remanei         CGAAC-AGGTGT-CAAAATAATGTGCGAATTTCGGA-ACTTCTTGGAATT----CTGACT 
elegans         TGTGCGATTCATTGAAAATCAGTCGAGCGTCTCCAC--GTTCTGCGCATT-----TTTCC 
brenneri        CGAAATCTTTATTCAAAATCAGTCGAGCGTATCAACTACTCGTATCAATATTCTTCTTTT 
                 *         *  ***** *   * *  * **      *  *    **            
 
briggsae        TTCATCTGAAGCTTTTGTTTTATT-ACTTAGTTGGTGGTCCGAACAGGTGTCAAAACAAT 
remanei         TCCAATAAGAATGGGGATTCTGTAGACACGATGGATGATGTCATTCTAGCCTAATGCAGC 
elegans         TGAGGCTTTTGTTTTTTCTGTATAGGCCTAGATTTTCTTGTTAAAAACAAATAACG-AAC 
brenneri        TTCCTGAGTCTTTTGTCTTTTGTTCTTCCGTTCGAGGTCCGGAAGAAATGTAAAAATAAC 
                *                 * * *                   *         **   *   
 
briggsae        A---TGTAAATTCTGAAAGT--TTTGGGAAAATTGGGATCTTCTC-AGAACGGGGAAA-- 
remanei         A---TTAAAATGGTGCAA----------AAACCTGTTACGATCTC-ATACCCAATGAGT- 
elegans         A---TGTAAATTAGAGGAATAACTTTGAAAATCTGCGATACTAAA-ACTTGAGGGAAATA 
brenneri        AAAGCGAACATGTTTTGAATTTTCGGAGAATATTAGTATTTTCTGGATTCCAAAGGAATC 
                *      * **      *          **   *   *   *    *         *    
 
briggsae        --------AAGAT--------------------------------------AATCTGAGA 
remanei         -------TATTTT--------------------------------------AAGCTGAAA 
elegans         -------TAAATT--------------------------------------TTGCAACAA 
brenneri        CTATGGATAAGGTGATGTCATAGGGACGATCTTCAGAATTAAAAACTGAGAAACTCGAAA 
                        *   *                                              * 
 
briggsae        TCTCTGATC-----------TTTCAGCACTACTGGAATGATTCGTCACCTGAGAAGCTGT 
remanei         A-TGTGAT------------TTTCAGCACTACTGGAATGATTCGTCATCTGAGAAGTTGC 
elegans         TTGTTTATAC----------TTTCAGCACTACTGGAATGATTCGCCACTTGAGAAGTTGT 
brenneri        TCTATAGTGAGAACTGTAATTTTCAGCACTACTGGAATGATTCGACACTTGAGAAGTTGT 
                    *  *            ************************ **  ******* **  
 
briggsae        CACGTGCAAGAGTATCAACTGGTTCAGGAAGCTCGTCAAAACAGTATGATTGTCAAAATG 
remanei         CACGTGCAAGAGTATCAACTTGTTCAAGAAGCTCGTCAGAACAGTATGATTGTCAAAATG 
elegans         CATGTTCAAGAGTATCAGCTTGTCCAAGAAGCTCGACAGAACAGTATGATCGTCAAAATG 
brenneri        CATGTTCAAGAGTACCAACTTGTTCAAGAAGCTCGTCAGAACAGTATGATTGTTAAAATG 
                ** ** ******** ** ** ** ** ******** ** *********** ** ****** 
 
	 145 
briggsae        GGTAAGT-CGGGGTCCACATAGATTTTCTCAAGAGTTCAAGCTTTGATCTATATTCGATT 
remanei         GGTAAGTACGGGGAAGATATTAAT-----CAAGAGTTCAAGCTATGATCCATAATTCTTT 
elegans         GGTTAGT-TACAAAGTTTAAATATTG---AAACATTTGAAAGTTCAATTCATAATC--TT 
brenneri        GGTAAGTTCCCTGCTGGAATGAAT-----AAGGGGTTCAAGCCATGAACTGTGTTATCTT 
                *** ***           *   **      *    ** **      *    *  *   ** 
 
briggsae        ATTTCCCTT----------TCGATCGG-ATATCTCAGTTCAGAAGAGGTTGCGCAACGAT 
remanei         CTTTCTCTCCCCCTGATCATCGTTCAGTGTATCTTAGATCAAAAGTGGTTGCGCAACGAT 
elegans         ATTTCTAT-------------ATCCAAGATTTCTGAGATCAAAAGCGGTTACGTAATAAT 
brenneri        ATTCCCTTCA----------TCTCTAGGATATCTAAGATTAAAAGTGGTTGCGCAATGAT 
                 ** *  *                     * *** ** * * *** **** ** **  ** 
 
briggsae        TTATATTTATGTACATATGTCTGTCTGGCTAGATGCCAGTCTC-----CAGAACCCCC-- 
remanei         TTGTATTTATGTACATATATCTGTCTGGCTAGATGCCAGTCTCTTCTCCAGAATCCC--- 
elegans         TTGTATTCATGTACATATATCTGCTTGGCTAGATGCCAGTCCTGAA--CAGAACCTCCCA 
brenneri        TTGTATGTATGTACATATATCTGTCTGGCTAGCTGCCAGTC-------CAGAACCCCC-- 
                ** ***  ********** ****  ******* ********       ***** * *    
 
briggsae        -ACCGACTGAAAAA--CGAAGAAAATGAAGGGGGGAGGAAGAAG-AAACTGGTTCGTCCA 
remanei         --CCCACCGCGCCA--CG--GCAGACCAAAAAAA-AGAGAGAAG-AAACTGGTTCGTCCA 
elegans         CAGTCACCACGGCAGACAAAAAAAGGGAGAGATGAAGGGGGAGGGAAACCGGTTGGTCCA 
brenneri        --ATCGCCATGGCA---------GACAAAAAAAT--GAAGGAGGCAAACTGGTTCGTCCA 
                      *      *             *        *   ** * **** **** ***** 
 
briggsae        GTTATTCTCATCTTACAGGACGGT----GGTCAGCGACTAAGACAGA------------- 
remanei         GTTATTCTCATCTTAAAGGACGGTTGGTGGTCAGCGACTAAGAGGAAAGAGAAAGAGAGA 
elegans         GTTATTCTCATCTTAAAGGACGTG--GTGGTCAGCAACTGAGAAAAGAGA---------- 
brenneri        GTTATTCTCATCTTAAAGGACGTG--GTGGTCAGCGACTAAGAGGAGAAAAAA-----GA 
                *************** ******      ******* *** ***                  
 
briggsae        ----CATAACAACACGGTAGAAAAAAGAAAAATCTCTCTTTTGCA--------------- 
remanei         AATGCATAACAACACGGTAGAAAAA-GAAAAATCTCTTTTGCGCG--------------- 
elegans         AATGCATAACAACACGGTAGGAA---GAAAAATCTCTTTTACGCG--------------- 
brenneri        AATGCATAACAACACGGTAGAAAA--GAAAAATCTCTTCTTTACGTAGGCACCACAACAT 
                    **************** **   ***********  *   *                 
 
briggsae        ------------TTATGTTTT--------------------------------------- 
remanei         ------------CTATGTTTT--------------------------------------- 
elegans         ------------CTATGTTTT--------------------------------------- 
brenneri        AATTTTCAAACTCAATGTTTTGATGGAAATTGTATATAGATTTCTTCCAAATATTGATAT 
                              *******                                        
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         ------------------------------------------------------------ 
brenneri        GAGTACGCCCAAAAAATTTTGCGAAAAAATATTCACTACCAGCTGAGTTATTATCACTTT 
                                                                             
 
briggsae        ------------------------------------------------CGAAGAAGAAGA 
remanei         ------------------------------------------------CGAAGAAGAAGA 
elegans         ------------------------------------------------CGAAGAA----- 
brenneri        TCTATGCGCCAATTACTACTGAAGTTTTCGCGAACTCGAAGGCGGCGGCAAAGAAAAAGA 
                                                                * *****      
 
briggsae        AG-------------------------------------------CTGGT-------TGC 
remanei         AG-------------------------------------------CTGGT-------TAC 
elegans         -G-------------------------------------------CTGGT-------TGC 
brenneri        GGGGGAGAGCCAGGAGGAGGAGTTGAACTCGCGCCGCCAGATCGACTGGCAAGCGTGTAC 
                 *                                           ****        * * 
 
briggsae        GCAAT-----------------AGATAGCCGGAGC------------------------- 
remanei         GCAAT-----------------AGATAGCCGGAGC------------------------- 
elegans         GCAAT-----------------AGCTAGCCGGAGC------------------------- 
brenneri        GCCACTCGAACACGCCTGCGGAAGGCGGCCGGCGCCCGAGGGTCTTTATATTAGTGGGGT 
                ** *                  **   ***** **                          
 
briggsae        --------GCTTTGT-------------------------------AGACGAA------- 
remanei         --------GCTTTGT-------------------------------AGACGA-------- 
elegans         --------GCTTTGT-------------------------------AGACGA-------- 
brenneri        GTCGGCCGGCTTCGTCAGGCATTTCGAGTGCCAAAACTGCAATTTCAGACGAAAATAACT 
                        **** **                               ******         
 
briggsae        ----TTGCGCGATGGGCAG---------------------------AAA--------AGA 
remanei         ----TTGCGCGATGAGAAA---------------------------AGATGAAAAGGAGA 
elegans         ----TTGCGCGATGATGAA---------------------------GGA---------AA 
brenneri        TTTTTTGCGGACTAAGGATTTTTGATTTTTTCAAGGAAATTGTTGCAAATTTGCTGTAGA 
                    *****   *    *                              *          * 
 
briggsae        CACCGATT------TGAGAAATGACA-----CCAAAAAAACTTGTGAGAA-------AAT 
	 146 
remanei         CACCGATT------TGAGAAATGACA-----ACGAAAAAACACGTGTGAC-------AG- 
elegans         CACCGATT------TGAGAAATGACG-----CCACTGGA--TTGAAAGAA-------AAA 
brenneri        ATCCGATTCTGTAATAAAAAGCGGCGAGTTTTCACTGCATCATACCTAAATCTTCGAAAA 
                  ******      * * **  * *       *     *         *        *   
 
briggsae        ACTAGGTGT---------------------GGGGAAGCAGAGAACG--TTCGGTCTGCTA 
remanei         ACT-GACTT---------------------GGAGATATAGG--------TGGGT--ACTA 
elegans         AGTAAAACT---------------------GCCAGAGTGAA------------------- 
brenneri        ACTTGATTTCCAACCGATCATCGCTTGTTTGGAAAAGTAAAAAAGTACTTCAAACTACTT 
                * *     *                     *                              
 
briggsae        AAATAACGAAGTTAACTACCTGTAATAGACGGACCCCCATGCT-GTCAAGTCTGAGAGAT 
remanei         AGA--------------------GGTAGAGATATTCCAGAACT-ATTTAACCGGAGATA- 
elegans         ------------------------------------------------------------ 
brenneri        CAAAGTTTCCAATATTTTTTACCTATAGTCTGGGAGTGTTCCTTGATCGAAACCAAAAAT 
                                                                             
 
briggsae        CTAAACTTTAGGCTTCTGTTATAAACCACGGGCTACTGTAATAACGCATTTTCCCTGATA 
remanei         --GAAC---------------AGAACAAGGGACTTCT-------CGAGGTTTTCCAAATG 
elegans         ------------------------------------------------------------ 
brenneri        AAAAACCTATGGTCATCACTGAAAATTTTTTCCTATTGTCACCTGAAGTTTGGCTCGATA 
                                                                             
 
briggsae        GCTTACCCAAACCGCTAACTTTGAGCTTAATTTTCCTG--------AATCCTATGCA--- 
remanei         AA--ACTAGCAGTGGTGACTCTG--TTGTACTTTTTTG--------GCTTTCATTAA--- 
elegans         -----------------------------------TAG--------GTGTTCATACT--- 
brenneri        TAGAAAAAAATGCGGACTAAGGATTTTTTATTTTTTGACAAAAACCATTCCTACATATCA 
                                                                    *        
 
briggsae        --AGATATCAGAAATGTGCCAACTGATAAAATGCTTCT--------------------GA 
remanei         --AGCTAT------------------------GCCTTT--------------------GA 
elegans         --AATTGT---------------------------------------------------G 
brenneri        GGAACTATCAAAAACAGCAAAAAAACCTTGCGAGTTTTCATTTCTTCGGGGTAAATATGG 
                  *  * *                                                     
 
briggsae        TATTATGATGAACAAGTCATTAGTTGACAACTTTT------------------------- 
remanei         ATTTTTGGTT--TAGGTCC---GTTAGTGACCTCT------------------------- 
elegans         AATTATGTCTAATGGA------ACTGGCGGA----------------------------- 
brenneri        AGTTTTTCTACATGAGACCCTTAGTTTTGGCTCTTTTCTCGTCTTTATCTCCTGAAAGGT 
                  ** *                  *                                    
 
briggsae        --------------ATGTGTCTCTGCCA-------------------------------- 
remanei         --------------ATTTCGTTATACAA-------------------------------- 
elegans         --------------ATTTAATTCAACCA-------------------------------- 
brenneri        TGGTGTTATGAGAAATCTGATTTCACCATCGGATTCTACGTGAAAAGTTACGTACGTACA 
                              ** *   *   * *                                 
 
briggsae        ---------GGAATCGAGATAAATTGTCCTAAAG-------------TTAAAAG------ 
remanei         ---------AGTG-CAAAGCAGTTCCTTTT-----------------TCGAAAG------ 
elegans         ---------GAGCTCGGTAAAATAACTACC--------------------AGAG------ 
brenneri        TGTGGTTTCGAACCCAGTTACGATCCTATTCGGAGAGCTGAACCGGCTCGAAAGTGCCGC 
                              *           *                       * **       
 
briggsae        ------------------------------------------ATAGAAGGGCCCATCTAT 
remanei         ------------------------------------------ATCGAAAACCCGCTCTC- 
elegans         ------------------------------------------GCTCAGTTTCCGTTCTT- 
brenneri        AGACCCCCTCGTGAAATTTTTTCGACGCCCCTCCCCCTCTTCATTGCGCCCCCTATCTTT 
                                                                   **  ***   
 
briggsae        TACAGGTGTTT------------------------------------------------- 
remanei         -----GCCTTC------------------------------------------------- 
elegans         ------TGATT------------------------------------------------- 
brenneri        ACGCTATGTTTTCATTTGAGGAGAGGGAGGAAGAAGAAGCTGGTTGCGCAATAGATAGCC 
                         *                                                   
 
briggsae        -----------------------------------------------TGGTATA-CGAGC 
remanei         -----------------------------------------------GACTATTTCAAAT 
elegans         -----------------------------------------------GAACAATGCA--- 
brenneri        GGAGCGCTTTGTAGACGATTGCGCGAAGAAAATGAAAAGAAGATGAAGGAAATACCGAAT 
                                                                   *   *     
 
briggsae        CTACAATGATTAAAGCATCTTTGACGGTT------------------------------- 
remanei         TTACAATAAAATAAATGT-------AGAC------------------------------- 
elegans         CGATGAAGCTTCAACTAA-------AATC------------------------------- 
brenneri        TGAGAAAATGAAAAAAACATTCGAAAGTCAGAAATATATTGGATTTGTAGTACAGGGAGG 
                  *  *      **                                               
 
briggsae        ------------------TTCTTGATTTGGAAGGGTCTAGATTT-------AGTCA---- 
remanei         ------------------TTTTGAATATCATAGACTCAATTACC-------TGTC----- 
	 147 
elegans         ------------------TTTCCCCTGTTACACA-----------------TATCG---- 
brenneri        TATGGGAATAAAATATAATTATTGATGTCAGAAACTGATTTACTGTACAGTTGTCGGACA 
                                  **     * *   *                     **      
 
briggsae        --------------------TATACTCTAT-------------------------GCTCT 
remanei         --------------------TGTGCATTA--------------------------GCTCA 
elegans         --------------------TGAGCGC----------------------------ACCCA 
brenneri        CTTTTGGAAAATATTTGAAATGTGATCTATTCTCTTACCGCTAGGACAAAGACTTGTTCA 
                                    *                                     *  
 
briggsae        CTAATAGAGCGGCAGC-CTCACATCAATATCATAT-----TACTGTGAGTCCACATTACC 
remanei         TAAATTTTGAAG-AGG-AGTATTAGAGCACTCTGT-----TTATGAGCATGAACATTTCA 
elegans         TAAGC--GGAAGCCCA-GTTAATTGAAAATTCTAT-----TTCTGT-CACCAATTTATCA 
brenneri        TAGGTTTTGAAATTGATCTCACTTTTGTATAATATGTGTCTTCAATGTTCGAATACTTTC 
                        *           *       *   * *     *           *        
 
briggsae        GTAAAA-----------------CTTGTAATAGAAGTTATCTCTTATGTT--T---AACT 
remanei         CTTCAA-----------------ATAGTTTTCGAATTCATAATTCAAATT--T---ATTT 
elegans         CTCCAA-----------------ATTTTTCTCAAATCAAAGTTATTCATT--TCAGAAGT 
brenneri        ATTAGGGGGCTTGTTCTCCTTTCATATCTTTCCGTTTCATATCTCCCGTTACTCTGACTT 
                 *                      *     *       *         **  *   *  * 
 
briggsae        T--CGAGTTGACACATTTTTGATATCTTTTACAGTAATCGAG-----ATAATTGAGCTG- 
remanei         TAATAAGACATGTTATCTCTAAAGTCTGTCCCAA-AACCCAG-----GGAATATAGTCA- 
elegans         TTACATTCTGAGAAAACTGTAAGCTACCTTTTTTTAGATCAA-----ACAATTT------ 
brenneri        TTTGATGTTATTTATGATTTTAAGTTTTTTTTGAGCGGCGAATAATCACAATTTACGGAT 
                *                * * *  *   *           *        ***         
 
briggsae        ---------AAAGTTGGTAGTGTGGGGGACTCCATGGCT--------------------- 
remanei         ---------G----TCATTTTTTCGGGTACTTCTTTGAT--------------------- 
elegans         --------------TAACTTTTAAGGAGCAAACTATGTT--------------------- 
brenneri        GTATGCCACAAAAATTATTGATAAAGGGCCGTCTTTTTTTTCTGAAATATTAGTTTTCTA 
                              *          *      *     *                      
 
briggsae        ------------------------------------------CGTTATTCTTGGAAGACA 
remanei         ------------------------------------------TTACATTGACGGACAA-- 
elegans         ------------------------------------------CAACTTTGATCTACCTAC 
brenneri        GTAGCGCCAATTCTAAAGCTCTATCGATTCGTGATAGTATGGCTCTTTTGCTGAGCAAGC 
                                                               **            
 
briggsae        TTGTTGTTGAATACACCAATAC-CGTAGTACA---AGCAATTCTGAATTCAGAATAACCT 
remanei         TCCTCATT------ACCACTTT-CGTTTTTTG---CTTCCTTCT---CTTTCGATGACCT 
elegans         TTCAAATC------------TT-TAAAAAATA---CGCGATCAT---CTTGAAATTGAGG 
brenneri        TCTATTTTCCAGAGCCCAACCTGCGCAGGATGAAGCCTGCTTCTGATCTCACTTTCACAG 
                *     *                                 *  *    *     *      
 
briggsae        TTTTAAAACTGACAC-------------CTTCAAAATACGGTGTCCTATGATCTGA---- 
remanei         TAG-AAAACGGACAC-------------CGCCGTCCT----CGTGGTATCATCGAA---- 
elegans         AGA-AGGATCAGAAC-------------CATCCACATTTGAAAACAAGTTTTCTCA---- 
brenneri        TAACCAAATAGGATCACGAGTCTTTTGATATTTATTTTCGATGTGACGTAATTCAAGAAA 
                       *      *                     *           *  *   *     
 
briggsae        ----------------ATACCA----------------------------TTCCAAAAAC 
remanei         ----------------TAACCA----------------------------TTC-AAAAAC 
elegans         ----------------TTTCGA----------------------------GTC--GAACC 
brenneri        TGACCTTAATTTTAATATGCCAAATAGCGTCAATGGCACACTCGAACATCTTTGAAAAAC 
                                   * *                             *    ** * 
 
briggsae        AAGTTCCTTTTCGAATTCAAACCATCTGGTGC-------CATACTGCATGATG------- 
remanei         AAGTTT-TCCCCAAATTCAAACCAATTTGAACA------CATCTGGTGCCATG------- 
elegans         TTATTTTTCGAACGGTTC--GCCATCTGGTGCCAGA---CTTCAAACACTCGA------- 
brenneri        AAGTTTTTGTGTGAATTCAAACCATTTCGAACACATCACCATCTGGTGCCATACTGAATG 
                   **  *       ***   ***  * *  *       * *                   
 
briggsae        ---TTCT-TCCTCTTATCCACCAAGAGAATCTTCATTCCGTTTCAACCTTTCTCGCTTCC 
remanei         ---TTCCCTTCTCTTATCCATCAAGAGAATCTTCA--------AAACCTTTCTCGCTTC- 
elegans         ---ACACCTTTCCTTATCCATCTAAAGAATCTTCTTATTCTTTCAACCTTTCTCGCTTC- 
brenneri        TTCTTCCTTTCTCTTATCCATCAGAAAAATCTTCTT-TTCTTTCAACCTTTCTCGCTTC- 
                        *   ******** *   * *******          ***************  
 
briggsae        CCGTTATCTGGATCTTAATTACCGATATTTAATTT-CTCAAGGCTTCT--CAAGGATGCG 
remanei         ---TTATCTGAATCTTAATTACCGATATTTAATTT-CTCAAGGCTTTT--CGAGGATGCG 
elegans         ---TTATCTGAATCTTAATTACCGATATTTAATTTACTGAAGGCTTTT--CAAGGATGCG 
brenneri        ---TTATCTGAATCTTAATTACCGATATTTAATTT-CTCAAGGCTTTTTTCGAGGATGCG 
                   ******* ************************ ** ******* *  * ******** 
 
briggsae        --CGTTCAGGGGGGGGAATGGATGGAAGA-ACCAT----CTGGAACATCGCCAG--AAAA 
remanei         --C--CCAGGTGTAGAACCATCTGGAATATATCGT----CTC-ATCATCCAAATTCAAAA 
elegans         --C--CCAGGTGTTGAACCATCTGGAATA--GTAC----TTAAATTTTATTCATTTGAAA 
	 148 
brenneri        TCCGTCCAGGTGTAGAACCATCTGGAATATTTAATGACATTTGACTTCAAATATTTTAAA 
                  *   **** *  * *     ***** *           *  *        *    *** 
 
briggsae        TTAAAATTGAAAA--TTTGC-----TCTGAATTC-----GTATTAAT--GGGAATATGAT 
remanei         TTAATGATCATTG--TCTATATCCTTCAGAAAACAGGCGGTGCCAACTGAGAAAGACAAT 
elegans         TTTAAATGTCTCA--GCTGAAGTGAAAAGTAATACAATATTCGCAAACTACTTATCCAAT 
brenneri        TGAATTTAAAATAAATTTAGAAGATGTAGTGAAAGTTAGATGATTGATTCCCAATAAATT 
                *  *             *          *           *            *     * 
 
briggsae        TCAAGGTTC-TTGTT----TTCAGAAGAGAAAGCACGCGCAAAACTACTGCGAGAGATGA 
remanei         TCGTAACTT-TCATTATATTTCAGAAGAGAAAGCTCGCGCTAAACTTCTTCGAGAAATGA 
elegans         ACCAAGAAT-AT-TTAATTTTCAGAAGAAAAAGCCCGTGCAAAGCTTCTCCGAGAAATGA 
brenneri        ATCAAATATGTTAATAATTTTCAGAAGAGAAAGCCCGAGCAAAACTTCTTCGTGATTTGA 
                              *    ********* ***** ** ** ** ** ** ** **  *** 
 
briggsae        ACGAAAAAGTGATCAGCAACGGAATCGAGAACCATCCAATGGTTGT---CAAGAAAGAGA 
remanei         ACGAGAAAGTGATTAATAATGGAATAGAGAATCATCCGATGGTTGTTGTCAAGAAGGAAA 
elegans         ACGAAAAAGTTATAACGAATGGAATTGAAAACACTCCGATTGT------GAAGAAAGAGT 
brenneri        ATGAGAAAGTGATAACAAATGGAATAGAGAATCATCCGATTGTGAATGTCAAAAAGGAGC 
                * ** ***** ** *  ** ***** ** **   *** ** **       ** ** **   
 
briggsae        GGCCAGCTTCAGAATCCCAGAAGTCTCCGTCTGCATCTTCATCCGCTTCTGATACTGCAT 
remanei         CACAAACATCAGAATCTCAAAAGTCTCCATCAGCATCTTCATCAGCTTCCGATACTGCTT 
elegans         CCCAGAC---AGAATCTCAAAAATCTCCATCTGCATCCTCATCAGCTTCTGATACTGCAT 
brenneri        CACAACCATCAGAATCTCAAAAGTCTCCATCAGCTTCATCTTCTGCTTCTGATACTGCTT 
                  *   *   ****** ** ** ***** ** ** ** ** ** ***** ******** * 
 
briggsae        CATCTGCGTCCTCTTCTCATTTCTCAACGAATCCCCTCATAGGACTACCTGCTCCAGTCG 
remanei         CATCTGCCTCATCGTCTCATTTCTCAACAAATGCTTTAATCGGAATCGCTGCTCCCGTTG 
elegans         CATCTGCTTCATCTTCCCATTTCTCTACAAATCCTTTGATAGGTCTTCCAGCTCCAGTTG 
brenneri        CTTCTGCATCATCATCTCATTTTTCAACGAATCCACTCATTGGACTTCCTGCTCCAGTGG 
                * ***** ** ** ** ***** ** ** *** *  * ** **  *  * ***** ** * 
 
briggsae        CCATCAATCCTACTGCTCCTCAAACACCTACATCAACAATTCTGAACTTGAGCCAAAGCC 
remanei         CTATCAAACCTGTACCTCCCTCAACTCCTTCGTCAA---TTCTCAATTTGAGTCAAAGTC 
elegans         CCATCAAGCCACCTGCTCCACCAACTCCTTCAAACTCAATTCTCAATCTAAGCCAAAGTC 
brenneri        CTATCAAACCAGCTGTCACGCCCTCTTCTACAG------TACTGAATTTGAGTCAAAGTC 
                * ***** **        *     *  ** *        * ** **  * ** ***** * 
 
briggsae        AGAATCAGTGTCAGAATCAGAATCCAATGTTCAAAATGCAAAATATCAAAATTGAAGCAA 
remanei         AGAATCAATGCCAGAATCAGAATCCACTTTTCAAGTTACAAAACATCAAAAACGAAGGAA 
elegans         AAAATCAGTGCCAAAATCAGAATCCAATGTTCCAATCACAAAATATCAAGAATGAACCAA 
brenneri        AGAATCAATGTCAGAATCAGAATCCACTTTTCAAAATGCAAAACATTAAAAGTGAAGCAA 
                * ***** ** ** ************ * *** *    ***** ** ** *  ***  ** 
 
briggsae        CAGAAGTAGAAGAAGAGGAGATTGAGCAGAAGTGTCCAACGGAAA---TTCATCGTCCAA 
remanei         CAGAAGTGGAAGAAGAGGAAGTTGATCAGAAATGCTCTTCGGAGACATTGCATCGTCCAA 
elegans         CAGACGTTGAGGAGGAGGATCTTGAACAAAAGCGTTCAAGAGATATTCTACATCGTCCGT 
brenneri        CAGAAGTGGAAGAAGAGGAAATTGAACAAAAATGTCCATCAGAACTCATTCATCGTCCAA 
                **** ** ** ** *****  **** ** **  *  *    **     * ********   
 
briggsae        CCGATTTAAGTGGAAACACCATGTTGCTTTCTCCGAAATCTGCAAACTTATCATCTGCTT 
remanei         CTGATTTAAGTGGAAAAATGATGCTGATGTCACCGAAGTCAATGAATTTATCATCTGCTT 
elegans         CTGATTTGGGCACGAAAATGTTTTTTTCTTCACCTAGAACGTTTAATCTGACATCTGCAT 
brenneri        CTGATTTGAGTACAAAAATGATGTTGATCTCTCCAAAATCCACAAATTTATCGTCAGCAT 
                * *****  *    ** *   *  *    ** ** *   *    **  *  * ** ** * 
 
briggsae        TCTCAAGTATCGCCTCGTTTGTGGATAAGAAACACGAGAAGAAAGTAGAAAATGATCATA 
remanei         TTTCAACTATTCCATCTTTTGAAGAGAAGAAATATGAGAAGAAAGTGGAAAATGATCATA 
elegans         TCTCCAGCATCACCCCATTAGAAGATCATAAGTTCCAGAAGAAAATTGAAGATGATCATA 
brenneri        TTTCAAGTATTGCTTCTTTTGAAGAGAAGAAAAATGAGAAGAAAATTGAAAATGATCATA 
                * ** *  **  *  * ** *  **  * **     ******** * *** ********* 
 
briggsae        AAATTCATATGCAGGTAATTTCAGATTAGTCTCACTGCC-TCTCAATATTCCGTTAATTT 
remanei         AGATTCACATGCAGGTA-TGCTAGGTTC-TCTCAAAGAA-AGGCA-CGTCTCATTCTCTT 
elegans         AAATTCATATGCAGGTAAAATTTGCGTTAAATAATTTCA-AATATAAGCTTGAAAATGTT 
brenneri        AAATTCATATGCAGGTCGGTTCATTTTCATCTTGAAGAACACTCTTTTTATCTTTCCATT 
                * ***** ********          *    *                          ** 
 
briggsae        TCAGATTGCTCTAATGCTACTGCTTGATCAACAGCCCTCTCATGTTATTGATCGACCTGG 
remanei         CCAGATTGCTCTGATGCTTCTTCTGGATCAACAGCCATCCCATGTAATTGATCGACCTGG 
elegans         ACAGATTGCTCTGATGCTTTTACTTGATCAGCAGCCCTGTCAAATTATTGATCGGCCAGG 
brenneri        TCAGATTGCCTTGATGCTTTTGCTCGATCAACAACCTACTCATCTCATTGATCGTCCAGG 
                 ********  * *****  * ** ***** ** **    **  * ******** ** ** 
 
briggsae        ATTCCGATCCCTTTTCAAATTTCTGCTCCCCGATTACCATCTGCCCAGTGGTGACATCTT 
remanei         ATTCCGTTCTCTCTTCAAATTTCTGCTTCCTGATTATCATTTGCCCAGTGGAGAGATATT 
elegans         CATTCGATCGCTGTTTAAATTTGTGCTTCCCGAATACCACATGCCCAGTGGTGATGTCTT 
brenneri        ATTTCGGTCACTTTTTAAATTTCTTCTTCCTGATTACCATCTGCCTAGTGGAGACATCTT 
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                  * ** ** ** ** ****** * ** ** ** ** **  **** ***** **  * ** 
 
briggsae        CCAAGCCACTATCGTTCCTCAGTTGTTGGATCACATGAAGCTTCAAATTGGAGCAATATT 
remanei         TCAAGCAACCATTGTTCCTCAACTACTGGATCACATGAAACTCCAAATTGGTGCAATCTT 
elegans         CCAAGCCACAATAGTTCCTCAATTACTGAATCAAATGAAACAACAAATCGAAGCCCTTGT 
brenneri        TCAAGCTACCATTGTACCTCAATTATTGGATCATATGAAACTTCAAATCGGAGCAATTTT 
                 ***** ** ** ** *****  *  ** **** ***** *  ***** *  **  *  * 
 
briggsae        CAACAAC------ATGAGTTCATCCGGAAGGTATGTC------TCAGTG--------TCC 
remanei         CAATAAT------GTGAATTCATCTGGAAGGTACGTT------TCAAT-----------T 
elegans         TCATAAT------AGCAGCTCATTAAGCAGGTCAGTC------TCTAA---------CAA 
brenneri        CAATAATTCCAATAGCAACTCATCAGGAAGGTATGTCAAATATTCAGTTTTAGATCTCAG 
                  * **          *  ****   * ****  **       **                
 
briggsae        TTATTCAAACAATG--CTCTGAT-TGCCTTTGAAACCATCCTTAAATTGACCTATATCTT 
remanei         CAATTC---CAGAA--TTCGAACATGCTCCCCTAGTCAACCC-ACTTTGACCTATATCTT 
elegans         AAACTC-----AAA--TTCAACCGGGGGACCGTTTATGCCTCGATGTTGACCTATATCTC 
brenneri        TGATTCTATTAATAATTTGAAACATGCTCTCTCATTAGTCC---AATTGACCTATATCTT 
                  * **           *       *             *      *************  
 
briggsae        TGCAATTT-TCTCCTATTAAATTGTGATAAATGGCACAAACAGGGTCTCCCGCCG----- 
remanei         TCTAATTT-TCTCCTATAAAATTGTGATAAATGGCACAAAACTGGCACCCCGCCG----- 
elegans         CCTAATTT-TATCCTATAAAAATGTGATAAATTGCACAAA-CTGGCGCCCCACCG----- 
brenneri        TCTAATTTCTCTCCTATAAAATTGTGATAAATAGCACAAA-CTGGCATCCCGCCGTGGAG 
                   ***** * ****** *** ********** *******   **   *** ***      
 
briggsae        AGAGGAAGGTGTCCTATGGGTTAGGATGTCTCAACCCAAAACGATTGATGGGTTTTCG-- 
remanei         AGTAGTAGGTGTCCTCTTCGTCG---TGTCTCAA--CACAACGATTGATGGGTTTTTCTT 
elegans         AGATGTAGGT-TCCT----------------------GAGACAATTGATGGGTTTTTGG- 
brenneri        GGTAGAAAGTGTCCTATCC-TTGTGTCGCTTC------CAACGATTGATGGGTTTTTGT- 
                 *  * * ** ****                         ** *************     
 
briggsae        ----GGTTGGGGCGAGAATTTGAACAACAAGAC----AGACACATTTACATGCCGACGGA 
remanei         TCGTAGATGAGGCGAGAATTTGAACAACAAGA-----AGACACATTTACATGCCGACGGG 
elegans         -GACGAGTGAGGCGAGAATTTGAACAACAAGA--------CACATTTACATGCCGACGGG 
brenneri        ---GGGGTGAGGCGAGAATTTGAACAACAAGAGAAAGAGATACATTTACATGCCGACGGT 
                       ** **********************         ******************  
 
briggsae        CGATTATT--TTTGAAACAAAGAGAATTGGTAATGTGGGGAAAATTCGATGGAAGAGAAG 
remanei         GAGAGACTATTTTGAAACAAAGAGAATTGGTAATG---GGGGAATTTAATGGAA------ 
elegans         CAAAT-----TTTGAAACAAAGAGAATTGGTAACGGGTGGAAGAATAAAGAGGG------ 
brenneri        GTCGAAAT--TTTGAAACAAAGAGAATTGGTAATG---GGGGAACTAAGTG--------- 
                          *********************** *   **   * *               
 
briggsae        GGAAGAACGGGAGTTTGTATTGGGAATAGGGAGAGAGGGTACTGTAGTTAACTGAAATTT 
remanei         ---AGAACGGAAATTCG----GTGAAAAACGAAAAACG--------------TGAAA--- 
elegans         ----AAAAGTGAACTGA----ATTAAAATGGGAATTTGTA------------TAAAACT- 
brenneri        ----AAAGGGGAATTGA---GAGGGAACCAAGAACTCG--------------TAAGATCT 
                     ** *  *  *          *       *   *              * * *    
 
briggsae        AGGGCTTAGGAATGTTCTAGTAGGAGCAGCAGGTATCGAACATTAGCCCCGGATGAGCAA 
remanei         ----------AATGT---------GGGGATAAGTGT-GAATGT--------AATGAGTCA 
elegans         -------ACCAATG-----------GTAGGGATTATGACAGCT--------AGGAGATTC 
brenneri        A--------CAATG-----------ACGGGACTAATGGGATACTG---TAGGAATAGTTG 
                          ****                     *   *                     
 
briggsae        GATATCGTTTCAACGTAGAAAGAGAATATACATTTATTACAGGGGGCGCAAAATTACCCG 
remanei         TGTAGTGATCCATTATACAAG-------TGCACTCGC------------------ACTTT 
elegans         TAGGACATTTTTAAATTTAAA----------ATTTGAT------------------TTTA 
brenneri        TTACCCGCTTCAGAAGATGGA------ATTGATTAAGT------------------TTGG 
                        *                      * *                           
 
briggsae        GACTGATAAAAACGGGTATATCTCTAGACATAGGTATCTTTGATGCAAGAAAATTGTTAA 
remanei         GACTGTTCAA----------------------GTTAGCTCAGATTA--------TGTTAA 
elegans         CATTATTTTG----------------------GCAATTTGTGGTA------------TAA 
brenneri        GAATGTCACA-------------------------AACTCTATTTA-----------TGA 
                 * *                               *  *    *             * * 
 
briggsae        CAATATAATTTTACGTTTACTTAACTTTACGTTTGATTCAAAGCTACTGTAACTTTCAAA 
remanei         ------AGTTTTTTGATTA-------------------------TATTG----------G 
elegans         CG----ATCATAAAGGTTAA------------------------TATTA----------A 
brenneri        -------ATCTTGTTTCTAG---------------------------------------- 
                          *      **                                          
 
briggsae        ACGATTCCTCGAGTCTAGGTTTAGTTATGATAGTCCAAAGATGTAATGTCTGATTTGAGA 
remanei         ACCACCCTATCAATCTAGATTT--TTATCG---------ATTGGAATATTT--CTTG--- 
elegans         ACGTTTTTAACAGATTGGATCTAATCTTC------------TCGGTAGTTTGGTTCAGAC 
brenneri        -CCATTCACTGTGCCAGAATTCGATC----------------GAATTCTCTGATCTG--- 
                 *                 *    *                       * *          
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briggsae        TGAAGCAACATTGAAAAACGATAACTCAGCTCAAAATTGATCAAATAATTTGAAATTTGG 
remanei         ----GCAATATTTA-------TTACCCA--------CTGGTTAAAAAA------------ 
elegans         CTCCACCGCACTTTG------TGTGCTA----------GATCTGAAGA------------ 
brenneri        ----ATTATTTTTAG-------AGCTTT------------TCAAACAT------------ 
                           *                            *   *                
 
briggsae        ACAGTTTACTGATGAGTTATTTGAATTTTTGAACTCCAACTTTGAACCCATTACAACACT 
remanei         -CAGTG-GCTGAAAAAACTTATATATCTATATGCTCCA---------CCA-------ACT 
elegans         ---ATG---TGAGAAAGGTGACAGA---GTGCGGTAGA-------------------AAT 
brenneri        --AGTTCA-AGAACACCATCTCGAA---GCGCACTTCC-------------------ATT 
                    *     **  *         *         *                      * * 
 
briggsae        TCACTAAAATTGGAGGACATTCCAAATTTTAGTCCGGGTAGTTACGTGCCTGTAAGAGGA 
remanei         TCACCG-----------CATTCC-------------GCTAGTTTTTTTTTTTCAAAAC-- 
elegans         CTGAAA-----------CAAAAT-------------GCTTGCTATAT-CTTTCAAAAT-- 
brenneri        TTGGAA-----------TCTATT---------------TCGTTCAGAAATCTGAAAAT-- 
                                                      * * *          ** *    
 
briggsae        AAAATGAAGTGCCACCGGTTGCAGTTCGAATTCAACGTTTTGAGAAGAAAGTGAAAACCC 
remanei         ------------------TTCCAACT-GAACTAAATTTTTC------------------- 
elegans         ----------------------TACTCAAAAGCTCCTTTTT------------------- 
brenneri        ----------------------TATGCGAACTTTCTGTTTCC------------------ 
                                            **       ***                     
 
briggsae        GGAGCATCATTCCAATCAGTTTAAAATTAATCCGAGTCTTTTCCAAATACATAGTCAAAT 
remanei         ---TCTTTTTTTC-----------------------TCTCTCTCGGCGACAGTGTCGGAT 
elegans         ---TTTACATTTC-----------------------TAACTCTCTAGTAAATTTTC---- 
brenneri        -GAATAAATTTTC-----------------------GAAATTTCCGACAGTGTGTTGCG- 
                         ** *                           *  *    *     *      
 
briggsae        CAATTTGTCTCCGAAAGTCT-GGTACGTTGTTCGTTTCCCTGTCCTCCTCTCTTCCCGGC 
remanei         TAATTTGTTTCGGGTAGTCTTGGCACATTGTCCGTTGTC--GTTTTCTTCTCTTCCCGGC 
elegans         -AATTTGTTTCGAG--GTCTTGATGCGTTCTCCGTTGTC----------CCCATCTCGGT 
brenneri        -AATTCATCACACA-AGTCTTGGCACATTTCCCGTTGTC---TGTTTCGATCTTCCCGTC 
                 ****  *  *     **** *   * **   ****  *            * ** **   
 
briggsae        CTTCTTCTCAGTTCTCCCCAATGAAAATTTATTGTCTTTGTTTGAATCTCAAGACTCCTT 
remanei         CTTCTTC--AGTTCTCCC--ATGAAAATTTATTGTCTTTGTTCGAATCTCAAGATCCAAT 
elegans         ATTCTGC--AGCCCCC----ATGAAAATTTATTGCCTTTGTTCGATTCACAAGACTGAAT 
brenneri        CTTCTTC--AGCCTC-----ATGAGAATTTATTGTCTTTGTTCGATTTGCAAGACTTTT- 
                 **** *  **         **** ********* ******* ** *  *****       
 
briggsae        TCATCAAATTCGA--CCTCTTCATTTTCCTGGAACTCTTTTCCCGGTATTCAAAGTACAA 
remanei         TCG----ACCTCA--TGTCTT--ACCTCCCGGAACT------CCCGCATTCAAAGTACAA 
elegans         GGG---AATTTGAGCCACCGCACATTTACCGGAACT-------CTCAACAAGATGTACAT 
brenneri        -------ATTTGA---ATCTCTTTTTCTACGAAACGAAAT--ACCGCATTCAAAGTACAA 
                       *    *     *           * ***        *   *    * *****  
 
briggsae        TCC---TTCTTTTTCAGTATCCCTGACCAAGTGATGACGTCATCCTCTGCCACATCATCA 
remanei         GATGATCTTTGTTTCAGCATTCCTGATCAAGTGATGACGTCATCATCTGCCACGTCTTCA 
elegans         GTCAA--TATGTTTCAGCATTCCTGATCAAGTGATGACTTCATCATCTGCCACGTCATCA 
brenneri        AATTCAACGT-TTTCAGTATTCCTGAACAAGTGATGACGTCATCATCTGCCACGTCATCA 
                         * ****** ** ***** *********** ***** ******** ** *** 
 
briggsae        TACGAAGATAATTCAGTAAACGAATCACAAACGGCTGAACCACATATTGCAGATGAAGAG 
remanei         TATGAGGATAATTCTGTAAATGAATCACAGATAGCTGGTCCAAATATTGCAGATGAAGAA 
elegans         TATGAAGATGTTTCAGTAAACGAATCTCAGATGGCTGGACCAAATGTGGGTGATGAGGAG 
brenneri        TACGAGGATAATTCTGTAAATGAATCACAGATTGCTGGACCAAATACGGCAGATGAAGAG 
                ** ** ***  *** ***** ***** ** *  ****  *** **   *  ***** **  
 
briggsae        GGAGAATTATTGGAGGAAGAACTGGAAGAGGAAGAGAACGTAGAGGTGATAAT-ACAACT 
remanei         GAGGAGTTAATGCAAGAAGAGATTGAAGAAGAAGAAGAAGAGAATGTTGAGGTGATAACT 
elegans         GAAGAAATTATGGAAGAAGAAGTTGAGGAAGATGAGAATGTTGAGGTAAATAACGGAAAA 
brenneri        GAAGAGTT---GGAAGAGGAAATTGAAGAGGAAGAGAATGTTGACGTATGAAAAGATGAA 
                *  **  *   * * ** **  * ** ** ** **  * *   * **              
 
briggsae        GGTTTTTC-AATTATAGAATCTTCTGGAAAGTACAAATTTCAGATCGAAGATGACACATC 
remanei         AGTTCTTCTGAAAACAAATCCCAATAACCACAACAATTTTCAGATAGAAGATGACACGTC 
elegans         AGTTCT---GAAATTAAAAT--------GAATCTGTTTTTAAGATCGAAGACGATACATC 
brenneri        AATTCAGTGGAATACAATTT-----AGAATGAAACGATTTCAGATCGAAGATGACACTTC 
                  **      *    *                     *** **** ***** ** ** ** 
 
briggsae        ATCAGCTTCATCTTCAATGGACAACGACACGTGTGATGCAATTGCTTCGTTCATTCATTA 
remanei         ATCAGCGTCATCATCAGTGGACAACGACACGTGTGATGCGATGGCTTCATTCATTCATTA 
elegans         GTCAGCATCATCGTCAATTGACACGGATACTTGTGATGCAATGGCTTCATTCATTCATTT 
brenneri        ATCAGCATCCTCTTCAATGGACAATGAGACTTGTGATGCGATGGCTTCTTTCATTCATTT 
                 ***** ** ** *** * ****  ** ** ******** ** ***** **********  
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briggsae        CATTGGAAATGACTCGTTTCCCCATGTAAGACTAAC-----CCCCAGAGAC--------- 
remanei         CATTGGAAATGACGCGTTTCCTCATGTAAGACTAAC-----CCCTGAAATCATTT----- 
elegans         TATTGGAAATGACGCATTTCCCCATGTAAGACTAACAAAACCTGTGTAGACATCATTTAA 
brenneri        TATTGGAAATGACGCATTTCCCCATGTAAGACTAAC------CCATCAATTAT------- 
                 ************ * ***** **************           *             
 
briggsae        ----------TTTTGAGAAATTAACTTCT-ATCAG------TTATT-----TCGTA---- 
remanei         -----AACCGTTTCGATTAGTTGGTTTGAGATTAG------TTGGTAGTGGTCCTA---- 
elegans         CCAAAAATATATGTTATTGAATCGTTTTTCATCTGAATATCCTAGTAGTAGTCGTGTGAA 
brenneri        ----------TATTTAACAAATATCCTATTTTTAG-------TAGTT----TCGGAT--- 
                               *     *    *    *  *       *  *     **        
 
briggsae        ---GATTTTTCGTTT--AGTATCATAATC--TCTAGTAGTAGTGACTAAC---AGTTTTT 
remanei         ---GTTGTTTCTTTTTAACAATTAGTTTT--TCTGTTCTGTTTAGATGCT---AAATTTT 
elegans         TTTAGTTTTTATTCTGTAATGTTGGTTTTATTTCATACTTCATAACTGTTCAAAATATGT 
brenneri        ---AACTCTAGATTCATTTCGTTGCTTAATTTTCATTCACTCTGATCA-----AAGTTCA 
                        *   *        *         *          *          *   *   
 
briggsae        TATACAAATG---CAGGATTAGGTTAAAGTATTCTGAGAT-TCAA--------GTC---- 
remanei         CAGAAACTTA---CGTTTCTAAAT-GATGTAGTGTGAATC-TCATTTCCCGTCGTC---- 
elegans         CCGAAAGATCTACCAGAACTCAAAAATTTCAGACTAAAAC-TGTATTTCCGTTGTTCAAT 
brenneri        GAGAGTTATGCAGTGGGATTAGTTGAAACATTTCTGATGTATAGATCAGTTTCATTT--- 
                   *    *          *              * *    *            *      
 
briggsae        -ATTCGTTTCTAAGTTTCCCCAT-------AACCCGCTGTGCCA-ATCTAACTCCAA--A 
remanei         -GACAATATCTTTATTTTCTAATCATGTCTAACCATCTGATCAGTATTTAGGTACAGTTA 
elegans         AGAAAACAACAAATCTTTATAATAAC--CTAACAAAATAGTAGTAAGTTTATCTAACCCA 
brenneri        -TAATATTGTTAACTTTTCTAAT------TTCCCGAATAATAACAAG---ATCTAACTCA 
                               **    **         *    *       *         *   * 
 
briggsae        AACTTCAACCTACCATTTCAGGATGAGCTTATCTCTCTGCTTTCCGTTGTCACCAACATC 
remanei         ACCATTCAAATCCAATTTCAGGATGAATTGATTTCACTTCTATCCGTTGTCACCAATCTC 
elegans         AAACCATACTTACCATTCCAGGATGAGCTCATTTCTCTTCTGTCCGTGGTCACAAATCTC 
brenneri        AAACCTTATAAACCATTTCAGGATGAGCTGATATCTCTTCTATCCGTTGTCACCAACATC 
                *      *    * *** ********  * ** ** ** ** ***** ***** **  ** 
 
briggsae        TTCACCTACTTTTCA--------------------------------------------- 
remanei         TTTGCCTATTTCTCAACTCGTCAACACATCCAAACTCATCTTCAAATGGCATCTTCTCAA 
elegans         TTCACCTACTTCTCAACTCGTCCACATGTTCAAACACATCTTCAGATGACTATCATCCAG 
brenneri        TTCACCTACTTCTCAACTCGTCCTCATGTTCAGACTCATCTTCAGATGACTGTCTCTCAT 
                **  **** ** ***                                              
 
briggsae        ------------------------------------------------------------ 
remanei         CCAACAACTCAACCATTAGTCCAACAAGTTCGATTTGTTGCATCAAATTTATCGATAATT 
elegans         CCGACATCTCAGCCATTAGTTCAACAAGTCCAATTTGTTACCTCAAACCTGTCAATAATA 
brenneri        CCAACATCTCAACCATTGGAACAACAAGTTCGATTCGTTGCTTCAAATCTATCAATAATA 
                                                                             
 
briggsae        ------------------------------------------------------------ 
remanei         TCTGATTATATCCGTCATACA--------------------------------------- 
elegans         TCTGACTATATCCGACAGACTCCTGATATGCAGCTTCTCCCACTTGCAGTAAATCAGGAG 
brenneri        TCTGACTATATTCGTCATACTCCCGATATGCAGTTACTTCCGTTAGCTGTTAATCAGGAG 
                                                                             
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         GCAATGCTTGAAAAGCTTGTAGATCACATTGATCAACTTGTTTGAATATTTCAAGATACT 
brenneri        ACGA-------------------------------------------------------- 
                                                                             
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         CTGTAGCTGTTTAAATTCTCCTTTTTTGTGTTTAAAATCCCCTTCATCCAAACCCCAGTG 
brenneri        ------------------------------------------------------------ 
                                                                             
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         AAAAAAACGATTATTTTTCTGTGTACTTTGGTATCCTGAACCCCTTGATTTGTTCACAAT 
brenneri        ------------------------------------------------------------ 
                                                                             
 
briggsae        ------------------------------------------------------------ 
remanei         ------------------------------------------------------------ 
elegans         TATGTGAAGCTTTACTACCATCAGTCGATGTTCCATTTTTCAAAATGTTCTTTCAATGCC 
brenneri        ------------------------------------------------------------ 
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Appendix II: Locked nuclei acid (LNA) in C. elegans 
 
 
Locked nuclei acid (LNA)  
 
RNAi treatment against ncRNA genes generally did not cause the Egl 
phenotype except when high concentration of dsRNA was injected (Chapter 
5). The RNAi machinery mainly functions in the cytoplasm to silence the 
expression of target RNAs (Caplen, 2004; Zeng and Cullen, 2002); since 
ncRNAs may be restricted to the nucleus, RNAi may not efficiently reduce the 
level of ncRNAs.  
To overcome this issue, we tried LNA gapmers, a form of antisense 
oligos, to knockdown gene expression (Exiqon; 
http://www.exiqon.com/custom-antisense-oligonucleotides). LNA gapmers are 
single-stranded oligos containing 14-16 nucleotides. They carry a core DNA 
sequence (complementary to the target RNA) flanked by LNA nucleotides 
(Figure A1). Each LNA nucleotide is locked in a conformation through a 2’-O, 
4’-C methylene linkage in the ribose sugar unit, thus making the LNA 
nucleotide resistant to nuclease activity and increases the affinity of antisense 
oligo for the target RNA (Koshkin et al., 1998; Obika et al., 1998; Singh et al., 
1998). In addition, the entire LNA gapmer is typically fully phosphorothioated, 
which protects the gapmer from nuclease degradation and also enables the 
core DNA sequence to activate RNase H upon binding to target RNA (Figure 
A1). The cleavage of target RNA leads to functional knockdown of the target 
RNA. Recently, LNA gapmers effectively reduce the expression of nuclear-
localised lncRNAs such as MALAT1 and eRNAs in human cells (Li et al., 




Figure A1. Schematic diagram showing how the LNA gapmer works.  
A LNA gapmer carries a core DNA sequence flanked by LNA nucleotides. The core 
DNA sequence is complementary to the target RNA. Upon binding to the target RNA, 
the LNA gapmer can activate RNase H to cleave the target RNA, leading to down-
regulation of target gene expression. The LNA image was taken from Wikipedia 
(https://commons.wikimedia.org/wiki/File:LNASchem.svg).  
 
To test the efficiency of LNA gapmers in reducing gene expression in 
C. elegans, we used three indepdent LNA gapmers (unc-119_2, unc-119_3, 
unc-119_6) to target unc-119, a protein-coding gene (Table A1). unc-119 was 
selected because of the easily discernable phenotype when unc-119 
expression is depleted. The three gapmers target different regions of the unc-
119 gene. A negative control gapmer, carrying a random sequence, was 
included to control for non-specific effects of LNA oligos. Each LNA gapmer 
was introduced into wild type animals by injection or soaking. Similar to 
dsRNA injection, each LNA gapmer was injected into the gonad of young 
adult animals at various concentrations (200μM, 100μM, 50μM, 10μM). L4 
animals were soaked in 100μM LNA solution using the standard soaking 
protocol for RNAi (Ahringer, 2006). The injected/soaked worms were 
transferred to individual plates and moved to new NGM plates every 24 
hours. The progeny were examined for the uncoordinated movement (Unc) 
phenotype, an outcome of reduced unc-119 expression.  
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Table A1. LNA gapmers. 
Gene LNA oligo Orientation Sequence (5' --> 3') 
unc-119 unc-119_2 Antisense GTGGAAATTCATAGAT 
unc-119 unc-119_3 Antisense GAGGTCACGGATTTGG 
unc-119 unc-119_6 Antisense TCATTTGGTGTAATTT 
negative control (-) control NA AACACGTCTATACGC 
LNA gapmers were obtained from Exiqon. NA: not applicable.  
 
LNA have no obvious effect on unc-119 expression in C. elegans   
 
For the injection method, we used a range of LNA concentrations 
(10μM – 200μM) to target unc-119 but failed to observe any Unc progeny 
(Table A2), indicating that the knockdown was not successful. Additionally, 
we noted that injection of LNA gapmer at concentrations ≥50μM appeared to 
induce toxicity because fewer progeny were produced and injected parent 
worms also appeared sick. When the concentration of the LNA gapmer was 
reduced to 10μM, injected parent worms appeared to survive well and more 
progeny were produced but none exhibited the Unc phenotype.  
The soaking method is one of the established RNAi approaches, in 
addition to injection and feeding methods that can effectively knockdown 
target gene expression (Ahringer, 2006; Tabara et al., 1998). To ensure the 
soaking method works in our hands, we soaked wild type animals in par-5 
dsRNA solution and observed the expected embryonic lethal phenotype 
(Table A3), indicating that par-5 expression was successfully reduced. 
However, when wild type animals were soaked in LNA solutions, we did not 
observe any Unc progeny (Table A3).  
A possible reason for the absence of the Unc phenotype is that the 
progeny may not inherit the LNA gapmer effectively. For injection and 
soaking, cells may fail to uptake the LNA gapmer through the membrane due 
to the absence of transporters (RNAi is effective in worms because of the 
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presence of dsRNA transporters (Winston et al., 2002)). Another concern is 
that the concentration of LNA gapmer dilutes over multiple rounds of cell 
division from zygote to larva, such that the levels of gapmer may become 
insufficient to induce a phenotype. In contrast to LNA, dsRNAs are processed 
into siRNAs and the RNA-dependent RNA polymerase (RdRP)-mediated 
amplification of siRNAs sustains the level of siRNAs, allowing effective 




Table A2. Outcomes of LNA injections. 
LNA  
No. of WT 
injected 
Contents of injection mix 
Phenotypes of progeny LNA (μM) Coinjection plasmids Diluent 
unc-119_2 13 100 none Water  No obvious phenotype  
unc-119_3 12 100 none Water  No obvious phenotype  
unc-119_6 12 100 none Water  No obvious phenotype  
(-) control 12 100 none Water  No obvious phenotype 
unc-119_2 12 200 L4640 (7ng/μl) Water  No obvious phenotype 
unc-119_3 14 200 L4640 (7ng/μl) Water  No obvious phenotype  
unc-119_6 13 200 L4640 (7ng/μl) Water  No obvious phenotype  
(-) control 13 200 L4640 (7ng/μl) Water  No obvious phenotype  
unc-119_2 21 50 
L4640 (7ng/μl),  
pBSKSII (100ng/μl) TE No obvious phenotype 
unc-119_2 25 10 
L4640 (7ng/μl),  
pBSKSII (100ng/μl) TE No obvious phenotype 
unc-119_3 14 10 
L4640 (7ng/μl),  
pBSKSII (100ng/μl) TE No obvious phenotype 
unc-119_6 14 10 
L4640 (7ng/μl),  
pBSKSII (100ng/μl) TE No obvious phenotype 
(-) control 12 10 
L4640 (7ng/μl),  
pBSKSII (100ng/μl) TE No obvious phenotype 
unc-119_2 14 10 
L4640 (7ng/μl),  
pBSKSII (100ng/μl) TE and spermidine No obvious phenotype 
WT: wild type. L4640: myo-2p::yfp. TE: Tris-EDTA. Coinjection plasmids were used to facilitate identification of progeny that inherit the LNA 
gapmer. Typically, few fluorescent progeny (<10) were obtained.  
 
 
Table A3. Outcomes of LNA soaking. 
LNA/dsRNA Concentration No. of WT animals soaked  Phenotypes of progeny 
par-5 dsRNA 2μg/ul 10 100% embryonic lethal phenotype 
unc-119_2 LNA 100μM 10 No obvious phenotype 
unc-119_3 LNA 100μM 10 No obvious phenotype 
unc-119_6 LNA 100μM 10 No obvious phenotype 
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Wnt signaling is mediated by three classes of receptors, Frizzled,
Ryk, and Ror. In Caenorhabditis elegans, Wnt signaling regulates
the anterior/posterior polarity of the P7.p vulval lineage, and mu-
tations in lin-17/Frizzled cause loss or reversal of P7.p lineage po-
larity. We found that pak-1/Pak (p21-activated kinase), along with
putative activators of Pak, nck-1/Nck, and ced-10/Rac, regulates
P7.p polarity. Mutations in these genes suppress the polarity de-
fect of lin-17mutants. Furthermore, mutations in pak-1, nck-1, and
ced-10 cause constitutive dauer formation at 27 °C, a phenotype
also observed in egl-20/Wnt and cam-1/Rormutants. In HEK293T
cells, Pak1 can antagonize canonicalWnt signaling. Moreover, over-
expression of Ror2 leads to phosphorylation of Pak1. Together,
these results indicate that Pak interacts with Wnt signaling to
regulate tissue polarity and gene expression.
cell polarity | β-catenin | T-cell factor | patterning | asymmetry
Wnt proteins regulate diverse processes including cell-fatespeciﬁcation, proliferation, migration, and polarity (1). In the
canonical Wnt-signaling pathway, Wnt binds to a Frizzled receptor
to activate target gene transcription through regulation of β-catenin
and T-cell factor (TCF). A number of noncanonical Wnt pathways
also exist (2). In Wnt/calcium, Wnt/JNK, and planar cell polarity
pathways, signaling is mediated by the Frizzled receptor but is in-
dependent of β-catenin and TCF. The receptor tyrosine kinases
(RTKs) Ryk (“related to tyrosine kinases”) and Ror (“receptor
tyrosine kinase-like orphan receptor”) also act as alternative Wnt
receptors.
In Caenorhabditis elegans, Wnt signaling controls the anterior/
posterior (a/p) polarity of the vulval precursor cell P7.p and the
patterning of its descendants (3–6). During wild-type vulval de-
velopment, the P7.p cell becomes polarized (i.e., asymmetric)
along the a/p axis and after three rounds of division gives rise to
asymmetrically patterned tissue in which different cell types are
arranged in a speciﬁc anterior-to-posterior sequence (7, 8). Muta-
tions in lin-17/Frizzled (and lin-18/Ryk) cause loss or reversal of a/p
polarity in the P7.p cell and its descendants, a defect which has
been studied extensively using cell morphology and molecular
markers. In the wild type, descendants of the posterior P7.p
daughter (P7.pp) remain attached to the ventral cuticle during the
L4 stage, and descendants of the anterior P7.p daughter (P7.pa)
detach to form part of the vulval lumen. In lin-17 mutants, the
reversed pattern is observed, in which P7.pp descendants detach
and P7.pa descendants remain attached (i.e., reversal of fate be-
tween P7.pa and P7.pp) (3). In the mid-L4 stage this patterning
defect causes P7.pp descendants to form an ectopic vulval invagi-
nation that is separated from the main vulval lumen by adherent
P7.pa descendants; this phenotype is called the “P-Rvl pheno-
type” [from “posterior reversed vulval lineage” (6)].
More recent work using gene expression markers to look at
cell-fate patterning in the P7.p lineage conﬁrms the polarity re-
versal in lin-17mutants (4, 5). For example, although only P7.pa
descendants express egl-17::gfp in the wild type (9), in some lin-17
mutants only P7.pp descendants express egl-17::gfp, indicating re-
versal of fate between P7.pa and P7.pp. However, marker expres-
sion also reveals additional complexity in the lin-17–mutant phe-
notype. Among lin-17 mutants that exhibit the P-Rvl phenotype,
the expression pattern of egl-17::gfp can be normal (P7.pa+/P7.
pp−), reversed (P7.pa−/P7.pp+), or symmetric (P7.pa+/P7.pp+ or
P7.pa−/P7.pp−). In other words, although lin-17 mutations cause
the P-Rvl phenotype and abnormal egl-17::gfp expression pattern,
these phenotypes are not always correlated, indicating that Wnt
signaling regulates multiple aspects of P7.p polarity.
lin-17/Frizzled mutations also affect the a/p polarity of the P7.p
lineage at an earlier stage. In the wild type, asymmetry in the P7.p
lineage is visible initially as asymmetric localization of ﬂuorescently
tagged SYS-1/β-catenin (VNS::SYS-1) during P7.p cell division
and as enrichment of VNS::SYS-1 in the anterior daughter of P7.p
compared with its posterior sister (P7.pa > P7.pp) (6). lin-17 mu-
tations cause VNS::SYS-1 localization in P7.p daughters to become
symmetric (P7.pa ≈ P7.pp) or reversed (P7.pa < P7.pp). Whether
SYS-1/β-catenin localization directly controls cell-fate patterning
and the P-Rvl phenotype has not been demonstrated. However,
the correlation between the frequency of the P-Rvl phenotype
and VNS::SYS-1 mislocalization in various mutant backgrounds
suggests a mechanistic link.
In contrast to lin-17/Frizzled, mutations in cam-1/Ror do not
affect vulval development in the wild-type genetic background.
However, cam-1 mutations suppress the P-Rvl phenotype caused
by the lin-17 mutation (6). Quantitatively, about 75% of lin-17
mutants and about 45% of lin-17; cam-1 double mutants exhibit the
P-Rvl phenotype (Table 1). It has been hypothesized that in the
absence of Wnt signaling the P7.p cell adopts anterior or posterior
orientation at random. Loss of multiple Wnt-signaling pathways
appears to bring the frequency of the P-Rvl phenotype closer to
50% (6).
Because Rho family GTPases function downstream of Wnt
receptors and RTKs (10), we investigated the role of Rho family
GTPases and their interacting proteins in Wnt signaling using
C. elegans and HEK293T cells. Our initial results led us to focus
on p21-activated kinases (Pak), a family of conserved serine/thre-
onine kinases activated by the GTP-bound form of the Rho family
GTPases Rac and Cdc42 (11, 12). Here we report that Pak interacts
with Wnt signaling to regulate P7.p polarity and gene expression.
Results
pak-1 Mutations Suppress the P-Rvl Phenotype of lin-17 Mutants. C.
elegans pak-1 encodes the ortholog of human group I Paks, i.e.,
PAK1, PAK2, and PAK3 (13, 14). To investigate whether pak-1
functions in Wnt signaling, we determined whether the pak-1
loss-of-function mutations ok448 and tm403 affect vulval devel-
opment (Table 1). Neither mutation caused an obvious vulval
defect on its own, but both suppressed the P-Rvl phenotype of
the lin-17/Frizzled mutant. Previously, mutations in cam-1/Ror
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were shown to suppress the lin-17 P-Rvl phenotype (6). To de-
termine the relationship between pak-1 and cam-1, we con-
structed the lin-17; cam-1; pak-1 triple mutant and found that the
frequency of the P-Rvl phenotype was lower in the triple
mutant (26%) than in lin-17; cam-1 (43%) or lin-17; pak-1 (41%)
double mutants (Table 1). Because the cam-1 and pak-1mutations
analyzed are null alleles, this ﬁnding indicates that pak-1 and
cam-1 can function independently to suppress the lin-17 P-Rvl
phenotype.
pak-1 Affects the Pattern of egl-17::gfp Expression. The P-Rvl
phenotype of the lin-17 mutant is caused by the reversal of a/p
polarity in the P7.p lineage (3–5). However, other defects also can
cause or affect the formation of ectopic posterior invagination (3,
15–17). To determine whether pak-1 speciﬁcally affects P7.p
polarity, we examined VNS::SYS-1 localization and the pat-
tern of egl-17::gfp expression (Tables 2 and 3). Quantitatively,
38% of lin-17 mutants had the normal pattern of egl-17::gfp ex-
pression (disregarding morphology); the others had the reversed
or the symmetric pattern. In contrast, 71% of lin-17; cam-1 (P =
0.0041), 64% of lin-17; pak-1(ok448) (P = 0.0104), and 55% of
lin-17; pak-1(tm403) (P = 0.0915) mutants had the normal ex-
pression pattern, indicating that cam-1 and pak-1 mutations par-
tially suppressed the abnormal pattern of egl-17::gfp expression in
lin-17 mutants. Additionally, the percentage of animals with the
reversed pattern of egl-17::gfp expression (P7.pa−/P7.pp+) was
reduced in lin-17; cam-1 (0%, as compared with 13% in lin-17)
and lin-17; pak-1(ok448) (4%) mutants but not in lin-17; pak-1
(tm403) (24%) mutants.
pak-1 Affects the Localization of VNS::SYS-1. We also looked at the
localization of VNS::SYS-1. Although the pattern of VNS::SYS-1
localization was normal in all wild-type animals, in lin-17 mutants
the localization pattern often was symmetric (60% of animals) or
reversed (33%) (Table 3 and Fig. S1) (6). Eighty-one percent of
lin-17 mutants with asymmetric localization of VNS::SYS-1 (i.e.,
excluding symmetric cases) had the reversed pattern. In lin-17;
pak-1(ok448)mutants, this frequency was reduced to 29%, and in
lin-17; cam-1 mutants, the frequency was reduced to 40%.
Therefore, both pak-1(ok448) and cam-1 mutations partially
suppressed the P7.p polarity reversal defect of lin-17. However,
although the frequency of symmetric VNS::SYS-1 localization
Table 1. P-Rvl phenotype of pak-1, nck-1, and ced-10 mutants
Genotype P-Rvl (%) Abnormal (%) No. P value*
Wild type 0 0 109
egl-20(n585) 0 0 85
cam-1(gm122) 0 6 122
nck-1(ok383) 0 0 105
nck-1(ok694) 0 0 116
ced-10(n1993) 0 1 97
ced-10(n3417) 0 0 78
pak-1(ok448) 0 1 82
pak-1(tm403) 0 3 133
lin-17(n671) 74 3 100
lin-17(n671); egl-20(n585) 4 2 114 <0.0001
lin-17(n671); cam-1(gm122) 43 7 113 <0.0001
lin-17(n671); nck-1(ok383) 60 4 112 0.0481
lin-17(n671); nck-1(ok694) 20 0 35 <0.0001
lin-17(n671); ced-10(n1993) 49 8 132 0.0007
lin-17(n671); ced-10(n3417) 89 4 84 0.0039
lin-17(n671); pak-1(ok448) 41 4 422 <0.0001
lin-17(n671); pak-1(tm403) 43 3 126 <0.0001
lin-17(n671); cam-1(gm122); pak-1(ok448) 26 9 121
lin-17(n677) 67 2 116
lin-17(n677); pak-1(ok448) 45 7 219 0.0009
The P-Rvl phenotype was scored by the presence of an ectopic posterior invagination in the mid-L4 stage.
Several types of defects (e.g., migration defects, vulval precursor cell overinduction) can lead to ectopic invagi-
nations (15–17). However, P7.p reversal causes a distinctive morphology in which descendants of P7.pa (typically
P7.papx) remain adhered to the ventral cuticle, but descendants of P7.pp detach and form an ectopic invagina-
tion (3, 5). Thus, an animal was scored as P-Rvl only if some of the P7.pa descendants remained adhered to the
ventral cuticle and P7.pp descendants became detached. Other types of defects (typically overinduced, under-
induced, or migration defects) were scored as abnormal even if an ectopic invagination was present.
*Compared with lin-17 single mutants (Fisher’s exact test).
A B
C
Fig. 1. pak-1::gfp expression. Expression of pKY10.5 in vulval cells before (A)
and after (B) the initial division of Pn.p cells. Corresponding Nomarski and
ﬂuorescence images from the same region of the same worm are shown. The
strongly expressing cell (arrow in A) is a neuron. (C) The pKY10.5 construct.
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was not affected signiﬁcantly in lin-17; pak-1 double mutants
(48% compared with 60% in lin-17 single mutants, P = 0.3539),
the frequency was signiﬁcantly decreased in lin-17; cam-1
double mutants (26%, P = 0.0071), suggesting that cam-1 and
pak-1 affect VNS::SYS-1 localization differently.
pak-1::gfp Is Expressed in Vulval Cells. pak-1 previously was repor-
ted to be expressed in various cell types, including neurons and
distal tip cells, but not in vulval cells (14, 18). We constructed a
pak-1::gfp reporter (pKY10.5) containing the promoter, introns,
and exons of the pak-1 gene. In addition to cells previously re-
ported to express pak-1, this reporter was expressed at a low level
in P5.p, P6.p, and P7.p vulval cell lineages during the L3 and L4
stages, consistent with cell-autonomous function (Fig. 1 and SI
Materials and Methods).
ced-10/Rac and nck-1/Nck also Regulate P7.p Development.Biochemical
and genetic studies suggest that PAK-1 is activated by Rac and
the related GTPases CED-10, MIG-2, RAC-2, and CDC-42 (13,
14). cdc-42 affects vulval development at multiple stages (19).
Loss-of-function mutations in mig-2 or rac-2 did not affect the
P-Rvl phenotype (Table S1). We found that ced-10(n1993), a
reduction-of-function mutation in ced-10/Rac, suppressed the
P-Rvl phenotype and the VNS::SYS-1 localization defect of the
lin-17 mutants (Tables 1 and 3). In contrast, the null mutation
ced-10(n3417) enhanced the P-Rvl phenotype of lin-17mutants
and increased the frequency of animals in which the pattern of
egl-17::gfp expression was fully reversed (P7.pa−/P7.pp+) (P =
0.0038) (Table 2). Thus, ced-10/Rac regulates P7.p polarity, al-
though its exact role is unclear and may include multiple (e.g.,
positive and negative) functions.
In some contexts, the SH2/SH3 domain-containing adapter
protein Nck recruits Pak to activated RTKs (20, 21) and enables
Pak to be activated by Rho family GTPases (22, 23). We found
that mutations in the Nck adaptor protein homolog nck-1 sup-
pressed the P-Rvl phenotype of lin-17 (Table 1). Also, nck-1(ok383)
partially suppressed the VNS::SYS-1 localization defect in lin-17
mutants (Table 3).
egl-20, cam-1, pak-1, nck-1, and ced-10 Regulate Dauer Formation.
Next, we tested if pak-1, nck-1, and ced-10 mutants exhibit other
phenotypes associated with defects in Wnt signaling (also see SI
Materials and Methods and Tables S2–S7). Dauers are develop-
mentally arrested alternative stage 3 larvae of C. elegans formed
under stressful environmental conditions (24). Previous work found
that cam-1/Ror mutants exhibit the high temperature-induced
dauer (Hid) phenotype in which mutants form dauers constitutively
at 27 °C (25, 26). We found that egl-20/Wnt mutants also showed
this phenotype, indicating that dauer formation is regulated in part
by Wnt signaling. pak-1, ced-10, and nck-1 mutants all showed this
phenotype (Fig. 2 and Table S2). In contrast, a null mutant for
vang-1/Van Gogh, a Ror pathway component which regulates vulval
cell polarity, did not exhibit the Hid phenotype.
Table 2. egl-17::gfp expression in P7.p descendants
Genotype Normal egl-17::gfp (%)











ayIs4[egl-17::gfp] 100 22 0 0 0 0 0
lin-17(n671) ayIs4 38 9 11 2 22 7 2
lin-17 ayIs4; egl-20(n585) 100 21 0 0 0 0 0
lin-17 ayIs4; cam-1(gm122) 71 18 6 1 8 0 1
lin-17 ayIs4; pak-1(ok448) 64 22 10 2 11 2 3
lin-17 ayIs4; pak-1(tm403) 55 25 9 4 9 15 0
lin-17 ayIs4; nck-1(ok383) 56 7 7 2 2 3 4
lin-17 ayIs4; ced-10(n1993) 38 7* 1 0 7 6 0
lin-17 ayIs4; ced-10(n3417) 15 1 1 0 3 7 1
The expression of egl-17::gfp in P7.p descendants was scored in the mid-L4 stage using the ayIs4 transgene along with the P-Rvl phenotype (4, 9). Numbers
represent numbers of animals exhibiting each phenotype/expression pattern combination. Percentages represent animals that expressed egl-17::gfp in P7.pa
descendants but not in P7.pp descendants, regardless of the morphology (shaded in gray).
*All animals exhibiting wild-type morphology expressed egl-17::gfp in the wild-type pattern except for one lin-17 ayIs4; ced-10(n1993) mutant, which did not
express egl-17::gfp in any P7.p-derived cell.
Table 3. VNS::SYS-1 localization in P7.p daughters
Genotype
VNS::SYS-1
P valuesP7.pa > P7.pp P7.pa ≈ P7.pp P7.pa < P7.pp
qIs95[VNS::SYS-1] 12 0 0
pak-1(ok448); qIs95 10 0 0
pak-1(tm403); qIs95 7 0 0
lin-17(n671); qIs95 3 24 13
lin-17(n671); cam-1(gm122); qIs95 12 7 8 0.0186
lin-17(n671); pak-1(ok448); qIs95 12 16 5 0.0049
lin-17(n671); ced-10(n1993); qIs95 8 2 2 0.0040
lin-17(n671); nck-1(ok383); qIs95 4 2 1 0.0251
Localization of VNS::SYS-1 was determined using the qIs95 transgene (6, 34). Because the expression level is
low, we captured images using half-second exposures. P values are for comparisons with lin-17; qIs95 (Fisher’s
exact test) and calculated by excluding animals with similar VNS::SYS-1 levels (P7.pa ≈ P7.pp). Numbers represent
numbers of animals. See also Fig. S1.






Pak1 Negatively Regulates Canonical Wnt Signaling in HEK293T Cells.
We investigated whether Pak1 also regulates mammalian Wnt
signaling (Fig. 3). Wnt5a acts through Ror2 to antagonize ca-
nonical Wnt3a/Frizzled signaling (27). Expression of dominant-
negative Pak1 (dnPAK1; K299R) in HEK293T cells activated
the reporter for TCF-mediated transcription (TopFlash) (28),
indicating that Pak1 antagonizes canonical Wnt signaling (Fig.
3A). In both dnPak1-transfected cells and control (empty vector-
transfected) cells, Wnt3a increased the reporter expression. In
control cells, addition of Wnt5a to Wnt3a reduced reporter ex-
pression by 27% (SD = 10%) compared with Wnt3a alone. How-
ever, in dnPak1-transfected cells, addition of Wnt5a did not alter
reporter activation signiﬁcantly (average reduction, 5%; SD, 23%),
suggesting that dnPak1 blocked Wnt5a signaling. Also, constitu-
tively activated Pak1 (caPAK1; L107F) decreased the reporter ex-
pression (Fig. 3B), consistent with negative regulation of canonical
Wnt signaling by Pak1. We also found that both dnRac1 (T17N)
and caRac1 (Q61L) increased reporter expression, suggesting that
Rac1 regulates canonical Wnt signaling both positively and neg-
atively (Fig. S2).
To conﬁrm that the reporter assay reﬂects regulation of en-
dogenous Wnt-responsive genes, we measured the mRNA level
of the canonical Wnt pathway target, Axin2 (Fig. 3 C and D). As
expected, we found that dnPak1 increased and caPak1 decreased
the mRNA level of Axin2. Moreover, dnPak1 appeared to block
the inhibitory effect of Wnt5a. Together, these results indicate
that Pak1 can regulate canonical Wnt signaling negatively in
HEK293T cells.
Ror2 Overexpression Causes Pak1 Phosphorylation. We next tested
whether Pak1 is activated by Wnt5a or Ror2. Interaction of Pak
with GTP-bound GTPases leads to Pak autophosphorylation,
which converts Pak into the active form (29). We therefore used
anti–phospho-Pak antibodies to detect Pak1 activation. Because
we did not detect endogenous phosphorylated Pak in untreated
and Wnt5a-stimulated HEK293T cells, we overexpressed wild-
type Pak1 and examined the phosphorylation level (Fig. 4). We
found that overexpression of Ror2 dramatically increased the
level of phosphorylated Pak1 even though the total amount of
Pak1 was unaltered. Wnt5a had no obvious effect on Pak1 phos-
phorylation in cells with or without Ror2 overexpression, possibly
because Ror2 overexpression constitutively activates the pathway
and because the amount of Pak activated by Ror2 is small in cells
Fig. 2. pak-1, ced-10, and nck-1 regulate dauer formation. Each set of data
represents results of experiments carried out in parallel. As described (25), be-
cause of small temperature differences, the same strain may show different
frequencies of dauer formation in different experiments. However, cam-1,
pak-1, ced-10, nck-1, and egl-20 mutants always formed more dauers than
the wild type assayed at the same time (see also Table S2).
A B
C D
Fig. 3. Pak1 negatively regulates canonical Wnt signaling in HEK293T cells. (A and B) TopFlash reporter assays for activation of canonical Wnt signaling in
response to transfection of Pak1 expression plasmid and induction by Wnt3a and Wnt5a conditioned media. (A) (Left) Reporter expression in control cells and
in cells transfected with the dnPak1 plasmid. (Right) Same data normalized to reporter expression under Wnt3a stimulation. Wnt5a reduced reporter expression
in control vector-transfected cells (P = 0.0010, n = 8, Student’s t test) but not in dnPak1-transfected cells (P = 0.5091, n = 8). (B) Topﬂash reporter expression in
cells transfected with the caPak1 plasmid. (C) Axin2 mRNA levels in control, LiCl-treated (an activator of canonical Wnt signaling), dnPak1-, and caPak1-
transfected cells. (D) Axin2 mRNA levels in control and dnPak1-transfected cells induced by Wnt3a and Wnt5a conditioned media. Error bars represent SEM.
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with only endogenous Ror2. Alternatively, Wnt5a may signal
through Pak-independent mechanisms.
Discussion
pak-1 Regulates the Polarity of the P7.p Lineage. We investigated
the interaction of p21-activated kinase pak-1 with Wnt signaling
by studying the effect of pak-1 mutations on P7.p polarity during
C. elegans vulval development (Fig. 5A). We found that pak-1
mutations suppressed the P-Rvl phenotype of lin-17 mutants,
similar to previously reported suppression of lin-17 by cam-1 (6).
The P-Rvl phenotype was suppressed more strongly in the lin-17;
cam-1; pak-1 triple mutant than in lin-17; cam-1 and lin-17; pak-1
double mutants, demonstrating that cam-1 and pak-1 can act inde-
pendently of each other.
In the wild type, egl-17::gfp is expressed in P7.pa descendants
but not in P7.pp descendants (9). Both the cam-1 and pak-1(ok448)
mutations increased the frequency of the normal pattern of egl-17::
gfp expression in the lin-17–mutant background. Moreover, all lin-
17; cam-1 and lin-17; pak-1 double mutants with normal mor-
phology had the wild-type pattern of egl-17::gfp expression, sug-
gesting that these mutations suppressed the P-Rvl phenotype by
restoring normal cell-fate patterning and gene expression. The
frequencies of different classes of egl-17::gfp expression patterns
(normal, symmetric, reversed) generally were similar in lin-17;
pak-1 and lin-17; cam-1. However, there were some unexplained
differences, such as a higher frequency of the reversed pattern
(P7.pa−/P7.pp+) in lin-17; pak-1(tm403) mutants than in lin-17;
cam-1 and lin-17; pak-1(ok448) mutants.
cam-1 and pak-1 also affected the pattern of VNS::SYS-1 lo-
calization in the lin-17–mutant background. When the number of
animals with normal and reversed localization (excluding ani-
mals showing symmetric localization) was compared, both cam-1
and pak-1mutations increased the normal pattern of VNS::SYS-1
localization. However, the cam-1 mutation signiﬁcantly reduced
the number of animals with symmetric localization, but the pak-1
mutation did not. One possible interpretation is that the mech-
anism of VNS::SYS-1 localization has two genetically separable
components, one promoting asymmetric (vs. symmetric) locali-
zation of VNS::SYS-1 and one regulating the orientation of the
asymmetry. Under this model, wild-type cam-1 and pak-1 both
promote reversed orientation of VNS::SYS-1 asymmetry, and cam-1
(but not pak-1) promotes symmetric localization of VNS::SYS-1.
Although other interpretations are possible, these results do
indicate that cam-1 and pak-1(ok448) have different effects on
VNS::SYS-1 localization.
Together, these results demonstrate similarities as well as
differences in the effects of cam-1/Ror and pak-1/Pak on the
P7.p lineage. The similarities suggest that they may affect a
common process or function in the same pathway, a hypothesis
perhaps consistent with the interaction between Ror2 and Pak1
in HEK293T cells. On the other hand, the genetic interaction
between pak-1 and cam-1 demonstrates that they can function
independently to affect P7.p polarity, a conclusion supported by
differences in their phenotypes.
p21-Activated Kinase and Wnt Signaling in Mammalian Cells. In
HEK293T cells, activation or inactivation of Pak1 affected TCF-
mediated transcription in a manner consistent with negative
regulation of the canonical Wnt pathway by Pak1 (Fig. 5B). Ex-
pression of dnPak1 appeared to eliminate the inhibitory effect of
Wnt5a on canonicalWnt signaling, suggesting thatWnt5a signaling
requires Pak1. However, this result is difﬁcult to interpret, because
the baseline for comparison (activity in cells stimulated by Wnt3a
alone) is different for control and dnPak1-transfected cells, and we
saw no effect ofWnt5a on Pak1 phosphorylation. Finally, we found
that Ror2 overexpression in HEK293T cells induces Pak1 phos-
phorylation, suggesting that Pak1 can mediate the effect of Ror2
directly.
A recent report suggests that Rac1 acts through Pak1 to ac-
tivate canonical Wnt signaling through β-catenin phosphoryla-
tion (30). Positive regulation of canonical Wnt signaling by Pak2
has been reported also (31). Although contrary to our ﬁndings,
this result perhaps is not surprising, given that Rac1 acts posi-
tively in canonical Wnt signaling (32) and functions in both ca-
nonical and noncanonical Wnt signaling (Fig. S2) (10). Seemingly
contradictory results likely reﬂect the fact that these proteins can
act differently in different cell types and perhaps even in a same
cell. Pak is likely to function in different protein complexes and in
different subcellular compartments. Activation of different Wnt
pathways could affect different subpopulations of Pak proteins,
and these different subpopulations could act on different target
proteins, leading to different cellular effects.
Fig. 4. Increased phosphorylation of Pak1 in response to Ror2 overex-
pression. HEK293T cells were transfected with FLAG-tagged wild-type Pak1
and 0.05 or 0.2 μg of Ror2 expression plasmids. Two different anti–phospho-
Pak1 antibodies (Cell Signaling) that recognize different autophosphory-
lated residues (Thr423 or Ser199/204) were used to detect phosphorylated
Pak1. M2 anti-FLAG antibody (Sigma) was used to detect FLAG-Pak1. Trans-
fection with 0.2 μg of Ror2 expression plasmid increased Pak1 phosphoryla-
tion at T423, S199, and S204 residues but did not affect the amount of FLAG-
Pak1. caRac1 was included as a positive control.
A
B
Fig. 5. Pak interacts with Wnt signaling and regulates cell polarity and gene
expression. (A) In C. elegans, LIN-17 and LIN-18 promote and CAM-1 and
PAK-1 appear to inhibit normal P7.p polarity. CED-10 and NCK-1 may inter-
act with PAK-1 to regulate P7.p polarity. (B) In HEK293T cells, Ror2 overex-
pression activates Pak1, and Pak1 antagonizes canonical Wnt signaling. Pak1
may be required for the inhibitory effect of Wnt5a on canonical Wnt targets.
However, because we have not observed activation of Pak1 in response to
Wnt5a, it is unclear whether Pak1 is regulated by Wnt5a.







C. elegans strains were handled as described (33). Details are given in SI
Materials and Methods. HEK293T cells and mouse L cells were cultured in
DMEM supplemented with 10% (vol/vol) FBS and antibiotics. L cells that
express mouse Wnt3a and Wnt5a (CRL-2648, CRL-2647, and CRL-2814/vector
control) were obtained from the American Type Culture Collection. Condi-
tioned media were harvested from conﬂuent monolayers of Wnt3a/L,
Wnt5a/L, and control/L cells after 3 d of culture. HEK293T cells were plated
24 h before transfection and assayed 48 h after transfection. Wnt3a and
Wnt5a conditioned media were added to cells 24 h after transfection. See SI
Materials and Methods for details.
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